var title_f29_54_30560="MRI left occipit lobe infar";
var content_f29_54_30560=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F63481&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F63481&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    MRI left occipital lobe infarct",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Axial FLAIR MRI showing a left occipital lobe infarction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_54_30560=[""].join("\n");
var outline_f29_54_30560=null;
var title_f29_54_30561="Normal LV Ao pressure";
var content_f29_54_30561=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F66480&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F66480&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Normal left ventricular and aortic pressures",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 343px; height: 277px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal cardiac hemodynamics during cardiac catheterization wth a hi-fidelity catheter. One can see the relationships between the simultaneous ECG and pressure tracings from the aortic root (Ao) and left ventricle (LV).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Kern MJ (ed). Cardiac Catheterization Handbook, 2nd ed, Mosby-Year Book, St. Louis, 1995.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_54_30561=[""].join("\n");
var outline_f29_54_30561=null;
var title_f29_54_30562="Chronic actinic dermatitis";
var content_f29_54_30562=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F78558&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F78558&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chronic actinic dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An infiltrated eczematous eruption is present on the face of this patient with chronic actinic dermatitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Wolff K, Goldsmith LA, Katz S, et al. Fitzpatrick's Dermatology in General Medicine, 7th ed, McGraw-Hill Professional 2008. Copyright &copy; 2008 The McGraw-Hill Companies, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_54_30562=[""].join("\n");
var outline_f29_54_30562=null;
var title_f29_54_30563="EP study tracings RBB ablation for BBRVT";
var content_f29_54_30563=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F80017&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F80017&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 539px\">",
"   <div class=\"ttl\">",
"    Intracardiac and surface ECG tracings during radiofrequency catheter ablation of the right bundle branch in a patient with BBRVT",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 519px; height: 364px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFsAgcDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKK5PxH4C8P+ItVN9qukaZdXOxVMtxZRSsQM4G5hnj0oA6yivPpPhP4ROEHh7Q/mz8w0uD5f8Ax2nf8Ko8IqykeHdCbJwc6XBj/wBBoA7+ivP5fhN4PEbbfDmiE8cf2bD2/wCA0v8AwqbwioJHh7QmPXB0uDn/AMdoA7+iuBX4UeECAT4d0IErjH9lwcd/7tNX4T+EHUs3hzQ1YsTj+zIeOf8AdoA9AorgR8J/BxkyfDmiYXIx/ZkHPHX7tNT4TeDhKw/4R7RDyG502H34+7QB6BRXnx+E3g/zCv8AwjmiYK/e/s2Hrkf7NO/4VL4NVlx4c0U5bP8AyDoeB6fdoA7+ivP3+Evg4KQvh3RTyMf8S2Hj/wAdpG+Evg5BuHh3RW2jO3+zYfm/8doA9BorgT8JfBuJB/wjuh/MeP8AiWw8f+O0kfwl8HbCT4d0XLL302Hj/wAdoA7+iuA/4VL4NfJPhzRVJJ4GnQ4/9Boj+E3g0E58OaKSCME6dD7f7NAHf0VwI+E/g3zHH/CN6LtI/wCgbDwfb5aZJ8JfB3mDHhzRcMTnGnQ8en8NAHoNFefyfCXwYMFfDuigZAI/s6H6f3aWf4T+DQjNH4a0XcBwo06Hn/x2gDv6K4NfhL4LCsP+Ec0U57nToeP/AB2oh8JPBrxknw7o6Fh0/s6H5f8Ax2gD0GiuAj+Evg0oA3hzRQQTz/Z0OTz/ALtKPhP4OMuT4a0TYuAP+JdD831+WgDvqK4FfhN4NWfP/CN6KUx306Hr/wB80f8ACpPBgI/4pzRj6/8AEvh4/wDHaAO+orgT8JfBgxjw3opweQdPh5/8dpw+E/gxGLr4a0RvRTp0JH6rQB3lFcG3wm8FnP8AxTeijPpp0PH/AI7Sp8KfBm2Pd4Z0PKrj/kGw/r8vNAHd0VwX/CqPBcnP/CNaIoBIwNOh+n932pP+FS+DSzZ8OaKBxjGnQ+n+7QB31FcCPhJ4M3c+HNGwP+ofDz/47St8J/BnmJjw1ou0df8AiXw//E80Ad7RXBf8Kn8GrnHhvRW3cHOnQce4+Wj/AIVP4NQhh4a0VyP4Tp8GD/47QB3tFcG3wn8F+XIB4Z0UsTkH+z4ePYfLTB8JPBhAz4d0cH0/s+D/AOJoA7+iuAT4S+DWQb/Deiq3cDT4f/iaVPhN4NIG/wAN6KNrcY06H5hnv8tAHfUVwg+FPg0Ssf8AhGdD2kDrp0PB/wC+ajk+FPgwTQgeG9Fxg5/4l0POP+A0Ad/RXn8nwk8G5Gzw5o3Lc/8AEvh4H/fNK/wl8GhPl8N6MSO39nwDP/jtAHf0VwUnwm8GGP5fDei7gOMadDz/AOO0kfwl8GAKW8OaNu6kf2dDj/0GgDvqK4Q/CjwW2SfDWiA4wANOh9ev3ajj+E/g4hhJ4Z0QbSQpGnw5I9fu0Ad/RXAf8Kk8G7v+Rd0bb/2Dof8A4n6Uo+Evg0SA/wDCOaKV/wCwdD7f7P1oA76iuCT4T+DEBH/CN6I27gk6dBwPb5abJ8JvBvlgDw5ouQev9mw9z3+WgDv6K8/f4S+DFRmHh7RuBkf8S6H/AOJpIvhJ4OxuPh7RsnBwdNh49vu0Aeg0V58nwl8HtvLeHdEGScD+zIeBnj+H0qNfhF4QLSg+H9GAzgH+zoemB04+tAHotFec/wDCovCRnx/YGihAM5/s2Hk8jHSlk+EfhIuqr4f0UKcksNNh4xj2oA9ForzuT4S+EVKbfDuisC2D/wAS2Hgev3alT4T+EIWWRPD2il1II/4l0Iwc9fu0Ad/RRRQAUUUUAFFFFABRRRQAUUUUAFFFFABSBQGJA5PWlooAKKKKACiiigAooooAKKKKACiiigBCARzS0V5v8dNesvCPheDxLLevaapp83+gKoLC6dh81u690dQcn+HaGHKgEA9Iorwz9nv4y33xJ8Q6/Y6xb2lo8MaXNlBBnIiyVcMSfmIJj5wOp4Fe50AFFFFABRRRQAUVV1Ywrpd411cPbW4hcyTo+xol2nLBuxA5z2xXyT4Y/aK1hviBodhe3yTeFobg2stzLAsc9zGxKpNMckKVBViFwDg8c4AB9gUUUUAAAHTiiiigAooooAKKKKACiiigAooooAKQgZBIGR0NLXgnjb46ab8OPFGuaLcGfxDIJVngWGUD7KXB8y3kc/3WGVwDgPtONtAHvdFRWk8d1aw3EDbopUEiN6qRkGpaACiiigAooooAKKKKACiiigAIyMHpQBgYHSiigAooooAKK5m78TrpPimbTteNtZWE1ubmxvXfZG4Qfvo5GbhXXhx6qT/datbQdZ07xBpcWpaLeQ3tjKWVJ4TlWKsVOD9QRQBoUUUUAFFFFABRRXj37UF/b6d8PopzqU9hqH2yFbZobySBnBdRIMKw3fJnrnHXigD2GiqWiGzOi6edLm8/Tzbxm2l80y74to2NvYktkYO4kk9STV2gAoormPGl54stBaf8Ihpem6huLCf7ZcmHZ024wOc8/lQB09FeZjUPi1cZ8rQ/Cdnt7XF5LJu+mwcVF/a3xa09g1z4a8PauJxlUsr8wfZj6OZB82f9mgD1GivLpdO+Ini7/Q9ebTfDeiuClzHYTtNdTr3CyYAQHpkc0g03x34FQx6Aw8YaLnebfULry76LtsjkI2MuAD83Oc0AepUV5d/wmvxDkz5XwwlX0MmswChfFXxNvQIrX4e2lhIf+W17q8bxr9Qg3GgD1GivMnufi7b/AD/2f4NvA/8AAk88ZT2yQc00aj8XpGCDQfCUG7jzGvZnC+5AUGgD0+ivMW/4W/DtuD/wh1wI/vWkbTqZfo5HBH5cUw3nxc1A/Z00rwxpAbrdvcyTlfogHJ+tAHqNFeWL4G8VeGmbVPCniOTUtWnO69s9ZlY2lw55Z0CgmI56AcY4oPjvx+ibG+Ft28yjDMuqwbCw67e+PSgD1OivK18e+Psqr/Cu93N0I1aDA+vpViOf4uXSicWXg6wHUW0088r4z0ZlGPyoA9IuJ4raB5rmWOGFBlpJGCqo9ST0qQHIyOleat4T8WeK7gR+PtQ0lNDHEukaZG7R3Q6gySPhhzj5RxxUCXPjnwcn9l6Z4ZTXtBsOILkX6rcyQ9kCt1dRxknkAd6APUao63pGn67pk2n6xZQXtlMMPDOgZT+ff0PavPB8T9efJi+GXiwr/trEh/ItSr4s+ImuN5Oh+B4tGHe71y7XaB2xHHlietAHJ6P8D5/APxQ0nxP4FuDLpPmmG8024f544ZBtYo5++FzuwcH5erHivc7K/tL43AsrqC4NvKYZhE4by5B1VsdCPQ15xNafFbVf+JZfXXhrS7KX5ZtS04yvcKh4IjRxgN/tHp1qW68Kan4H8i8+HGm296zxLb31jc3Hlm5K/dn8w/8ALTkgk9d3tQB6XRXlx+JXiWIBLj4ZeJTMnEvkvE6ZHXYd3zCkbxj448SP9i8NeDLvQ2YZfUdeKrHEPaNCWcnp7d6APUqK8xGo/Fu2P77QfCl8o4zb3ssZPv8AMMe9RnV/i6TlfC/hcA9A2ovkfXigD1KvJfiT8BfCHjTzbmC3/sXVnyftVkgCu3q8f3W9yME+tW11H4vvg/2D4Qiz/evpmI/Jaka4+LpOFsfBIB4yZ7k7ffpzQB0nhaeTQdG0HQvE+q2UuutEYI2WTBu/LGN4Dc7ioBYc4JPJrp685tvh3calYXt34t1L7d4mudrRXkC7EsChyi24xkANySeWyc1THir4mWQ3Xvw/tr1G+RFs9UjV1I/ifdxtPUY5HegD1KivLB43+I2cH4Wy7u3/ABOoMfnilC/FfxCBJ5mh+EbZuPK2/brke5P+r/KgD1KivLl/4W3pB+yRJ4a8QQp9y+uHe0lcf7SKCoI9qUat8XTgf8Iz4WBHVjqEmD9Plz+dAHqFFeYpe/F5x/yCPBsR9Gu52x+QoDfGBzv8rwTHn+AvcnH44oA9OorzAwfGCYkm78F247BUuH/mKFtfjCq4N/4KY4xuMdwM+/SgD0+ivMVs/i9tGdU8HZPX9zPx9OOaadM+Lssflv4h8K25znzorKR2+m1uKAPUK+cfjx+z5Dr7XPiDwPFHb6uxMlxYZCx3JPJZD0Vye33T7Hr3o0/4u2f78a54Y1IxdLZ7R4BOPdxnafpmg6r8XsZHhrwqBnhTqEmcf984oA3fgxe3F98LfDbX0MsN5BaLZzxyqVdZISYmDA8g5Q5FdpXAeHfF+rWGsx6J8Q4LDT9RuzusLm0dja3PcxKW5Ei9weuciquqr4n8aancyeFPE/8AYOi2UhtRLHZx3DXkg++yljwqn5RjqQ3tQB6TSbhuC5GT2rzBPh/4zmJW++J+rmPHS2sYIm/76wajPwQ8POnnXGp+IZ9WHK6i+pSeaj/3gAdvXtjFAHqlV9RvbfTrGe8vZkhtYEMkkjnAVQMk15ulh8UvD4eDT9R0PxNZr/qpNSD29yB6MUG1vTPFS2vh3xZ4t1C3PxDXSrbR7ORZo9O02V3F1KpyrSsw+4p/h7kc0Adv4Z1yz8R6Lb6pppk+zTgkLKhR1IOCGU8g+xrUrz7xD4m0v4ea5eTat9oSy1bE9uIIXlMlyow8agZ+ZhtI6A81QHxZuJSRZ/D/AMaTYXdzYqn06vQB6hRXlbfEbxhd4TSPhhrZkbo1/cxWyj65Jp39rfF6fDw+GfC1qpHKXOoSOwP1QYoA9Sory37d8YmBH9j+DEJHDfa5zj9KkW6+L6D5tO8GSE+lxONv14oA9OorzF1+L93lA3g7TwefMHnyke2CMVGU+MGnYl8zwnrGfkMAEtvtH9/djk+ooA539qL4feLPG+j2Unhu6S4srHMsmk42NLJz+8Vs4ZgpwFOO+CScVj/sZ6xOvh7xB4X1BJIbvTLsTiGZSjosgwy7TyMMhJ93ruhq/wAXgefC/hcj21GTP8qq2GravoHi+DXPiD4e0XS01CP7CurWE7N5GSuyK5J4YMwAVuinIyAaAPXKK4bxXPrXiDWxofhLXE0h7ONbi+uxbLcff+5EA2ACRls+mKzV8E+OZHH2r4l3fldxBpcCE/jzigD0uiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoorA8M32oXd5qw1Dy/IW4Js9q4Jh5HPqdytQBv0UUUAFFFFABRRRQAUVzni25v0n02LTZDGUkN3cEfxQx43J/wIso/OujoAKKKKACiiigAooooAKKKKACiiigAooooAyvE3h3SfE+lvp2vWMN7aMc7JVztPZgeoPuKt6Vp1ppOnW1hptvHbWdugjiijGFRR2FWqKACiiigAooooAa8aOULorFDlSRnB9RTqKKACiiigAooooAKKKKACq2pWFpqlhPZajbxXNpOhSWGVQyup7EVZooAxPCPhfSvCWlnT9EgaG3MjSHe5dmJ9WPJwOB6AAVt0UUAFFFFABWR4j8S6J4aghm8QarZ6bFMxSN7mURhyBkgZrXrzb4/aPrfiHwIdJ8O6TLqV1PdQyNsmiiEaxyK5JMjLnOMDGaAOlt/HfhW51W20yDxBpkmoXKxvDbrcKXkDoHQgdTlWDD2IrpK8oax8SXXxx0nxE/hi8g0lNG+wSzPdWx8qR2EhyokLEKSUOAckZGRg16vQAUUVQ16wl1TRryxt7640+aeMot1bkCSIn+Jc96AFu9X06z1C1sLq+tob27z5EEkoV5cddqnk1erzyy+Enhz+zriLXftevahcEF9S1GUyXKkfd8t+qBTyMdz3rL/AOFc+L9FwPCXxD1Pym4aHWoxehR22scEGgD06a/tYb+3spZ0W7uFd4oifmcLjcR9MirJOBk9K850fQb/AMMRSeIPGviCLVb2ORd95JEII7W3wQVUDoCSCSetbPi0p4k0nT9K06+dLbWSGe4tnwWtQA77T23rhc+jGgDX1TxLoelWzXGpaxp9tCo3FpbhF49uea4O4+M2nSTu+heG/E2u6YnDahp9gzQk9wu7BbHqBWxpnwj8A6Zcxz2nhXTRLGdytIhl2n2Dk13KKqIqIoVFGAAMACgDJ8L+I9L8UaVHqGjXIngbhgRteNu6up5Vh6Gp9e1rTfD+myahrV7BY2aEBpZn2rk9B7n2rlPFXwy0vW9Vk1bT7/VfD+rzYE95pFybd7gDgeYBw2B361U0D4S6PYahHfa5qOreJ7mEEQf23cfaUhz3VCMbuvNAHfaffWuo2kd1YXMNzbSDKSwuHVh7EUzVdRs9JsZLzUrhLe1jIDSOeBkgD8yQK8+1X4P6QLh7zwjqOp+FL9m379LmKwsc/wAUJ+UjrxwOabo/w6143iP4u8aXfiKxjDMljLaRxRmTBCs23k4ySB0zj0oA9OrNv9f0fTnkS/1WwtnjG51muEQqPUgnisLSPGWl3Hhi/uLG7S7udIX7NdxDIZLhQB5ZyOpbjiszTvhL4TaBLjX9FstW1iUmW6vLtPMeWVjlic9snAHQACgCDU/i5pL3ZsvCOn6l4svF5caTHvhjH+1KcLn6E1oeEviNZ61qf9k6tpuoeHtbYbo7LU0CGcdzEwOHx3A59q7DTtPs9MtEtdNtLe0tk+7FBGI0H0A4rP8AFXhjR/Fem/YdesY7qFW3xluHibsyMOVPuKAGy+IETxfBoSW0she2aeS4XBSJs/Kje7AOR7L71t1ww8CxaF4Vm0vwez21xNcCZ7meVnkyQFZt55JC9KwmkuvHUa+FbfV9U0ufR/l1e6tCY5fNXiJFkIwd2PMOM5AA70AerVxOvfFTwToOqHT9U8RWcV2v30XdJ5f+8VBC/jWAnwmv79gnijx94l1az/itUlFtHIPR9nLA9/Wu70HwpoPh/TDp2jaRZWlk33oo4hh/97PLH3OaAIda8V6Rp/hs6ut/bz20wC2phkDfaJG4REx94kkDinaWP7NuNLsbgqJ5bMqec5dMFv8A0ImsvSPhj4O0fX11nTNBtLe/Qlo2XOyNj1ZEJ2qT0yAK1PGcGotpa3mg28Vzq9lIJ7eGVggl7PHuP3dyk8+uKAN6ivLx8TNetfk1T4b+JYpV4Y23lzoT/skNyPemn4i+KwpV/hxrEcl1xYMZ42RmP3RNg/uu5Oew9aAPUqbJIkYBkdVB/vHFeXRfCl9fb+0fiBrmpalqknPkWdy9va2w/uRoDnHqScmrCfA/wAebjRHuie893M3/ALPQB6CdRsgxU3lsGHBHmrkfrRJqNlHCZZLy2WJRku0qhQPrmuEHwS+HOMf8IpZf99Sf/FUJ8E/h0jqw8K2fynIBeQjPuC2D+NAG1omrWPiu41m50p/tNlCosorlP9XK4BZ9jdwCVGRxlTWz4c1MaxolnfCGaBpUy0Uy7XRhwQR65Bq1p9la6bZQ2en28NraQrsjhhQIiD0AHArg9bk8W+FdcvZ/D2jN4k0nUGEwthcxwPZS4w2C3DI2AcdQc+tAHolFeYf8LH8TwDbf/DLxEkn/AE7zQzKT9Q1Qnw1458ZyLc+I9dfw7otxy+i6cB54j/uSXHqw+9t6ZxQB6hFcQzFhFNHIVJUhWBwR1BqR2VFLOwVRySTgCvN5Pgf8PyF8rQRA6jHmQ3EqMfckNyfemf8ACj/AbupudKnuQP4Z7yZ1/LdQB283iTQ4QTNrOmRgHB33UY5/Oom8WeHFTe2v6QE/vG8jx/6FXOxfB/4fRgBfCWlHAx80W7+dSL8JfACtuHhHRs+9spH5UAb8Xirw9KwWLXtJdjwAt5GT/Orcer6bJGXj1CzdB/Es6kfnmuUf4R+AHGG8I6OB1+W3A/lVV/gr8OncMfClhkc8FwPyDUAdkNc0k9NUsD9LhP8AGsbxP8QvC3hmGCTV9YtkE7YjWI+axHc4XJwByTWQfgz8OyuP+ET07Gc9G/xrb8M+AfCvhe4nn0DQbGxmmXZJJHH8xX+7k5wPagDb07U7HU7aG40+7guYJkDxvFIGDKe4xVokKCWIAHJJ7V5zqnwX8EXk09zZ6W+k6jIxcXmmzvBJG3quDtH5VUi+CmiO23U9d8VanbE5a2vNUdo29cgYOD9aAPToJ4bhN9vLHKmcbkYMM+nFUNY8QaNopQaxq2n2DOCyC6uUiLAdSNxGa5TSrDw58NL+S2tpLTRtEvYTKkUspWNZo/vEFj1KkEj/AGabpHhTQvGLS+JfEWl2mqyXr7rL7ZCJBBbKcRhAw43YMh93oA0NQ+J3gjT7bz7nxVo/l/8ATO5WVj9FXJP4CuZf4rapcv8A2ho3gbXb7wzHky6gVWOR1HV4oSdzKOvuK7TTfA/hXS7r7Tp3hvR7a47SRWcasPoQOK6KgDB8NeL9A8SWK3Wjara3CYy6eYFkjPcOh5U/UVHovjfwzrerz6XpOu6fd6hCSrwRTAtx1wP4sdyM1n+I/hh4K8R3z3useHbGe7k5eZVMbv8A7xQgn8aXWfCelaVpFveeHfD9n/aGkBZbKO2iSOQqp+aJW7bl3LycHPNAHY1yWqfEnwXpgl+2+KNIQxHa6rcq7A+mFJNZuteJrrX4NP0fw/p16ZdWtxJd3LERf2bCxwS+TnzCA4CjnIz0rZ0nwD4S0gxtp3hrR4JI/uyLZx7x77sZz70AcnP8atFnkKeHNG8R+ICD/rNP09zGQOpDtgV0vgv4g6D4tLw2U8tpqUf+u06+jMFzF9Ub+YzXWABQAoAA4AHaub8X+BfDXjARHxDpMF3LF/q5uUkT6OpB/DNAHS0V5g3wM8DMRvsbxgOgN9Kcf+PUh+BngoDENtqEGf8Annfyj8etAHb654p0LQbq0ttZ1aysri7cJBHPKFZz7A9vfpWwCGAKkEHkEd64bRPhR4N0m2u4V0aG9a6QxzTX5NxIyf3dz5IH0xWJN8GbKxdpfCPiXxF4emPGLe8aWLb/AHdj8YHGOeMUAeq0V5P/AMKs8Rt/rPil4pOeuzYv5ela3hnwRY+Btes7nT77UZzqAa2vZb26MrTyY3I5z/Fw449aAO8urq3tI/Mup4oEzjdI4UZ+pqhc+I9EtUL3OsadCo6l7lF/ma5jWfDOlePPElyPENomoaRpYENvA7ExNOwy74B5KjC89MmlsvhD4AspVlg8KaXvU5BePfg/8CJoA7uiiigAooooAKKKKACiiigAooooAr39lbajZy2l/bxXNrMu2SKVQyuPQg9a5vwp4C0jwvrF7f6U94BcAhLaWcvDbAtuYRKfuAnHA9K6yigAooooAKKKKACiiigDk9T8A6Hf+JrHXDFNb3lqwYrbSmOKfDFh5qDh8Md3PeusoooAKKKKACkCqrMQoBbkkDrS0UAFFFFABRRWF4c1W+1G/wBXjvLaKK3t59lpIhP76PoWOe+4MPwoA3aKKKACiiigAooooAKK5zxhf3ls2nQaa7LM03ny4XOYY8FwfqSq/jXR0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAZXiLw5o/iS2ht9f0211CCGUTRx3EYcK474P1rTjRY0VI1CooAVVGAAOwp1FABRRRQAUUUUAZeiaNFpU2oypNJK97cNcMXx8gPRB/sjnH1rUoooAKKKKACiiigAooooAKyfFOgWPifRJ9K1VZGtZtpJikMbqykEMrDkEEDmtaigDJ8K+HtN8LaHb6TosLQ2UG4qrOXYliSzFiSSSSTWtRRQAUUUUAFZXiPxDpnhuyju9ZuTbwSSCFCI3kLOVLYCqCTwrHp2Natch8R/CFx4wstPgttWOni1ufPkjeEzQ3K7SNkiB03DnI5xkcg0ARWvxI0O78SaTpdtIZbbVbGW+s9RUjyJRExEkeeodQCSCOAPXiuWb44ae7aStn4f1W4fU7V723UyQRZhWVo9xMjqOSuQPQiq+o/BBbr4a6D4Yh8QyWt/pE9xJFqkNrhik7SGSPZv4BWQD738I+ldDd/CjRLzxbo2p3kFld6VpekDSYdLu7NZkwGysmWOAQOMbfxoA9AtZTPbRStG0ZkQMUYglcjODjjj2qSkRVRVVFCqowABgAUtAGR4h8R6V4dWzfWrtLOG6mFvHNLkRhyCQGboucYycDNaVtcQ3UQktpo5ozyGjYMD+IqLU9Ps9VsZrLU7WC7tJlKyQzoHRh6EGvPbv4K+FDI0mknVdFkbr/ZuoSxKB6BMlQPoKAO6udbsrfXrPR5Hb7ddRPNGoXICrjJY9s549cH0q3f3ltp9lPeX08dvawIZJJZG2qijqSa4rSfCejfD7TZr6K6uXHnJLeX2pXJmk8sAry7dFG7OPrWjrcum+J20XTlaK9069xfOFOVkiTDIT6qW29euKAOXuPjp4NMWNKk1PVbps+XbWdhMzufTlQB+JpYvE3xO1BRqOn+C9Nt9Ob7ljf3pjvGH94kfImf7pGRXpkNrbwHMEEUZ9UQD+VTUAch4Q8f6T4gtnS6caRq8B2XWl30ixzwN7g4yp6hhwQaXxX8Q/Dnhq0SW6vlu55DtitLH/SJ5D/souTj36Va8U+BfDHit1k8Q6HYX0yjas0sQ8wD03DnHtmjwx4F8L+FriSfw/oVhYXDja0sUQ3kem4849qAHeF/G3hzxRbJNomr2lwzEKYfMCyo391kPzA+xFXfE+u2fhzSX1DUC3kq6RhU5Z2ZgoCjuec/QGsTxL8NPCHiS4a51PQ7X7aRj7XADDMPfemDn3qjoPwo8NaHqS6hbR6hdXMasIhe3slwiFgQSFckA4J596AO9BDAFSCDyCO9ec658ZPCukard6cx1O8urZzG32OxkmQuOqBgMEg8fWtCw8Z6ZP4WvV0u9in1HTsae8IzlbrhFTB6/MR0966jQtLt9G0m2sLSNUihQA7Rjc38TH3JySfU0AecQeLfHvjCMyeD/AA5BoVhnAvfEIYPJ/uQpyB7k1csPHuqeHdRt9M+J1lZ6Y0/y2+sWjsbGdv7rFuYm9Nx5r0qq2o2FpqVnJaajawXdrIMPDPGHRvqDwaAOcsPGMWq+LU07Rlgv9JSE/aNRgnDpHORuSIY4JKhicHjj1ro9S1Cz0y0a61K6gtLZSA0s8gRRk4HJ4rndY8Of2f4XfT/BVlY6ZL5oeMQosSoTwzgAY3BScfQVgaZpt/4wvorDxjojjS9FUxML0B49SuMbRMF6MgXkEj7z/wCzQB0+s+OfC2jWjXOpeIdKgiVd3N0hZh7KDk/hXDv8ZZJt13pPgXxXqGhqcf2hFabQw/vLGfmI9+K67Svht4L0mfztP8L6RDNnIf7KrEH2JBx+FdYAFACgADgAdqAPObv4weFJtISXRdQ/tLU7k+Vb6bbqTdGQ8ANH95MHqSABXR2Df2Ne6LYXA+e6tWiLjOPNQbyM++XI+la1vo+mW2oSX9vp9nFeyjD3CQqsjfVgMmqXjLR7rW9Dkt9Nvjp2pRus1pdhN/lSqcgle4PII7gmgDborygaN8YrYBYvFHhi9A433Fi8RI9cICM0v9lfFnSH32mu6Hrn2ziVLuAwCyc/xRlcl0A/hNAHea74r8P+H3VNc1vTdPdhkLc3KRsR9Cc1hTfFjwDCuW8XaKR/sXSt/Kk8O/DLw7pkTy6paRa7q0533OpanEs00zf8CBCj0UYArfj8K+HojmPQdJQ/7NnGP6UAcwPjL8PC5X/hLNNyBnO44/PFSv8AF74frGX/AOEs0pgF3YWbLH2A659utdV/Yek4x/Zdjj/r3T/Co18N6GsgkXRtMEg6MLVAfzxQBz/hPWoPHK6lqlpZ3lvp/lfY7WW7iaIzA5Z3VTghc7R/wE1u+E726vtEhbUkij1GImC5SI5VZFODj68H8a2AMDA6V5/4r8HeIn1ybVPA3iSPQ5bxR9uhntBcxTOvCyBSflbHBI6gCgD0CmyyJDG0krqkaDczMcAD1JrywaZ8Y7dh5eveErxR3ntZYif++Qadb/CT+051u/G3iXWdbmlO+6sxcNDZSN2URL/AOmM896AOgl+KfgSK7ktpPFuirNGSrA3S4BHUZzj9ajn+LHgGGMu3i7RWAGcJdKx/IGty38JeHLe1jtoNB0lLeMBVjFpHgAe2KdF4W8PwuHi0LSkccbls4wf5UAcVJ8dPAKZ2arcTc4/c2M7/AI8J0pD8dfAXlbxqV2W/uCwn3flsr0eOytY8eXbQJgY+WMDj0pRZ2ytuFvCG65CDNAHnMPxz8Aufn1eWAes9nNGB9SV4q3H8Z/h68bOPFWnrjszFSfoCK7iXTrKZSJbO2kB6holOf0qu+gaO7h30nT2cdGNshI/SgDi0+Nvw7dgo8UWYOM8hgP5VV1L41eHCI18LQah4quSC8sOkQNI0EY6u5OAPYd6786HpJznTLE5OebdP8KsWWn2ViXNlaW9uX+95Mapu+uBzQBy2kfE/wVqsUTW/iXTIpXAJguLhYZYz/dZGIKsDwQau3/j7wjYWzXF34n0WOJep+2xk/gAcmptT8GeGNVkkk1Hw9pNzJJku8tnGzNnrk4yaq2Xw78GWNytxaeFdDhmUYV1sowR+OKALvhTxZoXi21nufDmpQX8ML+XI0R+62M8g81meKviV4Q8KagLHXtds7W82hjCWLOoPTcFzjPvVTxZaa3oV7De+A9A0+7ubqM21xHJKLaOMg5SV8D5gPmBA5weDWl4T8IWelaUP7StrO81e6Y3F/dtCpM07csckZ2joo7ACgDnJvjj4ASLfBrn2tz92K2t5JHb6KFzVE/FLxHdQNqOkfDbXbnRY+XnnlSCd1/vRwEbm/MZr06DTLC3kD29laxOOAyRKpH4gVboA8zsfjf4Hmi/4mGpTaRcquXttRtpIZFPpyME/Q1oeDPidpXinWn02Oy1TT5JFMtjJf2zQpfRjq8RPX6HnHNdld6bY3jBruytp29ZYlY/qKy/GEccGjf2gLcyyaY63kaxrlwqffCj1Kbhgdc0Aa2oXkGn2NxeXkgitreNpZHPRVAyTXl0PxV8Q3xA0v4YeJ5A/Mb3W23Rh2JJziuhv7dPHGraU8F/OPD1tFHfSwx8Jfs+GjV89UXbuI7k4NdxQB5gNV+LV8vmW/h3wxpankRXt7JO4HoTHgZo034qx6Xff2X8SrD/hFtSxmOeWTfZ3I9Y5ugPqp5Fen1W1DT7PUoPJ1G0t7uHOdk8ayLn6EUAc0PiZ4HK7v+Eu0LGM5+3R/wCNOi+JPgmUny/FmhNjji+j/wAatr4I8KqxYeGtFyev+gxf/E0x/AnhJyS/hjRWz62Mf+FAGBrPxh8IabfQ20N+2pK2Gnn05DcQ2qH+OV0yFH/6663TvEuhakqtp2s6bdKwyPJukfI/A0/SvD+j6TaTWul6XY2dtNnzYoIFRHzx8wAweprmNT+EfgTUSzS+GdOhkY5MltH5DH8UxQB1r6rpyEh7+0UjkgzKP61W0fxHomtXNxb6Pq9hfT24BljtrhJGQHoSAeK45Pgl8Pl27vDsMmP78sjZ+vzc1Lruj6N4AitNe8PeGSEtWMFxbaPaqJZIpMDO0Y37WCnk9CaAOt13xFovh9I31zVrHT1kOEN1Ose76ZPNYs3xN8Dwqxk8W6GMDOBexk/kDk1neHvC0PiWafxH438P2o1O7URwWV2FuPscA+6vIwGb7zY7nHaugg8FeFrdg0PhzRkYHIK2UeQfX7tAHQUUUUAFFFFABRRRQAUUUUAFFFFAFfULK21GzmtL6CO4tZl2yRSLuVh6EVieFvBeheFrzULrRLP7PLfPvl/eMwHJO1QSdq5JOBgV0dFABRRRQAUUUUAFFFFAHPXfgvw/deJ7HxDNpkJ1ezDCGdcrjOckqDhjycEgkZroaKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKRGV1DIwZT0IORQAtFFFABRRRQAUUUUAFFFFABRRRQAUVV1bULfStMur+9cpbW0TSyEDJ2qMnA7n270zRdTtda0m01Kwcva3UayxkjBwR0I7EdCD0PFAF2iiigAooooAxvDWiDRI75FnMqz3LzRgrgRIxyIx7Dn862a52bxnokXi2Hw410Tqci5wqExo2CQjP0VyASFPJAroqACiiigAooooAKKKKACiikdlRGd2CooySTgAUALRWP4W8Raf4n0w3+lPI0AleI+YhRgVOOh7Hgg9wQa2KACiiigArhfip4p1HwcmgarCsDaI2ox2uqmRTuihkO1ZQc8BWxnrnIruqzvEOi6d4i0W70nWrZbrT7pNk0LEqGGc9QQQcgHIOeKAPKtU+Inidvhr4r8YaLBpUlla300enG43gNaREoZvlzvZpAcLlRjv2PrGhXUl9omn3c23zZ7eOV9owMsoJx+dYuo+AvDeoeEbTwvc2DjQrUKsdrDdTRDCggBmRwzDk5DE5PJyea2dB0iz0LSbfTdNSVLO3BWNZZ3mYAknG9yWPXjJ4HA4AoAv0UUUAcj4m+IXh7wrqkln4lvDpi+Ss0U86ny5xkhlQjOWXjI68iubPxl07UUDeENB1/xIi/62Sys2VIj2BZscn2r0m8sLS9MRvLW3uDE26Myxh9h9RkcGrIGBgdKAOJ8KfEG21i6ks9Y0vUPDl8AHig1VREZ1JxmM5w2CQCOvIqLxj411fT9X/srwn4XufEN6iB55FnWGC3J6K7nPzEDO0diK3vFvhLQ/F1nFbeINPivEhLNEWyGiYjG5SOhwf5Uvg7wrpPg/R/7N0OBorcuZXLyNI8jnGWZick8D8qAODfxt8S0yx+GSsn91dXj3fypyfEPxrp7iXxD8NdQj0/q8unXkd3JGP8ArmME/hXq1FAHl/8Awu3wzIwSzsvEN4/dbfS5WK+ueB0qSH4x6M1ygutH8R6fYAgT6hfae0Nvb5+6XY9ATxXplRXVtBeW0lvdwxT28g2vFKgZWHoQeCKAPOr341eDfONpod7N4g1RuIrHS4HmklPscbfqc0ad8U5G1C2h1zwf4j0O0mkERvr2ACCJm4XewPGTgZ9SK9AsdOsrCNY7GztraNeAsMSoB+AFLqdha6pp1zYajAlxZ3EZilicZDqRgg0AYPi7xbFoekW91ptlNrl5dvstLOxZWefH3iD02qOSe1cZ/wAJ58SFG5vhZKwIyAurw5GexyOtdT4P+G/hrwhqt1qGh2TwzzJ5aq8rOkCdSsYJ+UE4Jx1xXY0AeTDx98RQDJJ8KrkRqRuVdWhZyPYY5qx/wu3w3akW+t2et6TqnewurB/Nz/s4BBHoe9eo0m0bg2Bkd6AOR8MfEXw34iUi1vTa3AnW3+zXyG3lLsCVAVuTkA4x6VS8WeNdVg1qTQvBvh+XWtUjC/aJ5JBFaWZYZUSP1JxztXnGPWtbxb4V03VZV1g6Zb3OvWMLCymfhlOQwUHoMkYz2yfervhG1uLbRIZNRgjg1K6JubtIzkCV+SM98cL9FFAHFZ+L39zwgf8Agc3H6VG3jnxh4ZkDeOvCSvpuMtqOhStcrF/vxEBgOnI4r1KigDznSvjL4Q1HUYLT7ReWYuHEcNxeWrwwyOTgKHYYyffFdl4n1caHolzfCBrmZQEgt0OGnlY7UjHuzED9asavpllrGm3FhqdtHc2c6FJIpBkEH+R9+1YFhatNN4ftGJaDTo3dw3zbmT91GSfX7x+tAHLt4H8d6tGZdW+It5ZC4+aaysLGFVhB5MaSH5uOm7qcZoT4f+MNCH/FKePbo20HFtp+q2qXEe3+60nDnvz1r1OigDy1PiH4m0Jms/FvgbWbi5iwPtuhQ/a7ecf3gOGT6Gnp8ZtJJIm8N+MYCP8Anro8g/rXp9FAHmR+M+gcBNJ8TyMeAq6TJk0g+M+hqpafRPFdug+80ukSAL9a9OooAxfCnijSPFemm+0K8S5iR/LkXo8TjqjqeVb2Ncvr48S+LtXvbLwxrsnh3T9NcQy3a2qTPdTYyyqH4CoMAnuT7V0VzHa6PquoXVvFFBNe2rTSFVA8x4uNx9ThwM+g9qu+GtLTRtDtLKNnYxpl3c5Z3PLEn1JJoA8+b4YeIr8BNe+JXiC6tz9+K1jjtNw9NyDP5UHSPE/w2T/ik7c6/wCE4zk6Q7k3ltk5dopGJ8wZydh55ODXqlFAHlcnxW1O4VX0b4deLbyJsYea3FuD6/ePahfinrcbf6Z8M/F0YBGTFCs35YPNeqUUAeWp8YoSCG8EeOllHVP7Hbp65zTl+Ljk8/D/AMe5PIxpBPHb+KvUKKAPLl+LrPxF4B8eM3odII/9mpT8W5Rz/wAK+8eYH3s6SRj6c816hRQB5cPi9vB8nwF48kx6aQcf+hU1fi/5Trcar4N8UaTosfN1qV/ZmOO2U/dYryWBOAcdM16nSMoZSrAFSMEHkEUAeWN8ZrDUEKeE/DniPXbiTBtzFZNFDOO7CV+Ao9SKjX4leM1P774U62q5x8l7E5/lXq4AUAKAAOAB2paAPMtP1lPiXqljDam/sNO0iRLnVLSaIxu1yDlLZ89lILNjIOF9am1bxho/w21W8s/EEt1Dp99I17ZypbtJGpc/vI8qDg78tj/b9q9GVVUsVUDccnA6mloA8wh+O/w9eRUl1w24bo01tKqn8dtdtpPinQdY0qTUtM1mwudPiBMlxHOpSMDruOfl/GtS4toLlNlzDFMn92RAw/WuI1T4ReA9U1RdQu/Ddl9oByRFuiR/TcikKfxFAGbefF+wuLqWLwloOueKYojtku9Mtt1uG9BIeGP0pkHxcjit5rPWdAv9K8Uv/wAeOizkNJe7uE8twNvJ+9/dwc16TYWVrp9pFa2FvFbW0Q2pFEgRVHsBT5baCWaGaWGN5YSTG7ICyZGDtPbI9KAORh0GaLwhczvYW8evzuNUmSH5gbsYcKG6nG0ID6VU074weAb5kRfE+nQzNgGO4fyip/uncAMjpXfVkaj4Y0HUlddQ0XTbkP8Ae821Rs/iRQBp288NzAk9tLHNDINySRsGVh6gjg1xXi34k6dompNpOlWN/wCIddQbpLDS4/NaEesrdE/HmsO++CHh8zSPoWq+IPD8cp/eW+mX7RwkHr8pzjPtXceEPCejeENMFjoNklvETukcndJK3dnc8sfc0AcJ/wALU8Qr/rPhd4rHptVG/rTx8VtXJx/wrTxh/wCAw/xr1WigDypfi5PZSC58TeDde0LRD8n266jDHzT91DGuWAPOG6Z4ol+LV7qK7fCHgTxLq0g+ZnuYBZRbOzK7/ez6V6qQD15ooA8l/wCFkeOU4l+E+rZ4zs1GJv6UP4qb4kInhIWeq6BqL/PrVvNGQ9vbD+APjBEv3Qw7buK9apoRBIXCKHIwWxyR6ZoA8+8Ta/o3w31z+0tZuJbTR9SiSAFYmkRJohhR8oJGU4/4DVWH46/DyWVEOviPf0aS2lVfzK16W6K67XVWHoRmo5bW3mQrNBFIp6h0BFAE1FFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB4B4e+LPiPUfio/h1JNNnQeILzTDY/Y5I3S0hyfPE5fYzDoUxnjP8AEK1vhl4+8VeKPHV/Z3oC6Ra6jd2h8nR5vLKx7gubrfsVs7cgjnp3Fd0/w28KNN539lYnGqPrQlW5lV1u3xvkDBsgHauVB28Ditrw74e0vw5Bdw6Na/Zoru6kvJh5jPumc5dvmJxnHQcegoA4HxH4o8S6h461/QPDd7p+lRaFp0d7JLd2xnN1I4LBfvLtjAGCwyc1yS/G3VzqHhO/k0yBfD93o41LV1VGMlspuPIaVDnlFYo2ME7cmvWvFHgTw34ovEu9b00T3SxGAyxzyQs8ROTG5jZd6Z/hbI9qmfwZ4ea6FwdKg3jTW0cICwjFoSCYtgO3GQO2e2cUAZ3wg8R3vi74b6JruqiEXt5G7yCFSqZEjKMAk9gO9djWb4b0LTvDWiWukaJb/ZtOtVKwxb2faCSx5Yknknqa0qACiiigAooooAKw9D8PrpWs6zqH225uG1GVZBFK2UtwB91B2BOSfc1uE4GT0rifDOqTjxPcG+v5p7bWt82nROAEiWE7WVf94EPQB21FFFABRRRQAUUUUAYfijw5beIlsBcyzQm0uVnBibBcD70bf7LDqPatyuS8c28usPaaLbtIpYNeytG5VgI8GMZHrIV+oU1t+HNWi13Q7PUoY5YluE3GKVdrxt0KsOxBBFAGlRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUhZQwUsNx5AzzQAtFFFABRRRQAUUZ5x3ooAKKKKACiiigAooooAKKKKACiiigArzT46y6ho+haX4r0qa5U+H76O6u4IXIFxasQsqMvQ8EHJ6YJr0uigD5k8Qah4guvAml6/dapc6fpninX2ubqWeSUR2liQwt4nKMGSJgqlirLnd1Ga9i+CWoz6p8MdFu7nTv7Od1kxCGkZSvmNh1MhL7WHzDcTwRzjFdzRQAUUUUAcN4yPxEXWDN4QHh59MhiU/Z7/zBLcOc7gGXhQOMfjWHF44+Idm2NY+Gc8m4DYdO1KGUZ77s4xXqM8ywqpfOGdUH1JwKkoA8rfxd4yU/wDCQ6l4duNI8P2OUuNObbcXdwG48xQmcbTjAHXJPauguviBY3PhSDVfDML6xeXbm3tLFDskecfejfP3NnJbPQD6V2lc7Z+DdEs/F114ltrMJqlxHsdgcJk9XC9A5AALdSAKAOMGsfGC5XbH4W8M2LNwJJ9QaUJ7kKOfpTh4I8f6sd/iD4hy2Qx/qNFs0iUH/fbLV6nRQB5Q8XxV8LN9m046X4xsOqTXsgtLpf8AZYj5G+vX1oF18XtdIgGnaB4WjHzNcvN9tc/7KqOBn1Ner0UAeTf2x8XtFKpfeG9B8Qwx/fn0+7NvI698JJxupz+JfiN4iH9m6f4RfwzLJ8x1S+uYp0iA5wEUksWxt9BkntXq9FAHC+GviJaXi30HiK1n0HULCEzzR3g2rLGvDyxHncgYEevT1rDHiL4p6spu9C8M6FZ6dMd1t/ady/nFD91nVDgZHOOvNdx4q8I6J4qOnnXbFLo2M4uICSRhh2OOqnjKng4Ga3qAPKD4a+KeuOG1jxpp2hwHrBo1iHOPTfLyD7int4H8beHU+1+E/HF7qtx1lsvEIE0E3+6ygNH+FeqUUAeUHQfiPqW7Wb/VLPT9ZXFrDYWLk2qQMQJJG3ctL/EvOBtA7mnf8LF1O1hXw7pWi3XiHxnYfu763B+zxqq/8tmlYbcOuCoGck47GvVaYgjLM6BdzcMw744wT7c0AeWS+PfiBPhNO+F94JDgZu9ShjUevIzSf2N8WPEOZdQ8SaT4WiPK22m2gupB7O8nH/fNer0UAeTroPxXv8aTqviXQ7fS/wDlrqVjasLyVOhQK3yKSP4gOM8V2niLTpLHw3btods8tzpISW1gQjdIqDBiBPdk3L9SK6SigDiNO+Kvgi+hRk8SadFIRloZpRHJGe6spwQR0IrX07xr4Z1GC5msdf0yeK2z5zLcLhMDJzzTtS8HeGtTkkk1Dw/pNzJIdzvLaRsWPqSRyax9Q+FXga/uLWa48L6YHtiDH5cIjGB0DBcBh7HNAGG3jTxf4pmaf4caNpsuhrkJqmrvJGlyw6mKNcMV/wBo4B7UwJ8aTyZfAg9tlzxXqcaLGipGoVFACqowAB2FOoA8qMPxpfA+1eBo8nlhFctgUw23xqz5X2/wTtJ/14hnyB/u16xRQBy/gXQNW0eC6uPEuttrOr3bKZJhEsUcSrnbHGo6KMk+pJNZeo+KdH8B67eW/iTUYrDT9Qb7XaSzAhN/SSPIHUEBv+B+1d5Ve9sbS+RUvbWC4RTkLNGHAPrg0AclZ/FXwJecW/irSWPoZwp/I1lX3xj8NTs9l4Ull8Sa0x2QWdjExDv/ALUhGxVHdieK6u98GeGL0Yu/DukTd/ns4z/Sr9jb2OnzrZWFpBbBYt4WGMIAucY4FAHnH9nfGG9/0k654Z03zPnFmLV5fJz/AAF/4sdMjrQdI+MhOP8AhJvCig/xCxkyPoK9XooA8o/4Rn4suPm8f6ZGRyNmkxnPscikHhf4s8/8XC00+g/siPn9K9YooA8pHh34t5XPjnRuO39lr8314/lStovxgDHZ4r8NEDGN2ntz65/+tXqtFAHlLaT8ZMHb4l8J+3+gyUo8J/E7VMrrHj6z05E+ZP7J09csf9ov2HoOteq0UAeUfYvjJprAQ6r4T1iFOB9pt5YZHA9dmFBNPOo/GOX92mh+ELcsdvnPdTOF/wBraOfw9q9UByMjpRQBx/gca1pRvNO8W6vHqV9tF6LkRiJArcOij+4hAwTzhua527bx74xuptQ8KeILHw/oAcxWm+yW5kulXgzHdwFJztA6gZ711HjnwJo3jX7ENb+17LVidlvO0QlU9UfH3lOBx7V0tpbw2drDbWsaxW8KLHHGowFUDAA9gBQB5f8A8IL8Q7s7dQ+KNxHEfvLaaVBGx+jdRU3/AApXw5JE013e65da395dYl1GT7Sj9mXBCDB5xtxXp9FAHlJ0n4t6KrW2la/4e1y1xtjn1W3eKdPQt5eFb606GPx34Slj1vxZ4ssdS0ONgb+3jsFi8hWOC6OBuKoSDzzgGvVKp3kaT3EcEyq8MsciPGwyrqcAgjuP8aAOd8Z+KJrKCx0/w5Gt7rmrKfsOAWiReMzyMOAigg/7XQVzK/DDxHdY/tj4neJplP31tFjtQfUfKDius8GaLPpkl811CsKxt9jso1bcFtYyfLx6Z3Hj2FdRQB5d/wAKN8HsTJcNrVxeH/l6k1SbzM+vDBf0qFvDnxI8Jnb4U1+08R6bji11/Inj9AsyY3D/AHq9XooA8mOp/Gf/AKF/wh16fapf8acdV+MiYz4c8Jy5/u3ki4/OvV6KAPJzb/GPVf8ASTe+GNBMQ+SzSJrkTn/bc8qP93mkOv8AxgsRm58GeH9TA4/0PUjCfr8+a9ZooA8nHiz4ryY8v4cafGG6GXWo+PqAK2/Bdx4yg1rb44m00/2jEz29rYqdlo0eMpuPLlgwOf8AZOK72sDxr4XtvFukLYXV5f2W2USpcWE3lTKRkEBsHggkEehoA5rxNc+M9f8AEFxY+CtQsNK0/T8JcXtzB55mnIBMar0AUEZPqcdqz18JfE+4wt58R7eBC2W+y6RDnHoCfyrvvC3h/T/C+hW2k6RG0dpBnbvcu7EkkszHkkknmtagAooooAKKKx/EfiPTfDv9l/2rM0X9pX0Wm221C26eTOxTgcA7TyeKANiiuL1X4m+GdLGo/abm5LWF/HpkyRWskjfaHBKooUEtkDtmoZ/ir4Vh8N2+uG7ums57/wDstUWzlMwusE+UYtu4N8p4x6etAHdUVxOsfErRdJ0Cy1m5tNbNlcrLJ8mmTFoY4mw7yrtzGoJHLYyDkZFdZZaha32lwalZzCaynhW4ilQEh42XcGHfkEGgCHWd5jtAnObqLP03Z/pWhXE6B420fxhq8mlWK6jaahZeXePb39nJbO8OcB1DgZUnFdtQAUUydDJDIgOCykA+lRafA1tYW0DkM0USoSD1IAFAFiiiigAoopk0giheR87UUscegoAfRVDQLtr/AEa0unDKZkD4YYOD0/SptTvoNM0+4vbttkECGRyBk4Hp6n2oAh027uLm6v454BGkE3lxsDneuAc47dav1maY4F9fqzRB3kDIFb5mXaOSK06ACiiigAqrpjF7ZiVK/vZeD1/1jVh+KtcudLu9HeziM9tJeC2ulVeVDDAOe2CQa1dHkiht4rZnRZ28yQRFhuK7zkgegyPzoA0aKKKACimyOscbO5CooJJPQCqWh6vZa5psN/pswltpc7W6HgkHj6igC3dTLb20s7/ciQufoBmi2lE9vFMAQJEDYPbIzUepY/s663Y2+U+c9OhqLSrq3nt1ihmhklgRFlSNgShKggEduOaALtFFFABRRRQAUVUbUrNdVTTWuYhfvCbhYC3zmMEKWx6ZIFW6ACs75/8AhIvvN5f2XpjjO/1rRrIvL23stbD3lzFBEYFQGRwoLNJhRz3J4oA16KKKACiiigAooooAKrakwXTrpicAROc9McGp5HEcbOxwqgkn2qDVADpl2Gxt8l856Y2mgA0sbdMtBknEKDJOT90VZqhpN3azRfZbeWNpraOMSxA/NFuUFQw7ZHNX6ACiqGq6xYaUha/uUiIiknCk/MyRrucgdTgc0aDq9lruk22paZMs1pcIHRh1GR0I7EdxQBfooooAKpTrnV7M56RS8filXay9auZLMC5jAbyoJW2EfeOFIGfqKANSiqmnaja6jbLcWkqvEzMgPTlTgj8xVugAopGYKMsQB6mloAKKKKAKmqyywWEslvt80Y27unUVbqhrsYl0uVDzlk/9CFT2d7bXqytaTxzCKRoXKNna6nDKfcUAWKKKZLNFEUEsiIXbaoZgNx9B6mgB9FZfhzXbHxFpxvtMkZ4BLJDlhg7kYqePTI49sVqUAFFFFABXBfF/wRceOtP8OWUMkC29lrdtf3YkleIvboHDqjIMhyH45X6iu9ooA+f9V+COqLpet2Ojyab9ludfttVtobm9uM+RGhBR5NrOGJPUE/WjUPg34jn8BWujR3OkmWLxKNbSya7uFt4INrgwJOF80kls7sKeSRg9foCigDx/xP4M8b3/AIA0nwzo/wDYFlZkSJqsDahdP5sRckRRzPG0m1lPzE4PYHFdnp3hWSGLT75pp7PVLS0WFLK01G4/s5GVNqgQ5VWQcdVB4HeutooA8y+H/gzxFpnxA1nxNr8mj2y6haLA9ppss0yyyh93nM0oBU4JUIvy4PqOfTaz9dCrYPO28ND86spIK9ifyJrQoAK4fxn4U8QeI9ajNp4rvtC0iKIFU07AmklyclmII24xgeua6jxDbi60W7iZmVSm5tvUgHJH4gY/Gr6MHRWGcEZ5oA8rHwr1zgt8T/F5I54lQc/l09qP+FVa0ufL+J3jAFsbt0yNn6fLxXqtFAHlX/CqNWJYt8S/GW5vvYuEAP4baP8AhWGv2rrdWfxF8S3N1CQ0UV7KrwOAeVkUD5gRxXqtFAHlt94AbxPeT6hB4l17Rxv+yzW9jdFY5Vi+VeOq85Jx1zS2Xwx1azu4HPjrXryyLZubG7ZZY5ABkBSRlfmA5544r0+NFjBCKFBJY4HcnJNOoA8vu/Ceqa9BY3VhqxsdSSEWV1qEY/fIMkT7OwY7I8HtULfCPUHwZPiR41ZvX7ao4/75rtPBEpmtNUdgwzqdyORjo+OPbiuioA8o/wCFQXWdx+IfjUuPun7eOB34xj8aP+FQXTIfP+IfjSR/4WF6FwO/AXnivV6KAPO/DejSeF7TU9B083d/e29u15DdXrlmunc/xN/e3JjPoRUd74SPjGztZ31TUdHu4I0MU+nv5csYfc0iZIPByoP+6K9A+zf8TEXWf+WXl4/HNU9FIa81c91u9nXjHlof6n8c0Aefn4PyYUJ498agKcgHUiefypv/AAp+Vy/neP8Axq6sc4Go7cfiBXq1FAHkd18L73TRHHYeJfEOorfsLC9+33ZlCWjZMm3phuMbv9qrd/8ACNXv7qbRvFOuaLbzMGENjIE2YA4B9Cyhj+Veo0UAeUP8J72JvtZ8ceK9Qu49rJFdXuYZCCDtdAACp9Kv6v8ADey8QTLqthq2r6Bfz5W6k0u48r7Qo4AcY5wBgGvSKo6HZy2GlwWtxMZ5YwQ0h6tyTk/nQB5y3wdUqmPHHjVXHVhqZ5/DGKB8HEYHzfHHjV/+4ow57dB2r1SigDyf/hS8JlE7+NvGjXOMGX+02BPXPGMdDUsnwdQn93438aop4Zf7VY7h3HTivU6KAPMLb4VC+0+Z/EOtajLrE04f7bbTbJYolBQRI+MhSuN3q3NRj4RTE7ZPHni/7P18mK+8tc9WIOM8nnGeK9TooA8of4NKxBHjrxsuP+oo3+FWNO8GWSJdeE9Va/1fTuGWe/uTJKQylid/X5W5Hoelen1nXCRrrdm4UCR0kye5wFoA87/4UvZ9vGHjUdjjV35HYfhSf8KXtgV8vxn42RAc7Rq78mvVqKAPKh8F7Pn/AIrHxtt9P7Yk/wA+n5Uv/CmLL/ocPG3p/wAhmSvVKKAPJZfgjYyoRJ4v8ZsSoGW1ZzUsXwXso4vLHjDxpt6EDV3Ar1WigDyiX4KafNEY5fFvjSSMggq2ruRz14oPwsh0BY9QsNf8V38tqy7LS51N5InUnawKHgjaTxXq9FAHnGp/DbSfE8o1L+0NX0+WZmFwdOu2g+0qDgCTHXAXA9O1Uj8GLTqvjLxsr44b+2HOK9E8Ptv0qJtnlnc4K5zzvOa0KAPNLD4a6Z4bkiv49S1bUNQM0SG51O4a5OC2GAB+6GBwcdqZqHwltZdTuV0rWdU0XRLp2u7iz024aFnuicbww6Lt6qOCcGvRdQge5txHFIIzvRiSM8BgSP0qzQB5W/wYsy/y+MPGyx/3P7Yfr65oHwYsf4vF3jVhjjOsycV6pRQB5Y/wYsmAH/CXeNcDkD+2JOKt6R4UTw3dXOjW2o6rf2l5Gsrm/na4kDElW+Y9iFAx9a9IrO1TYlzp7HId7gICOp+Vjj6cZoA8+l+EVjq4Eus6trJTy4zbW0NyYVspMDeU2/3iFODn7oqL/hS9vJHm58aeNJZ2HzyDVGXcfXaOBXq9FAHka/A3TBbPC3irxgwY5OdVfHtx0681Y/4Uvp4+74s8aAY6f2xJxXqlFAHln/CltMJG7xR4yI6Y/tiTilPwX0v+HxP4zB9f7Zkr1KigDyp/hvF4Xmh1XStc8QXUkcqrNHqF+9whhJ+bCn+LIBB9qku/hF4f1opqCXet6bJcosskVhfvDG7nkuVHVj3Nej6qrtpl4sWfMMLhcDPO04pdNVl061V/viJAfrgUAebf8KU0XPHiHxgMfd/4nMny/Sobj4PaFplvLqrX+v6hqNlG08El7qLy7XUblIB4zkfqa9YqK7t47u1mt5xuimRo3HTIIwf50Aeb6p8J7LVL8X0Or6vpH2mKNL630+4MazBFAABH3fmAJI64pv8AwpnSAQV8R+MQQc/8hqSvTgAoAHQUtABRRRQAUUVxXxT8dReAbDQ766hie0vtWg0+4lkkKC3jcOWl4BztCZxQB2tFeH6l8doxpGsajo9jZXlnaazBpUFw10yxSpIhbzWIQkAY6AGlvvjhPB8OLDxKulWAluNc/sZ1e+PkJw587eE3BflBwVBwc46ZAPb6K8q1n4o32l+BfD3iBdGtdQTVLoW8s1lehraANLsUhmVXckeiYBBBI4J9Bl8Q6LDrUejzaxp0eryDKWL3KCdhjPEedx4BPTtQBoXEKXELxSjKMMEZxUleeeDPGevX/j7UvC3iTSdPt7m2sI9Q87Trpp44g77RDKWVcSY5GOCATXodAFXVUaTS7xEJVmhdQRwQSpp2nlzYWxlx5nlLux64GalnVXhdGO0ONufrxVObUbLT5rezurhInaMlDIQoYLjPJoAv0Vnf25pPH/E0sef+nhP8afHrGmyqWj1GzdRySs6kD9aAL1FZg8QaMWCjV9OLHsLlP8aP7f0fcVGrWBYdQLhCememaANOisgeJ9B8mCY61pqxzxiWJmuUXeh6MMnke9Qan4r0qz0i7voLqG9NugPkW0ivIzNgKuBzkkgfjQBd0hdkuoL5Qjzcs/B+9kDn8cVo1jWmpW0F1Ml5PFA8xaWJZHClkVVLH6DcM1JL4j0OEjzdZ01M8/NdIP60AatFY6eJ9AkcLHrmlsx6BbuMk/rRL4o0CJ9kuuaUj/3Wu4wf50AWby8lh1bTrZIy0Vx5m9sfd2qCPzq1BbxQNM0SBWmfzHI/ibAGfyA/KuXPjDRbloL+1vFuLRL06cZYjuTzWwOCOoycZ6Vuf25pQALajZoCZFG+ZVyYzh8ZPO09fSgDRorEHi7w2TgeINHJ9Bex/wDxVK/ivw6ibn17SVX1N5GB/OgDaorm7/xnoUVleSWerWN1NbwG4MdvKsp2ghc4U+pA/GmaL440HVLWOVr+3tJW3EwXMgjdMPt5z7449xQB09FYV74w8OWcEstxrumKsYywF0hP5ZqO18aeHp/JSTWLC3uJLaO78ie4VHWNxlSQTQB0NFYS+MPDLMQviLRiemBfRf8AxVKfF/hoYz4h0cZ/6fYv/iqANyiuePjfwqLt7U+I9HFwgyyG8jyP1p7eMfDKwySnxDpBjjQyMVvIzhQMk8H0oA3qK5JfiD4fTWrzTby8Szkt4RciS4OyOWIqpDqx4P3sY68Vp3Hivw9boWuNe0mJfV7yMf1oA2qMc571gL408LMVC+JNFJYZA+3Rcj/vqorjxhpUBlunvrE6JDbtNLqK3KtGjBwuw4z6+tAHSUVzsfjnwnLny/E+htjHS/i/+Kp//CaeFv8AoZdE/wDA+L/4qgDfornF8d+EmIA8UaHk9P8AT4uecf3qVvHHhRQxbxNoYC/ezfxcf+PUAdFRXLTfETwbCheTxTooUEAn7bGefzp6eP8Awg6hl8UaIQRkf6dGD+WaAOmornR458Jlio8TaJkcH/TovXH96nSeNfC8au3/AAkWkMVVmKpeRs2ACTgA5PANAGR8TvG1v8PNN0O7mt4fsV9q8OnzyO+xbeOQOzy8A52hScU34afEC28d3niMackLWGmXa28FzFIWFwpXO/BAx6Vk+P8AXfA+sWXh648Qa8lo+nalYavBBFPGsvmE4i8xWBPl/vCWxggAnIxV7wxeeB9C1fX7/T/FWnST6zcrd3Cy6hCVV9uAEAwQMepNAHoNFcXqfjCLUZWsvCl5Z30jxSo13bzLKttNtHlBgM8McjPtU2heNtOfwrbap4hvbPSnaRoJRcTqi+YpPAJxnIww9jQB11FcuPiD4OLMo8U6JleT/p0fH60H4heDR/zNWhf+B8X/AMVQB1FVry1FxNZucf6PN5vI/wBhl/8AZqxX8d+EkXc/ijQ1GAeb+Lp/31VR/G2i6q9xY6BqNpqU/wBmldntZhIkRAG0OVzjdnj6GgDrqK5Of4heGLFYF1jWtP065lYqILi4VXGGI5B6dM81PP498I287QzeJ9FSVfvKb2PI/WgDpaK5S1+I3gy6CeT4p0U7+ADeIp/U0k/xH8FwMyy+KdFBU4P+mIcHp2NAHWUVx6fE7wO7bV8V6KT/ANfaf406T4l+CIzh/Feig4z/AMfiH+tAHXVh+OtUuND8EeIdWsghurDTri6iEgyu9ImZcjuMgVkT/E3wj5TfYNdsNQucZjtrWdZJJDkDCgHnr/OovEPjjwFd2mp6JrfiHS/KlElhd273OxiGUq6cEEcE8j86AOQ8BfFXU/E3i/whpUlhPaw6hopvbx7mxkgEk4RTugZjho8k4IzxjmvZ68n0TxR8J0/4R7V7PWdLtp9P05bOxEt8wkt7cqP3bIWPIAAO7JBHWuib4neGLi/t7HR9UtdVu5JUSSO0kDmFG48xsfwg4z9aAO2orgvDHxG0+bSr9vFE0Gj3umSLBd/aXEcbFvuuhP3lb2q9H8TPBMhwnivRTzj/AI+0/wAaAOvooooAK5/xf4VsfFX9i/2hLcx/2TqcGqweQyjdLFu2q2Qcr8xyBg+4roKKAPO9Z+Eui6odUdtQ1a3l1DVYtYeSCSINFPGpC7N0ZG3nOCDz3qG6+DuiXGiJYnVNcjuRrA159RSeP7TJdhSA5JjKADPQKOg98+lUUAcF4l+GsHiPw5pmjap4l8RSQ2Mxn8/zYDLcPv3o0hMRB2HhdoHHXNdhb6bHFawxySPcXMcQi+2SqnnOQuN5IUDcevAAyeg6VdooA4TwD8NrTwVqN3d2Ova/e/a2eS4ivpopFlkYjMjFY1YtxjJPeu7oooAK4zxb8NfDXjDWE1HxHaz3zxxCGOJrmRI0AJJIVSOTnBPoBXS60zLYEoxRjJEMgZ6yKKvUAecj4I/DsEkeGbfn1nmP/s9Ml+B3w7lYE+HI1x1CXMyg/UB69JooA86b4J/DtiCfDFtkDHEso/8AZqH+Cnw9ZNq+G4E9GWaUEc+u6vRaKAPOpvgr4Anu3ubjw9BJIzlxl3Cp0wqqCAFGOB05NWdL+EngzS9VstTsNIWK/tHMiTCVzuYgjLjOGx1GRwQK7yigDz3UvCOjeMnhsfENpLNHBDFOMSGMscsrKSDnB2jI74FCfBf4drj/AIpaybHI3s7fzau20dzJplu56lf61coA89f4L/DtgR/witgue671P5huKVPgz8PEXH/CKae2eMvuY/mTmvQaKAONtfCelQ2154Zt7RbbR/sqiJImwybiQdp7EbevXmsmH4K+CFXZcaZLdwqIxFFcXDssOwc7OQRv6vydx613XkMNbM+PkNvsz7hs/wBavUAcE3we+HxUqfCWlYPpFg/zpkfwZ+Hkbsy+E9NJbruVmH5E8V6BRQBwX/CtPDmlT2reHdCs7LzLhftZgGwtEATj/vpU4qPW/hH4P1Q3c9zosM93MFIaR2GGVNgIweOAM+/Neg0UAcDbfB7wBbNG0XhewEkbB1dgzNkHI5Jqxd/C/wAJak0smt6LZ6jcPcST+bNGNw3HhcjHyquAB0GK7aigDhn+EfgB8Z8I6Pxxxbgfypo+EPw//wChS0n/AL8iu7ooA4MfB/4fCPZ/wiWlY/65c/n1pB8H/h+LmGdfCumq8Ryu2MgZ46gHnp39672igDj4PAOk3WkW9n4lgh1qSC4adZLmMf3n2LjoVVX2gdOKoQfBz4fQyFx4V06Rj1MqtJ+jEiu/ooA4U/CL4fltx8JaRnOf9QMflSQfC/w1ZTommabb22nSXAuLmx27oZSqFVGw8dTk+uK7uigDh5PhN4Af73hHRhjP3bZR/KlPwm8AkAf8Ijo2P+vZa7eigDiG+E3gBlAPhHRsD0tlFKPhP4BAwPCGi/jaqa7aigDiP+FTeAdpX/hEdGwf+nZc/nSx/CjwDGm1fCGikYx81qrH8yM121FAHFf8Kp8BYx/wiGif+Aif4UL8KvAiOjx+FNIjdGDq8duFYEHIwRz2rta8g/aF8Y6noVjpOj+GtRfT9Z1BpZ/tCQGYxwxRk4KhWxvcxoDjuaAOku/hR4Rv486jpUF1c/ahdm6lRWlJEqyeXuIPyfKE2/3cjvT2+EvgBlIPhHRsEY4tgK0fhn4nTxj4D0XXEI8y6twZlH8My/LIv4MGrp6AOT0/wn4e8JIZPD+lWmmC4lhSb7PHtEgDcZ/PrUOofDTwrqXiC41bU9LhvZJo1T7NcAPboQMb1jPyhyAAW64ArodckaO1iZI/N/fxArnHG8ZNaNAHGH4V+AyMf8IhoX4WaD+lIPhX4CBJHhDQ+fWzT/Cu0ooA4n/hU/gHIP8AwiGi56f8eq0678F6bo9mE8HaHp2nz3EixzvbRLDiPDZY4HzYz0rtKKAOIsvhj4Vd3vtX0HTr7V7mNftdxcRCUyPtAYgNkKMjtikg+EngCCBIU8I6OUXoXtw7fixyT+JruKKAOIX4T+AVhMQ8I6NtJJ5tlJ/M89qmtvhf4Ftoljj8I6HhRjLWUbE/UkZNdjRQByY+G/gkKQPCWg4PH/HhF/hSL8NfBC/d8I6AOc/8eEX/AMTXW0UAchP8P/Blugmj0DR7CSNt0dxBbRwtGxBUMGAGDzUdl8MPBttptvZyeHtOuvJiEPn3ECvM4HOWcjcTnvmuM/aA0XW/GlzpHhXSdIubzTzHNf3kxcwRBgpjhXzSCpYO+8p1IQcYrtPhBf6rffDzR/8AhIrG7stXtovslzHdRNGzNGdm/kDIYANkcc0AOt/hj4Ggto4I/CWiFI1CqXs0dsAY5Ygkn3Jon8EeG9I0q7k0TQ9P0+dIJNklrAsbDIyRkDodorsKpa3bvdaNfW8a7pJYHRR6kqcfrQBi6x4F8Pa7f6ffa5pdve3FnEY0WdQ6c4+8p4YjHBPTJpP+Fe+Dd4b/AIRPQdw6H+z4s/8AoNdOM4GTk+tLQAUUUUAFFFed/FvxBqGgah4HNjeG0tb3XoLS8YhdrxMrfKSRxkj2NAHolFfO1/4t8ZapF4kTQ9WSeK38UzWiQx3UFtPLaRopMVvJICuQTk9W9DWVrHxB1y50HwavhzWNfX7ZqN9aXIupLSO5JiVTs8518ohSThzjI460AfT1FfMPxT8eeKPD2r2VtaazrcSR+FINQJt1tZtl21wY/MuG2lTHyFYx8E7ccZr0Hx94k1/SdR+GskOv2S2mp31rb38VvEpFxuUlpFkJ4jPYBR67u1AHrtFAORkdKKAAgHrzRUdzKILeWYo7iNC+1BlmwM4A7mvNk+NPh1xldN8SH/uFS0Aem0V5kfjR4e2BxpviQrnqNKk496R/jR4fU4/srxMfppUlAHp1FeZj4y6Eemj+J+3/ADCpO/Sh/jJoqn/kB+KSOmRpb/40AemUV5n/AMLj0f8A6AXir/wVt/jR/wALi0rt4e8WH0A0tuffrQB32iMW0uBiQScnj6mr1eWj4waVbKoPh3xLa2kfMks2nMionrwST8xVcDuakX4w2ZC7vCHjVSeoOldP/HqAPTqK8y/4W/Zc48I+NCAMkjST/wDFVHcfFpZoHSz8I+MIpj92SfTNkaepZt3AAzmgD1GivMP+FwWxk3ReEPGFzZvzBd2+nb451/vp8wO09uKePi7bEAjwb43wRkf8Sn/7OgD0yivMx8XbYoHHg3xuVJxkaT/9nUI+K6pPLjwx4qmnlKtFp40/FwsQGGmI3Y2ZwBzkmgD1KivMT8XF2b18DeOCnqdLA/8AZ6E+Lilk3+B/G6q/3T/ZgOf/AB+gD06ivLZ/i6PKYx+DPGMZ6+ZNpwVEHUsx3HAAyT16VInxdhkJlt/B/i+5sHy1veW+n74507OoLA4PbIBoA9OorzE/FwKMt4F8cBcZz/ZgP/s9Kfi2MEf8IL45Lg42jTF/+LoA9NorzFPi4jnK+B/HDR/3hpY69ur0r/FogMU8CeOGx0/4lg5/8foA9NorzEfFskA/8IJ44yRnH9mr/wDF0D4tMcY8BeODn/qGrx/4/QB6dRXlZ+Kt2ZEnfwh4lsrRVaPy7uzCSXU7Y8qKLDH5id2c4FSr8Vr3AWT4deNllxnaLJCPz30Aen0V5cvxXvjx/wAK48cB923H2FPTPXfT/wDhal/z/wAW58b/APgCv/xdAHp1FeYf8LU1AsMfDnxoR3P2NOD6Y3frTj8UtQ27h8OfGuP+vNM/luoA9Nory/8A4WpqITLfDjxoH6bfsiY9ud1PPxS1AEA/Dnxr74s04H/fdAHptVTp1kdTGpGztzqIh+zi68pfNEWd2zfjO3POM4zzXnjfFO+CsR8OvGxI6D7CnP8A4/TI/irf+UDL8OfGqttBIFipAOOed1AHoumaZYaVbtBpdla2UDO0jR28SxqXbqxCgDJ7mrdeYn4qXwHHw58bk45H2Ff/AIulHxUvSBn4deOAfT7Av/xdAG14m8af8I9468P6NqNrGmlavFNsv2kwI54hv2MMYAK9DnrV34c+JLjxd4TtdcnsfsUV48j28RbcxhDEI54GCwG7HoRXlfxJ1mH4heH10rWvh38QYoopxcRS2trGkqMARlSSw5DEEEd66HTPiRc6bptrY2Pwz8axWtrEkMUYsk+VFUAAfP2AAoA9ZorzJfijqRGf+FceNB7G0T/4umn4p6kAf+Lb+NT9LSP/AOLoA9Pory8fFTUzk/8ACtvG3Bx/x6R//F0H4p6pkY+GvjUjvm1j/wDi6APUKK8tPxU1XcQPhp40Ppm1j/8Ai6P+Fp6uenwz8ZZ97eMf+zUAepUV5RN8U9eKE23wx8Wkqfm8yJFwO2Pm5/pUg+KWtkkf8Ky8X8f9Mo//AIqgD1OivKv+Fpa//wBEw8Wf98x/40D4oeI2+78LvFPvnyx/WgD1WivKR8UPEu3LfC7xOMjjDRnn0PPA96cPiZ4oIH/FrvEme/72L/GgD1SuQ+IHi+Twhc+HZJbNZtL1HUE0+6ufM2m1Mn+rfGOVyCCeMcVzP/CzPFX/AES3xF/3/i/xrC8b+Jdc8Y+GL7QtV+Fnib7HdKAzRXMKyIVYMrKSCAQQD0NAHpPgXxTJ4qbXJ47RYdOstQksLWffk3IjwHkxjgbsgdc4NdTXiXg/xTr3hPwzp+iaZ8K/EgsrKPy0Ml1CzsSSxZsYySSSTgck8VtL8SvFJPzfC7xEB6+dF/jQB6nRRRQAVV1TTbHVrKSz1Wztr20kxvguYlkRscjKsCDVqigDFm8J+HJtJi0ubQNIk0yFt0dm9nGYUPqqbdoP0FJfeEvDeoWNrZX/AIf0i5s7TIt4JrKN44c9dilcLn2rbooAyF8M6CowuiaWB9k/s/AtI/8Aj2znyOn+rzzs+77VWvfBPhS+jto73wzodxHaxiGBZrCJxFGDkIgK/KuSeBxzXQUUAIiqiqqKFVRgADAApaKKACikBGSARkdRS0AFFFFABRRRQAUUVHLMsUkKMeZX2L9dpb+SmgCQgHrzRRRQAUEZGD0oooARVCqFUAKBgAcAClqvFMXvZ4cDbGqEH65/wqxQAUm0bt2BuxjOOcUtFAATgZPSkVgyhlIKkZBHIIplzj7PLkkDYckduKr6KNuj2CjoIIx/46KALhGRg9KAMDA6UUUAFFFFABRRRQBCjk3kqZOBGhx25Lf4VNVeP/kIz/8AXKP+b1YoARlVsblBwcjI6H1paKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACo554oEDTypGpOMuwUZ/GpK8n/aK0TUtf0Twja6RpyahKviS0kkjmtmuIEj2ygtOq/8ALIZG7oMHrzQB6oLiEmMCWMmQZQBh8w9vWka4gVZC00YEZw5LD5fr6V80aP4Z1rSvhpper2Wg6rF4r8K6/LeSaets6rNFJJtmitQBhoWQqRtz91vXm1qvhTxHqXgTQ9Ck0O9ub/xRqUuveIAWaBI1BDrbvKVIjb/VADrmM8CgD6Ku760s4llu7qCCNjhXlkCgn2JqcEMAQQQeQRXzbdQ3978E7LQfFfhLWZ/EenJc6XBcJoZvxH5YUK6A4wHTaFlGRlGOfX1LwDY+LbLwt4Wg26Xp9lbadDFcafcwyy3KuqYIEwkCjovBQ45HNAHfCWMymISIZAMlM8geuKfXgXwt8P8AjHSvjlquo+JtL3Pf6WTd6hHO7wFzLlVjJjAyAETy88KN2Sc177QBivf2+n6xKLxxF9rnitoCc/vJDGzY/JTW1WN4puIbHTm1C6V2t7AG7kEaF3wmCdqjqcZrgo/H3j0hivw0u50OTFLHfwqrqeVOGII4xkHvmgD1aivKF8ffEBhx8Lr7PvqMAH6tQvjn4iRIwuPhlcPK5zH5GpQlQvcMSeD9KAPV6K8n/wCE7+Isn+q+F9yvf95qcA4/Okbxx8SVGT8MJSB1A1SDJ+nNAHrNZmtXBtpLB9m/ErsVHU4hkPH/ANevOP8AhOfiU4Yx/DCRR236pDn+danh3VfGWu3czeJvDC6DaWkLMh+2JN9odht24HQAEnJ9qAO70e9/tLSrO9MLwG4iWQxSY3RkjJU47jpVuvLtT8YeLbe/ns/CXhD+2bGxc2s0klwtsyyryQobhlwVwR3qq3jb4nh+PhmpX/sKw5/nQB63RXk6+LfimP3z/Dyz+zoMvEuqoZX/AN3t+Zpv/CZ/E84x8NYwT66pF/jQB3F3fXFrrMn2a3SQSXNvBKztt2xlWJYeuDgY+tdFXDWV5rMnhmfVPEWlNp+pDdctZWzCd1VAQACM7iQM4HrXPv4y+JrKZbX4e288Ex8y3Y6ikbCM8qJFbkPjqPWgD1mivJj4t+K2ePh1Y4/7C0dNXxh8VR8snw3tC55BTV49v0OaAPV7lglvKxzgITx9Kx/D7373c3nOp04Wtv8AZ024IYqS5J7/AMNcHH4k+KN/IlnN4DsLNJ2CyXEmpI6RRnhjhTktjpXQeK9X1vRltYPCejHV7+bKpHI/lRLDGFLZfoGIYBc98+lAHcUV5IfF3xWZsp8ObNUIyA+rR7h9cUf8JT8XJWIi+H+lRY5zLqynI9OO9AHrdFeRv4v+K8g3W/w5sox6Tasmf0pP+Er+Likbvh7pbA/3dWXigD12ivIx4o+LxYqPh/pAx3OrLg/ShvFPxdVsH4f6SwH93VV5/GgD0e61C3sb25mumaOMC3h3N93c7so/VhmtWuB0qw1nUNDvZPF1pBHqWpMHlsLeXzEgSMMUVW7k7QSfU+1YQ8TfF1xmPwLo2H/eKX1MKVU9FYf3h37UAet0V5IPEnxh7+A9EOfTVV4/WlbXvjFComk8HeHp1bjyItRKuh9Sx4I9hQB61RXkra/8Yjjb4L8PL7HU80n9vfGTaf8AijfDme3/ABMj/jQB63RXkZ174y4+Xwd4bHsdRJ/rThr3xj7+DvDnP/USPH60AetUV5Mde+MXbwd4c4/6iR5+lJ/b/wAY/wDoTPDv/gyP+NAHrVFeS/2/8YgOfBfh4+w1OlHiD4w4JPgrw+fQDVOaAPWaK8k/4SP4w5/5EXQv/BqKUa/8YpPlHgzw9ETzufUtwHtgHqf60AertIiSIjMAz5Cj1wM0+vGZ9f8AHr6jBqGp6PaabJcRvFpGnyTBitweNs7g4O7BIx0Bq4dd+MUR2Hwd4dnK8GRNSKh/cA8j8aAPWqK8kPiP4wk8eBdCGTjnVQcUv9v/ABjHJ8F+Hj7DU6APWqK8kPiT4wHkeA9EX2OrKaUeJ/i5Cd9z4C0mSL7uyDVFL5/vcnGPbrQB6rbXMNzGJLeVJEyRlTnkHB/I8VLXl13Y694bsrP/AIRKwt9V1W13rLZS3PlqonYOzEnsHBPuCcVV/t/4x5/5Ezw7/wCDL/69AHrdFeQNr/xowoXwZ4cDdydQyB/49ThrvxnztPhDw1n+/wD2gdv0xnNAHrtFeRrrPxob/mVvCqjnrfP/AI0j6r8ajnb4c8JAHt9rkJH60Aeu0V5D/aXxrDZ/sHwiwx0+1Sf40v8AaHxsY8aL4PX/AHrmU/yoA9dqtfXK232fd/y0mWMcnqa8sW7+NkjBG03wZCG48zzpm2e+M849Kp3uo/ES3ubfUvFVtpttZxM0ENtaMXVpwCEnc5+6zdF7DrQB7RRXkyn4zW+1EHhK7DDzTJL5qFSeTHhTztPAbvij7Z8aAwB0vwcQTyRPMMCgD1miiigAooooAKKKKACjvmiigAooooAoySn+2YocZAhZyf7vIFXqpiyxrBv/ADW5gEHl9uGLbvrzirlABRRRQAUUUUAFUNaJWyysbSfOuVX0zV+s/XjKNO/0dS0hmhGAM8GRQT+A5/CgDQooooAKKKKAM+Ybtbgyx+WIkKPxBJrQrOZh/wAJFGu5cm1Y4zz99ecelaNABRRRQAVQ0dSsVx2BnfAByMZxx7cVfqnpYRbZwgXPmPuKjALbjk0AXKKKKACiiigAooooAzLt1/tuxiJXeQzgYySACPw+9WnVOSCVtXt5wqeSkEiMf4gxZCPwwGq5QAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBBc2lvdPC9xEsjQv5kZYfdb1FT0UUAFFFFABRRRQBlaTp8ltqerXcwG66lUqR1KKoAH861aKKACiiigAooooAKKKKACq19ZQ3yRJcoHjSQSbSOCR0/XB/CrNFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUgOSR6HFAC0UUUAFFFFABRRRQAUUUUAJtXeH2jcBjOOcUtFFABRSMQoyfUCloAKrabbG0tRCz7zvds/7zFv61ZooAKKKKACiiigAooooAKKKKACikVtwz7kfrS5/SgAoozzjvRQAUUUUAFFFFABRRRQAUUUhb5wuOoJ/l/jQAtFFFABRRRQAUUUUAFFFGecd6ACiiigAopHbajN1wM0tABRQDkZHSgEHpzQAUUZ/SjIzjIz1xQAUUZ5x3oJ/WgAooooAKKKKACsDVrPxPJqLy6PrOj2toVAEN3pUlw4I6netxGP8Ax2t+igDk/wCz/HG8N/wkXhvgYx/YM+P/AEsoOn+Nyyn/AISLw3xzj+wZ/wD5MrrKKAOUaw8bsMHxF4b6g/8AIBn/APkyhrDxuykHxD4bwRj/AJAM/wD8mV1dFAHKCw8cZJ/4SLw3z2/sGfj/AMnKFsPG6qAPEPhvAGP+QDP/APJldXRQByi2HjdRgeIvDfUn/kAz/wDyZSLp/jcMx/4SLw4dxzg6DPx/5OV1lFAHJ/2f443lv+Ei8N8jGP7Bnx/6WUh07xwW3f8ACSeHQf8AsAzf/JldbRQByR07xwRg+JPDp5z/AMgGb/5MpDpvjhgQfEvh3B4/5AM3/wAmV11FAHJf2d45/wChl8O/+CGb/wCTKQab44UADxL4dwOP+QDN/wDJlddRQByI03xwBx4l8O+v/IBm/wDkygab44BOPEvh3n/qAzf/ACZXXUUAch/ZvjncT/wk3h4EjH/IBm/+S6VtN8cEg/8ACS+HQQMZGgzf/JlddRQByJ03xyVAPibw9xg/8gGb/wCS6Dpvjkgg+JfDpB/6gM3/AMl111FAHJf2d45/6GXw7/4IZv8A5Mpq6Z45Vdo8TeHsdv8AiQy8f+TddfRQByC6Z45UADxP4e7n/kAS8/8Ak3SDS/HIkZx4n8PZbqP7Blx/6V12FFAHH/2X4480P/wk3h7OMf8AIBm/+S6DpfjknJ8T+H8jOP8AiQy8f+TddhRQByDaZ44bGfE3h7g5/wCQDN/8mUNpnjllKt4m8PEH/qAzfl/x9119FAHInTfHJ3f8VP4e5/6gM3H/AJN0g0zxyAoHifw8AvH/ACAJef8Aybrr6KAOO/svx0Dx4p8PgcnH9gS//JdC6V46Uuf+Ep8Pkt66DLx/5N12NFAHHf2V463bv+Ep0DOMf8gGX/5LpTpXjksjHxP4fyucH+wZf/kuuwooA4+TS/HDgZ8TeHhg5GNBm/8AkuhtL8cMpVvE/h4g4/5gMv8A8l12FFAHHnTPHJQqfE/h857/ANgS/wDyXTl03xyqhR4l8O4Ax/yAZv8A5LrrqKAOQTTPHCLtXxL4dwP+oDN/8l0LpfjhQ23xN4eG45/5AM3/AMl119FAHILpfjhWLf8ACTeHsnGf+JDN/wDJdIdL8dF1b/hKPD/Axj+wJef/ACbrsKKAOPbSvHLY3eJ/D5wQR/xIZe3/AG90sml+OJEKnxN4ewfTQZv/AJLrr6KAORbTfHLKVPiXw7gjH/IBm/8AkukTTfHKqF/4Sbw8ceugzf8AyXXX0UAcfHpfjiMYXxN4ex2B0Gbj/wAm6VNM8cLux4l8O8nP/IBm/wDkuuvooA5AaX44DMw8TeHgWxn/AIkM3b/t7pf7N8clgf8AhJfDuQMf8gGb/wCS666igDkG0zxywX/ip/DwI5z/AGBL/wDJdIdL8dHGfFHh8jOcf2BL/wDJdddNIkMTyzOscSKWZ2OAoHUk9hWcviDRncKmraezGUQAC5QkyHonX7x7DrQBhPpnjlwR/wAJP4fAIwQNAl/+S6BpfjoD/kadA/8ABBL/APJdLJ8RvDceiaxqsl5IttpN6dPu1ML+Yk4ZV2BMZbJYYwDnn0rXvPENna+JtN0FhM+oX0MtwqooIjjj2gs5zwCWCjrk0AYyaV46Rdo8U6AR2zoMvH/k3SLpPjpWyPFWgYznH9gy4P8A5N10Ka7pEklzHHqtgz2xAnUXCExEnADDPy8nHPei213SbqWCK21SwmknZliSO4RjIV+8FAPJHfHSgDmxo3joO7DxZofzDp/YMuB9P9Lpv9h+Od27/hLdEzjGf7Cl/wDkuu3ooA4oaL46zk+LNDJxjnQpeP8AybpyaP43DLv8VaG4B5/4kcoJ/wDJuuzooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAMXxvpU+veC9f0izeJLnUNPuLSJpSQgeSNlBYgE4yRnANeNX/wMun07VI7KDw/BdT6fpVvbSqhUxT28itO+RHld4BAI5bvivZfG813b+Dddl025itL9bGc208siokcvlnYxZvlADY5PHrXz0nj/wAT6b4O8TWd3rt7Lr1lcabbXV95ltcW9qkzEPJC8aAAnkYfJHHOc0Aeh6v8LL68+Lia9DfWyeFri4t9SvrAlvMkvIEdY2Ubdu35lY88kdOhrf8ADmi3+o+K/GOu6rHPZSXWNJ07PDx2sSnMq+m+R3YeyrVP4OazqN/deMNNvtRm1S00jVmtLS9m2l3TYpKMygBipPXrzXLJ8VfFt5rNvaafpGgiK+vNSsLRp7iYMr2gLF5MKeCqkbRyT3AoAjf4Ta9J8OLjwmbTwnGUt4beHUIhIs10EuopWMv7v5crGcgF8sRyBVyL4PTWniJdS0+DQ7Xy/FUOrxtEhR0slhKtCMJwSxztB2985qlffGXX5NFsb3SNI0ve/hpvENyLqaQBQkojdE2jkntnHXk8YPR+H/idefZvGk/ieysbVNAs7bUU+yTM4eKeJpEjJYDLjbtyAASwwBQB6pRXjmq+KfFPgXwB4ae6gOp6zf8AmXGozXG6VrXI8xgIVIdlXcE+XhQoz1FZN38bNYluoU0PSLHUI4LC1vrkq0ifaFl5byS+3YqgHlweeMCgD3mivOfCHjbVfEnia8jVdEtNIt9TudL+zyzt9uZoVY7wv3eSudmMhcnPGK9GoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAIrq3hu7aW3u4Y57eVSkkUihldT1BB4IPpWdZeGdCsdLn0yy0TTLbTp8mW1htI0ikz13IBg/iK1qKAKek6Xp+j2a2ekWNrYWiklYLWFYkBPXCqAKrxeHtFiliki0jTkkhklmjdbZAUeUYkYHHDOCQxHJ75rUooAx18L6AsIiXQ9LEQtTZBBaR7fs5O4w4x/qyedvTPaq2seDdC1W3eGewhiSWW3kn+zosZuBAwaJJCBlkUgYU9BwK6GigDN1vQdI16KKPXNKsNSjibdGl5bpMEPqAwODUOpeFvD+qG1Op6FpV4bVQlubizjk8lR0CZB2ge1bFFAGYPD+jDWv7YGkaeNXwV+3C2Tz8EYx5mN3TjrWnRRQAUUUUAf//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Shown are five surface ECG leads (I, II, aVF, V1, V6) and intracardiac recordings from the His bundle region (HBE2-3,1-2), the right ventricular apex (RVA3-4), and a mapping catheter (USER1) positioned distal to the His catheter along the RV septum. Application of radiofrequency (RF) energy to the tip of the mapping catheter causes two accelerated beats with a typical left bundle branch block (LBBB) morphology (black arrow), likely from heating and activating the right bundle branch. After these beats, complete right bundle branch block (RBBB) is present (red arrow), as evidenced by the change in QRS morphology, particularly in lead V1. Following right bundle branch ablation, the HV interval increased to 105 ms, though no infranodal A-V block was noted. Right bundle branch reentrant tachycardia was no longer inducible. A permanent pacemaker was placed becaued of the markedly prolonged HV interval.",
"    <div class=\"footnotes\">",
"     H: His bundle electrogram; A: atrial electrogram; V: ventricular electrogram.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_54_30563=[""].join("\n");
var outline_f29_54_30563=null;
var title_f29_54_30564="Interferon alfa-n3: Patient drug information";
var content_f29_54_30564=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Interferon alfa-n3: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/27/38323?source=see_link\">",
"     see \"Interferon alfa-n3: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F183332\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Alferon&reg; N",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F183333\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Alferon&reg; N",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10016794\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691858",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat genital warts.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10016793\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701469",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to alpha interferon or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701030",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to eggs, talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701035",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to mouse proteins, talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701037",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to neomycin, talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10016798\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697259",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor. The flu-like side effects of interferon may be stressful to heart patients.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10016799\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698085",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flu-like signs. These include headache, weakness, fever, shakes, aches, pains, and sweating. Mild pain drugs may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698222",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low white blood cell count.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10016801\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699075",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low mood (depression), thoughts of killing yourself, nervousness, emotional ups and downs, thinking that is not normal, anxiety, or lack of interest in life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10016796\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696011",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696152",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Treating genital warts is done in a doctor's office.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10016797\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696446",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor to find out what to do.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10016802\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10016803\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11972 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-61.234.146.186-69ABC6F150-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_54_30564=[""].join("\n");
var outline_f29_54_30564=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183332\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183333\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016794\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016793\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016798\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016799\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016801\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016796\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016797\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016802\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016803\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?37/27/38323?source=related_link\">",
"      Interferon alfa-n3: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_54_30565="Acetaminophen, dextromethorphan, and phenylephrine: Patient drug information";
var content_f29_54_30565=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Acetaminophen, dextromethorphan, and phenylephrine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/5/4182?source=see_link\">",
"     see \"Acetaminophen, dextromethorphan, and phenylephrine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F5093662\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Alka-Seltzer Plus&reg; Day Cold [OTC];",
"     </li>",
"     <li>",
"      Comtrex&reg; Maximum Strength, Non-Drowsy Cold &amp; Cough [OTC];",
"     </li>",
"     <li>",
"      Daytime Cold &amp; Flu Relief Multi-Symptom [OTC] [DSC];",
"     </li>",
"     <li>",
"      Mapap&reg; Multi-Symptom Cold [OTC];",
"     </li>",
"     <li>",
"      Theraflu Warming Relief&reg; Daytime Multi-Symptom Cold [OTC];",
"     </li>",
"     <li>",
"      Theraflu Warming Relief&reg; Daytime Severe Cold &amp; Cough [OTC];",
"     </li>",
"     <li>",
"      Theraflu&reg; Daytime Severe Cold &amp;  Cough [OTC];",
"     </li>",
"     <li>",
"      Tylenol&reg; Cold Head Congestion Daytime [OTC];",
"     </li>",
"     <li>",
"      Tylenol&reg; Cold Multi-Symptom Daytime [OTC];",
"     </li>",
"     <li>",
"      Vicks&reg; DayQuil&reg; Cold &amp; Flu Multi-Symptom [OTC];",
"     </li>",
"     <li>",
"      Vicks&reg; Nature Fusion&trade; Cold &amp; Flu Multi-Symptom Relief [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10026412\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700543",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before giving this drug to a child. Check all of your child's drugs, including OTC, with doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10026414\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691646",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop coughing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691980",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat nose stuffiness.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10026413\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701418",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to acetaminophen, dextromethorphan, phenylephrine, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken certain drugs used for low mood (depression) like isocarboxazid, phenelzine, or tranylcypromine or drugs used for Parkinson's disease like selegiline or rasagiline in the last 14 days. Taking this drug within 14 days of those drugs can cause very bad high blood pressure. Talk with your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10026418\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696680",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid other sources of acetaminophen. An overdose may cause problems.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697679",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is not for coughs due to smoking or lung disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705887",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you abuse beer, wine, or mixed drinks, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697055",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are on a low-salt diet (this drug has salt), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697329",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have PKU, talk with your doctor. Some products have phenylalanine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid or limit drinking wine, beer, or mixed drinks to less than 3 drinks a day. Drinking too much alcohol may raise your chance of liver disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697564",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your use of caffeine (for example, tea, coffee, cola) and chocolate. Use with this drug may cause nervousness, shakiness, and a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696699",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful if you have G6PD deficiency. Anemia may happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10026419\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698279",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to sleep.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698201",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the liver may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10026421\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698625",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure, a fast heartbeat, or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699124",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10026416\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694768",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take more than what your doctor told you to take. Liver problems may happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695714",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694286",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid (solution) if you cannot swallow pills.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10026417\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10026422\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10026423\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11702 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-217.117.136.88-F836DB8729-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_54_30565=[""].join("\n");
var outline_f29_54_30565=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5093662\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026412\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026414\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026413\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026418\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026419\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026421\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026416\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026417\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026422\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026423\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?4/5/4182?source=related_link\">",
"      Acetaminophen, dextromethorphan, and phenylephrine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_54_30566="Orbital structures";
var content_f29_54_30566=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F72674&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F72674&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 558px\">",
"   <div class=\"ttl\">",
"    Structures associated with the orbit",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 538px; height: 511px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAH/AhoDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACuE+K0jxW2lMjMuZ2BwcZ+Q/4V3dcL8XBjRdPf+7eAfnG/wDhXPi/4Mjowv8AGicNHdS4/wBa/wD30aRLqVblh5j4cbvvHqMA/wBKowyU6V9rxydgcMfQH/6+K+b1Pdsjbt7mQn/WP+ZrQjnkx99vzrDtm5rUhbiobZLRc85/77fnSedJn77fnUOaM0rsViwsr/32/OpVlf8Avt+dVVNTL0pXYWRaSV/77fnU6yP/AHm/OqidBU6UrsmyLCu395vzp29v7zfnUS0+ldisO3t/eb86N7f3m/Om0UrsB29v7zfnRvb+83502ii7Advb+8350b2/vN+dNoouwHb2/vN+dG9v7zfnTaKLsB29v7zfnRvb+83502ii7Az9bmddLnIdgd/r7Cr0Lt5SfM3Qd6yvEvy6LcMP+ev9ErTt/wDUR/7orKg3af8Aif5IbSsibe395vzo3t/eb86bRWt2Idvb+8350b2/vN+dNoouwHb2/vN+dG9v7zfnTaKLsB29v7zfnRvb+83502lAp3YtBd7f3m/Oje/95vzoxRTuwDc/95vzo3P/AHj+dFLRdgJuf+8350b3/vN+dLikouwDe395vzo3t/eb86CKQii7DQXe395vzo3t/eb86bRSuxjt7f3m/Oje395vzptFK7A6bw6SbA5OTvP9K1Ky/Dn/ACDz/vn+lalfV4P+BD0PFr/xJBRRRXSZBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXF/Fld3hiJv7l0jfow/rXaVyPxTXPg64b+5LEf/AB8D+tY4hXpS9DbDu1WPqeRxNVkYZcHkHiqMR5q2hr5pn0JasHONrHLJwc9/Q1swngVhIdkqSdBna30PT9f5mtqA8VEiWWs80E0wHmgnmoJJlNTIarKanQ0AyzH0qdDxVaM1YjqSWTpT6jWpKRLCiiikAUUUUAFFMl3bDsxu96r2d4twWQ/LKpwynsaAsW6KKKACiiigDH8UZHh67/668fklaVoc20R/2RWd4m58O3vtIT/44tXNLfzLCBvVRWdDaf8Ai/RD6FuiiitBBRRRQAUUUopgKBRRRTQgpcUClFUkIQClxS0Yp2FcTFFLRRYLjcUlPpCKVh3GUYpxFNpWGhKKWkqRnTeHP+Qef98/0rUrL8Of8g8/75/pWpX1eD/gQ9Dxa/8AEkFFFFdJkFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFcr8UP+RH1D/eh/9HJXVVzPxKXd4I1Qeio35Op/pWVb+HL0ZrR/iR9UeJofmq3Gaog/NVyI8V80z6ItBd6MhOAwxmtOxkLwox4JHI9D3rMjNW7BsGRPRifwPP8AjUMTNQGlqJTUgPNQSSJU6VXTrU8dIRZj61PGearx9qnTrSJLC1IOlRLUo6VIhaKKKQgooooAKyNVUWt3BeLlVLCOUj0PQ/ga16r39ut1ZywN0dSKa10YImQ5Xnr3xTqztFnaW0US581P3Un+8P8AEfyrRqYtta7jaswooopiMzxBj/hHNS9QWP8A5DH+FO8PuH0i2YdCgqTVYfO0fUk9VH6giqfhFt/h+zP+xWVD/l4vNfkPobNFFFaiCiiigApVpKVaYC0opKUVSJFpRSClBqkIWiiimIQ0UppKYBRRRSsAhpppxpDUlIbSU40lSyjpfDn/ACDz/vn+lalZnh3/AJB5/wB8/wBK06+qwf8AAh6Hi1/4jCiiiukyCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACsDx+u/wZrA9Ldm/Ln+lb9Y/jFN/hLWl/wCnKb/0A1FTWD9C6ek16ngGeatQmqY6D6VagNfMH0hejNWrY/6VJ/uL/NqpxdqsxHFyuP4kOfwIx/M1LEzTQ1IDVdDxTw1QItKeanjPSqSvViJ80iWXUqdetV4zU61JJYWpl6VAnSplqRMdRRRSEFFFFABRRRQBjqRZa4Y2O2G9HDHosi9PzH8q1xkjkYIOCPQ9xVPVrP7ZZsinEq/NG391h0pulXpvLNZX4nT93cIeqsOM/Q/4etKT5Zc3R/n/AMEfS5fooopiGtg2t/kZwkZ/Vq5/wG5bw7bg9VyK6FBmK/HrCv6Fq5vwOcWE8X/POZ1/WsqHx1V/h/Jgtvn+iOlooorUAooooAKKKKYDgaUUylBqhWH0UmaM07iHUUgNGaYh2aKbmlzTAKKWkoASkNKaKTGNNJS0lSNHTeHf+Qef98/0rTrM8O/8g8/75/pWnX1OD/gQ9Dxq/wDEYUUUV0mQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVn+Ik8zw/qaf3rWUf+OGtCq2pp5mnXaD+KJx+hpS1THHRo+bYzlEPsKtw1Ttz+5j/wB0Vchr5dn0xdjqccTxN65X+v8ASq8dTycRiT/nmQ34d/0JqBMvqaM01e1GakRIGp8M3+lLHnqhb9R/jVfdUEUn/E3hHrEw/VaLAdNF0FWV6CqsB+UVaXoKzZDJ06VMtQJ0qZKTJY+iiipEFFFFABRRRQAViajHLp19/aVom9GGJ4gPvD1xW3SEAggjINDSacZbMadiK3mjngSaBt8D/dbPI9jU1YcsTaNK88IL2MhzNF/d/wBof5961opUdUZHDxuMo3r7H3/nWMZOnJU5u99n3/4INFi3GZbgH+KA/of/AK9cx4S+S61SPsLhmH4nNdRaf8fLj1gf+a1yXhwlPEWrRHplW/NQf60qH8eqvJfoJbM6qiiitwCiiigAooopgFApCQBknAoBB6EH6UwHUUUUwDNOzTadTJFopBS0wFFFAoFMQlGKcaTNJgMNJTqQ1LKR0vh3/kHn/fP9K06y/Dv/ACDz/vn+lalfU4P+BD0PGr/xGFFYPi3xfoXhGG1l8Ragtkly5jhJjd97AZIAUE9K0NE1Wy1zSrfUtLm8+ynBaOTay7gCR0YAjkHqK6TIvUU1JEcsEdWKnDAHOD6GqOsazp2jabPf6peQ21nAypLK54RmYKoOO5LKPxoA0KKjaaJZliaRBKwyqFhkj2FZ3h/X9P19NQbTJWkFjey2E+5Cu2aI4deeoB7jigDVooooAKKKKACiiigAooooAKKKKACiiigAooooAKZOu6CRfVSP0p9FAHzFb/8AHvF/uirkNU4vliQegxVuA18sz6cuxnmrcYBXB5B4NUoz0qyW2wO3opP6VDEWLQk20JPJKDP5VIT1pkY2xqvoMUtIQhNVYj/xOYP9xh/KrBPNVIj/AMTi39ww/SmM6+2Hy1aFQWv3Kse1YmZInSp1qCPpU6UmSPoooqRBRRRQAUUUUAFFFFADXUOpVgCDwQax0j/sq6CgFrGY/c7Ifb09vQ1tVFcxLPA8bjIYYpTipxcWNOxasY2+0ueWQQna+PvAkY/HjmuQ0kbPF97n+ONT+mP6V2fhxmbTvKkOXjyprjl/deMlH9+D+TNXn4GcniJqe9rfdYUPtL0Ooooor0QCiiqs95HFkL87egp2E2luWSQoySAPU1Rub7GVh6/3qqTTvMcuePQdKiqrGEqt9hzuznLsWPuaFypypIPqKiuJGht5ZI4ZJ3RSwijKhnPoNxAyfcge9Yn9ra7J/qfDTof+ni9iX/0DfVqLexi2djZXRchJPvdj61ergRceKpMFdO0W29C19LKR+AiX+f41qWq+LruPJ1PQrbsQLCWYj6EzKPxx+FP2fdr+vQ2p1L6HV0Yrm/7G8Qy587xS0ZP/AD7WESY/773/AOfyo/4Ri6c/6T4o1+b/AIHBF/6LiWjkXf8AM05n2OkxS1zX/CGac+PtN3rdwf8Appq91t/75EgU/lSjwL4Zb/X6PbXPr9qzPn67yc/1qrQ7/h/wQvLsbF3q2nWWftl/aW+M582ZUxjr1NZUvjjwrG5Q+ItJeQdUju0dh+CkmrVp4Y0Czx9k0PS4MdPKtI1x+QrWjjSJAkaKiDoqjAFHuLuL3jnf+E20Rj+5fULj/r20y5m/9AjNN/4SwP8A8e2ha/MT/wBORi/9GFa6akNK8e34hZ9zmf7f1iX/AFHhHU19Dc3Nqg/8dlY/pSf2h4rl/wBVoOlwg97jVGyB9EhbP0yPrXSk0lS5r+Vfj/mVyvuR6EvjaWwPlS+HLQbj96Oe4weP9qP/AD+daX9leL5T/pHinTo/+vTRyn/ocz1r+Hf+PA/75/pWpX0+Ed6MfQ8iv/EZ5t8UvBGpeLL7wWsF1OsOm3pmvbqC4NvOF8vbuQryGJ9KpxfDHd8QrjU7ppbmzg0mC2sLy6uWmuI7lJJG8wknLMNwIJrZ+Kvjm88FQac9npP2yO6MhmupDL5FoqAHdJ5Ucj85wMLj1IrkP+FtTW95rF1bWD6iT/Y0cNsNRT7OrXiMf3TCEMACOS2d3BATkV0GRzcHwg8TJ4d1WzistLsbh9BbS5Gt7kt/atwZg4uJflGCADy2W+YjpV/xN8GLqex8X2eh6dp0Frf22myWkJk2obmByZWIwdpZSy7u+456muq0r4rXUl/a6bq+hRWuov4gOhTiK98yOM+V5iyK2wFsjA2kD69qzNW+Nd1b2X2q38OotpHd3dtPezzzNbxCCTYCzQwuyl+SMqFGPvHnABg+L/hh4m1fxDa3mn6Ho+n21sbCSyFtNCj2axFfMjL+V5jkYO3a6IB2J6+qfDLw9f8Ah6HxMupLGpv9fvdQg2PuzDK4KE+hx2rqtNuhfaba3aeWVniSUeW+9cMAeG7jnr3qzQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHzGw2sR6MR+tTwHmo7kYnlHpIw/8eNPgr5eW59Oti9HVoKHjZDwGBFVI+1XIulQwJoHLwo54JUE041Faf8AHrF/uD+VSmpERv3qnF/yF7b6t/Krj1Si/wCQva/Vv5U0B21n9wVZI5qvZ/cFWjWJkxUqZaiSplpCH0UUVIgooooAKKKKACiiigAooooAtaIoWe5Ud8N+Yx/7LXHasPJ8Zaef76uv5f8A667HRv8Aj9nH+wn82rifFkgh8T6Q7E/flBx/wGuDDq2Oa9f/AEm5MXZy+R1lQT3EcI+Y5b0HWqE19JJxH8i+3WqpJJyeTXo2M5VexYnu5JQQPlX0FVxRQKZg23uLQKKUUwY4UtIKWgQYqzp8mybHZuKrU4ZByOoqrAnZ3N0UtMibfGrDuM0+kddwpDS0hpgFFFFJgLTCaUmm0hoKKKSpZR03h3/kHn/fP9K1Ky/Dn/IPP++f6VqV9Vg/4EPQ8Wv/ABJGJ4m8KaF4nFsPEGl21/8AZt3kmZclN2NwB9DgZHQ4HpUTeC/DjSSP/Y1mGdrd22ptGbfPk8DgbMnFdBRXSZHOan4H8M6pb3kGo6JZXMN5dC9nWWPcHnA2+Z9cccduKpSfDPwXJBDA/hrTTDCztHH5WFG85YY/ukgHb09q7CigBsaJFGscaqiKAqqowAB0AFOoooAKKKKACiiigAorl7jxakPxItPCP2RjJcaa+oi58zhQsmzZtx+Oc1FdfETw3a+IP7GlvJ/tf2gWZdLSV4RcFdwgMoUp5hHO3Oe3XigDraK5Gy+I3he/ggk0/UZLsT2MmpRrBaTO7W6P5bNtCZB3/LtPzE9BWFq/xl8N2Okm9hTUZ3j1CHT7i1NlNFPbvJyCyMm7G3kcfN0GTxQB6XRXIH4j+GBrcGlG+mFzLJFAGa0mWJJpV3RxPIV2pIwPCMQe2M8Vd8O+NNB8R6leWGjXr3NzaM6Tj7PKioyPsYbmUKSG7A+445oA6KiiigAooooAKKKKAPmrUMfb7sDtPIP/AB402DrUmuIU1rUto6XUoI/4GaggcE46N6GvmJr3mfTR+FGjH2qyM7Ds+9jj61UiPSpkLSSFQxVV447n/OKzYy5bY+zx7fu7Rj6YqU1VTNuiDcWi4XkDK+lWqkRG/eqNuM6zbe24/pV5+9U7LnXYR/ssf5U0B29oPlFWiKgtV+UVaxWDMhFFSqKaop4FIQtFFFIQUUUUwCiiiiwBRRiq91crAMD5nPb0osJtLVkzMFUliAB3NVZL+Nc7AWP5Cs6aWSU5kbPt2plOxhKs+h0XhmZp7y5ZgBhUAA+rVx3jfH9vaV/11kH6LXYeER81w3qQPyH/ANeuK8bEHxLo49ZZT+i159FXxt/X/wBJKje0r9kaY6UtFFeic4UCiimAtKKQVFcXMFsu64mjiXrl2Cj9aEBYoFYdz4r8PWmftOu6VFjs93Gp/U1EPGWgn/VX/n/9e8Mkv/oCmrVOfYV0dGKWudHiy0f/AI97DW5/TGlzoD+Lqo/HpS/8JDeP/wAe3hnWpfQt9niH475Qf0/CqVOXUXMjtdObdBjupxVvNcXp+r+IWd1t/DaLkZxc6gidP9xX9avef4wkPFhoFsP+v6af/wBopRyPy+9HTCV4nTGm9a5o23i+UfNq2h2w7hNNlkP4EzgfoaP7G1+T/XeKpo8/8+1jCn5bw/8An1pcq/mX4/5FXfY6WkJxXNHwzcuf9I8T6/N3/wBZDF/6LiWk/wCEN01v+Pi71u4P/TTV7rH/AHyJAp/KlaPVj17HSE1Tu9U0+zJF3fWsGOvmzKuMfU1jf8IN4Zb/AF2j21z6/agZ8/XeTn+tXLXwv4fs8fZNC0qDHTyrSNcfkKXud3/XzH7xWl8b+Fon2N4j0gyf3Eu42b8gc0z/AITbQ2/1M15cf9e2n3E3/oEZroYo44U2xIqL6KMCn0rw7P7/APgDtLuM0HxlH9hK2uheI7k7zjbprxA5xj/Wbf16d8Vpf8JPrMv/AB7eCdcx2ae4s4wfwE5b8wK1/Dn/ACDz/vn+lalfUYT+DG3Y8ev/ABGeS/GvUNaTSvDv2LVbTR5pZWlutNm1X7BJdqqjMcd0OhUsOhGR9K5fwl8XRYadpCXUjWel3Wm39zHNrl2biV7mGTCxJcZAlQ5IHG44HPr7T4o1Lw9p1pH/AMJTeaVbW0hOwahJGiuQMnG/qQOeKztR8U+C4tJ0y/1HWNBXTrjIsZ5p4vLfHB8sk446HHToa6DI8h1D4zeIV0pLpbjw7Yyp4etdZENxBIWu5pGYNBH+9GM4GOGI/UdHdfEnxFH/AMJrfTppVhpHh5UDB7WWa53yQI6gqJFU4d8H7vHp1rq5Y/AWn+LZtVudS0WHVEs4oTFNdxKIYkDSowQn5fl3Nu/ugnoK3Jtb8MQxXskupaMkb2y3d0xniw0DDCyPzyhHAY8HoKAPGtM+MHiKXTNSguX0YXEGr2OnDVSim3t4rlGYyyrHM6HYV28S4ywBIwa1tM+JfirVpfDWn6ZHoT3mpajqenm+lilNtcLaoWSeIK+QrYPGWzjgjrXqPh6bw5rWlSXHh86Ve6dP+7ke0CPG+0Y2tt4OB2PStVbK1U25W2gBtwRCRGP3QIwdvpxxxQB4D4K8ca5p3i+405tUsNRS+8ZX2ny6a4d7uGLLHzkYyHbEm0DbswMnn0r+CvGmuy3vwtf+07DTNI1SxumntZzNKJnSfBVXklLs5UqEyWIJPDAgD6Cg02xgu3uoLK2juXzumSJVdsnJywGTk80DTbER28YsrYJbtuhURLiI9cqMcH6UAfNt18XNc1/R/FFkLuzktJ/D13qFrc2sYtp4GRgo4WeRgOTjfsbgHAr6K8Lu8vhnSJJGZ3azhZmY5JJQZJNSrpGmqZCunWYMgYORAvzBvvA8c5xz61dRVRFVFCqowABgAUAcL4t8B3eseMrTxNpHiO70TUbeyNiGhtopg0ZfeciQEdcdu1Zy/CLTIvGj+Ire6QSzXseoTpNp1rM5mUgkxyvGXjDFQSFPBJK7Sa5r4weL9c0vxzf6RpWtajYhPDq31hbWNilw1xfGeRERsxuQrbVB5A469c5PiTxr42tvHOmwwtqdo8dzp0N3ZNbh7eZZVTzigEB+UMWBczA54A4oA7Sy+D2ixWfjGG11O9VfEAaLdE4BsYzI8hiix0Xe7EjuOKgtfgrZW2marbx6zPHPe3VnepNBZwQrBLbD5NsSKEx6jH5nJPB6br2peGv7J0+TVNQ0PTdU8Qa59sltrNZZiigvGUDRufvY5A6Gl1Xxb8TBonhn7bcz6QbjS5Jmv3tWUPdCZxGJlS2mIzEI38vCZLN8wwBQB6Y/wvsrrXWu5dcvZbZ7+31O9sVWIJPeRKoWQkLuUHaGKA4J6YFdT4K8MQ+FdPvbS3uJLhbm+nvizgAq0rlivHYZrwax1XxJY+NtZn0y51KPXNQ1bTn+wQ6extruNoIhOzs8e5FUbv4lI7jPTpZPEPjKLwP4k1u91PVZWTVJbC2trWyhia3iF0AJi/lO23y8gtsbg5wTzQB7pRXzVb+M/iC/g+IyXN61vHr1xZXGpi3aOVbVYUaJifsrEKzsw8zyOwHy5Jr0eDXPEqfAW71iS8W58TQ2Fw8d1b2rKJJEZwjiOSNSSQFPKAHqBgigD06ivnSfXPiFY3OqSHXtRuk0+fSJ0jfT4gLgXWPOjO1AdiYPC4Izya950XWbbWG1FbWO4Q2N29lL50RTc6hSSufvL8wwRx1oA0qK57VPGOkaVfy2moHUIHjIBlbTbkwnIB4lEZQ9ezcGmWPjzwlfP5dr4l0Z5e8X2yMOO/Kk5H5UAeMeKF2eJNXX0vJv/QyazUAbr+fpWv4zMbeKtWaF1dGuCwZDkHIB6/jWPH1r5qqrTa8z6Sk7wT8i2A4jz5rDp0A6VoQqEGFHXk+9UQf3LD1rQQ9KxZZYwGjKsMgjBFNhkJGx/wDWLwff3py1HMu7BUhXXocZpCHsar6YN/iBf9mM/qR/hT4nLKdwwwJBp3hxPM1q4fsqqP5//Wo6MDuLdcLU4FMiHy1KBWBiAFOoFOVc0rCG0AGpRHn3qdLZ2HAq1BvYlyS3KoQ04IKvpZn+Kn+RGvXFbKhLqZusuhnhR2FLsP8Adq63ljpimB0Hel7K3UOe/QpzAxxM5XoM1iOGdizck9a6K7KPbyKOpHFYDSqKTgl1MKspXRA0dOW3AhaSRgqj1qN5fSsXxleXK6BILUEsoJIFEVFuzM/eZ0+lXtxb6fcy6bapeXAPyRGURBugPzEHHrXmviHUPEN54p01DpelwSJ5jKGv3fOcdcRDHT1NXfBvjKKLRIRJkzFMN7N3H51naFfPrHjWeZfmht08sN2zyT+px+FcmGpyhWk5R2u769dD0KtLkhzX3sbgj8VSDm60O3P/AF7Szf8AtRP8/lQNN8Qyf67xDCnr9n09U/8AQ3f8P610YXNLsrp532X3HBoc3/YF9J/x8eJ9Yb/ZRbeMfhiLP60v/CLW7n/SNS1ub/uJTR/+i2WuhKkUlHtJDsjn/wDhDtDP+us3uB6XFxLN/wChsalg8J+HIG3Q6DpSOeSwtI9xPqTjJrbop+0n3YWRDbWltajFtbwwjGP3aBePwqekozUXGPFKDTQaXNAFvTj/AKSPcGtasewP+kr+P8q1s0XOil8IuaDTS2KZupXNbD6KQHNLmi4wpM0UUgCiinouaEriOj8O/wDIPP8Avn+lalZ2hDbYkf7Z/pWjX1eEVqMV5HjVtajOT8Y+E28Q+IvCmoGWEQaNdyXMsUqbvNDRMgA7ZBIPPpXmh+Bt5BbWTWup2jyxR3lrLayNcwwSwTzNKFzBIjDGdpU5Vh24Fe70V0GR5z4N+Glvo2s6xd6klheQXmnWFhFEsLfulggaJwC5ZgrAj+InA5J61yum/A2eHwVq+k3mvGbUri4tTa3gRgIoLXHkRMFZWx97JVgckEcivcKKAOO+GnhSfwpYail2bM3F9dm6lNtJcSbmKqpZnnkdmY7euQOn1PY0UUAFFFFABRRRQBRGk2A1ttYFrH/abW4tDcY+YxBiwT6biTV6vMvi/wCPdV8GXukx2ltDbaZdLI1zrF1ZzXcNsVxtRo4SGyc9SexwDg1Jp3xV0waPeT3xF7Pp+jrrNzPpihreWIsy4i3sG3fIflYDHQnNAHd3mk2F5qWn6hdWsct7p5drWZh80Rddr4+q8VerzXUPi/pNldXqNpOsPZ6e9mt9ehIvKtxdIjRMR5m4j94oOFODnrxn0qgAorytfjboTeFLbX30vWLayvJY4LI3iwwLcyN5mQrtLsUL5Z3MxCjI5Oan0r4w6XrsOnr4c0fVtW1G7imnaytjBvgjifY7M7SBCNxAXax3ZGKAPTaK8mg+MIt7nxfJrXh3VbbTtCuIIRKixlm81okVWUycMTKGA6bQckN8ta3iv4saJ4buNbt7u1v5J9Ku7Wyk2iNI3kuIvMQh3cKqhQdzOVAPrxQB6HRXKp42sv8AhXk3i+e1uUsYbeS5eFHhmcqhIO1kcxtnbkENggjp0rk0+Nel/aJI7jw/r9ssM9rHcSSxRbYI7nHkyNiQnDZ6DJGDkDpQB6tVe8srW+jCXttBcIP4Zow4/I/QVYooA+b/AIkeEtCt/GWorb6RY26ny2XyIVix+7X+7juDXMp4ftlx9nudRg/3L2Uj8mYj9K9O+LkPl+LA/aW1jb8QzD+grik614GIlKNWSv1Pfw8YypRduhRXSdQWNhb69ekYOFnihcfmEB/WrkUfiJEDJe6XcKRkB7V4j+YkYfpV+DtVi0/1KD0GD9RxXM5v+ka8i/pmet74gh/1ukWUy+tvfHJ/B4wP1obXbmP/AI+tA1WLH8SCKUf+OOT+lba9Kaxpcy7fmHK+5z8nifTodzyi9t8/fW4spox9QSmP1ra8Ea/oc7ztHrGnNK8n3PtKbhjjpnPamX0wigYk9Bmuh0DSbSfSoI760guPlywljDjJ69fqaUnC2wpcyW51EDK8YZGDKehByDUoGa5tvA/hlmLx6JY28h5L2sYgYn1ymDUieDLRf+PLUtdtD22anNIB9FkZlH0xislGL2f4f8Ewcmuh0saZPFXYbUsPm4FczH4e1m1GbTxdft3C3tpbygf98IhI6dTn39Emn8YWinbqHh++A6BrOW2P4kSOPxx36evTCjCOs2YSqSlpFHYrFHEOcVHNeJH0xXm+peL/ABFZZ+26LYSgd7TUtxP4SRpj6ZP1rltR+JsqZEukanAw68RyD/xx2rXme1NfkEaV9ZHsVxqiqDlgKyL3xFbQAl5V/OvDdQ+IX2gkPLcW4P8Az1gkjx+LKBWfHr1tft8mp28reizKT+Wah06j1kdEYU11PYb3xxbRkhDuNZcvj7J+VDXnqxMwznINPEJqPZxNlBHbt49lPSM1Sn8ZOXLiI89RXLrCfSpVtx6UckQlTjJWZ0C+Nh/FGaZP4yheMho2weoxWE1ojDpg+tQPZFe2RRyQMJUOU5/xObW71COa0gliVnBmKEqCK9P8G3OlW9oken7E459a4xrZSMYqNIXt33wkqR6Vc/fjymbge0wzKwGDVyPaw6815RpXia5tSEuQXX17122la1DeRho3GfTPNc7i47mE6T6HQtFxkVC0eKdBchuCc1YKhxkUuVS2MruO5QIxRViRPaoGGDWbVjRO4lFFFK4wooopgW9MGbn6Ka1c1n6Un33/AAFaFS2dVJWiNc0zNOc81GWFBqSA0uai3UZoAlzSio1PNSLRYTHKMmp1woqEMBUFzcYB5rWNoq5DuzrtAffYkj++R/KtGsPwfKJdKdgc4lYfoK3K+mwrvRi/I8iurVGgoryH9oLxDrmht4Tg8PX1zaNf3zwzC3eCN5FCZADzDYvPc1S07xR4si8d6RosmoW76dL4aa/mW7liaZpRKFLCSJdrSDOAFOwjJ610GR7XRXzz4J+J/inSfB+lPr1vY6hHceHLzVrW4+0SNPI9su4iYkY+bjp09TVq4+MPi2ztr67u9G0I29lDp1/MIrmYube7ZVVFyuN4LZJOAPQ0Ae+UV5JB8UtQk8ZLZmxsP7KfxBJ4dEIlY3gkRC32gr08skdMcAg5rm9O+JesT+DdDtNMFvBeahZ6pdy3mp3Uj7EgmkTajcFpDwRk4UAcGgD3+ivnG0+Mms6J4W8Psi2urm303T5tTM3meeGnIGTISFycgjAc9c4r1D4Tane6lP45F/dTXAtPE11bQCRi3lRLHEVRfRQSePegDvqKKKAOd8UeEbLxFcRT3F7q1pKkZhJsL6S3EkZ6qwU4I98Z9653Uvg74QvYYYY7W9soI7D+zTHZXssKyQZLBZAD8+CSfmzknnNbfiPx1pOhawukyR6hfaoYPtTWmnWclzJHDnHmMFBwM8ep9K2bfWdOnsvtaXkKwCKOZjI2wxo4ypcNgrkeuKAPP7b4R6fJ4u1rUtVubi40y6ksZINPSd0jP2aFUXzlBxJhkDDP4132i6NbaO2otayXDm+u3vZfOlL7XYKCFz91flGAOOtSjV9NN6lmNQszeOzKsHnL5hKjLALnOQCM+lXaAONX4ceH18H6Z4bWK6Sx0uQT2Usdy6T28gLEOsikEEb2/Oo7n4a6PcfZZXvdcXUbdZI11FdTmFy0bkFkaTdkrkDA6DHGK0fEPjbQ9E8Manrz3kd7Yadj7R9idZmUlguMA9cnoSKdrHjPRtMhsJTdLdx3mpRaSjWjLKEuJDgB8HjB69x6UAZN/wDC7w3fHW1uI74waxDHFd24u5PLcx7NkgXPEg8tPm68H1OYofhXoMNvqEcV3riy38sM9xcHU5Wmdo4zGuXJJYFWIKnI6cDAx0ll4l02fTEv7qZNPgedrdftsiR7nViuAdxBzg4Gc+1X01OwdSyXtqyiLzyRKpAj/v8AX7vB56cUAYdr4G0K08DTeEbW2ki0WaGSGRFkJdhISXO485JJOao3Xw08O3X9oebFc/6d9i87ExGfsn+px6Y7+tdPNrGmQ3NrbzajZx3F0AbeJp1DTD1QZy34VLfX9np8Ykv7u3tUOSGmkCDgZPJPYc0AVdE0a20dtRa1kuHN9dvey+dKX2uwUELn7q/KMAcDmsmbwLozyvLBJq9nI7FibTV7qFck5PyLIF/DHc1u2eq6dfTmGyv7S4mEazFIpldgjDKtgHoex6GrlAHhPxZ8LTafe6bJb+IdbPmxyKPPljnI2leMuhOPm9f61wK2WsRn9zrEL/8AXxZhv/QWWvb/AIzwZ0/TLnH+rmaLP+8uf/ZK8n/irw8Y3Gsz28GlKiilAfEMfRdJuPxkhz+j1PFf61DKRLokb7hnFteq/Tgn51T2rQgNWsHKunJXjHqDXG5Lqjp5X3M4a9Mn/Hzoerw+v7uOX/0W7UjeKNNU/v8A7bbn/pvYzRgfiyAflW1FIHTcM/Q9RTZW2qTSvHqgtLoznZPEOi3t1DBFq1gxZxuX7QoIHXkZzXqmhvFLao1vLHKmB8yMGH6Vw2lWcOo6m32iGOWONduHUMMnr1+grqk8FeGrjDzaBpZl/wCei2qK/wD30BmpnyPTX8/8iJuSOpjWp0ITrXMDwTo8YzbNqloR0+zapcxD/vkSbT+IrN1TSJ9PhZrXxRrsAHZpIZh/5EjY/r/WiMYrVP8Ar8TD3paWOt1DUUhUlmwBXn/iTxgkQaO3bc1cRr+r680jxQ64k6dMz2ak/wDjjLXNhdaLbm+wTn3Lxf8AxVbRpX1bNIrl6G7e6ndX0hLucHtUEcJY5PJqlFJqif6zSkf/AK43Qb/0ILVqPUpI8efpGpxfREk/9AZq05WtjTmRdjthxUj6bbXAxcW8Mo/20Dfzqumuaev+u+1wf9drOZB+ZXFXLfXdFlbbHqtgz/3PPUN+Wc1DU10K5oPqUj4X0nOY7CGEnnMA8o/+O4oXw5Ev/HvealD6YuncD8HLV0MLRzLuhdJF9VIIptxI8bpFCgeVwSM9ABQpzk7JjVOL2RzN9YX2nQrJ/bc5Rm25nt43xxn+EL6VnLf3kbkNcWV0BzloZIc9PRmrrrzT5bxfK1GWNYxiRR0Hcex9e9UToNgkYJmty5baMyjDZPU88etdtOLiveSubwpwS3d/UZBPZSxp5N+qyk4w7MABnqcjHSriJLlvLeO5jXGXTH8xkVTm8P2bFlt5UaRVzmOQd8jpk1nS2OoaZEJ7OWWIFd2CdrEe/YinKnF7o15Yy2NxVjmLAArIpwynqPrTXtmx0z9KoeH9Ql1K7WMxKPKUs0o4LfX3ORXTeVXDVioSsjlq0UnY5+W2yOlQIZrZw8LsrDuK6OSBW6j8aqy2YPQ/nUKRzuk1sW9G8VtG6x3gx/tCu903UI7hA0bAg15Jd2LAH5Tj1FS6LrFxpM4ViWhJ5HpScOsTnqUrns7gMuRVaRaraJqUd7boyMCGFX5BzWUlfU5V7rsyoRRT3HNMrI0CgAk4HU06ON5GwikmrG6CwzJcOCyjJx0WgpRuX7dBBbgOQMDLE1T1B57jT5zErwxmNjuJw54OMDtn1PPtnkJayJfbWuWcbuRA3Cj0z6n68Z7Veu3MVrM4XcVQtt9cDpS2Z1xa6FQia3H7v9/D1ALfOvsCfvfiR9TQk6yorocqwyKfGnl20SBtwVAu71wOtUpbcB2aGR4mJzwcrn6Hj8sUyy8rUu6qVpP5qHcAsina656H/PI9qp3+v6Tp+ft+q2Ftjr51wiY/M01FvRCem5tq1SiQYrjh440Bv+PbUPtnp9jhkuc/Ty1bNO/4S3zf+PPQteuc9P8AQ/Iz/wB/in61fsp9iXKPc6qWXiuf8QaqllbsxPPYVm3Ou6+6FoPDfkj/AKfL+NPz8sSV59r+oeINQuiJP7LtgpxhTJOB+PyZ/SrhSber/EqLXY9/+D9w914VllkOWN0/8lruK8b+EOjeILvwo5XxVLZQ/aXBWzsIQ2cLzmUSfyrt/wDhCvO/5CHiXxPeev8Ap/2bP/fhY8fh/hX0uHVqUUeLiP4si/4vs/DF1ZRN4xttFmtI3/dnVY4mjVyO3mcAkelZttF4Rkv1t/7I0qFNGSIWlzJbwCKNZlJAgb+EEDnAGc8ZrC+MvgPUvGI0WTRDZx3en+fsnuLp4miMiqMjEciuPl5DLk8YYc55m6+D+t3TX6Xd3o11DcyaGWBjMaOlmrLMDEqbVDZ+VRxjg7a2MT0+1sPCF3Y2i2tpoE9mI5LC2EUcLRhHGJIUwMYIHzIOD3FM1C28FwWkh1GHw7FbT+XaOZ0hVJPJOUjOeDsIGF/hI4xXnc/wq1uwvJ7zw4+h27Q+JhrdlaSb0g8ow+WyNsT5Gzk/KCPesK++DHim4sYmS40RNWF1ez/akuZVWMXEofHltE6yL6qQp/2/QA9pMPhePxRFdGPRU8RXEf7ubbELuRMY4b75XH4VVGk+CtSKaGLDw5dnT3eRdP8AJgk+zMxyzCPHyEkkk4GSa81k+D2rr41GqNcabqFs95aXvnSSvaywSQqinZGiMCPlO1dyAZxyK1Phh8Nda8KeMp9RuJ9Nh0kxzBbWB2uGLyOG3K0kavEPVd759e9AHoFx4L8LXJgNx4a0SUwRLBD5lhE3lxqcqi5XhQeQBwK1rKws7A3BsbS3tjczNcTmGMJ5spABdsD5mOBknngVZooAKKKKAPJPi58ONS8YayLzTbTRo7lLUQ2+pveXNreWrZJJ/dgrKoyCFbGDnnmsTxf8KfGF9B4ls9M1XSLyDX9NsLW6utRaVJ/OtVxvwisPn5Yk9z0717tRQB4D4e8Aa3q/jLVrq4sLPTtPtPGkmri9njdbydEVNqRAoAYWJPzbsfewK9afTda1nwZqul+ILiyttRvYbm2E+mh9kSOGWNhv53hSCe2c44rpKKAPAZ/g34guvC2uWTS6DY3lzotpo0EVm0ggm8mUObiY7MhyBjADY9T1rTT4V63Pqr6rKdDsJptf0zUnsLFpPs8UFoGB2koMyPu/uqOBzXtdFAHhY+FWvWFjocy/2LqM+mTao72ly0jRMt05ZXT5CfMUYGCMHJAI61jeHfhv4uuvBulz6YNOs5b7wjJ4fvLXVlmilgLSSMGACnn58YOMdeelfRtFAHgWo/BbWJtViufP029hls9PhlWa6lga2lto1TMZWNi6kruAyhyT616P8QPBreK9f8JXE0Vhcadpd3LPd292u8Sq0RVQq7SCQxB5x0rtqKAPEfh/8Kdd8GHR73TzoA1Wy0K7sZHHmbJ7p5d8TOQgZoxhQScMOwr027XxYYLFrOXQhOIFF3HLFKVM2PmMbBshM9AVJ966GigDyv4knxhL4UuDeaPoUkUDpMZLfU5Q4wccI0GD1/vD9OfHf7S1ND+90OZv+uNxE3/oRWvqfX7P+0NDv7MDJngeMfUqcfrXzcpyqn1FeTmCSmpW3PWy9twavsUYdcdD+/0jVY/+2Kyf+gM1XI/E2nov75b+D/rrYTqPzKY/WrcPWr0fSvObj1R32l3Mc+KtCWRWOrWcRPysssojJ/Bsc/0qy+r6fOhNvfWso6/u5lb+RrRYArggEHgg1gX2k6fdsLeaxtJGZgoLwqTj8R6Z/KhcjF7x13hNRDbiR1ZpZTuCKMs3+eK7S3uGiKrcxrErDhw2V+hOBg/5zXEaJ4G8OiAY0i1jY94V8o/muK3U8GaYiZt7jWbc/wDTLV7oD/vnzNv6Vk+Rvf8AD/gmU3Lsb1xexiJikisBwSpzivL/ABrrrSyGCJ+B1wak8VaXLp0Mj2niHW43bGQ8scoPb+NDXms9tqUkxI1Z5D6ywIf/AEHbWtOmm+a443itjQXLuSa0raHgcZPpWHBbaypG260+Uf7Vu6H895/lWtaHXUyRZabMvTIunjPHoPLP861kuzKUu6NRImA+6PwNTxIG7YPpVBbzVkH7zQpHx/zwuo2/9CK086rKuDNourwsM8iOOT/0B2rPlf8ATK50ayR4omt4pk2zxJIvo6gj9ayh4htVH76K/gI7yadcYP47cfrQfFOiocT6paRjsZG8r/0KlyT7Bzx7kknhrRJn3PpNjv8A74gVW/MDNZXinw7Z2mjtc2TXdvJGw5iu5VGCcEY3Y647V0Fpq+mXRH2bUbOb/rnOrfyNQeMpAPD8yggh9mP++gaunKamldlQjByWiPOILYwvuNzcTBsjEr7sdOc4z+tWc/cP0/Q00fcX8P5UDov1/rXo7npqKirIeCNj8fxD+X/16bJdzLbCJJpFjK4Khjg59qTkI31P8hVe4HAA9hSGzvfAdkI9Ja4I+eZic+w4/nmuiMdYvha9hj0qGMMBtXB+veq3inXhFA9pbNiZx87j+Aen1NefKEp1GefrUm7F46kk00sdmEmMRwwDcn6DHIqWGZJ8gBkkH3o3GGFee2s8ttMktuzJMDlSvUe1dnb30Oo2InTA1KI/OqA469R/s4z+P4V0PDRa03Np0VHY0GTIrK1C2U87RW1AwnhVwMZ6j0NQXsOY641o7M5mujJfA90Irr7PIzBe3NerR2SzQhll5+leJ6a5g1OJunNex6JdGW3G05OKmpo7nNVpRethZLONP9ZOB+FNjSzDAFix/wBrIFUpZPmZpG9yTVc3PmDEEcjnHUqVH5n+mawaORSSeiOgnkS1t2fbwo4VR1PYD3JrnUhLfvbkebPndzyFPouf51d+1NFb29xqFzDFbxufNzhUUBGOWYnsQOeK5WXxDdanK0XhWx+1R5I/tC5zFaj3XjdL/wABG3/aFOMG9jSs1ZCya1rixtMnh9baNBuL3+oRxBR6koJMVRXxb4y1mMnw9pujPbKpMt87TPbKAP4HIQyn/cUr6sK07Twuk8q3PiG6k1i5UhlSVdtvGR02Qj5ePVtze9dtZRrNZTQOPkYYIHoRit04LZJ/eY02+a1zml0PxA0SpP4n8pVAX/QtPjj/APRhkqrJ4W8w/wCma7r1z6/6X5Gf+/IT9K6y2dpLKCRzl3jVifciq0x+aoc5I7FFX1OVl8D+H5gfPsTct/eu5pLg/j5jNnvwfU1f0vSNKsgVtNK0+0ljIBEFuiD2IwOn+e1amaqXLPHcoYVVmcEMGOOB0Ofx/Wpc5PRstQS6FwNS7u9UzdBM+akkY/vEZH5jOPxqZ2whNSVYxPFN99ntGCnDNwK89dixJ9TW94rujNebAeErDRcsK6aasi9ke7/BMY8Gv/19P/Ja76uG+Da7fCDD/p5f+S12d3d21nH5l3cQwR/3pXCj8zX0OH/hR9DwMR/FkTUVx3jvxmPDcHhWezgiv4dc1m00tZFlwqpOGPmqQDuwFGB0OetN8ffEbRvAssI12G/EEiBzcQxBo0G7HOWBJ7kKCQOa2MTs6K49/iDpR1650yztdUvjaukd1dWtqZLe3d1DKrv64IJwCBnnFZNn8UdO1hvD0ujLdR2eqXqWyS31hNGs4ZHbETHAJGzluQOlAHo1FeXf8Lv8MNF5kNlr8yNBNcRNHprkTrC5WXYeh2YJJ4A6ZzxWj4k+LXhvw9baZd34vjp2oWsV5FexwgxCOT7pOSGJxyQASARnrQB6BRXJ+APE1z4kl8ULdQwxDSdan0yLy8/OkaxkM2T975z04rrKACiiigDxj4lajbj4qW+n+M9avNF8I/2M89rLDeyWcc14JMNmRCCzqmCEJP0OcHkNK+JnirTPCvh231vWrDSprjRbu+F7q1vuluDFNiAYLr8zpjsxPXBJzX0nJGkq7ZUV1BzhhkZrLuvDumXXiO2124t/M1G3t2tY3LHaI2YMRt6Zyo5oA8Gv/GniSXV9Ym1nU7ayjuvBX9ppodxG6CSX7PKzpH+8DBgyliQN20beCN1dBY+P9S/tTTdNuNa0fw1aQ6Rp91brewNK2pvKnzpGS4OFIC4G5snPNe2SQRSsDJEjkAqCyg8HqPxoaGJvL3RIfL5TKj5fp6UAedfEbxD4jtfGGjaB4bvLCy+3WF5dSXFzamcqYQhAUB1HO4jnP0NeZXvxo8WzWejSw/2NprzaRDqAa9McUN7IXIkUPJKuFAXom5sn0xX0o0aM4dkUuAQGI5APWmG2gKIhhjKRnKLtGFPt6UAeSReLPG+rx+O7jRZNIWPQ5ZYrS2e1d5ZmWJJACwcDnJHTkkdK5+8+L3iG88Gt4m0y3trbRr/V4dPtLiaH/j2hEX72Vy7qvMoKAsQoxz2z78kaIWKIqljliBjJ9TTVgiSHyViRYsEbAoC4PXigDivhx4qvdV8BHV9da2u7iCWWOSTSR9qWVVbhlWIvlsEZVS3OcVe/4T/QF/17apbY6/atIu4MfXfEMV1MaLGgSNVRBwFUYAp1AHKf8LG8HD/XeJdKtu3+lXCwYPod+MH2rQtPFvhu8x9k8QaRP0P7q9jbr06NW3Wfd6HpN5n7XpdjPnI/e26N169RQBcgninQtBKkqg4yjAjP4V87+JrP+zvEepWmMLHO20f7JO5f0Ir2Wf4feDp23yeFNBMnQSCwiDD6MFyK8e+KfgjRdK8TI1lYC2t7mAOqwSPGAwJDAbSO20/jXDj4J0030O7ATaqOK6mfCeavxHiuVj0C1BHlXOpx8YwuoTEfkWIq5FosoH7rW9Wj/wC2kb/+hoa8Zxj3PXvLsdA/ANVNPi8/VQ3aNf1P/wBb+dZkunanGp8vxBdv/wBdreFv/QUWp/DuneID+8g1fTyXYn9/p7P7D7sq+lLlSW/5/wCQuZ9vy/zPUtMj2xqK0bp/LgP0rlbOLxbHja+gz45wUmi/Dq35/pRqt74siiIl0fRZF/vRanIG/wC+TBj/AMerOMNG7o55SvI43x1eGS48sHgVyVsmTzS+ItS1SS+k8/SGDZwRHco4/XFU7bUZ1H7zR9RX6eU3/oLmuqMGom3Mv6Rv2yAYJ6Vt2UR2AEYPU1zFrrECN+9sdTQjqfsUj4/75BrZtPEmlLjzZLmL/rtaTR/+hIKiUJdhqce5vJDxWH4m8QWugRK93n5jgYGavR+K/DpwG1vToyegkuFQn/vois/xFa6J4ktfLXUbKVwflKTq3P4GpjFp++nYTmmvdepW0HxfpmrOI45lWU/wtwf1rplXcMjkV4nrPhG80x/PtmLhTlWTr+BHWul8CeMm3Cx1WQeYOFZjjd/9etalFNc1MiFVp8szvZtH0+4H+kWFrL2+eFW/mK4fxnouixzRW9lplnBIxyxgiEfT/dxXe3mpW0NoZhIpBGRg1x2mQtqt7PqVyD5CfJHn+I98fSrwkJzmFWrCnaUkczbeGUmkCQC6TkD5LiQDp6bsVqL4Iuxs2X17Hnn74bH/AH0DXXRyw2kbTylIo15LHiur8HaLJ4gsY9UvZZbTTZj/AKNHGAJZ1zjeSQQiEjg4JPUcYJ9Oq6eHg51pWSOZ4+c5WpRseWXfgzUYo8Q6rJIecCSFD/ICsC/0nWbYlnmtnUdzbsv67z/KvpxvD2kzRbEt7qMlVIkSVmbJ9mGD+lefeI9Jl0+5e3n2yKVDRyKPlkQ9GH8sdiCKwwuLw2Nv9Xle3lb8x/W61F/vF+LPGtMvtZgh3LDasM8bpWT/ANlNWLaS5ld3vYRGeoIk37ifwHNaep25t52BXnPA7VSJ79T6noKclZ7Hs4WnGMU4vcCSCDjBI4HoKsadqMtjeJLbkfL98Ho47g1UUSTyCOBWd29Bkmu58M+GI7RFub5RJcHlUPIT/E1lUqKCuzepOMVqa2m7jAW8iRFdt6rtCkAgdfSpZg0sWVTavq3f6Yq/wqlj0AzUFz+5sRu/hQA/lXmylzSuee3d3OaciO7DN91TkkV3fhfVlCCOMh5GHyLn7x7V5hdTz3EsiwfdHJNXvAV+8fiOBZH3LyB9a9nEZFjKeDWMnD3Hr526NrszzYZlhqld4eMveR6zqFqzXDedKWRsMUUbVP8AX9aran9t+xSf2X9m+1nAQ3O7yxzySF5OBnjjPqOtP1vXtHskje91XT7Yjg+dcomPzNY3/CY6G3/HvdyXf/XnbS3Gf+/atXgKM3qkTUspNEtj4ZicPd69dTaxeQssyeeNsEZUg/JCPlHTqdzf7VdRqabZ1fsw/WuVHiWWS2uRZ+H9cud0RQHyEhwTwM+a6Vp3V74kvUC2/hy2gOeGvdRCY/CNJP8AOPwcozlv+hcUnTsjUgUEVp6anEh7YArl7XTPGVydv2nQrFe58iW5IHt88f8AKtNPDetmPbceLLyNe4srOCLP4ushH4HPvW0aatuYRTUrtF2zGLCFe6L5Z+q8H+VVLplQMzsFUdSTgCsm18IW0tqn27U9cumQsjA6lLErMCQfljKggkHgjvUD+C/DiSB5NGs7iQdHuk89h+L5OamSh3/D/gnbFyvsNvPFOgWb7LnWtNic9Ea5TcfoM5NZ8ni7SpLuM2v2+7OxgPs1hPIDyvcJj9a37aytLIbbO2gt1xjEUYUfpUdwf9ItyOpYr+G0n+gqE4dn/XyNFzdzHHiG8lH+ieG9XlH96TyYV/8AH5A36VUuLvxKkL/Z9L0+2h9Lm+Ziv0VYz/6FXUZ5rP11yljIfampK+35j5X3PLLsa3dXDvLeWEOT0jtmc/mXH8qINJu5T+/1i9x/diWJB/6AT+taOMsau2idK6edpFciPS/hd4K0q98NNJqEuq3TfaGGyTVLkRnhf+WauE/8d9uldraeAvCVpKJYfDekef8A89ntEeQ/V2BY/nVL4UDHhZv+vh/5LXZV7mGd6UX5HhYhWqyOV8deCLDxjpel2Nzd32nLpl7Ff2sunskbxyxqwTG5WGBuzjHYVyWpfCTw/wCLLfz5/E2uX7vaNp094l1BI86CVn2s3lEAqxK/Lt4ABzzWt8YJdajttAXSzrCaU+oBdUk0eNpLtYdjFdoUFtpfbuKjOK8z8DT+K/Cel+Gj/Y/iZtMlfVlubaKyZpRK8xaB5UIBGRnDHjmtzE9XT4dWEGs3N/p+ra1YR3bpLd2dtcIsFy6KFDOChYEgDO0qGxyDTrL4daRaaR4T06O4vzB4anFxaMzpukYKy4k+XBGHPQDtXl2h3njOWLRH8YN41hgbSYWg/sm1YyNeeY3mfaRtyrY2YD4TGc8113wP0i90TVPG9pqK62sj63czxG9iIgmidyUljfaFdmH3sE4wMgUAalj8JNCs7HT7SK71Mx2VnfWUZaSPJS7YtIT8nUFjtxgDuDWdrfwP8O6taQ20mo61BEmmW+kv5MsWZYYMbCxaM4bgZ27QfSuR0VPH+p+KtfsXuvESxzwXht9QlWW0htXyfJUxunltzjBiY8ZJ98/TfEHjrxV8MJfE8N9qltLqGoW8MNtY28k4FvDEVlYGJTIgklDEuoYjCjoSQAe7eF/DVn4bfWWsZbiQ6rqMupz+cynbLIqghcAYX5BgHJ681uV86eEtO8U/8J54b1zVbPxPbXM2hT2yGZmuFW4FyWSOdwgKRsuG+fB4UEkg5z9LvPiZFoGvyzz+J21g6VJvtZLCZgt2JFw8L7dnQsAseQRzgYoA+m6K+e5bTx7p2v3pt9U8W3drY6xpZt1mj3pcQzohui2IxuRTkYGFTnoea+hKAOKu/Fd9D8YLHwosVsdOn0eTUGkKt5okWXYADnG3Htn3rM1T4rWWm+PIfDU2myyGa7SxS5guYZMTOm5VZA25AeR82DxnGOa2/FXw+0LxPrVvq2pC/j1CCD7Mk1pey27CPcW2/Iwzyarn4Y+GTrqasLe8Fyt8mphBezeT9pVdvm+Vu2biMZOMmgCP4ReMdS8a+HrjUNV0g6c0dzLAjK6MkgSRlOAGYgrtAOcAnpkVc8V+NU0DxFpWiRaRqOp3+owyzRJZ+XwIyobcXZQPvZ/A/Sm2Xw78PWLJ9lhu4449RGqxw/bJTHHcDecqpbCqTIxKjg55HArau9A0+78RWGuTxM2o2MUsEEgcgKkmNwx0Odo60AeeW/xx0CXXbmze0u0sITdD7cGRxm3RmkLRhi6qQjbSRzjtmo/EPxU1yz8NaZrFl4NvY4NQurRLdrqeAiWKduOFkyr424B4BYZOAcddD8O/DkGpXN3DbXaR3LySzWQvZhaSPICrsbfd5ZJDHPy459aqL8LPC40qbTTDqL2jmHy0k1K4c23lMWjEJLkxhSeNuKAK958ULCytdZku9Mv4pdJvLSxuIiYy3mXATGCGIIXeAeexxmm+G/ijY6947vPDNtYSwy2s0sDPPcQpIWjHLeQW8zYccMAexOBVjUfhP4S1DUpL+6s7trmUwNK326cCV4cCN3XfhnAUfMQSee5JOjp/gLQbHxKmvJDdzajEZTbtc3s0yWxk/wBZ5SOxVN2SOAOOBgUAYHjX4r2nhXWtRsZdE1O9i01bWS9uYGiCQpO+xDhmDMd2BgD8RXQ+BPFy+K4tVD6bdaZeaZeNZXNrcMjMrhVYHchKkEMOh9frTdd8BeH9cn1abUrWSR9Vjt47oiZl3rA++PGDxhhnjr3p58C6F9tkuhbzLPJqi6wxWdxm5VNgYjPTb/D09qANXU9e0fSp44NU1bT7KaQbkjuLlI2YZxkBiCRmnQa5pNwSINUsZSOSEuEbH5GrNzZ211/x820M3G394gbj05rMn8J+HbgAT6BpEoXpvs42x+a0AbEbpIgeNldDyGU5Brz/AOM+nG40C2v0GWs5sMfRH4P67a2ZPh34LkYufCWgCQnJkXT4lbPruC5qrqPwz8KXdjcW8ekQW/mxlAYSyAHHDYBAJHv6VnVh7SDiaUans5qR4nGelXIWrmx4bs4neJxfRSxsUYJfTqQQcEcPU8ehQA4jvdVT0/0+Vsf99Mc/jXzrjHv+B9DeXY2ryULG3sM103hmDYkS/wB1QK85m0Z2mRE1bVAGYKcyq3f3U12+i+H9RVQYvFGrJjoGhtWH/onP61E4q25MpO2x6HaLiqOvNiJvpWZb6Nr6g+V4plI6/vbGFj/46F4qhrOn+Ktj7Na06YhSSraS54/4DOKmME1ZP8/8jDm967R5trb5vpfrSWAyazdUs/EAu33vZSHPUWsiA/8Aj5x+tS2EHiHdiO0spP8AgUi/+ymuv2btZGntUdVZp+8bPXAx9K2LcYxWDY2Hi6Voynh+0cDqy3rjt7wgenei21TWDGr/ANhqwIDDy7xTkfiBWU6E4q7VhxrQk7RZ0t3cx2lm8sy7l6BQM7ie1cZq+u6elw0N3oFjcAqDk7Tkduq1LrusakfsiP4fvh85YBZoDuPTH+sHrXO+I5nnvkmezkt2aIZjnVCwwSOqkjt2Nb0KC5eaX5nVRjCekkJfXHh66RgvhfTonb+NI0VvzCg1xuo+HbO4uDJbJ9nUj7qs3B9etbpYY5jH4Cm5H93FdMVy7G0sHRlvEk8KeEptRlCXeq3xtwfuJO+T+JJA/Kuyv/D502x3LrepwW8K4RQYmwPQbozUnggKsAbAB9ay/iH4pg0/W7OylBMMeJJPQnsDXbB8lPm6nzuLhH2/s46Iw9f03VZ0sI7zVZxBdzJColijyiMwG47QOcGvoKbTvE9tc7E1bSWgiBQL/ZDIVRCFO0rcDbhQMZBryG+u9O8XaOYIbhY58ZQg9D2x+NemeE/Hmm6vbx2viS5tdL8QxgJOl1iOK4IwPMic/LkgD5SepP4/O5pCvi6HLTV5J3astVZ7X7HSoQpSTWx1zoigiRQowQVIA/hHyjdkk5xjt6VznjxTKulgkMwFwC3ByAIj27ZLVqXuu6Npih7zVbGLKr+7hmSSSQ5JwEQlzzjBGPeuQ1vWX1K4M+x4oAnlwROcuFzks3+0xOT+A7VycOZdiKVd1qsXFJW13fyMsZVi4cqd2cF4rth98Y4GD61xUxkzgISPrgV3HiVWEbE555rjyVzz/M19PW+I9XLk5UEr2NLQr63sHDyglu+FrvodTgaza4cOirGJSCOdpGQa8xUp/dz/AMCNdrZhzFpmDlZIBGcgYOQeD69BXJKlBvmnt+hrWocsW4vXzNy21S1uSsRJjaQfKJBjdn0PSma3L/xKN3crUfh7wXZavNcx3F4bKSMrt8sD5s57E47V0w8IRQoljf3txNE2fLlCLk+x5r0MTluFqxjWwLfnGW/qmt/R6ngUsfVpSdPFJeq/VM8uEaS6BPGS6mRuWRirY9iORXN6NpOnf23bLdWqXEbOAVuCZQfqGJzXsMvg6wt2lthcXRjDEcqM02x8H6PBeQOIndw4wXc+vpjFfoGIx2ErYWVNxbbjZaLTSx8lRpVaddTv1v8AidNYaLpdpp6tp+mWVsVww8mBEx+QqUVrxLFGSiH5FA4IwB+NNAs0O7Mefrn9K/G8RTlSqOEnex9tZVEprQriEx2BdhyXRiPYMDU+ozPH5YRiuc5xVa9vhImxVwjMq5PX7wqbVesX4/0rEttKHuj7G7mQ53kj0PNbkMqzw7147Eelc9bjC1qac+El9OMV1Q0ickJNzsVrTm2c+ssv/obVTufvGrtqcwyt6yycf8CI/pmqV11NZSO+O5RkqlMf9KhHorN+PA/rV2TrWfOf9Mj/ANx/5rSRqiwhyazvEX/IOl+lXozzVbXo9+ny/wC7TW4Hn6feNX7XqKzx98/Wr9oeRXQyz3D4Vf8AIrt/18P/ACWuxrjvhV/yLDf9fD/yWuxr38N/Cj6Hz+J/iy9QoqtfX9np6RNf3dvarLIIYzNIqB3PRRk8k4PHXiiLULKa/nsYru3e9gAaW3WVTJGDyCy5yAcjrW5iWaKKyLDxLomoXFvBZarZzzXHm+SkcoYyeUdsmB32ng+lAGrLGksbxyorxuCrKwyGB6gj0qHT7K106zis9PtoLS0hXbHBBGI0QeiqOAPpTNW1Oy0ewkvdUuobSzjKh5pnCqpZgq5J9SQPqat0AFFFFABRRRQBxHiHxRf6f8VfCXh2BYDYapb3ctwWQlwYkBXac8deeDWXrvxWt9H8fW/hyXTDPBNfW+nfa4LlXMcswXbvQD5RlsYLBuCQCMVc+Iek+BtY1uzXxasr6pZWc11biGe5ikSAFRIw8lhnnaMcn0qeD4Z+DZ7601eLS5DOksF7E32u4CmWIL5chTftLgKMlhk985NAHG6T8ZdQh8NXOoeIvD4juX1mTSbKO3mULIys+Q5yxXYE+ZsEMSNorY074tPqT6HbWHhbVJtS1NLki182KMxGBlViWkKgqQ24MOo7Z4ropfhr4Tlh1GF9KzFf3YvpVFzMAtwCxEseH/dNl25j29auaV4J0DS76wvbOzl+12KypBNLdTTOolxvyXc7s7V5bOMcYoA4HWfjGE1jVdEttO8ucQagLK/huFnjMttE7/MANo4TO3cxHAYCung8bjSPgzpXjDXhJcytpdpczrAgDSzSrGAFHAGXcD0GalX4V+DV1B71dIYTsbggC7nEaeejJNtj37V3K7A7QOuRggGt9/DekSeFk8OS2MUuiJbJZrayEuvlKoVVySScADnOeM5zQBxHij4map4Y06GXWPCwgvpWkKWg1KN2kjRFYsm1SzfeIPygDHJwQTQ1H40pFYm70vw1fX8Eejwa3cN9oii8m3kJyCCclhg8DOa2rP4b+AdXs45rO3+3RRySqLmLVbiVskCOSMyiUsVwgUoTgY6VrRfDrwrFZ3FpHpeLe401NIkT7RL81qudsed2RjcfmHze9AHnWv8AxU8RPZ/EdtP06K0ttDtLeexvMqzr5sSOvmKWIYsGJGAAo4PNbSfFuW1tdYi1fQXsdU01LRxDcX0QW4W4yFIZcgNwfkAY+ma6m7+G3hS7l1CSfS2J1C0Syuwt1MizRIoVAyhwCwCgBsbscZqTWPh54X1ie5n1DTPNnuBbh5VuJUYeQSYipVgUZcn5lweeSaAOK0P4o3fibxP4JhsLeTTra+v9SsNStJlDNvt4N4AYgEDdg9AexFej634n0jQ7iODVLvyJXXeq+U7ZGcZ+UH0rN0b4e+GNGurG507TWinsrm4vIHa5lcrNOmyVzuc7ty8c5A6jBrq6AOV/4WF4Y/6Cf/kvL/8AE0f8LC8Mf9BP/wAl5f8A4muqooA+aviDrmhw+LLm4srzdbXYEwIhcYY8MOV9Rn8a5/8A4STSgeLr/wAhv/hXvPxi0v7X4ZW+QfvbGQP7lG+Vh/I/hXjLHKA14eLpxp1Hpue5hKkqlNa7af1qZtr4i0pr+ItdfKuT/q3+np713mleMNCjUbr7H/bGT/4msHQk33sjegAr0DS+AK4ajh2/H/gG81Lv/X3kMHjfw8BzqH/kGT/4moJvG3hr7Rul1JVH8O6GTBP/AHzXVQfcNZ2pSmGUSdlOTzjitMPOEZxbXX+uhyVIyaaRHpPifQtTuhbWV6s820ttKyLkDrywxWvd6jZ2Nu87eWiIMkhs4rzvUPix4dsLhoGe/dkOPkiYD9WpsHxc8M3IKXEV2UbgiSHcMfma+k5l3PK9nLqh+sfEe9u5Wg0m28uEnBlZeT9BVC1IWNABtAAGPStaC+8Ea0ubS6+yyk5Cj5efoay71Y7bUrm3hlEsUZULIP4sqG/rivIxsKrXNJ3SPVwk6SfJFWZT8RHbDazD+CTH5jP9K5Lxeqie0kbcWaMqQW9D/wDXrs9Rj+1abLGBlhh1HuOa4/xGzto1pMGH7uQpnJ6Hp/6DUYWV4W7Hr0Xsc5leyfqaaCA3CnP41E9w3rn86jExJ5x+VdB13O58HupUjHNct8TdGuH1V71ozJbyqPnAztI7GptFv/ss6klgpPOBXoMM6XEIHDZH3GxzXVTtUhynzuY05UqvtOjPntYrizbfaSuh/wBk4r1bwbc3+raKqX2midwdoluFwuPXnrXSQ22nx3W7+z7YS5yGMYq892zAqRs9hSeFU/jOFYlx+BGdZ6ZZ6awlKo9x6hQAv0FXxIZQzk4UCoZhHvBZhxkfpWPr+tx6bbpHGryPKSAExxj1re8acdDOMJVZamZ4hvPMkKhs/iKwPmz1FF1cyXLlmRwT2ZTVdvMTkoQPauGbu7n1mGUIQUYstqWz9wN+Ga72CPamixgYIiRvwKbj/SvNJLa3v3jEiEyqcIQxVhn0YYIrtxp15bXjy2GuSCG3QBVvkE6DgADIKt2x941MlzRst2TiJuCu1odRcabJqAP2aKSSRTjKA8H8K0PDmk6sszx3E8kkP92Q7gnvmuKXx5r+hRXFtBYQzNM24y2zknoB9xwpHTsTVJPibq9vGIzdx2bE/dnhMTMfbdjP4V6NHBSy+EaldNSeyenzt2PmKtf67JwpW5e/6XPWrq2NvO0ZKHbjn5RnjNU59HsNXubaPUIFmRG3ACRl+v3QPSvOIvFXiG7Vrr7ZC4PPzISD+RrY8H+LdZvtVEX9nW90VB3FDtwOmeQfWvfrUK1LC+3qRtG17+qPEp8sq/s4PW53F54O0WO2PlxXcYJACpqNwAP+A7+Kzh4S0wZ2S6tGPSPV7tB+QlxXSSl/LUSDa7HcQDnH+eair88xWIc6rlF6H0ShypRZzlx4WskiLRXutIRj/mLXL55/2nP6Vpan4VhQxGLVtdVueTqMr+nZiRV6RS5iUfxSxg/TeM10U9n56qScFelYKc31NFFOD0OLj8NMFG3XdcVuxF0Dj8CpB/GrtxoEmnafJc3fivXIYY1MkjF4MKP+/VUPE/jG10aaWz0tBe6lH8rOw/dRH0Pckeg/MV59qmpa3rO1dV1CWWEsD5XCp7fKOPzroipNe8yqVB/Ezv8Aw9YXuqaRHd2/i3X0ildyqtFYkj5jwf8ARzhu+Pf0xVibQtXXIHirUWHYvbWxP44iA/SuK0u61Hwu5mtXVoXx5sEg3JLjpkevoRyK7fS/Guj6g0UNwZdOuX4xPhoc+0g5H4j8aJQctYW+5G7jy7/qUJdH1tM7PEkrD/prZxE/oBWdcafrsdzGV16JiVZf3lipHY9mHpXdXlu8TskilXHUGsXUFwYmPRXH6gj+tYqck7Nfgi1FP/hzCjs/EQOU1vTyfR9NYj9JQf1qW7svE8lq4OraKwx0/suUZ/H7Qa1VOGq9H80ZWj2j8vuQ+Rf0zxy4h1yK5dGuNNyD/wA8H/8Ai6ntm10EAHTD74kGa6DxRaGG+3gcNzWdbseK6FO6vYrl8z1X4ZTeL18NsLS00CWLz2+aW6mjOcDsI2/nXWfa/HCH/kC+Gpge/wDa88WP/JZs/pVT4RNu8KMf+nh/5LXbV7uG/hR9DwsRpVkeWfHbwpqPjTw54X0yK3kDnWoJbtrZy32VPJlVpA2FJCsw5wO3Fef23gHx/o2o+PLjTppJ/EOp6XAw1OJvLSa4M26VIiSNpEfyr0xgHI617h4y8V2/hhNOjazu9Q1DUrj7LZ2doE8yV9pY8uyqqgAkkkYrk/Fvxh07wmLM69oup2nmwiaaN5rYSwAyNH/qvN3vgrnKBhgqc84rcxOBs9D8ZR6bBHMviy50A6rFLeWCFra4WHymBSF2u5ZTHvCFh5g5J28ZxZ8CaF400Wx0eK203VoYY7XWnkspLsxhpnk3W4kYMRuOeHJOMk5rvX+LWlr4gGmnR9aEA1r+wXvzFH5C3ZxtXhy2Dkc7eO9cr/wuLWrnR9OvofDl1bs/iddHkiZUdp4sTZSP95xKDGoO7CgtwSMkAHFL4a8dX3hTxRYz6drbW97a6dNFZ3TSMq3C3cbSiPzZ5W4UHJLDcFztHFfU1eWXnxn0q18Nrqsmkagjrd3FlcWk01tBLBLBjevzygOeRgJuJ56YrR8G+PH8UeOJLSyCjRJdDtdVty8e2YNK7AhuSOABwO+eTQB6FRRRQAUUUUAeR/Fnwp4i1nxLc32gWryA+Gr2wjlSdI2Fw7oUUZYEZwfm6D1FeXfFAajY+INQ068868167ttJh0kQagPNstpQTp5Ibc29g53KGGCckYr6tooA8F/4Q/xk3xkg10aU9tZx6y7PdW13GIprEoQCwaQyM3TK4Cj+EHrWJY/CfxHLpmn/ANpWN+13NpmqR6gDqxw85lZrNSBLgjG0gD5QeW5r6VooA+bte+H/AI9vp9JuLxdTu5U0iwiiktL6FZbC7iQedkvIBlnGS678jjBrauPh54hl12XWTbXn9oDxot1HINRwo0k7PMwnmbQD82VxvPTHSvd6KAPM/gX4UvPB+jarp2o6VJZTfbZXW4N0JkuozI5RkAYlcKQDkKTnvXplFFABRRRQAUUUUAFFFFAEF/axX1lcWtwN0MyGNh7EYr5q1Gyk029urGf/AFttK0Z98Hg/iOa+nK8Y+M2npa+IbS9QBRexEP7umBn8mUfhXBj6fNBT7Hfl9Tlm4dznfDcfyO/95/5cf0rtNPGMVynh1cWMR/vZb8zmuqsj0rwJ7nqyN225U1nawm5Gq/bHiotQTchqVsY7SPAfFekwDUZCUAJOapWejW7jkV2Pjm12XIkA61haeQGwa74VZcujNeVMS00aCKQMma3rYeWPL9OnuKSADApbqVIEDtyQflUdT9KzlKU3Zlxj2L0LkVlXmnWF80lobvYsjbjGhHB9jUKm5vi24FIgcFckD1Oax9Y1SCOEQ6dy5wZJh/C3ov8AjW9OhKOt7HRCm76M6CHwhpEY5jklPq7/AOGKrXnhO1bPlkRL7VkXvjgWunIZl23H3SQOCfUVw+r+L9Y1NikEjQxk4HqaUKdZvVnLXruD5ZN3O2n8L6arETXvPpuqpf8Ahm3tLf7VblmA5Un+dYvhbwxfalcR3GqPM8YORHISc/UentXqN3ZhtOaEDd8tE6jhJLmuZRXOrtWOP07xDKLWJZ/nlQbdx6n61LLrrHJPU8Vg3EX2e5eIjGG/rUfXP1ruVWVtzspYKlKKk0asuqyOxAPr/I1Utla/1GGOQk/N61VXqD64q94e/wCQ7Avr/gaicnZm9ShBQaSPRLbTrP7OoEKnAwdw5BqT7BbCMoIU2HqCMipCvOVZlbHOO9NZpFHO1x6AYP8AOvK5m+pxowrzwzZNdRXFsvkujhig+42D6dquJpkTWBt5ifmbezIcHPtVsy7iQQVYdjTWkxWsMRVptShKzWqY6n72DhPVMpf2VaRMXClnJyWdizN9SaztZiim0vymVSpUZBGQa1ZpSQcHmsbUnC2h9MVcq9WtU56sm33epnClCnHlgrI5m00axi0yd4RLay9jbStGD9VB2n8Qa7X4UaLr9rZXep6fdWNwjYUxX0bIzDnpInA/74Nc/pVnJfhLeMHDH5z6CvcfD1klt4aW2gAXcxP8h/SvvuJ68KGAjh4btR5vuVk18rnxmVQlUxUqj7uxzEviO+gkLaxoF/AveWzxeRj8E/ef+OVb0zxDpGqSeVY6jbSzjrDv2yr9UOGH4iuiTT5D95lA9uaZeeG9K1KMR6pYW18B0FxErgfTI4r8z5oPp/X9eZ9J7Obd2Lp1u8moWpIwoLOc9wBj+bLWD8QvGEtlcNpGiugutpFxP1MORwF/2sflx36ZviuwTwrp89zoGrapp955i21rbC4+0REkBnOyYPtXB6Lt+6PWvPbK112J2kdLXUy7F5H3tDKxJySc7gx/EV1U6cVG9zanDutCw5g0uxM9wcID1PJJqvZ63aanIiW7fODnBGDWX8QdRzo0cdzY31i6tz50WU/77Qsv61yHhy6WLU7aWGRWXeBlTkVvGlzR5nuaSrWkorY908TIiaerE44Fc1CbS8j8sOPMA6Vf8fXDf8IyJVJ+51rxyzvp7W4WSNyCPfrWdGk5xuVUqqDSPpLwFrU15D/YV+5e6gUtZu33pEHJjz6gcj8R6Vr6rETbOyjJUbx74Of6V5JpGpPeWkN7ayNHdwkOrqcMpH9a9j0/Uode0aDUYtqzN+7uYhxslA549D1H4+lZ1o3XN1W4l7r02ZlHrkcg8irds/OKqom2BVxymU+uDjP6VLbnDVzs1K3ifTvtVnvQfOnIrgwNjkV6zEokjKnpXDeKNIa1uGmiX92xycDpV05dAi+h6p8HDnwi/wD18v8AyWu5rg/gwc+EH/6+n/ktd5X0uG/hR9DwcR/Fl6nMeOdK0DWF0q21+5Nrc/awdOmiuWgnW42n/VspBzt3ccgjtXK/8Kx8GeLdMN3bX+p3tpeQfZZ7iHVJGF4I5WOZGyd7K+7r3GO1avxK0m/1LX/Ak1jayTxWOtLcXLJ0ij8qQbj7ZIH414r4gv8AxJoHhrRG8bahrkQXS9TaOKPVvs9yt79pcwyyEyo7oIyoAyQOBjnB2MT3hvh7oTeZmO4+fXF8Qn96f+PtduD/ALvyj5arwfDPw/BdiaP7cEXVl1tIDdM0UdyN+WVTwoJkYkDrx6CvGddtfiDqOmeHbzTLXX/tkOj6VLBeQXMrmeUhDceaDOqqeTkNFIz9yBXRa14Y8X3/AIsuLz7X4ljt38UpAqw6hIkSaY8BEjKobCjdgZHIPTHWgDu7z4TeGrq4luP+JjBcy3V3dvNb3jxOWucecuVI+RsDjtWx4X8D6N4ZvYrrS0nWaPT4dMXzJCw8mIkqPryea8TvvD/xEfw1oFpcS699gt3v4ZvJeSW6QmY/Z5GC3ELuAnQl2A7qeKt654a8dahputzNe+KjeWmiWDabsu2tzLeKD5haNJGTfwNwyRk9T1oA+hIriGWSWOKWN5IiFkVWBKHGcEduKkryf4ZeHtR0b4n+M7vUrTWFXUjHcwXMlwXtZAUj3rt34EgfIHy/KoIBAwD6xQAUUUUAcZrnjk6T490fwsdDv7ifVAXguo5IRFsXBkYguGGwHJGMn+HNRr8VfBUjzx2/iC0nmhgluDHHksVjBL44wSACcZzjnpzUfiHwTqeq/EnQfFMGuW1tBpKvGlk1gZDIkmBKDJ5owSBwdvy+hrF074RCz0vwpZ/23vOhf2n8/wBkx5/2xZB03/Ls8z33Y7Z4AOq+GXjD/hOfC0euJZCygmkKxR+eJWKgDlsAbTkkbecY61cvfGPh2w15dFvdYs4NWbbttZJNrncCQQPTANUfCfhbUfDmn+GtOg1zzNM0qxNpcW/2RR9rcBQkm4klNuD8oJznnpTW8EQzeKvE+rXV20kGuafFp8luse1o1QOCQ+TkkP6DGO9AEmnfETwlqMN/Laa9ZNFYw/aLh2YoqxZx5gLAbkzxuXIz9ayJfjB4OXWNI06PUJJpNSlkiSRYWVYWVAw8wNhgGyAuAc5HQc1zNh8CoItFvtLvdZingmsFsIJ4rDy7iNVljlQu5kYOA0S/KFUHnNdHd+BPEF/q+gaxqHiu2l1bR7qWWGRNKCRNFJEInjKebndjJ3bjgn7uKAOnXxf4fMcMn9rWoSa7exRi2A06Z3pn1G1s/Sm+G/GOgeJp5YdC1FLx4l8w7EcArnG5SQAy57jIrgl+D94uqROvijOlQaxPq8FlJpyMUeVXDKX3fMMuSMjHYg9tj4XfDaTwNf31wdZa5huIliSyt4Xgto8EneI2kkw5zj5dq4z8vNAGpf8AxO8F6fqc2nXviKxhvYXkikiZjlXQZZTx970HUngZNdFoWsafr+kW2qaPdR3dhcrvimjPDDOD9CCCCDyCK4SD4XeVq6X39sZ2+JpfEez7N/fiEfk539sZ3/htrT8DeC9R8JaV4f0u18QeZp2nNeNdw/YlH20zSNJH8xYmPyyx6E7u+KAO3orG1vwxpGuXEc+qWnnyouxW811wM5x8pHrWd/wr3wx/0DP/ACYl/wDiqAOqorlf+Fe+GP8AoGf+TEv/AMVR/wAK98Mf9Az/AMmJf/iqANnxBq0GiaVLe3ILBMKqL1djwFH+fWvnjx1qd5qV+l3fy7rl2wEB+WJeyqPT+ddB8QPD2gDW3tbSx2wWKAyfvpDulYZ7t2GPzNeUavpWmtep5dtgBwMeYx7/AFryMVWVSfInoj1sJRdOHPbVnq+lp5VtEnooFdBYnpXC2/hXRSi5su3/AD1f/wCKrYsvB+hMRmx/8jSf/FV5UlDu/u/4J1ty7f19x3tr0p843Ia5mDwV4fOM6f8A+RpP/iqmbwP4ewf+Jf8A+RpP/iqlKHd/d/wTJuV9jn/Hdnvs2cDlTmvPIW2uPavSdb8DaEbaQJY4OOP3rn/2avJ7zw5p9tdPGbbof77f410UnFq1/wAP+Caxcrbf19x1NpKCBWbreoQ28r+arvIF/dheAPxrMg0TTMjNt/5Eb/Gsfx1pWm2GnpcQW+JM9N7HP61vSUVP+v8AMtVZU/ea/H/gF7UNZuNQQqT5UQPMSHg+59SKplv4xg54Yf59a52ytbG5gWWODDD7yb24/WrqaZYkbhD8p6je3H612aHoU5uUU4pW9f8AgF24hSaMxyDKnoT/AJ61qeDfDsMsjTSOrMhwfVawf7JsQcGDKn/bb/GpIdOtbeVZIounUF2wfY81M48ysmZ1qLqatK68/wDgHsFvFHDGEjUACrCYxzXE6JZaDqUYX7II7kD5ozK/5jnkVsDw1o//AD5/+RX/AMa86UUnZt/d/wAE5Gpxdmv6+45jxlGqa86x/wB1c49TzWOO/wBau33h8f21Lc2dhIEWQhCCzdBjoTTTp96oKtaXAbOcGJumB7V6EFaKPRpO0UmU8YCfhVjTJPs+sWkp6LIufpnmnmwvWC7LO4JCjpE3p9KlfSL5pGK20gHVS3y5596pq6sW2mrHo5emNJxVJLgtEjNwSoJHoaY81eVY82xNMyt94AgetVmcr0yV9M8imNITTGbAp2GDzA98H3qlLaT6lPHa2y5zyzdlFXbWCW8nEcS5z1PpXoOh6HBpWnT3MvMgjLZPsDVJ2aRnUkoxbZzPh7TI9OtQSOe2epr0TSFI022z3Xd+fP8AWuEe4VjjcK9Et0CQxqpBCqAMV6ueV3KEYXvd39f6ueBlUPflMkqaBcmo1GSKp+KtQGjeGtQvc4eOE7Pdz8q/+PEV4FON2exJ9DybxNqh1/xI8kR3WtsWVPdzjJ/ABV/4DWxpdrshyRXI2UsGm2sRmZR6knGTXV6RqcU6AKRg101L9DoirKxk+MrMXekzw46jivEINPhkuo/MiAcPgspKt19Rg19E6xEJIGPYivEruD7NrciEceZkVvhptJowrwTszqfF2mXlt4Uja31a6khZf9RdBZVH0bAf82NeXlrlIgZLcOP70T8/kcfzNe0eL8P4Nh91rybb+5FbUJ+7qY1o66HQfD/WbOG7a3u7hLffwBP+7yfQZ61634Lvhpuumzd1FnqQWPfnhZP+WbfTJIPsxrzP4dWSz3cjSxq8R+UqwyD+FdP4g8Lafb5l06N7B87s2bmIZ9do+U/iKznKCqGsIydOx6ncRNHeTRupVm+baeoYfKw/DiogNprndOfxNeadp+qwavaam87PFLFfW4icOoOR5kWByFQ/6s/e/OSXXr6zP/E30C+gHeWzxdx/kn7z/wAcrknS5ZNRdyo1LrU6y2fFT3Vul3AVcAgiuc0bxHpOpy+VZajbyTjrCX2yr9UOGH4iuntn4rFpxdmVdPVHRfDey+waDLD2+0uw/Ja6usjwuMaacf8APQ/yFa9fT4X+DH0PExDvUkFVruws7x4nu7W3neI5jaWMMUPqMjjoKs0V0GIUUUUAFFFFABRRRQAUUUUAZs2vaRBqa6dPqthHqDEKtq9wglJPQBCc89uK0HdY0Z5GCooJZmOAB6mvJfEenXUv7QHh/VU8O3s+n2tm9tNfLboYxK5BR85zhe56jHFcPYeDvGreG9AN9P4nuL3UdF1S31mK51CWQCQJ/oy4LfKSfTrznqcgH0HoOuaV4gsmvND1C11C0VzGZraQSJuGMjI4zyPzrRrgvhdBfeHvDHhPw7caZqPGkRy3N1PMZFt5wqboDuJI5LYA4AXA4xXIeP8ASfGtx471KXSk1pnklsDodzbXmyztI1YfahcR7wG3fN95WyCAOmKAPYdN1Oy1MXJ0+6huRbTvbTGJg3lyocMhx0YHqKp6Z4l0TVZLRNN1Wzunu4WuLdYpQxljVtrOuOoDcZ9a8U8M+HPE9n4/ley07XbJ38WXt/c3b3JWxl052b5fL37WdjtIOzPA5wBiHwX4e8faT4U0HT9Oiv7GeDwxqEXlPJtijvWmJh3LnbvweCRxQB9EUV8wQr4tePxHovh4+K7bVINC0+5S0vtTdpmnF0DO6EysF3qrjA255GMHnb8Sw/EXXbrxHe2Fjr+n6XPqVhKthNL+9+yLbssyxrHOmMybWZUkRj65yKAPoSivNvCNj4gtfhDqdncXGrz6uILtbN7xPJuRlWMYH72RhgnCkuWwBnFeXX/hDx7DoV5LZ3fix9RGhadeRBtRlcnUgwEy8tzhc5U/L9SBQB9NUVm6fqNzdaxqtnNptxbW9m0QhupCNl1uTcSnf5T8pz3rNvv+Ev8Atk32H+wPsu4+V53nb9vbdjjP0oA6SkdgiMzHCgZJrlv+K4/6lr/yPUN3F44ntJos+Gx5iMuR5/cYoYHk2r3zvpE17N/rruZpXz6sScV54pM+oQKOS0grqJLfxBqOh/Z86SBgFT+8yKxNE8OeIob4XE39mgxnKhy+Cfwr5yNldt6n0LfRI9Gh+UKPQVt6e2cVw+7xHu/5hH/kStGwk8T5AX+xvx82ueUPNDcvI9FtzwKtqc1xcD+LMcf2F+Pm1bjfxd2/sH/yNUKFuqMm/I6C9g3RnivLPG+lmGYTovB613yr4vkQj/in/wDyNWDrmm+KbiF45l0Ig+nm1qocjvcVOprY8zjbB4rK8ZWrX+klV5ZOQKvatp2vWF0ySrp/sRvxVPOsEYYacQfXfXTHRqSZrJ8ys0edW072rDaWVxxiulglLIjN+7kI6HgGtRdGumuPOMOmF85/jqze6TqN5CFK6YpXgbd4rodWNyaEqlHbVdjLSQdCPqpqUHHKnI9KoXWn61aDbItrIo6H5siq8cmonhWtC3odwNaKz2Z6NPFwnpZ3NlThg8bFXByMHBB9jXQ6X4mlhxFfqZF/vjhh9R3rlIpn8tRcqvmY5KcVOGBHBBB7MKmcIz0Z0SjGa1O7SW2vT5llcqGPJX39cdRSst2Cu2VRjuCQT9c1wgBBypII6EHP/wBersOrXsGALglfSQZ/nWfJOPwsydKS2Z1f+md5Bn1zTPJlZFSadyi/w7iR+tYC+ILj+IQH8x/Wg6/KekcR/E1L9qyHCodLuAAC8AcCkyTR4ejfUojLcbI1HTBxn8624f7NDeVbhLi4/ug7mH4ZIpLCTau2kjgq4iNOXJu/IxDwKmsbCa/mARSEzy2K6OHRbm8kUPtigHWNMDP1IrftbeKziEcCjI43AdPpXNWlCnpF3YlXdryViDSNNt9NiBKAyen+NP1m5aTTp2LZXbgAdBnin3TiOFmbOO+OtUNWHl6QQerEZ/PNY0PfrRXmjhxNRypybMG0TzLqFP7zgfrXdWtw0Mg5Ow9RXHaKm/UovQZP6V1dd2ayvUjHyOHL/di5eZ0duNzgjpXBfGW9PkaXpqNxNK08gH91Bxn2y36V3WkNut1J6gYrxn4s6ov/AAl1yGPFrAkIHuRvP/oQ/KuSgj10+aSZ5X41vXm1MRIx8uJcYB4zXQeBtRkFom5idrY/CuI1CU3N2792Ndf4TtWitVB6sc13VElTSCnJuo2esBxPZA+1eSeK4hHrikdzmvVLEEWiqf7tea+NgBqcRA7muahpKxvVXunSeKcHwdCP9ivKtuVA969S8UnHheFR/wA8/wCleb6XF9ovooz03c1vR0izGqrySPSvAFh5NtHlcH7xrc8SyhYSvrU/hmAR2qnHJrL8UPumC1yt80zpSsjU+GV1JI91YBGZFcXe7Iwg2lG49yyflXa3Cda8h+HOufZvidYWLnbbXRNo/uXHy/8Aj+017PcJz0oxMWuWT6mMZJyaRhajpGn6pF5ep2NrdoOgniV8fTI4qrD4YW150bVtU009kSfz4v8AviUMAPZdtbmzmpYxg1gpyWiZTimafhubxlYacWS30fXLcOc7Xeyn6DoD5iMfxQVrHx1Z2fHiHTNY0Mjq93al4R7maIvGB9WFafhD/kEn/rof5CtuvpsK70YvyPDrq1RnnfxQ+Iv/AAi/gvTvEHhyG112O9vorWIQzBklD7vuMuQTlcfWue0X45abqHiTxH5sKReFtL04X8OojLPcAOsZwvTG8so9SteleJPDVh4hj0yO+81F07UIdShELBf3sTblzxyMnkVh3nwv8LXV7qEz2Ajt73TRpUlnDiKBYQ/mDaqgbW3c5BroMjHsvjV4cvbSZra01STUEu4LJNOjSKSeWSZWaPYVkMeCEcklxjaQcHArd+FXiq98X+H73UNSto7WaHUbm0WJFKlUjcqob5m+bHXBxnpVE/CvSGskgm1TXZpobiG5trp7zM1s8YYKYztxyHYHIO7jOcDGh4c+H+m+H3086ffatts7q5vNkl1lZ5JwQ/mjHzgZyM9DzQBNq/jjTtM8YweGntNSuNRlt47stb2++KKF5THvds/KqlSST0Hr0rmNJ+OPg/UpLzEt3b29vaS3y3EyJtmijOGKhWLg+iuqk9hXbnw1YHxhJ4kPmnUJNPGmspYGMwiQyfdx1yx5z0rmdO+E/h2wtbmwSTU5dHnhkt/7Nlui0CI/UKMbvpljjtigDL1v4tzWE+gLH4O8RBdUulhAuIURijIWBj2uwZjj7pIIwc44z0LfEbRF8zKXnya+vhw/ux/x9Ntwev3PmHPX2qnP8LtNuLK1guNa8RTS2lxHcWlzJfbpbYorKoQlcAYds5BJ4yeBSXPwo0CfxE2r/adWjZtUi1g2kd4RbfakIPmeXjGTgZ/TFAFjwF8StH8c6hc2+iW195UKM/2mXygjBXC42q5dCScgOqkgE13FcV4T+G+i+GvEM2uW0t/d6pJCbcT3k/mMsZYMRkAFuQOWyeOtdrQAUUUUAFFFFABRRRQBGLeEXDXAijE7KEaQKNxUdAT1xUlFFABRRRQAUUUUAFFFFAHz5df6BrGoWo4WG5lQD2DnH6Uv2jNP8dJ9n8baug4zKG/76RT/AFrIWUivmasbTa8z6Sm+aCfkam/mtCxkwwrDjkzir9tIRWLRTOqt5uBV+KSubtZ+nNa9vLkDmsmjNo3rabB56VYuIVmjrIikrQtrjHBNaQmrcsjCcHfmRyviLQo7pGDLz615lq2jz2MjfKSnrX0BJCk6ds1z+qaIsysCgI+lWuan6GkKqejPCssp5qVZT613Gr+ExkmNSp9hXL3eh3UDHCFh7VqppmqfYpNIHXDgMPes+60q0ueSm0+1X2tLhPvRv+VRmOUfwN+VUnbYGk9zGfQWB/c3DY9DzVWXSbxPuhH+mRXSqkv9xvyqZIbhuFic/hWirSRUXKOzZyAsbwHBgb8G/wDrU4Wd72gk/wC+hXcwaXeykYib8a2LHwvdS48wlQfQUPEWL9tUX2vyPNYdLv5T8yBP95//AK1Xrbw7cyk/OTjk7FJxXsWmeCohhpULepeuih0qxskAJjHsozWbxE3sZTxNt5Hl2j+CrmZEW8nnMP8Azz38fkOK7jTdBtdLhCxxrGv91RyavxXKQtPDbLtiR8ISOQMAkD25/p2qJ5CxySST3Nc1SpKXxM5JV/5ENlkO3bGAq5Ax6/WkFIRkEHvUNvNueSJ/9bH97jqD0I+v88+1YdTJty1e4y/JP2eLtNLg/RRuP67aq+IjixQesg/kavXy/wDExsE/55wNIf8AgZ4/QVn+JP8Aj1i/3/6Gt8v1qxfm/wCvwMMXpTa8il4cXN67f3UP8xXSVheGl5uG/wB0fzrdrfMZXrvysZYNWpI3dG4s/wATXzT8Srs3PiHVbgHKvcuqn/ZVio/RRX0pZzLaaS9xJwkSNI2fQZP9K+Ytct3uNPSQ5LldzH1J5/rRhtNT0oK8TF0bTxMVlcZBPAr0PQdP2gEiuG0C6TyhGTh0PQ16LouqW8cQE2OK1rORtRUUrnQwrsiYkYGK8t8YSCXVoUHc/wBa7LXPEsEduwjcKMeteXtetf6ukhzjeMfnU0YO/MwqzVrHoXif5vD8Y9Ex+lefeHSBqgz716Pryf8AEkjBHBFeURTNa3Syp1U1pR1i0RVdpJnvmgyq9mm09qzPEtuS4cCue8N6+gVdr5Q9s9K6qfULe6g5ZScVzOLjI6E0zyTVHl0nxLb38BxJHIsyH0ZSD/MV9UXbRz4ng/1MyiWP/dYbh+hFfN3i+KKRU2gFt/Fe9eCZTc+CNGLnc8UTQMT/ALDEAf8AfJWtK/vUk+xzcvLMndcGhOtTyrzUKiuE1O68H/8AIJP/AF0P8hW3WH4P/wCQSf8Arqf5CtyvqMJ/Aj6HiYj+JI4j4uxa3ceHLGHw3JqEV1Jqdqk0liSJFgMgEhyOgC5z2rz7wlpPjXTfF+kSXF94nubCHX9RsXS8neSJtPCsYJHz97LHhzk9AOMCveKK6TEzfDepyazolrqE+nXmmyTqSbS8QLLFgkYYDp0z+NaVFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB4P8SBnxxqZx3j/9FJXN/wAVdj8TbYw+Mbl2HE8ccqn227f/AGWuRZcNXzmI0qy9T6LDu9KPoiaHtV6E1Qiq7E2MVgzU0IHwa1LWXpzWNG3ORV63bpWbRLOggk6VcRqybZ+BV6NqzZm0aUM7J3q5HcI4w1ZKtmpVarjUlEzlTUjQmt4ZhyBWXdaNFJkgCrKuw6Gn+e2Kt1Iy3RKjKOzMKTw/Ef4RUY8OQk/cX8q3/MNMlmWNGeRgiDksxwBUcyL5pGOPDMA6hRUi6LZQfNIVA96judbhJIgfcv8AfUFv5VQe+gYkyXCA/wC22D+tPm8jKVV9DXD6fAMRxbz9MUh1HH+qjRB7DNZH2y2/5+If++xTXuPNAS2JZmON4U7VHc56H/GjnkYtyluzTlvZZBhmJHuaznuZLkYtshT/AMtSOAPb1/l/Kj7JEf8AWBpT38xiw/Lp+lTj0FS5N7kpJDYo1ijCIOB6nP40+iipAKhWB5tVtBHgNIGiJPoRuGfxUVNUk08elabJqU2PMwUt07sx4z/Ssq0uWDtu9F69C4K8itJKLnVryVP9WhEKfRRVHxAm7T8j+Fwf6f1qxpkBt7NFc5kPzOT3J5NTzRrNE0cgyrDBrow8vYzi+xnWj7RSS6mb4cTFm7f3n/oK1qhtoEtoVijztHr1q5aWk90+23iZ/UjoPxp4mtGdSVR7MilDkgoh4un+x+A9TYHBa1MQ+rjb/Nq8aa1WS2KYyAMV75r+kW1z4a1SPVmQRxWzTCNHI2snzKSe+CBx0+teFWzjYea2oyUqalHY9Gi072PPNZ06S0naRAQueoqiL26VcLM+PrXoOq2wmjOVBBrhtSs/ss/A+RuldsJ8ysyKkOXVFFmkmOZHZj7mr+joBfQD/bFVeB0FXdJ4v4T23Crk9CIrU9V8QqP7Fi47V45MuZHHvXs/iAZ0KI+1eNzAi4k/3jWGH2ZrW6EMck9pJvhYg+1atrr95jaVU/hWekbTSLGgyxOK6nStFjiALjc/qe1bTcUtTOClfRiaZb3OoTpNc4CryBXtPwuu1fSr3TSQZLab7QoP9xwFbH0Kp/31XncapbQYUc+taXhHUzo+v2uoSqTb5McyjujDB/LOR7gVzt8109mbuHu6bnrsyVVK81qXcPlysmQw7MOhHY1SdOa89pxdmCd9Udd4P/5BJ/66H+QrcrF8JDGlH/rof5CtqvqMJ/Aj6Hi4j+JIKKKK6TEKKKKACiiigAooooAKKKKAOZvvHOgWPi238M3N1crrVxgxQCynYODjkSBCmBkZO7A74rXutZ021guZp762WO2hNxKRICUjHVyBzjiuG1zw94iufjNoniO1srBtHsLR7N3e8ZZWEhBZwnlkfLzgbufUVwOlfBC9stA8NQLZaMt/b6Vqdnqsq/8ALzJMmLck7fnCnufu9qAPaPCfirTvFGjxanp3nxWs3zRfaozE0iHGHVTyVORg1q22oWd1NLFbXdvNLF/rEjlVmT6gHivJ/CfwmjsPEXhS61XTdJkstJ8ORWUkaKDjUFlSQzKNoByQ53nkk5rkbT4NeLrjUL2a9uNJsbi506+sZryykCiZpSDGfKSJNicYILOepzmgD6HgvrSeAzQXUEsIbYZEkDLu9MjvWUPFmkf8JNPoL3Sx38MEdwd5CoVdmVQGJ5bKnivIZfhLrl3oeuxNaaJph1GbTAum2UzG3C2zgySFvLX5nGeAvQDJJ6S+PPhHe3+t6nH4c0Tw8uk3mkRaZbtcOYzp7CV3aWNBG2T83GGXmgD1a+8X6Rp108GpzSWWLyKwjeeMqk00gyoQ9x2z0Hetb+0LL7YLT7Zb/aiNwh81d5GM525z0rxPxD8I9WvpdUnMOlam/wDblhqUEd8/FzDDCscsch2Nt3454YEdaTXPhj4m1L4jWGt/Z9EitbbV7G9jkgkETxW8SorxbRCGc4XAZpMYAAUDoAeweE/ENh4q0G31jSWkaynaRUMibWykjRtx/vKa16474R+HL3wl4A07RtUMJvLeS4dzCxZcPcSSLgkDs4/Gp/7E8T/9Dd/5TYv8aAOqorlf7E8T/wDQ3f8AlMi/xo/sTxP/ANDd/wCUyL/GgDqqK5X+xPE//Q3f+UyL/Gj+xPE//Q3f+UyL/GgCH4j+H21fTUu7RC97a5IVRzIh6r9e4/8Ar145IOTkYI4IPUV7T/Ynif8A6G7/AMpkX+Nct4m+Gmsaq0l1H4mQX+Ov9nxosh/2sH9a8/F4P2r54bnfhcX7Nck9jz5OKnjboKxb/Rde069ls73VWhuYz8yG1T8wc8j3qMWGrf8AQa/8lE/xryXCzs3+f+R6qnfVL8v8zqIW5rStzkCuNhsNY7a5/wCSif41pW1hrRxjX8f9uaf41Dgu/wCf+QnJ9vyO0tj0q/Ga4+303XD08RY/7ck/xq8mla9j/kY//JGP/GsnBfzL8f8AIhyfY6dpUiXdI6qvqxwKd9rgXG6eIZ45cVycmla79rty3iLPDBT9hj4bj39Af8mrQ0vX8YPiTj/rwj/xpci/mX4/5Cu+x0sl5EgIU+Y/aNOWPp/+s8UgS6kGXmSL/ZjXJH4nr+QrnotH11BiPxGqjrhdPjH9akGleIP+hm/8kI/8aXIv5l+P+Qrvsb3l3R4NxEF9Vi+b/wBCx+lUdQjAdUeR5nB3Zcjj0wBgfpmqQ0rxB/0M3/khH/jWPNpuvPK5PiPJz1+wx/40KK/mX4/5GVWbStY3aK5/+y9d/wChi/8AJGP/ABo/svXf+hi/8kY/8afKv5l+P+RzX8joKK5/+y9d/wChi/8AJGP/ABo/svXf+hi/8kY/8aOVfzL8f8gv5HQVV1zVbfRLDz5tpcjPPQCsn+y9d/6GL/yRj/xrlfiHomt3OlbpNYNzGuN6i0Rflzz09s1dOEb2cl+P+Qbs09O8T+JdWP2jTdBnuLDs+Au4eoB/+tXX2dybmBHeJ4JD96NxgqateDobqx0iOZtcS4t0hAVPsqRqh4OSVOSPf3raudfTTQsurWDIh5FzEvmR/wDfQ6fjivKlj5zm1GCa6Wv/AF+Bu6VtLamfbWirC93ft5FnGMszfKW9h/jXNSTS+ItWF5ICmmwHFtFjAOP4sV1N34v8L6hDtvJraaP+5IykflmqT+MvC9moFnaxOR0EcWf5CilWqOXM6bb6aPT8Nx8kkrW/IWKCabHkxSPnptUmtGHRLgrvunjtk/22yfy/+vWPL421C9UppdgUB6NJ8gH86yZ7bWNSfdqWosi/3IMj9etaqOJnvaH5/wBfcTyxXxP9Tq7q70DSFP2mdZ5R2Zuv0Hf9aoL4pv8AVJ0tdGszbwHjzXG0Aew6/wAqy7TSLO2HyxB36ln5JrodDjzcMwHCiqp4SF7zbk/Pb7v+CCkr6I4D4kNPBqNlZSXckjmB5pgGIDbmAXI/4C1cRua3Yq2QO1b3iu9OpeNdUlBzGkotk+kYwf8Ax7dU13psd3bLgAPjrXq2jTtFKyOyF3G7Obe4Dpg1h61AJbd8D5l+YVsXlhPasQVJWqsuHjKsOcYrSLtqhSV9GcTV7Sh/p0I/2hVV12yMD2JFXtKH+mRf71dD2OeK1PU/EB/4kEGPSvH7vi6lHoxr1rXXJ0WBf9mvJLzm9lPqTWNDZmlbobPh62G8SsOTwK61FCR7q5/SsJBEf9mtmLfOyonOaU9WXBWRYgjku5Qig4JrZ1WyEFqqgdBWjouni3iDuBuqt4guV27awcruyNkrHongzUl1bwjZMxzc2ebWbPXA5Q/988fhWk6ZrhPhBdBrzWLLcB5sCzgepRv8HNegMKzxK95S7nPH3W4nS+FRjTD/ANdD/IVsVk+Gf+Qaf+uh/kK1q+iwf8CHoePX/iSCiiiukxCiiigAooooAKKKKACiiigDyX4g/E7WvDur+JLfStEsLy00C0t766kuLto3eOQkFUUIRu46kgfXpTLP4sanqPjeTTdN8OST6Pb6nHplzOPM82IuB++JCeWEBYDBbcRzXpF94c0a/e/e90y0na/iWC7MkQJnjXO1X9QMnAqtceDvDVzrUGr3Gg6XLqkBVort7VDKpXG0hsZyMDB7YGKAPPtP+K2sS+CrTxdf+H7K20CS/S1mmW+LPFEbh4HmK7AAFYJxk5yTkYqldfGTV5rDQjpHhtZb3WY7q7tY3aV99vE+1MCNC29xhvRQRnNerp4d0ZNBfRF0y0GjuGVrPyh5RDMWb5enLEn6moNV8JeHtX0u007VNE067sbNQltBNbq6wgAABAR8vAA47CgC14a1KTWPD+m6lNaSWct1bpM9tIctCxAJQnvg5FaVQ2Vpb2FnDaWMEVtawII4oYkCIigYAUDgAelTUAFFFFABRRRQAUUUUAFFFFABRRRQBh+KfDVl4itQlyDHcJ/qrhB8ye3uPavE9X0y70e/ezv49ky8gj7rr/eU9xX0RWR4m0G11/T2t7obZBzFMB80beo9vUd648VhFWXNHc7MNinSfLLY8JhbmtG2bAFVNW0+70XUnstQj2SryrD7si9mU9x/KpLZ8ivCnFxdmeympK6Nu2kwRWpC+RWBC+CK1LWTpWLQmi5nzrxQPuQjJ/3yOPyBP/fQq2KpWZ3XNy3QZVceuBnP64/CroqGSKDUgaowKUUhEwNYjcMfrWwDWVcoUncHpnIoMK60TGZpaSlpnMFFFIaAGt0qF9rqVcAqeCDUzVA3BoQzJt9QufCl6skY8zS3PzLjJiz1+q+1dFfRXOn2B1jwrNvsyN8+nud0eD1Keg746VRliS4haKUBlYY5rO8HanJ4e1r+y7pibOYnytx4H+zWGIpe66sFqt13X+f9bm8ZuXuvfp/kauk/8Iv4nkIn0+Oy1DqwQBCffHQ/WtFvDGnwzNHaT2pkTqkvysKoa/4ft4rsmHKK/wC8t5E4KeoBrOijj1iUWmqARazAMQ3AOzz09M+v+fpklNpVKVR8j6PW3/A/IlKMvU6N9IvIhkW5ZR3jIYfpVSSN4+JUdP8AfUj+dZcVlf2zZtdWvoXHGGfdj2IOauJqXiOAYW+huB/01j5ra1ZdU/vRFovqTA56Vom6XSPDt7qUgyIo2cA/xEDgfiePxrI/tzV92LnRrG49XBAJ/SofE/jLTdGsEg8Q6M3lXCttgGCpZRkEgnpu21rQdVzSlD8UylFbp3PKrM7HzK2ZPvOT3Y8n9TXU2E4kjUVxFvdw3S7oJFY9wK3dEnIl2E9a75xO6L6I6WW1SVTuUEVg6po6KjSJxgE4rqoB8gqjqrqkL5x0rGMmmUeG3SkTyD/aNXdFQvexD3qDUADeTEdNxxV/w0hfUYhXoP4TkS949C1wf8SuFe4WvJ7wYvZB7161rgxAqk9EFeUajxfS/WsqBdY09CuDJiFuo6V6V4a01VQSuOTyK8z8JqsuoYIr2rSIx9nQD0rPEO2hdLVXHXTiKEntiuG1e53u7scKOTXZ66rLAcV5zrpb+zrsjrtNZ0ldmknZFX4feLG0z4iaddzsRZPIYJV7CNwUJ/AHP4V9LyK0bMj/AH1JU/UV8YQggq/evrTwrqra14Y0vUXOXnt1Ln1dcox/FkJ/Gt8ZBcia6HFTbcrvqegeFznTW/66H+QrXrG8KHOmN/10P8hWzXr4P+BD0PNr/wASQUUUV0mIUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVHcOI4HcsFCgsSewFSVk+LWZPC2rsnDC0lx/3waUnZNjirtI+d/iF47vtZvVBSNLOCQmAbBvx0yW68+nTp6VPod8l3bRyofvdR6VxuqpuQjuKXwbfm3vTbO2Fc8fWvn6t6i5nue9TtD3VsepQc4xWjbcVj2kvTNa1uwNcUjZlyFtt98p4ePLexB4/mfyrTQ5FY9u228k3dWQbfcDOf1P6itKN+KhkMsUoqPeKUNSFYlFV76IvGHX7y/yqUGnqaRMo8yszGFKKnvIPKfco+RuntUFBxNcrswNJmimnrTEBqNxT6SgZGvFZHizT2urDzoOJ4SHUjrxW0F5p5UMhUjIPBqoy5WmgLGiX/8AbfhOGdv9fbfe+nQj8x+lZ2pWS3cQ2nZMh3I46qai8BuLLXtR0uU/uZhuUex4P9PzrTkQxyNG/wB5CVP1FclFexqzpLbdejNamrU+4Wt2NUsmmcbL63wtwv8AeHQMP89PpSVRmn/szUIb4AGIny51PQqeOa07qEQzFVO6MgMjeqnpWkVyS5Oj1X+Xy/ImWq5gtl3zIvqQK8e+Ot8bvxe1tu+S1hSPHuRuP/oX6V7TpCb71f8AZGa+ePiRMbjxrrLE9Ll1/I4/pXo4RathTRy+kSNBqUWCQGODXqOi2hNwrdq8utgE1CFm6BgTXtfh9Izaq+RkjNb4h7M6aHVGsrBI+ewrivGuriCIxRt+8Ydu1bWv6tHY2zuWHA4HrXlOoXkl7dvNIep4rGjTu7s0qS5VYouS7k10ngy2aTU4+OBWJBA0hyBxXofgHTwJ95Fb1ZWiZQjd3LXiY7ZiPQAfpXleqr/prn1r1bxKm+acgdDivM9SizMx75qaD0Kqq5F4en+zaihY4Br2rQL1HhQ57V4OdytkcEGut8PeJDCoSU4YevenXp86uiaU0tGevXypcQke1eeeJ7UW9jdFjgFDWjH4pj8rkj865DxZr329DBEcg/eNY0qclI1nJKJyMMZK19FfCGRz8P7MOOEuJ41+g2N/NzXgFqgzj16V9I+EbJ9J8I6TZSqVlWEzSKezSHeP/HSldGJf7t3OaC95Hpvg850pj/01b+QrcrA8Endo7H/pq38hW/Xq4T+DH0PMxH8SQUUUV0GIUUUUAFFFFABRRRQAUUUUAFFctrvjrRdC8Y6N4b1KSSG/1VHe3kKgRfKDwzE8E4wOOuKzfDnxY8I654budfXU0sNKhvm0/wA/UGWASShA+Fyecq2R34PHFAHd0Vjx+KNAlhjlj1vS2iktmvEYXceGgX70o5+4O7dBWBq3xH0zTnnIi+1QJeWVmktrcwSiQ3QBR9quWVeR94DI5XI5oA7eiuLs/iV4caz1K51W/g0iGy1S40ndfTJH5ssJwxTnkd/WtqXxX4dhkto5te0mOS6jjmgVryMGZHO1GQZ+YMeARwT0oA2qKzbHXtHv5baOx1XT7mS6iM8Cw3KOZowcF0APzKDxkcVU1Dxf4e0/WF0i71rTYtWcApZSXSLKxIyBtJ6ntnrQBu0VycXxA8Nx6PY32r6zpWlG7gFwkNxqEDNsLbcgo5VhnjKkj3rYl8Q6LEly8usaciW0KXE7NdIBFE/3Xbn5VPYng0AalFYa+LvDra8miLrumNq7DK2YuUMp4zjbnOcc46456VuUAFFFFABRRRQAVW1K3F3p11bHpNE0f5gj+tWaKGr6DTtqfIF/bSLO6OhDAlSCOhFYk8ElvcrIgKsDkGvWviJpQ03xbeLtxHM32iP6N1/XNYzaZBeQ/Moz6189J+zk4s92PvpSRHoGsxXsCgsFmA+Zc101rcY7157eeG54JTLaOVcdCKij1LWbI7ZE8wDvisnTUvhZpzW3PUkuB9riOf8Alm381rQS5A715Tb+LZY3BuLdwQCOPw/wrRh8ZW7Hnen1FZujILpnpQuV9aeJx2NcDB4ot36Sj861bXWYpQMODWbptDsdYsvvU8cgrmotSXcOa0re7VxwalxE0bLBZIyrdDWTMhikKt26H1q3FMCKW5UTRcY3jpU2MasOZXRQ3UhOahL4NORs0HLYeaSlNAoAMU8dKRacKBGNqObPX9Nvk+XLeU5+vT9cV0+tL/p7SKBsmVZFx7jn9QawNfhM2mS7fvp86/UVumUXnh/TrtfQofxGR/WsK3u1YT73X6o1WsLdv6/QzbyAXFtJE3RhimaDO91ozQzHNxYP5bZ6lD0P+fU1aqjBKuna9FM//Htdr5Eo/l/M1pVTcLrda/5/gKGr5e50egr87ufoK+bvH8Bh8b6ujd7qQ/gWJH86+l9PjNuuxjllYgn156/iMGvGvjh4cmtNa/tuBd1pdbd5H8EgAGD7EAH65ruwk01oaJctjyq4iO4ECtbT/EeoWUIiRtyjgZpsESzgEcg1aXTCx4GK6209GWk1qjNvb281B91y52+lNt7cuwGDW7DokjEd63NO8NuxBYDFS6iSKUG9zI0nTWmZUVTg16T4btBA7Kg4RcfjVW00+HToNxA3Yre8PRYgLsOXOa5KlTmNkrI5XVRuu7lCP4jXBa1aYkZlH1r0XUYx/a86nuTXOapbATMrD3FaU5WFJXR55NEc9KrMMN0NdddaYCcqMVVOlsT0BrqU0YODOeBfH3jilVfQEmujXRs/ewKsQaVHvAAzR7RB7Nlr4V+G/wC2/FEJvI91hag3FwD0KLzt/E4X8a9xvJ3mkeSQ5dzk1k+E9IHh3w+YpE8u9vWWSVD1SNfuKfQnJbH+7ViaTrXJiZ8zUSqcdbnoXgM50Rj/ANNm/kK6Oua+H5zoTH/ps38hXS172E/gx9Dx8R/FkFFFFdBiFFFFABRRRQAUUUUAFFFFAHnXj/4ZWvjfxVbX2rTldOj057No4SUmDmVJFdH7Y2Y/Guei+Eur2GlahZ6PrVvaw3HiO51kW6iaONoJECLCzRurjaB/CwB6HivZqKAPCrj4I6hd+B/Dfhy41XTlXRDdXCXC2xdpp5JXdEIbpDh/nXJLYHpW5qnww1PU9V1jUJ7+yil1HUtK1Bo40ban2SNVdRn+8Qceg616zRQB43qPwp12SO6Sx163ihuta1DUp7dhMiSx3ONqs0To5KEZ252tnnpWh8PvhY/hvW9Gv9RuLK+GnaDHpSjyckSpcPL5qk9OGA9eK9UooA8h+CXgS58OeIfFWpXsM8Nqt1Lp+jQzgAw2QleU7QP4WeQ4zz8vaptb+GOrX3xCm13T9Zg0yynuI57mO3E2+7CJtCSoXMTf74UEDpzzXrFFAHjej/B+4tLS0gu72yuBB4Wn0AboSR5rybxKM9gOPWqOqfBzXn0ifT9L13TYoL7QLPRr3z7V3Ja3XaHjIYYDe4OP5e5UUAeTaJ8MdW0z4gJrcGswWmm/aWup7S0EwF2xTaPMjdzGGH99VBOOxOa9E13Rv7X8j/iZalY+Vu/48p/K35x97g5xjj6mtWigDlf+EN/6mPxL/wCB3/2NH/CG/wDUx+Jf/A7/AOxrqqKAOV/4Q3/qY/Ev/gd/9jR/whv/AFMfiX/wO/8Asa6qigDlf+EN/wCpj8S/+B3/ANjR/wAIb/1MfiX/AMDv/sa6qigDxj4s+BjFpVvqces63OYH8uTzrrdhG6Hp64/OvPNN0bf8p1XVR9Lj/wCtX09rFhFqmlXdjOP3c8ZjPtkcH8DzXzhaRy2l3Lb3AKzQuY3HoQcGvJx8XGXMup6mCkpR5X0LEXhtXODq2r/+BP8A9apz4LilGW1PVj/28f8A1q1LZwSprctWBUV5TqSXU7eVHDy/D22k/wCYhqn/AH//APrVSuPhnCwO2/1H8Zv/AK1eqRIp6irIt1I6UvrE11J5Y9jwPUvABtXwl/fZ/wCuv/1qzV8PXlm4b7fqGwHJCzYyPyr2fxRbhSrAVylyoMTAit4V5Naj9nE6K5+EE89hHd6F4j1SUOgdYrifG4EZ4YD+lclPot7pN39l1S+1u1mHZrjAPuDjBFe4/CnUDf8Agy0VzmW1ZrZv+An5f/HSK6LWNJsdZtDb6lbRzxnpuHKn1B6g/SvVlhY1YKUNGzzViHSm4zVzwOy0oSqD/bWtfhdf/WrRj0HP/Mb1v/wL/wDrVL4r8OXfhK8Dozz6VI2I5j1Q/wB1vf370ljeeYBzXkVY1KcuVnow5JrmiUr3w3scMNZ1ohvW67/lS6fo/wBluo5v7T1SbYfuS3G5D9RitxmEsZRj1qmpKsVbqKx55WOerTUXdGipyKcBUELZqwOlZGTFFOpBS0CGSqHiZT0IxT/CDC58N3lmfv27MQO+VOf5ECioPDEwsfFE8DcJcAOB+h/pXPi03RbW8bP7jWlq2u5PVa/tPttuYh98/dPoe1XLiIwTyRN1RitT6bHvn3dlGfxreMrpSREVd2H6JdG4tEaTiZf3Uo9GXofxH8hVrVrO31XTprK9iWWGVdrKe/8Ah9aoX8ElndG8t1LRvgTRr3/2h7itG3mWeMOhB+lRSbpSstun+Xy/I7ZLm1Pnjxf4ZuvCWpgKXl06YnyZiPTqrejD9eoqKx1AYBIBr6C1W0hvrZ4LuGKeF/vxSrlX+vv6EYIrznVPhjC0ry6Dd+VnkWt22MeyydD/AMCx+NerGpGqvMzTcdzGsLuKQDAArdgulWMcgVzUvh7WtLy13p9yka/8tAhZP++hwfzqWGR3ADZzWc4WOiDTWhvPMbuZYx0JrrtPVUiAFcno0GCHbr/KujikKg46AVzz7DZyuuzrHq8r/wC1io76yF/bCSMfOB+dZuqTCa7YseSxNWrbU9kaxJknpxW1mkrCTMaeCWPKupBHrUHlyY4Fei2Hhm/1JA9+gsLbr5lwCGb/AHV6n+XvWva6LouljMNoL2f/AJ63Y+UfRBx+ZNaX5fi0Ico9NTznRfDOr6wN1lZyvEOsp+WMfVjgV3Oi6Dpvh90uZJU1HUU5UBf3EbevPLkdu1ad9fTXAVZpSyL91Bwq/RRwKzJXJqHWS+BC5XL4ixc3bzStJI5Z2OST1JqsZM1HyaeqGsDS1j0v4dHOgN/12b+QrqK5n4ejGgt/12b+Qrpq+lwv8GPoeDiP4sgoooroMQooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK8M+J2nNp/jaaYLiG+RZlx03AbW/UZ/Gvc64P4vaYLnQYL9RmSylBJ/2G4P67T+FcuMp89J+R04SfJUXmecWcnyiugsGyBXNW2B0rc0x+QK+dmj2Tfi6CrsLZ4NVbdcqKtxLhhWJLMLxSn7sVxVxwDXd+KkxCK4a6Hyk1tFFweh3PwNujv1qzJ4DRzKPrkH+Qr1avEfg1ceT4yuoSeJ7VsfVWU/yzXt1fRYKV6SPGxkbVWVNWsINU064srtN0MyFGHp7j3FfPmnpNY3txY3P+vtpGif6g4r6OrwLxQQPHus7ehmH57RXPmUE4qRtgJO7iXon6VLLHvAdR8w6+4qvCOAavQ8CvDZ6UoqSsyCFsGraNmoZ4NuXj6dx6UkTVDOGUXF2ZbBpajQ0+kQOrJ1hvst3ZX448qTa5/wBk8Gtaq99ALm1khbowxRZPR7MqMuVpo2tdQNLDcqPlnQE/UcH+lTWUPlQDI+Y8mqnh+6Go+H1EwzNasCw+nDfpzWnXHhG1B05bxdjojBKTYh5BzVD7I8E2+2OEPJT09xWhRXS9VZmlyPG9RuGDUEsJAO2rdMbNNDKMU81sx8p2TPXacZqjeWmmX5P9oWEZc/8ALaD90/6cH8RWvJGGHSqcsAraFWUdEwsnqc9ceGJoyX0W5F0uM+RJ8so+nZvw59qofbPLtZkkBWVQQVYYINdRsKEEdVORWxNa2uoQJJf2cF2SOHcEP9CykE/jWqlCe+j/AABycd9TxbS9B1LX9RkWwhLIvLysdqRj1Zugr0PQNH0/w/Gj24W71L+K6cZVD/0zB/8AQjz6YrU1ucW9mlpbRx29uTxFCu1fr7n3NZiPwKqVZJe594lFy1kW57l5GLSOzuepY5JqlLKaSR6gY5Nc/mzRKwjnNR7cmpguaVUpjGxx1Jsp6jmlNAj0HwCMaG3/AF2b+QrpK5zwH/yA2/67N/IV0dfTYT+DH0PCxH8WQUUUV0GIUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFVdUs49Q065s5wDHPG0Z/EYq1RSavoNO2qPnO2Do5jlBWRCUYHsRwRW1p7bXFSeO7D+zvGF4AMR3GLlP+Bfe/8AHgar2pwVNfMVocknHsfQQkpxUl1Oss2yoxV+PtWVp7ZQVqxdRXL1EzM8Vx5swa89uPutXp3iFN9ifpXmt4uGYV0LcdP4SXwBciz8e6TIxwryNEffcpUfqRX0PXy407Wd3BdJ9+CVZB9Qc19P20yXFvFNGcpIodT7EZFezl0rxcTzswj7ykSV84TXJ1HxFf3gORNcO4+meP0r6F1WZrbS7ydBlooXcfUKTXzn4eTKKanMpaRQ8vXxM6m2XKCrqLiorNMrVmVgi14bPSHoKbJaBjuiwD/dp8PzKKtRCpIlFS0ZnbGTh1IPvT62EAYYIBHvSi1hbkxj8OKm5zui+jMcVatrN5SC+VT36mtJIIkOVRQfXFS0XHGjbcyYMaTrkTou22uPlb0Df/XFa80awyssbBoc4Ug52/7J+lU9UtftllJEDh+qN6MOQaxIry9hxe2kXnZ/c3tqf7yjqPqOfwrnnTkqntYddGu5ta+p01FU9N1C21GPdZuSw+9C/wDrEPoR3q2DkZFaxkpALRRRTAQqDUMseRU9IaYGZKhD1q6Gd8LxN/CeKqzp3qfQ+LmQdjWtJ+8hVPhZg+IMtfhR0WqwXCgVc1YbtUkHoagZe9D00NI7IrMM03bU+2mlcUDI8elSKvFCipVXigBmMU3GSamZcVHjmgD0HwKMaI3/AF1b+Qroa5/wP/yBW/66t/IV0FfT4T+DH0PCxH8WQUUUV0GIUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHnfxdsd0Onago5jcwP9GGR+oP51xVkcgZr1rx5aG88J6gijLoglH/ASD/IGvH9PbJFeHmMLVL9z18FLmp27HVaaeBW3B1FYOnHGMVuwnpXlPc6ZC6qu6zYe1eZamu2dh716leLut2+leba1GVuH471t1FS2ObvY9yOPUV718M7/wDtDwTpkjHLxR+Q31Q7f5AV4lLHlTmvQ/gden7Pq2nM3EcizIP94EH/ANBH516OAnapbuYY6F6d+x6i6q6MrgFSMEHuK8Qn8LJaazd2+mXjm2V8Rgpkqe4z3wa9qvZfIs55v+eaFvyFedeH48/O3LHkk161SjCr8aueXTqzp/CzAZL7SubxVlt+nmKMEfUU+aZZCpQ5U9K7HV7dGsHMwBUqcg15zp8d6u4Qw+bCGIRieozXkYvAcrUqSPRw2L5k1Uep0dgjORmtJkCLmsm11CS0UG8tWjTu6nIH1q9dXaSwh4mDKehFeZOnKDtNWOpSU9Ysek2JMVdSQE4rBtyzyZratIieTUWKehOWAHNKCD0rOv59k6oDVm3YtipaFYs1j6if7OuxehSbeXCXIHYdn/A1pTSBeM80hKTIY3AZWGCD3pOKaswRSuNKtruTz4yYrgdJYjgn3p7S38AxOouVH/LReH/Hsagti2mzi1fPkH/UOfT+4f6flWqsisAVIIPSs/j0nugKsOoRSHBO1v7rjaf1qws0bHG4A+h4pNqSEhlU/UUn2eJRhVwPQdKajKPW/wDX9dA0JqWoVYDCr0qUVbENcZFPslEUhYdTSU5TjNOLsweqsYN/k6lIT3NNZeKmv8m5FNYYUVd7lrYgx1qF6mZhzzUDnJoQxFqzGOKrqMVPE2DihgPZagfireMiq8w4oEd54GOdFP8A11b+Qroa5zwF/wAgNv8Ars38hXR19RhP4MfQ8PEfxZBRRRXQYhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAMmjWaGSJxlXUqR7GvAIY2tLye2k+/DK0Z+oJFfQVeI+Nrb7F411FRwspWcf8CHP6g15uZQvBSO/AS95xL2myZxXRW54Fcjpj/MK6q1OVFeBJanpSNFvmgI9q4HxBFi4fivQIuY65DxPBiUt61r2ZFJ6tHIFcqa0fhxqH9l+ObZWOIrtTbt+PK/qB+dVWTBNZGpGS1uIbqA7ZYXEiH0IORW9GfJNSNKkeeLifSWrJ5ulXaDq0Lgfka4PQ5FCR5OMnFdvpGoQ6nottfIR5M8Ik69ARyPw5H4V46/iKx0+6W0mmKOsvyM6lQwz1yR3FfSJ3V0fPNWdmdl4yuNmmMqdSMVBoFuqQouOFGKqeI7lLuyt2jYMruoOPqK1tGUFce9MRcu9NjngJ2jpzXn9zDcWGpta2QEsbjdtJ+5Xqd2RFZMfauA0r9/f3Vwed8mxfovH881jWoQrLlma0qsqTvEjhXUoF3NbRP7K3P61p6bq0M4aNgYp16owwa6W2t0aEAqCa5vxVpISP7RB8k8fKkfyrgrZZHlvS3OqnjW3apsZ9w5lvM+9b1lHtiBNcdp+pTzkOlm8jDgnOBmtyHXQoEd3bvbseAScg/jXkujUSu4ux3ucXpFkl9KBP7CprJi5zWTduZZxt5z3ra01NkYzWLLeiLFzbpNA0cqhlI5FYUM0lrOUlYsueG9f/AK9dHMwETGuYZvMuSpGQTQ4omGpv2o3rkd6fMNqnNP05AoUe1O1RQqEiny3jzC5vesZXnYar0LblBrD3kyY962rT/VrUtFtWLLRkDNQ561ddlEWM81ms4DMKqSSehnF3KtyoMme9LJD8gPbFITuetFlU2oz1xTgrlSdjl7rKykU2M7mqzqEXzEiobRcvig0Ww8pgUwnaa0Wh+WqNyu0GlcEy1bnetR3KY5pLBhjk8ClvL6zXKtOgb0zQI7XwD/yA2/67N/IV0lc14AdJNDdo2DL5zcj6Culr6jCfwY+h4eI/iyCiiiugxCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK8r+LUAj17TrjGDNAyH/AIA2f/Z69Urzn4xp+60eXussifmoP9K5car0WdODdqqOT09vmWutsjlBXHaefu11+nn92K+ZmeyzXtjlaw/E0O6MnFbFu2GxUGsxeZA30rRaxMFpM85kGGqnexCSMgitG6Ta7CqzjcpBpo6Tofhz4iWDR9Q0G8kCFY5HtSTjIIJZPrnkfU0vibw7DrdhHGqoJWwFYjpXFSR7LpZMZ2MG/KvWNK2yRwM3BQ17uAqucHF9DyMbSUJKS6nmDpqvha0+y6gpuLQMDEytlkwc4x3HH4V6Fpt8uyKSJwUYggg8EGo9WjS58QlGAIWAgA+5H+FchqT3/hqZo4YPtFjncig4aLvj3H1ruOI9X1ubGmtj0rjPC4zFET3Bb8yTU1n4nsta0nbDKPNK4MbHDKfcVW8PyhLROxVNv4jigDv7HBX6Vz3jO4ItDEh+eRgo/E1peHZzLY7ick1zniNzNq0EfZAzn8sf1oAj0yFVCKqgKOAK3bnRo7qxYOoOR6VR0qEkrXS3T+RpzE9lNJq+jBOx5hZfa5JpLRG2iJ9pk6n6VvRaJKwB8+4ZvXzDVXw3GJGErDmRzIfxNdxZJuPtXNDBUYfZudE8VUl1scTfrqGkpvZ5Jrb+IPyR+NUnv4otsqLvdvuoOua9E1aGN7d43UFSMHNeeeFtNV5DdSfMpYiPPZc4zXJWy5SmnDRdTopYzlg+fVmhbNrcwDp5UK9lOSaJ9RvLcbdRiBQ8eYhyB9fSuut4gFAAqHV9OSS3bcoIYYNayy2k48q0ZlHGT5rs455UjbzWPyDnNPhm1DUgPsp+zw9mxkmsUwzfbhpb5KhtxP8AsivQNGhVI84rkwmAUm3V6HTicVypKHUxV0zUIlLpdyFv9oZBrPbU5Y7gwXsfly/wsOjfSvRViDJ0rjfGdgsllM6r+8iBdCPUV1V8upzj7isznpYySl7+qMmXUJRKsFrH5ty/Qdh7mrkenanPg3F+6t/ciXAH59aZ8O7Zbix+3SDMk3r2APSu5W3VUzjmlhsvhGN6iuyq+MblansefX8V9pq77lxPb92xgr9aSK8hiCyLly/CIvJY+ldvfwJNbyRyKCpGOa4bw/pwtvEE8TncsQBiz2DZ/wAKzrZapTTp6LqVSxtotT3NNLPVLlN7yR2wPRAm8j6nNZmpxX9kpeXFxAPvFVwy++PSvSfIX7MCoHSsO+VcHIroeXUeWyXzMljKidzjdNVtVufKici3UAuVPLZ6Cuph0OGGL5YEHr8orJ8PwLaa9dRIoEbhZQB2ySD/ACrurkbYQR3FaYbDRoxt1Ir13VldbDvCFtHa6XIkSKimZmwoxzgVuVmeHv8Ajxb/AK6H+QrTrqStsc+4UUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAV558Yv8Ajz0v2mY/+O16HXnnxh/49NM/33/ktc2L/gyOjC/xYnGaZ9xTXXacfkFchph/dCuq0psqK+Zme0zVQ4YVPdLvgP0qsOtW0+aLFOk+hhPuef6tD5dw3oay5BjNdV4htuSwHSualHFUjoTurmW3N2qnoTXf6HclrcAn5+p+veuCm+WdG967mG0EsSXFrMsUxA3I33W9/Y124TEKjP3tmcuLpOpFW3Qksx/t5Gb+KIj8mH+NdPa2qSySO6ggqAM1xdwk8d9DLMyHaSvyH1/+viu10q4V7YHPOK9qlWhWV4O55VSlKm7SOQ8W6Np9zcwWy28SySvy4UZAAyf5VzWtadqfheAzaSxms2JJhmG7YT6Ec4rrL6Td4jUnnZE2PqWFbd3Ct5HbW7AEMct9K1MzhvA3jqLP2TUlFpN23H5G+hrdvplm1neCCGhYj/voVqah4W0uKBpXtYSfdBzXEQ6U8fm3ulDbIkp8qEsQjJ0Ix7/0FAHf6KQVWrviebydGnYdlNcTo3iSCKTyrnNrOOsc3y/kehrf8RXy3fh+cIQTsPQ+1AFPw7GEjjX+6oH6V2ulr8gNcZpJ2tx3rstLf5KAM/xXc/ZNLvJx1jiYge+OKx9Mt1toIIU6IoX8hVvxyc6Y0Y/5azRR/m6imW4+YUAbNnyyir1+v+jke1VNPH7wVc1A4iP0oA86WNW8T3LnqsKD8ya6zTz8uK5a3517UG9Ni/pn+tdPphzxQBuwj5K5zxCoaKUeoIrpbcfLiue15OHoAxPhwPL0G2Q/wlh/48a7iUDyxiuL8CqBpcWO7Mf/AB412r/6qgDLuz8jVyqHZ4hU/wB+A/8AjrD/AOKrq7kfKa5S4GzxBZH+8kq/+gn+lAHeWZ8y1Un0rG1VB82K09Mb/RADWbfcuQaAOdgPl69Cf78BH5MP8a7ST57RW9q4m4+XXrEDoY5R+qV2cBzZgH0oAv8Ah8Ysm/66H+laVZ2hDFm3++f6Vo0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFeefGJf9B0t+3nMv5r/9avQ6434q2b3XhuN4xloLlH644OV/rWGKV6Ukb4Z2qxPOdOH7oV0ukZAFY2l2UwXBT9RXQ2FtIh+7+or5mcX2PabRo1LC+DimiGTA+X9aUROD939azipJ7Gbsypq0IliNcRfRGORlr0N4XZSCvX3rl9b06UtuVOfqK0Sd9iqcktDj7pScH0rp9NuSbNOegrKl0+c5/d/qKu6VbXAiKFOh9RVSi2tjS6L1uyT3DRTZ2OME+nvWiqX9ih2J58fZoyOfwNUYLKbzA2z9RWiFuYxjbx9RWlCvUoN8nUwrUoVbXMZZ2n1pGeN0PlEHcPcV2+nxblSQYyBXJiynmn3ov7xCSoLDn1FdJpE0iwYZOPqK9vB4l1o+/ueZiaKpS93YPF90YtNcjghCawdMhEaRxDooArR8VpLcaXKVXOFPGRUdpbSiYHb+orsOYsXHh2y1SMJcwo4I7iuR8R+ErfSY9ml3F1BNIyxxxpKdhZjjkfjXp9hEwwSO1c14mgkl1ywwuUFwCeR2ViP1oA5RLbxFosCAwR6nBGAN0R2ygfQ8NVyy8f21q3l38F7aN3863P8A7Lmu0tEkBOV/WtFLRJB88amgDzvV/F+kaktlHHfRbhdxMQ2V4De4+ldRBsOCGHNZvivR7e6NnE9pE8clyqvkD7uCf6VVfwdD1064vNOPpby4T/vk5H6UAdhZMFbORU+oTKYTyK4f/hGPEEX+o8UT49HtYm/XFIfC+uSj/S/El269xHDHH+oFAC2i51fUMdd6/wDoArpNLwHIJrhU0TWdL1mT+ybj7WZYt8iXsmclSAMMOh5+lPbxFrNjLi70NlYdfLu0b+eKAPVYZFVCSaxNUxJ5jD0rik+IBT5ZdJvwfZ4iP/Q6B4s1DU90Wn6LMWIPMs8aAfkTQBueCBjR7Zj33f8AoRrr2lUx4Bry/wAN63e6XokCX+j3G0AlXiliYMMk9CwIq03jgs22PSb/AD7tF/8AF0AdtcEVzF+P+J5ppHeR/wD0A1BHr2q3f/HtoVw+em+4iUf+hGsfVZPFI1LT7hNNsrcFzEiyT+Z8zDqcY7A0AekW0yxwjJxVC5mVnLZ4rnjYeMp12vd6Rar6xRO7f+PHFMHhC8n51TWtQux3jRlhQ/ULz+tAFbU9a0211+yFxewRtGkpcM/3c7QAfQnn8q1JfHGiwRbTqMBOOiZY/kKzNS8O2luth5FlCnlXcZyoGSC3OfWu1s7KJjl4I93rgUAXPA2qQ6voz3Nt5vlecygyRlCcAcgHnHNdDVXTYxHb7QMDdVqgAooooAKKKKACiiigAooooAKKKKAP/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This drawing illustrates structures that are associated with the orbit that can be damaged in orbital fracutres.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_54_30566=[""].join("\n");
var outline_f29_54_30566=null;
var title_f29_54_30567="Effect of advanced paternal age on fertility and pregnancy";
var content_f29_54_30567=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Effect of advanced paternal age on fertility and pregnancy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?29/54/30567/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?29/54/30567/contributors\">",
"     Isiah D Harris, MD, MSc",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?29/54/30567/contributors\">",
"     Randall B Meacham, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?29/54/30567/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?29/54/30567/contributors\">",
"     Louise Wilkins-Haug, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?29/54/30567/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?29/54/30567/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?29/54/30567/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women are generally aware of the reproductive issues related to advanced maternal age, typically defined as 35 years of age or older on the estimated date of confinement. These issues include higher risks of infertility, fetal aneuploidy, gestational diabetes, preeclampsia, and stillbirth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/7/31865?source=see_link\">",
"     \"Effect of advanced age on fertility and pregnancy in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Reproductive concerns related to advanced paternal age are less well defined [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/2\">",
"     2",
"    </a>",
"    ]. Analysis of pregnancy outcome in the partners of these men is confounded by the fact that the partners are often of advanced maternal age. Nevertheless, both women and men need to be aware that childbearing after age 40 years is associated with higher rates of subfertility and adverse pregnancy related outcomes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21502920\">",
"    <span class=\"h1\">",
"     SEMEN QUALITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The probability of conception is primarily dependent upon maternal age, and to a lesser extent, paternal age. In contrast to oogenesis, which appears to be limited to the fetus in humans, spermatogenesis continues even in elderly men. Since the adult male's germ cells have passed through more mitotic replications than the adult female's germ cells, there is a greater opportunity for error. Increasing age has been associated with more breaks in sperm DNA, loss of apoptosis, and a higher frequency of point mutations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/3/31800?source=see_link\">",
"     \"Male reproductive physiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A literature review on the association between male age and semen quality compared 30-year-old men to 50-year-old men and found decreases in semen volume (3 to 22 percent), sperm motility (3 to 37 percent), and percent of normal sperm (4 to 18 percent), but not sperm concentration, with age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/5\">",
"     5",
"    </a>",
"    ]. Similar findings were noted in a subsequent series that evaluated men age 22 to 80 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/6\">",
"     6",
"    </a>",
"    ]. However, standard sperm parameters do not correlate perfectly with fertilizing capacity and achievement of pregnancy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21503027\">",
"    <span class=\"h1\">",
"     FERTILITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies have consistently shown that increasing male age is associated with an increased time to pregnancy and decreased pregnancy rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/7-10\">",
"     7-10",
"    </a>",
"    ]. However, only a few studies have examined these outcomes adjusted for female age.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A large population based study conducted in the United Kingdom used self reported surveys from 8559 pregnancies to determine the effect of age on time to pregnancy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/11\">",
"       11",
"      </a>",
"      ]. After adjusting for female age, conception during a 12-month period was more than 30 percent less likely for men over 40 years of age as compared to men younger than 30 years of age.",
"     </li>",
"     <li>",
"      A self-report survey study of 1976 British women that controlled for multiple potential confounders (eg, female age, coital frequency) found a five-fold increase in time to pregnancy in men 45 years of age and older compared to men less than 25 years of age [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/7\">",
"       7",
"      </a>",
"      ]. Men 45 years of age and older were also 4.6 and 12.5 times more likely to have a time to pregnancy greater than one and two years, respectively. These increases in time to pregnancy were similar even when restricting the analysis to men who were conceiving with women less than 25 years of age.",
"     </li>",
"     <li>",
"      A French study examined 901 cycles of intrauterine insemination and found that the age of the husband was the most significant factor contributing to a decreased probability of a pregnancy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/12\">",
"       12",
"      </a>",
"      ]. After six cycles, the pregnancy rate of partners of men 35 years of age and older was half that of men less than 35 years of age (25 versus 51.7 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Few studies have assessed the impact of paternal age on outcome of assisted reproduction. A review of these mostly retrospective studies did not observe an unfavorable effect, but there was considerable clinical and methodological heterogeneity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The effect of the male's age is best evaluated by studying pregnancy outcome in couples using oocyte donation, thus allowing male age to be the dependent variable (most oocyte donor programs seek 18 to 34 year old women, often with proven fertility). These studies are often confounded by the use of intracytoplasmic sperm injection (ICSI) and have reported discordant results; some [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/14,15\">",
"     14,15",
"    </a>",
"    ] but not all [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/16-18\">",
"     16-18",
"    </a>",
"    ] show a trend towards a negative impact of advanced male age on fertilization and implantation rates, suggesting that if an effect exists, it is weak. There is more consistent evidence regarding increased miscarriage rates in partners of older men (see",
"    <a class=\"local\" href=\"#H10\">",
"     'Miscarriage'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1007003086\">",
"    <span class=\"h2\">",
"     Sexual function and coital frequency",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to female age, sexual functioning and coital frequency are variables that affect time to conception and pregnancy rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/19\">",
"     19",
"    </a>",
"    ]. &nbsp;Decreased coital frequency with age is due, in part, to diminished sexual functioning (age related erectile dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/20\">",
"     20",
"    </a>",
"    ]); however, sexual dysfunction itself does not affect germ cells and its impact on infertility can be overcome by assisted reproductive technology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/21\">",
"     21",
"    </a>",
"    ]. Failure to control for coital frequency may introduce a significant confounder when assessing time to pregnancy and pregnancy rates in partners of older men.",
"   </p>",
"   <p>",
"    The impact of age on sexual function and coital frequency was illustrated in a study of 1290 men enrolled in the Massachusetts Male Aging Study (MMAS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/22\">",
"     22",
"    </a>",
"    ]. The probability of having complete erectile dysfunction increased three-fold (from 5 to 15 percent) between ages 40 and 70 and the probability of moderate erectile dysfunction increased two-fold (from 17 to 34 percent). Secondary data analysis of this same cohort observed that men engaged in sexual activity an average of 6.5 times per month prior to age 40; this frequency decreased by less than once per month after age 40, by one to two times per month after age 50, and by another one to two times per month after age 60 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     AUTOSOMAL DOMINANT DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Advanced paternal age is associated with an increase in new autosomal dominant mutations (eg, achondroplasia; Apert, Waardenburg, Crouzon, Pfeiffer, and Marfan syndromes) that may result in congenital anomalies in progeny [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/24\">",
"     24",
"    </a>",
"    ]. The precise etiology of this finding is not known; however, it is hypothesized that the activity of antioxidant enzymes in the seminal plasma and spermatozoa of older men may be reduced, thus making the spermatozoa more vulnerable to mutational changes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/25\">",
"     25",
"    </a>",
"    ]. In addition, spermatids and immature and mature spermatozoa of older men do not have a DNA repair system. Chromosomal aberrations, but not aneuploidy, also may be more common in men over age 45 to 59 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/26,27\">",
"     26,27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the collective increase in risk of progeny with autosomal dominant disease rises exponentially with advancing paternal age, the actual risk of any specific disease is small because of the rarity of autosomal dominant inherited disorders. One author calculated the overall frequency of offspring with autosomal dominant disease from fathers of various ages [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/28\">",
"     28",
"    </a>",
"    ]. The estimated frequency of any autosomal dominant disease due to a new mutation in offspring of fathers 40 years of age or older was 0.3 to 0.5 percent. This risk is similar in magnitude to the risk of Down syndrome in offspring of mothers age 35 to 40 years (",
"    <a class=\"graphic graphic_table graphicRef75423 \" href=\"mobipreview.htm?16/60/17357\">",
"     table 1",
"    </a>",
"    ), but was based upon several assumptions for which there are scant data.",
"   </p>",
"   <p>",
"    Fetal karyotype analysis assesses the number and overall structure of chromosomes and would not be expected to detect single gene defects. Currently, there is no method available to screen for sporadic new autosomal dominant disease. Prenatal ultrasonography may detect some abnormalities suggestive of such disease, but there are no data regarding the efficacy of this approach.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CONGENITAL ANOMALIES AND DISEASES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies reported an increase in some congenital anomalies (eg, neural tube defects, cardiac defects, limb defects) and diseases (eg, Wilms tumor) associated with advanced paternal age and suggested de novo mutations might be the cause [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/29-33\">",
"     29-33",
"    </a>",
"    ]. As an example, a population-based retrospective cohort study including over 5 million births observed 1.5 percent had a birth defect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/34\">",
"     34",
"    </a>",
"    ]. When stratified by paternal age, the adjusted odds ratios for any birth defect among infants born to fathers aged 30 to 35, 40 to 44, 45 to 49, and over 50 years, compared with fathers aged 25 to 29 years were 1.04, 1.08, 1.08 and 1.15, respectively. These data suggest infants born to older fathers have slightly increased risk of birth defects; however, the association is weak, thus paternal age likely plays no more than a small role in the etiology of birth defects.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     NEURODEVELOPMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22760119\">",
"    <span class=\"h2\">",
"     Cognitive ability",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is limited information on the relationship between advanced paternal age neurocognitive ability in offspring; modest adverse effects have been reported when assessed by Bayley scales, Stanford Binet Intelligence Scale, Graham-Ernhart Block Sort Test, Wechsler Intelligence Scale for Children, and Wide Range Achievement Test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/35\">",
"     35",
"    </a>",
"    ]. In contrast, advanced maternal age has been associated with better scores on these tests.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22760086\">",
"    <span class=\"h2\">",
"     Schizophrenia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Paternal age appears to be a significant predictor of schizophrenia, but not of other psychiatric disorders, in offspring [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. This risk appears to be transcultural [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/38\">",
"     38",
"    </a>",
"    ]. In one study, the relative risk of schizophrenia in children of older fathers compared with those younger than age 25 increased in each 5-year age group, reaching 2.02 (95% CI, 1.17-3.51) and 2.96 (95% CI, 1.60- 5.47) in offspring of men aged 45 to 49 and 50 years or more, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/36\">",
"     36",
"    </a>",
"    ]. The actual incidence of schizophrenia in offspring at age 21 according to the fathers' age at their birth was: age &lt;25 years (2.5 per 1000), 25 to 29 (3.5 per 1000), 30 to 34 (3.7 per 1000), 35 to 39 (4.4 per 1000), 40 to 44 (4.6 per 1000), 45 to 49 (5.0 per 1000), and &ge;50 years (11.4 per 1000). In another series, the overall hazard ratio for each 10-year increase in paternal age was 1.47 (95% CI 1.23-1.76) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/37\">",
"     37",
"    </a>",
"    ]. The causal mechanism underlying the well-established relationship between advancing paternal age and schizophrenia is hypothesized to involve mutational errors during spermatogenesis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22760093\">",
"    <span class=\"h2\">",
"     Autism spectrum disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;A small but statistically significant association between advancing paternal age and risk of autism spectrum disorder has also been observed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/40-44\">",
"     40-44",
"    </a>",
"    ]. This may be related to de novo spontaneous mutations",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    alterations in genetic imprinting. Although not proven as independent risk factor for autism, paternal age should be examined in large, population-based birth cohorts that have carefully examined potential confounders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22760100\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;One report linked advanced paternal age and dyslexia in male offspring [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/45\">",
"     45",
"    </a>",
"    ]. This requires further study.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     X LINKED DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spontaneous germline mutations in X-linked genes may also be more common with advancing paternal age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/46\">",
"     46",
"    </a>",
"    ]. These mutations would be transmitted from carrier daughters to affected grandsons and have thus been called the \"grandfather effect.\" Examples of such diseases include hemophilia A and Duchenne muscular dystrophy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ANEUPLOIDY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The bulk of evidence shows that there does not appear to be a significantly increased risk of fetal autosomal or sex chromosome aneuploidy related to advanced paternal age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/46-51\">",
"     46-51",
"    </a>",
"    ]. These data are limited by small numbers of cases and biases related to undetermined early losses of chromosomally abnormal embryos and confounding by the female partner's age. Of concern, direct studies of paternal gametes have suggested an increase in sex chromosome aneuploidy with advancing paternal age, which could lead to sex chromosome aneuploidies in the offspring [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although a small increase in risk cannot be definitively excluded, there is insufficient evidence to determine a specific cut-off level for screening for fetal aneuploidy in the progeny of older men.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Germ line cell mutations have been associated with aging and may be a cause of childhood cancer among children of older parents. A population-based study that evaluated 4.3 million children (up to 14 years of age) and their parents observed paternal age was associated with a small, but statistically significant increased risk of leukemia and central nervous system cancers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     PREGNANCY COMPLICATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Miscarriage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Older women experience an increase in both trisomic and euploid losses that is largely due to a decline in oocyte quality. It is not clear whether there is an association between paternal age and risk of miscarriage. One study found no relationship between paternal age and risk of either chromosomally normal or trisomic pregnancy loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/53\">",
"     53",
"    </a>",
"    ]. Two other retrospective studies examined the risk of pregnancy loss in young women as a function of paternal age. In one, women aged 20 to 29 years were not at significantly increased risk of spontaneous abortion as the age of their partner increased [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/54\">",
"     54",
"    </a>",
"    ]. In the other, there was a higher risk of spontaneous abortion for women under age 25 whose partner was age 35 years or older than for those whose partner was younger than age 35 years; however, there was no increased risk of spontaneous abortion related to paternal age when the woman was 35 years old [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/55\">",
"     55",
"    </a>",
"    ]. Subsequent prospective studies, however, have also suggested an increased frequency of miscarriage with advanced paternal age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/56,57\">",
"     56,57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The affect of paternal age on miscarriage risk has also been studied in pregnancies conceived using oocyte donors. One retrospective analysis included 558 oocyte donation cycles in 441 couples and found no association between male age and live birth rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/16\">",
"     16",
"    </a>",
"    ], while another observed an association between advancing paternal age and miscarriage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/58\">",
"     58",
"    </a>",
"    ]. A retrospective study that evaluated pregnancy outcome of 1023 infertile couples undergoing anonymous oocyte donation cycles found no significant association between male age and fertilization rate, embryo development through the cleavage stage, implantation rate, or pregnancy rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/14\">",
"     14",
"    </a>",
"    ]. However, male age over 50 years was associated with fewer live births, suggesting that advanced male age affected late, but not early, embryonic development.",
"   </p>",
"   <p>",
"    In summary, advanced paternal age appears to be associated with a modest increase in the risk of spontaneous abortion; this risk is lower than that observed with advanced maternal age and seems to occur at an older age than in females (over age 40 in males versus over age 30 in females), but there is no age threshold after which men cannot father offspring [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/59\">",
"     59",
"    </a>",
"    ]. These conclusions, however, are based upon small numbers of miscarriages among couples in whom the male partner was of advanced age and therefore should be interpreted cautiously.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Fetal growth restriction, preterm birth, and stillbirth",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no clear effect of advanced paternal age on the risk of fetal growth restriction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/60,61\">",
"     60,61",
"    </a>",
"    ], preterm birth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/62\">",
"     62",
"    </a>",
"    ], stillbirth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30567/abstract/63-67\">",
"     63-67",
"    </a>",
"    ]. However, data are scant and do not adequately take into account confounding factors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Both women and men should be aware that childbearing after age 40 years is associated with higher rates of subfertility and adverse pregnancy related outcomes. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The effect of the male's age has only been reviewed retrospectively, but the bulk of these data point to a decrease in fertility with increasing age. This may be due to a number of factors, including decreased coital frequency, reduced sexual functioning, and poorer semen quality as men age. (See",
"      <a class=\"local\" href=\"#H21503027\">",
"       'Fertility'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"     <li>",
"      Advanced paternal age appears to be associated with a modest increase in the risk of miscarriage; this risk is lower than that observed with advanced maternal age. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Miscarriage'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Older men can be reassured that any excess risk of disease in their offspring related to paternal age is very small, but not zero. Advanced paternal age is associated with an increase in new autosomal dominant mutations. The best estimate of risk of autosomal dominant disease in progeny is &le;0.5 percent. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Autosomal dominant disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infants born to older fathers have slightly increased risk of birth defects; however, the association is weak, thus paternal age likely plays no more than a small role in the etiology of birth defects. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Congenital anomalies and diseases'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Paternal age appears to be a significant predictor of schizophrenia, but not of other psychiatric disorders, in offspring. (See",
"      <a class=\"local\" href=\"#H22760086\">",
"       'Schizophrenia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There may be a small, but statistically significant, association between advancing paternal age and risk of autism spectrum disorders. (See",
"      <a class=\"local\" href=\"#H22760093\">",
"       'Autism spectrum disorder'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Spontaneous germline mutations in X-linked genes may be more common with advancing paternal age. These mutations would be transmitted from carrier daughters to affected grandsons. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'X linked disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There does not appear to be a significantly increased risk of fetal autosomal or sex chromosome aneuploidy related to advanced paternal age. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Aneuploidy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Germ line cell mutations have been associated with aging and may be a cause of childhood cancer among children of older parents. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Cancer'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/1\">",
"      Leuzzi RA, Scoles KS. Preconception counseling for the primary care physician. Med Clin North Am 1996; 80:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/2\">",
"      Thacker PD. Biological clock ticks for men, too: genetic defects linked to sperm of older fathers. JAMA 2004; 291:1683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/3\">",
"      Singh NP, Muller CH, Berger RE. Effects of age on DNA double-strand breaks and apoptosis in human sperm. Fertil Steril 2003; 80:1420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/4\">",
"      Glaser RL, Broman KW, Schulman RL, et al. The paternal-age effect in Apert syndrome is due, in part, to the increased frequency of mutations in sperm. Am J Hum Genet 2003; 73:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/5\">",
"      Kidd SA, Eskenazi B, Wyrobek AJ. Effects of male age on semen quality and fertility: a review of the literature. Fertil Steril 2001; 75:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/6\">",
"      Eskenazi B, Wyrobek AJ, Sloter E, et al. The association of age and semen quality in healthy men. Hum Reprod 2003; 18:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/7\">",
"      Hassan MA, Killick SR. Effect of male age on fertility: evidence for the decline in male fertility with increasing age. Fertil Steril 2003; 79 Suppl 3:1520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/8\">",
"      Klonoff-Cohen HS, Natarajan L. The effect of advancing paternal age on pregnancy and live birth rates in couples undergoing in vitro fertilization or gamete intrafallopian transfer. Am J Obstet Gynecol 2004; 191:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/9\">",
"      de La Rochebrochard E, Thonneau P. Paternal age &gt;or=40 years: an important risk factor for infertility. Am J Obstet Gynecol 2003; 189:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/10\">",
"      de La Rochebrochard E, de Mouzon J, Th&eacute;pot F, et al. Fathers over 40 and increased failure to conceive: the lessons of in vitro fertilization in France. Fertil Steril 2006; 85:1420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/11\">",
"      Ford WC, North K, Taylor H, et al. Increasing paternal age is associated with delayed conception in a large population of fertile couples: evidence for declining fecundity in older men. The ALSPAC Study Team (Avon Longitudinal Study of Pregnancy and Childhood). Hum Reprod 2000; 15:1703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/12\">",
"      Mathieu C, Ecochard R, Bied V, et al. Cumulative conception rate following intrauterine artificial insemination with husband's spermatozoa: influence of husband's age. Hum Reprod 1995; 10:1090.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/13\">",
"      Dain L, Auslander R, Dirnfeld M. The effect of paternal age on assisted reproduction outcome. Fertil Steril 2011; 95:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/14\">",
"      Frattarelli JL, Miller KA, Miller BT, et al. Male age negatively impacts embryo development and reproductive outcome in donor oocyte assisted reproductive technology cycles. Fertil Steril 2008; 90:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/15\">",
"      Luna M, Finkler E, Barritt J, et al. Paternal age and assisted reproductive technology outcome in ovum recipients. Fertil Steril 2009; 92:1772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/16\">",
"      Paulson RJ, Milligan RC, Sokol RZ. The lack of influence of age on male fertility. Am J Obstet Gynecol 2001; 184:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/17\">",
"      Bellver J, Garrido N, Remoh&iacute; J, et al. Influence of paternal age on assisted reproduction outcome. Reprod Biomed Online 2008; 17:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/18\">",
"      Whitcomb BW, Turzanski-Fortner R, Richter KS, et al. Contribution of male age to outcomes in assisted reproductive technologies. Fertil Steril 2011; 95:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/19\">",
"      Weinstein M, Stark M. Behavioral and biological determinants of fecundability. Ann N Y Acad Sci 1994; 709:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/20\">",
"      Rosen RC, Wing R, Schneider S, Gendrano N 3rd. Epidemiology of erectile dysfunction: the role of medical comorbidities and lifestyle factors. Urol Clin North Am 2005; 32:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/21\">",
"      Sartorius GA, Nieschlag E. Paternal age and reproduction. Hum Reprod Update 2010; 16:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/22\">",
"      Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/23\">",
"      Araujo AB, Mohr BA, McKinlay JB. Changes in sexual function in middle-aged and older men: longitudinal data from the Massachusetts Male Aging Study. J Am Geriatr Soc 2004; 52:1502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/24\">",
"      Auroux M. [Age of the father and development]. Contracept Fertil Sex 1993; 21:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/25\">",
"      Tar&iacute;n JJ, Brines J, Cano A. Long-term effects of delayed parenthood. Hum Reprod 1998; 13:2371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/26\">",
"      Martin RH, Rademaker AW. The effect of age on the frequency of sperm chromosomal abnormalities in normal men. Am J Hum Genet 1987; 41:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/27\">",
"      Sartorelli EM, Mazzucatto LF, de Pina-Neto JM. Effect of paternal age on human sperm chromosomes. Fertil Steril 2001; 76:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/28\">",
"      Friedman JM. Genetic disease in the offspring of older fathers. Obstet Gynecol 1981; 57:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/29\">",
"      McIntosh GC, Olshan AF, Baird PA. Paternal age and the risk of birth defects in offspring. Epidemiology 1995; 6:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/30\">",
"      Olshan AF, Schnitzer PG, Baird PA. Paternal age and the risk of congenital heart defects. Teratology 1994; 50:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/31\">",
"      Olson JM, Breslow NE, Beckwith JB. Wilms' tumour and parental age: a report from the National Wilms' Tumour Study. Br J Cancer 1993; 67:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/32\">",
"      Zhu JL, Madsen KM, Vestergaard M, et al. Paternal age and congenital malformations. Hum Reprod 2005; 20:3173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/33\">",
"      Lian ZH, Zack MM, Erickson JD. Paternal age and the occurrence of birth defects. Am J Hum Genet 1986; 39:648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/34\">",
"      Yang Q, Wen SW, Leader A, et al. Paternal age and birth defects: how strong is the association? Hum Reprod 2007; 22:696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/35\">",
"      Saha S, Barnett AG, Foldi C, et al. Advanced paternal age is associated with impaired neurocognitive outcomes during infancy and childhood. PLoS Med 2009; 6:e40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/36\">",
"      Malaspina D, Harlap S, Fennig S, et al. Advancing paternal age and the risk of schizophrenia. Arch Gen Psychiatry 2001; 58:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/37\">",
"      Sipos A, Rasmussen F, Harrison G, et al. Paternal age and schizophrenia: a population based cohort study. BMJ 2004; 329:1070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/38\">",
"      Tsuchiya KJ, Takagai S, Kawai M, et al. Advanced paternal age associated with an elevated risk for schizophrenia in offspring in a Japanese population. Schizophr Res 2005; 76:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/39\">",
"      Perrin MC, Brown AS, Malaspina D. Aberrant epigenetic regulation could explain the relationship of paternal age to schizophrenia. Schizophr Bull 2007; 33:1270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/40\">",
"      Reichenberg A, Gross R, Weiser M, et al. Advancing paternal age and autism. Arch Gen Psychiatry 2006; 63:1026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/41\">",
"      Tsuchiya KJ, Matsumoto K, Miyachi T, et al. Paternal age at birth and high-functioning autistic-spectrum disorder in offspring. Br J Psychiatry 2008; 193:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/42\">",
"      Durkin MS, Maenner MJ, Newschaffer CJ, et al. Advanced parental age and the risk of autism spectrum disorder. Am J Epidemiol 2008; 168:1268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/43\">",
"      Croen LA, Najjar DV, Fireman B, Grether JK. Maternal and paternal age and risk of autism spectrum disorders. Arch Pediatr Adolesc Med 2007; 161:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/44\">",
"      Lauritsen MB, Pedersen CB, Mortensen PB. Effects of familial risk factors and place of birth on the risk of autism: a nationwide register-based study. J Child Psychol Psychiatry 2005; 46:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/45\">",
"      Jayasekara R, Street J. Parental age and parity in dyslexic boys. J Biosoc Sci 1978; 10:255.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Obstetricians and Gynecologists. Advanced paternal age. ACOG Committee Opinion #189, American College of Obstetricians and Gynecologists, Washington, DC 1997.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/47\">",
"      Erickson JD. Paternal age and Down syndrome. Am J Hum Genet 1979; 31:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/48\">",
"      Stene J, Fischer G, Stene E, et al. Paternal age effect in Down's syndrome. Ann Hum Genet 1977; 40:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/49\">",
"      Roth MP, Feingold J, Baumgarten A, et al. Reexamination of paternal age effect in Down's syndrome. Hum Genet 1983; 63:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/50\">",
"      Hook EB, Regal RR. A search for a paternal-age effect upon cases of 47, +21 in which the extra chromosome is of paternal origin. Am J Hum Genet 1984; 36:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/51\">",
"      Sloter E, Nath J, Eskenazi B, Wyrobek AJ. Effects of male age on the frequencies of germinal and heritable chromosomal abnormalities in humans and rodents. Fertil Steril 2004; 81:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/52\">",
"      Yip BH, Pawitan Y, Czene K. Parental age and risk of childhood cancers: a population-based cohort study from Sweden. Int J Epidemiol 2006; 35:1495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/53\">",
"      Hatch M, Kline J, Levin B, et al. Paternal age and trisomy among spontaneous abortions. Hum Genet 1990; 85:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/54\">",
"      de la Rochebrochard E, Thonneau P. Paternal age and maternal age are risk factors for miscarriage; results of a multicentre European study. Hum Reprod 2002; 17:1649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/55\">",
"      Slama R, Werwatz A, Boutou O, et al. Does male age affect the risk of spontaneous abortion? An approach using semiparametric regression. Am J Epidemiol 2003; 157:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/56\">",
"      Slama R, Bouyer J, Windham G, et al. Influence of paternal age on the risk of spontaneous abortion. Am J Epidemiol 2005; 161:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/57\">",
"      Nybo Andersen AM, Hansen KD, Andersen PK, Davey Smith G. Advanced paternal age and risk of fetal death: a cohort study. Am J Epidemiol 2004; 160:1214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/58\">",
"      Gallardo E, Sim&oacute;n C, Levy M, et al. Effect of age on sperm fertility potential: oocyte donation as a model. Fertil Steril 1996; 66:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/59\">",
"      Practice Committee of the American Society for Reproductive Medicine. Aging and infertility in women: a committee opinion. Fertil Steril 2002; 78:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/60\">",
"      Olshan AF, Ananth CV, Savitz DA. Intrauterine growth retardation as an endpoint in mutation epidemiology: an evaluation based on paternal age. Mutat Res 1995; 344:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/61\">",
"      Chen XK, Wen SW, Krewski D, et al. Paternal age and adverse birth outcomes: teenager or 40+, who is at risk? Hum Reprod 2008; 23:1290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/62\">",
"      Shah PS, Knowledge Synthesis Group on determinants of preterm/low birthweight births. Paternal factors and low birthweight, preterm, and small for gestational age births: a systematic review. Am J Obstet Gynecol 2010; 202:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/63\">",
"      Resseguie LJ. Paternal age, stillbirths and mutation. Ann Hum Genet 1976; 40:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/64\">",
"      Yerushalmy, J. Age of father and survival of offspring. Hum Biol 1939; 11:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/65\">",
"      Woolf, CM. Stillbirths and paternal age. Obstet Gynecol 1965; 26:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/66\">",
"      Selvin S, Garfinkel J. Paternal age, maternal age and birth order and the risk of a fetal loss. Hum Biol 1976; 48:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30567/abstract/67\">",
"      Astolfi P, De Pasquale A, Zonta LA. Late paternity and stillbirth risk. Hum Reprod 2004; 19:2497.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 415 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-61.234.146.186-D438A33F91-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_54_30567=[""].join("\n");
var outline_f29_54_30567=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21502920\">",
"      SEMEN QUALITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21503027\">",
"      FERTILITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1007003086\">",
"      Sexual function and coital frequency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      AUTOSOMAL DOMINANT DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CONGENITAL ANOMALIES AND DISEASES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      NEURODEVELOPMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22760119\">",
"      Cognitive ability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22760086\">",
"      Schizophrenia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22760093\">",
"      Autism spectrum disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22760100\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      X LINKED DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ANEUPLOIDY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CANCER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      PREGNANCY COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Miscarriage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Fetal growth restriction, preterm birth, and stillbirth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/415\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/415|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/60/17357\" title=\"table 1\">",
"      Maternal age-related Down syndrome risk at 3 gestational ages",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/7/31865?source=related_link\">",
"      Effect of advanced age on fertility and pregnancy in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/3/31800?source=related_link\">",
"      Male reproductive physiology",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_54_30568="Physiology and clinical use of heliox";
var content_f29_54_30568=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Physiology and clinical use of heliox",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?29/54/30568/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?29/54/30568/contributors\">",
"     David J Feller-Kopman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?29/54/30568/contributors\">",
"     Carl O'Donnell, ScD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?29/54/30568/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?29/54/30568/contributors\">",
"     Bruce S Bochner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?29/54/30568/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?29/54/30568/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?29/54/30568/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Second only to hydrogen in universal abundance, helium is an inert, low density gas under atmospheric conditions. Discovered in the late 19th century, the first clinical use of helium is indicated by a patent filed by Charles Cook in 1923 for the use of a helium and oxygen mixture (heliox) to decrease the risk of decompression sickness in divers. In 1934, Barach first described the airway physiology of breathing heliox and advocated for its use in a variety of medical conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/1\">",
"     1",
"    </a>",
"    ]. Used sporadically for several decades, heliox has been revisited as a therapeutic option for a variety of upper and lower airway conditions.",
"   </p>",
"   <p>",
"    The physiology and clinical applications of helium-oxygen mixtures in patients with pulmonary disease will be reviewed here.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanics of the respiratory system are determined by both static and dynamic properties. Static properties define the basic pressure-volume characteristics of the respiratory system, and are measured in the absence of airflow. Respiratory system compliance (Crs) is a static property that is determined by the elastic recoil of the lung and chest wall. It can be expressed as:",
"   </p>",
"   <p>",
"    &nbsp;Crs = change in volume &divide; change in pressure",
"   </p>",
"   <p>",
"    When applied to tidal breathing, the compliance can be expressed as:",
"   </p>",
"   <p>",
"    &nbsp;Crs = tidal volume &divide; transthoracic pressure applied",
"   </p>",
"   <p>",
"    Dynamic properties of the respiratory system are measured when there is a gas flow during inhalation or exhalation. Airway resistance is a dynamic property determined by multiple factors, including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Density and viscosity of the inspired gas",
"     </li>",
"     <li>",
"      Airway caliber",
"     </li>",
"     <li>",
"      Airway configuration",
"     </li>",
"     <li>",
"      Flow rate",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The relative importance of each of these factors is variable and complex. Principles of fluid dynamics can be applied to model their interrelationship, and are discussed below. The force (or work) required to generate and sustain air flow throughout the tracheobronchial tree is a function of both respiratory system compliance and airway resistance.",
"   </p>",
"   <p>",
"    Therapeutic interventions in pulmonary medicine often aim to improve static compliance, decrease airway resistance, or both. To decrease airway resistance, bronchodilators or steroids are often used to increase airway caliber. However, clinicians have little ability to decrease airway resistance by manipulation of FiO",
"    <sub>",
"     2",
"    </sub>",
"    because the density and viscosity of oxygen, nitrogen, and air are very similar (",
"    <a class=\"graphic graphic_table graphicRef53132 \" href=\"mobipreview.htm?12/31/12795\">",
"     table 1",
"    </a>",
"    ). However, substituting helium for nitrogen in a gas mixture changes the physical properties of the inhaled gas, and underlies the theoretical rationale for the clinical application of heliox. Stated differently, by decreasing gas density, airway resistance can be decreased in the absence of any anatomical change.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Reynolds number",
"    </span>",
"    &nbsp;&mdash;&nbsp;To understand the effect of changing gas density or viscosity on the pressure-flow characteristics of the lungs, a review of basic fluid dynamics is required.",
"   </p>",
"   <p>",
"    Movement of gas through a rigid tube is modeled by two basic patterns of flow. In a given tube, laminar flow occurs at lower flow rates and is characterized by the existence of streamlines parallel to the sides of the tube. Gas in the center of the tube moves more rapidly than gas at the edge of the tube, and gas viscosity is the major determinant of flow rate.",
"   </p>",
"   <p>",
"    In the same tube, turbulent flow predominates at higher flow rates, and the movement of individual particles is not organized around streamlines. Gas density is a major determinant of flow rate in turbulent systems (",
"    <a class=\"graphic graphic_figure graphicRef79552 \" href=\"mobipreview.htm?11/33/11792\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The tendency for flow to be laminar or turbulent within a given region can be quantified by the Reynolds number (Re), a dimensionless ratio of inertial (turbulent) to viscous (laminar) forces:",
"   </p>",
"   <p>",
"    &nbsp;Re = [p x d x V]",
"    <span class=\"nowrap\">",
"     /",
"    </span>",
"    [u]",
"   </p>",
"   <p>",
"    where p = density, d = tube diameter, V = fluid velocity, and u = viscosity.",
"   </p>",
"   <p>",
"    At any anatomical level within the tracheobronchial tree, gas velocity is equal to flow rate divided by total cross sectional airway area (",
"    <a class=\"graphic graphic_figure graphicRef55429 \" href=\"mobipreview.htm?10/41/10909\">",
"     figure 2",
"    </a>",
"    ). Therefore Re can be expressed as follows:",
"   </p>",
"   <p>",
"    &nbsp;Re = [4 x p x flow]",
"    <span class=\"nowrap\">",
"     /",
"    </span>",
"    [&pi; x u x d]",
"   </p>",
"   <p>",
"    where d = airway diameter.",
"   </p>",
"   <p>",
"    When Re is high, the force required to generate a given flow rate is determined to a greater degree by fluid density, and flow is more turbulent. Conversely, at lower Re the flow rate is determined to a greater degree by fluid viscosity, and flow is more laminar. In a straight, smooth, unbranched tube, laminar flow predominates when Re is &lt;2000. When Re is &gt;4000, flow is mainly turbulent.",
"   </p>",
"   <p>",
"    Re also determines the entrance length (EL) of a tube, which is the distance from the beginning of a tube for laminar flow to become established (",
"    <a class=\"graphic graphic_figure graphicRef63878 \" href=\"mobipreview.htm?18/38/19041\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    &nbsp;EL = 0.03 x d x Re",
"   </p>",
"   <p>",
"    Thus, when Re is low, not only is there less of a tendency for turbulent flow, but laminar flow will become established more quickly after changes in airway caliber or configuration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the normal human lung, most resistance is due to the large airways. Flow is primarily turbulent from the trachea to the start of the bronchioles, particularly when the flow rate is high. From the formula for Re, one can see that this results from a smaller overall cross-sectional area and thus higher flow velocity, leading to a higher Re [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/2\">",
"     2",
"    </a>",
"    ]. In addition, there are frequent branch points, and EL may be longer than the length of a particular airway. In combination, these factors inhibit the development of laminar flow.",
"   </p>",
"   <p>",
"    In theory, the benefits of heliox in patients with high airway resistance are due to decreasing Re and facilitating laminar flow, resulting in improved ventilation and a decreased work of breathing. By decreasing the density of the inhaled gas, heliox decreases the applied force required to achieve a given flow rate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL APPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapeutic use of heliox capitalizes on the physical effect of lowering gas density to improve air flow as predicted by the fluid dynamic paradigm. In contrast, the diagnostic use of helium to measure lung volumes by gas dilution is not based on low density, but on the fact that helium is inert and has low solubility in blood. The measurement of lung volume by the inert gas dilution technique is performed routinely in pulmonary function laboratories around the world, and accounts for the vast majority of helium used for medical purposes. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/53/4952?source=see_link&amp;anchor=H6#H6\">",
"     \"Overview of pulmonary function testing in adults\", section on 'Lung volumes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The energy expenditure required to overcome airway resistance is negligible during resting ventilation in the normal lung. Thus, the physical properties of the inspired gas do not ordinarily play a significant role in determining the work of breathing or in limiting ventilation. However, with alteration of airway geometry, particularly during excessive ventilatory demand, the resistive work of breathing can become sufficiently elevated to limit ventilation and fatigue the muscles of breathing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/2\">",
"     2",
"    </a>",
"    ]. Under these circumstances, manipulation of the physical properties of the inspired gas mixture can have important clinical applications.",
"   </p>",
"   <p>",
"    In theory, the benefits of heliox in patients with high airway resistance are due to decreasing Re and flow resistance, resulting in improved ventilation and a decreased work of breathing. By decreasing the density of the inhaled gas, heliox decreases the applied force required to achieve a given flow rate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Limitations of clinical studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most clinical trials of heliox have enrolled fewer than thirty patients. Furthermore, inclusion criteria and clinical outcomes are not standardized across studies, making direct comparison difficult. As an example, the ratio of helium to oxygen varies across and within the studies presented below. Most protocols employed an 80:20 or 70:30 helium to oxygen ratio, but little information exists regarding optimum dosing. This is an important consideration because increasing the oxygen fraction diminishes the beneficial effect of low density gas inhalation, while increasing the amount of helium can worsen alveolar hypoxia.",
"   </p>",
"   <p>",
"    Heliox also affects the performance of diagnostic equipment, mechanical ventilators, and the delivery of aerosolized medication. These factors may introduce methodological error or uncontrolled variables, and further limit generalizability of some study conclusions.",
"   </p>",
"   <p>",
"    Finally, heliox may provide its greatest benefit in urgent cases, particularly acute upper airway obstruction. Randomized application of emergency therapy is difficult, and many patients are treated with multiple interventions simultaneously. With these limitations in mind, the following is a brief review of modern clinical trials of heliox therapy in both pediatric and adult patient populations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Use in children",
"    </span>",
"    &nbsp;&mdash;&nbsp;There have been several reports describing the use of heliox in the following pediatric populations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Children with upper airway obstruction due to compression [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/3,4\">",
"       3,4",
"      </a>",
"      ], postextubation stridor [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/5,6\">",
"       5,6",
"      </a>",
"      ], and croup [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/7,8\">",
"       7,8",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Children with lower airway obstruction due to bronchiolitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/9,10\">",
"       9,10",
"      </a>",
"      ], status asthmaticus [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/11,12\">",
"       11,12",
"      </a>",
"      ], or respiratory distress syndrome [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/13\">",
"       13",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Children with bronchopulmonary dysplasia (in whom heliox decreases the work of breathing) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/14\">",
"       14",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Postextubation stridor",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two studies have found that heliox is beneficial in patients with postextubation stridor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. One described the use of heliox in eleven children with postextubation stridor. Following initial extubation, none of the patients responded to nebulized racemic epinephrine, and all were subsequently reintubated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/6\">",
"     6",
"    </a>",
"    ]. Eight patients developed recurrent stridor at the time of their second extubation, and again all eight failed to respond to treatment with nebulized racemic epinephrine. Following treatment with heliox, seven patients had improvement in their respiratory distress scores, and six (75 percent) avoided reintubation. Both of the patients in the trial who required reintubation were started on heliox much later than those who were successfully treated (10 and 20 hours, versus a mean of 1 hour).",
"   </p>",
"   <p>",
"    A randomized, double-blind crossover trial studied the effects of heliox (70:30) in 13 children thought to be at high risk of postextubation stridor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/5\">",
"     5",
"    </a>",
"    ]. Each patient served as his or her own control by breathing air-oxygen or heliox for 15 minutes following extubation. Respiratory distress scores were significantly lower while breathing heliox.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Croup",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of heliox for croup has not been recommended. A more detailed discussion of the use of heliox in croup can be found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/26/31144?source=see_link\">",
"     \"Approach to the management of croup\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Bronchiolitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of heliox in bronchiolitis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/19/27962?source=see_link&amp;anchor=H23#H23\">",
"     \"Bronchiolitis in infants and children: Treatment; outcome; and prevention\", section on 'Heliox'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Asthma",
"    </span>",
"    &nbsp;&mdash;&nbsp;In children with acute severe asthma, two double-blind randomized controlled trials and one meta-analysis have reported conflicting results. One trial enrolled 18 patients, aged 16 months to 18 years old, who presented to an emergency department with status asthmaticus. Treatment arms compared heliox (80:20) to room air at 10",
"    <span class=\"nowrap\">",
"     L/min",
"    </span>",
"    via a nonrebreathing face-mask [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/11\">",
"     11",
"    </a>",
"    ]. Patients breathing heliox had significantly greater reductions in pulsus paradoxus (from a mean of 23.3 to 10.6 mmHg) and in subjective dyspnea, as well as significantly greater increases in peak expiratory flow compared with patients breathing air. These variables returned to baseline values after heliox was discontinued. The authors estimated that intubation was avoided in three patients due to the beneficial effects of heliox [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, a crossover study of 11 children with acute asthma presenting with a mean FEV1 below 50 percent predicted randomly assigned subjects to treatment with either heliox (70:30) or 30 percent oxygen-enriched air [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/12\">",
"     12",
"    </a>",
"    ]. No differences in FEV1, FVC, clinical assessment of disease severity, or subjective dyspnea scores were noted. Although there was a significant increase in FEF25-75 and peak expiratory flow rates (PEFR), the clinical significance of these findings is unclear.",
"   </p>",
"   <p>",
"    A systematic analysis pooled and analyzed results from seven trials enrolling nearly 400 patients with acute asthma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/15\">",
"     15",
"    </a>",
"    ]. Studies included both adult and pediatric populations. No significant improvement in recovery of pulmonary function was noted in patients treated with heliox. No significant differences in outcome were noted when adults and pediatric populations were analyzed separately, or when high versus low helium ratio studies were compared.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Respiratory distress syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of heliox has also been studied in infants with the respiratory distress syndrome (RDS). One study randomly assigned 30 infants with RDS to treatment with either heliox (78:22) or \"AirOx\" (78 percent nitrogen:22 percent oxygen) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/13\">",
"     13",
"    </a>",
"    ]. After two days of mechanical ventilation, there was a significant increase in the transcutaneous",
"    <span class=\"nowrap\">",
"     PO",
"     <sub>",
"      2",
"     </sub>",
"     /FiO",
"     <sub>",
"      2",
"     </sub>",
"    </span>",
"    ratio in the group receiving heliox. In addition, mean airway pressure required for ventilation was significantly lower in the heliox group by day four. Nonsignificant trends toward fewer days of mechanical ventilation, lower mortality, and decreased incidence of bronchopulmonary dysplasia were also noted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Work of breathing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breathing mechanics have been studied in infants with bronchopulmonary dysplasia treated with heliox. One group found that compared to breathing air, infants breathing heliox (either 80:20 or 70:30) had lower swings in esophageal pressure, as well as significant reductions in inspiratory and expiratory resistance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/14\">",
"     14",
"    </a>",
"    ]. In addition, the mechanical power of breathing",
"    <span class=\"nowrap\">",
"     (work/minute)",
"    </span>",
"    and the oxygen cost of breathing were reduced with heliox.",
"   </p>",
"   <p>",
"    These changes were observed in the absence of any change in tidal volume, respiratory rate, or minute volume. Stated more simply, the infants breathing heliox had to work less in order to maintain the same ventilation. The authors calculated a caloric savings of 1.87",
"    <span class=\"nowrap\">",
"     kcal/kg/day",
"    </span>",
"    for infants with bronchopulmonary dysplasia treated with heliox. The decreased energy required to maintain ventilation in patients treated with heliox may increase calories available for growth and hasten recovery, but these findings are speculative.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Use in adults",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are numerous case reports of clinical improvement in patients treated with heliox following upper airway obstruction due to thyroid masses, radiation injury, lymphoma, cancer, or angioedema [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/16-19\">",
"     16-19",
"    </a>",
"    ]. As noted, the greatest theoretical benefit of heliox is achieved by decreasing turbulent flow in large airways and at branch points in the tracheobronchial tree. Thus, patients with upper airway obstruction would be expected to derive the greatest benefit from heliox therapy. However, because upper airway compromise is relatively rare and often a medical emergency, few controlled studies of heliox treatment in this setting have been published. For this reason, the use of heliox in adults has primarily focused on treating patients with severe asthma as well as chronic obstructive pulmonary disease (COPD).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Asthma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heliox is unlikely to be of substantial benefit in adults with asthma. As noted above, a systematic analysis pooled and analyzed results from seven trials enrolling nearly 400 patients and found no significant improvement in recovery of pulmonary function in patients with acute asthma who were treated with heliox [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/15\">",
"     15",
"    </a>",
"    ]. Furthermore, no significant difference in outcome was noted when adults were analyzed separately, or when high versus low dose studies were compared. Other systematic reviews have reached the same conclusions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/20,21\">",
"     20,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On the other hand, beneficial effects may be seen with heliox early in asthma therapy, before steroids are able to affect the underlying disease process. This was demonstrated in a randomized, controlled trial of heliox therapy in 23 adults with acute severe asthma and peak flow (PF) &lt;200 despite treatment with 5 mg of nebulized",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/61/16344?source=see_link\">",
"     albuterol",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/22\">",
"     22",
"    </a>",
"    ]. Heliox (70:30) was compared with standard oxygen supplementation. Patients in both the heliox and control groups had significant improvements in PF and dyspnea during the eight hours of the study. There were significant differences between the heliox and control groups only during the first 20 minutes of the study. By six hours, there were no differences between the groups.",
"   </p>",
"   <p>",
"    As in the pediatric population, heliox has been shown to reduce pulsus paradoxus and improve PF rates and dyspnea scores in adults with asthma exacerbations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/23\">",
"     23",
"    </a>",
"    ]. In a study of 27 patients, the improvements in pulsus paradoxus and PF were significantly greater in patients breathing heliox than in controls. No significant change in PaCO",
"    <sub>",
"     2",
"    </sub>",
"    or PaO",
"    <sub>",
"     2",
"    </sub>",
"    was noted in the seven patients treated with heliox who had blood gases drawn.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Asthma complicated by respiratory failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two small, uncontrolled series investigated the effects of heliox in intubated patients with status asthmaticus and respiratory acidosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. Following ventilation with 60 to 80 percent helium, all patients in one series experienced significant improvement in respiratory acidosis (mean reduction in PaCO",
"    <sub>",
"     2",
"    </sub>",
"    35 mmHg) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/24\">",
"     24",
"    </a>",
"    ]. In addition, six of seven patients had a dramatic reduction in peak airway pressures (mean fall 32 cmH",
"    <sub>",
"     2",
"    </sub>",
"    O).",
"   </p>",
"   <p>",
"    One series of twelve asthmatics presenting to an emergency department with hypercapnic respiratory failure analyzed both intubated and nonintubated patients treated with heliox (70:30 or 60:40) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/25\">",
"     25",
"    </a>",
"    ]. Treatment was associated with a mean rise in pH of 0.9 (from 7.23 to 7.32 mmHg) after one hour; however, results were not uniform, with eight patients demonstrating a positive response and four not improving.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Stable COPD",
"    </span>",
"    &nbsp;&mdash;&nbsp;One study examined the effects of heliox (80:20) in 15 patients with stable, but severe, COPD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/26\">",
"     26",
"    </a>",
"    ]. Heliox was associated with a small drop in CO",
"    <sub>",
"     2",
"    </sub>",
"    production and a reduction of the functional residual capacity (FRC), which implies decreased dynamic hyperinflation (ie, air trapping). The PaO",
"    <sub>",
"     2",
"    </sub>",
"    , respiratory rate, minute ventilation, tidal volume, breathing pattern, and dead space fraction did not change. In contrast, another small study found no effect on dynamic hyperinflation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Heliox may improve exercise performance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. This is illustrated by a randomized, crossover trial in which 82 patients with moderate to severe COPD had their exercise performance measured and dyspnea evaluated while receiving one of four different gases: Heliox28 (72:28), Heliox21 (79:21), Oxygen28 (72 percent nitrogen:28 percent oxygen), or medical air (79 percent nitrogen:21 percent oxygen) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/28\">",
"     28",
"    </a>",
"    ]. Patients breathing Heliox28 had better exercise performance and less dyspnea than all other groups. All of the gases improved exercise performance and dyspnea compared to medical air. In a separate study of patients with severe COPD (mean FEV1 45 percent predicted), the use of heliox (79 percent nitrogen:21 percent oxygen) during exercise decreased dynamic hyperinflation, improved exercise tolerance, and improved lower-extremity oxygen delivery and utilization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Future studies will need to confirm these findings and determine whether the improved exercise performance and dyspnea warrants the additional cost (approximately 3.5 times more expensive than oxygen per tank and requires more tanks per day). (See",
"    <a class=\"local\" href=\"#H22\">",
"     'Cost and availability'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Acute exacerbation of COPD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several trials have compared noninvasive positive pressure ventilation (NPPV) with either air or heliox in patients with exacerbations of chronic obstructive pulmonary disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. The use of NPPV in this setting is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/51/1850?source=see_link\">",
"     \"Noninvasive positive pressure ventilation in acute respiratory failure in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In one well-designed trial, patients with acute exacerbations of COPD were treated with low or high pressure NPPV in combination with heliox or oxygen-supplemented air [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/31\">",
"     31",
"    </a>",
"    ]. Differences in breathing pattern, work of breathing, and gas exchange were measured in nine patients using an esophageal balloon technique. Heliox was not associated with changes in breathing pattern, whereas high pressure NPPV produced significant increases in tidal volume and minute ventilation.",
"   </p>",
"   <p>",
"    Heliox was associated with a reduction in PaCO",
"    <sub>",
"     2",
"    </sub>",
"    and improvement in all measured indices of respiratory effort and work. The beneficial effects on the measured variables were further increased when high pressure NPPV was combined with heliox. Compared to the low",
"    <span class=\"nowrap\">",
"     pressure/air",
"    </span>",
"    group, respiratory effort was reduced by:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      15 percent in the low",
"      <span class=\"nowrap\">",
"       pressure/heliox",
"      </span>",
"      group",
"     </li>",
"     <li>",
"      35 percent in the high",
"      <span class=\"nowrap\">",
"       pressure/air",
"      </span>",
"      group",
"     </li>",
"     <li>",
"      50 percent in the high",
"      <span class=\"nowrap\">",
"       pressure/heliox",
"      </span>",
"      group",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The authors suggest that the addition of heliox to NPPV may allow a larger number of patients to benefit from NPPV. In addition, heliox may allow the use of lower levels of pressure support, which could reduce complications and patient discomfort resulting from high pressures and flow rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A crossover study monitored the effects of NPPV plus either heliox (70:30) or air-oxygen (70:30) on gas exchange and dyspnea in 19 patients with severe COPD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/32\">",
"     32",
"    </a>",
"    ]. The use of heliox decreased PaCO",
"    <sub>",
"     2",
"    </sub>",
"    , reduced dyspnea, and favorably changed the breathing pattern of patients. Peak inspiratory flow rates were higher, while inspiratory time and the ratio of inspiratory time to respiratory cycle length were both decreased. All of these findings suggest a reduced work of breathing.",
"   </p>",
"   <p>",
"    A third series involving 23 intubated patients with COPD and respiratory failure found that the administration of heliox significantly reduced intrinsic PEEP, trapped lung volume, and peak and mean airway pressures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/33\">",
"     33",
"    </a>",
"    ]. There was no effect on hemodynamics or arterial blood gases. Twelve patients had a pulmonary artery catheter in place at the time of study; no changes in mixed venous PO",
"    <sub>",
"     2",
"    </sub>",
"    were noted. Similar findings were noted in a second small study of 12 patients recovering from acute exacerbations of COPD. In this randomized prospective crossover trial, heliox decreased the resistive work of breathing and intrinsic positive end-expiratory pressure (auto-PEEP) without changing the breathing pattern [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The effect of heliox in the absence of positive pressure ventilation is less well studied. A retrospective review of 81 patients presenting to the emergency department with COPD and hypercarbic respiratory insufficiency found a significant reduction in the rates of intubation (8 versus 50 percent) and in-hospital mortality (3 versus 24 percent) in the patients who received heliox as compared to control patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/35\">",
"     35",
"    </a>",
"    ]. The retrospective nature of this article precludes causal inference between heliox use and the endpoints studied, but does support the need for larger randomized trials.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Work of breathing",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a study focusing on physiologic, rather than clinical endpoints, researchers used an esophageal balloon in recently extubated patients without significant lung disease to quantify intrathoracic pressure swings and estimate the work of breathing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/36\">",
"     36",
"    </a>",
"    ]. Fifteen of 18 patients exhibited a drop in their work of breathing, although gas exchange parameters were unchanged. In addition, patients reported decreased dyspnea while breathing heliox.",
"   </p>",
"   <p>",
"    Finally, one study examined the impact of heliox on pulmonary function in ten patients with mild COPD during cardiopulmonary exercise testing. Heliox was associated with an increase in minute ventilation, in the absence of any change in the metabolic cost of breathing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     TECHNICAL ISSUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two technical issues concerning both the clinical and research application of heliox. First, significant changes in the delivery of nebulized medicine occur when heliox is employed as the driving gas. Second, because the difference in physical properties between air or oxygen and heliox, calibration and function of pneumotachometers and ventilator flow sensors can be significantly altered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Aerosol delivery",
"    </span>",
"    &nbsp;&mdash;&nbsp;To understand the effects of heliox on nebulizer function and aerosol delivery, it is important to consider that nebulizers use Bernoulli's principle to generate an aerosol. Mathematically, this can be described by the equation:",
"   </p>",
"   <p>",
"    &nbsp; (P1-P2) &nbsp;= &nbsp;0.5 &nbsp;x m &nbsp;x ((V2)2 - (V1)2)",
"   </p>",
"   <p>",
"    where P1-P2 is the pressure drop across the nebulizer orifice, m is the mass of the gas, and (V2)2 - (V1)2 is the change in velocity of the gas across the orifice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For a given flow rate, the use of heliox as a driving gas results in a lower pressure drop across the nebulizer orifice. This causes a lower inhaled mass of medication, or longer nebulization time in order to deliver the same amount of drug [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/38\">",
"     38",
"    </a>",
"    ]. One group concluded that when heliox is used as a driving gas for nebulization, the flow rate should be increased by approximately 50 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/38,39\">",
"     38,39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On the other hand, when heliox is used as the driving gas for aerosolization, the particle size of the nebulized solution is reduced, which may enhance drug delivery. This hypothesis was evaluated in two studies examining lung deposition of heliox-driven aerosols in humans. In one report, nine subjects with stable asthma inhaled radiolabeled Teflon particles suspended in either air or heliox [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/40\">",
"     40",
"    </a>",
"    ]. Heliox inhalation resulted in significantly lower oral deposition as well as higher particle retention in the lungs at 24 hours. Another report found a similar increase in lung deposition in patients with induced bronchoconstriction who received heliox-driven nebulized therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, the results of clinical trials designed to take advantage of these findings and look for improved patient outcomes using medicine nebulized with heliox have been mixed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/42-44\">",
"     42-44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Instrument sensitivity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Graham's law states that the flow of gas through an orifice is inversely proportional to the square root of its density. Thus, the actual flow rate of heliox through an oxygen flow meter is 1.8 times greater than the indicated flow [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/39,41\">",
"     39,41",
"    </a>",
"    ]. For this reason, mechanical ventilators and pneumotachometers need to be recalibrated when heliox is being used [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/45,46\">",
"     45,46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The changes in delivered FiO",
"    <sub>",
"     2",
"    </sub>",
"    and tidal volume induced by heliox vary among ventilators. Suggested correction factors are available for most ventilators in the United States and Europe (",
"    <a class=\"graphic graphic_table graphicRef77384 graphicRef74753 \" href=\"mobipreview.htm?39/10/40110\">",
"     table 2A-B",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/45,47,48\">",
"     45,47,48",
"    </a>",
"    ]. In addition to errors of calibration, some of the most commonly used critical care ventilators, including the Puritan-Bennett 7200 series, are unable to function when heliox is used. Servo ventilators are able to deliver heliox and require relatively simple calibration.",
"   </p>",
"   <p>",
"    High-frequency oscillatory ventilation (HFOV) with heliox requires a lower oscillation amplitude than HFOV using oxygen-enriched air to achieve the same minute ventilation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/49\">",
"     49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/29/5591?source=see_link\">",
"     \"High-frequency ventilation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The lack of a clearly defined calibration scheme for pneumotachometers has been raised as a possible confounder in many of the studies investigating the role of heliox in acute asthma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/50\">",
"     50",
"    </a>",
"    ]. It is possible, particularly in studies where PEFR improved in the absence of a clear change in FEV1, that much of this effect might be due to inaccurate sensing of low density gas flow rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Cost and availability",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hospital cost for a size \"H\" cylinder (159 cubic feet) containing helium is approximately $100, and does not vary with the ratio of helium to oxygen (available ratios include 80:20, 70:30, or 60:40). This is approximately 3.5 times the cost of oxygen. With flow rates of 12 to 15",
"    <span class=\"nowrap\">",
"     L/min,",
"    </span>",
"    3 to 6 of these cylinders may be used each day in nonintubated patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/39\">",
"     39",
"    </a>",
"    ], and approximately 3 tanks per day in patients receiving mechanical ventilation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Medical staff should be familiar with the use of medical gas cylinders, as cylinders containing oxygen, heliox, or other medical gases may appear identical. The availability of heliox for clinical use is variable [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The therapeutic effects of heliox relate to its low density and its ability to reduce turbulent air flow. This decreases airway resistance, pleural pressures swings, and dynamic hyperinflation. These factors in combination reduce the work of breathing.",
"   </p>",
"   <p>",
"    There are no evidence-based guidelines regarding the use of heliox. Nevertheless, since there are no significant side effects with heliox therapy, a therapeutic trial may be reasonable in the following clinical situations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30568/abstract/52\">",
"     52",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Mechanical upper airway obstruction",
"     </li>",
"     <li>",
"      Postoperative stridor",
"     </li>",
"     <li>",
"      Severe exacerbations of COPD, particularly in conjunction with noninvasive ventilation",
"     </li>",
"     <li>",
"      Asthma complicated by impending respiratory failure and refractory to standard therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The effects of heliox are typically seen within the first several minutes, so the patient and clinician can often assess its therapeutic efficacy quite quickly. We guide therapy based on serial clinical assessment, since the measurement of common indices of pulmonary status, such as peak flow and FEV1, may be inaccurate unless instruments are calibrated for use with heliox. Careful attention must be given to respiratory rate, accessory muscle use, pulsus paradoxus, air entry, and the patient's subjective sense of dyspnea.",
"   </p>",
"   <p>",
"    We recommend considering treatment early, in order to reduce the work imposed on the respiratory muscles and to forestall the development of fatigue. Treatment with the highest helium ratio that will maintain oxygen saturation above 90 percent is suggested because the benefits of heliox are proportional to the percentage of helium in the inhaled gas. It is possible that a patient with a high oxygen requirement due to high airway resistance and alveolar hypoventilation may tolerate heliox if treatment results in a substantial improvement in minute ventilation.",
"   </p>",
"   <p>",
"    Treatment of respiratory failure requires appropriate ventilatory calibration and meticulous respiratory monitoring because of the variable effect of heliox on ventilator performance. Calculation of delivered FiO",
"    <sub>",
"     2",
"    </sub>",
"    and tidal volume should be based on published algorithms (",
"    <a class=\"graphic graphic_table graphicRef77384 graphicRef74753 \" href=\"mobipreview.htm?39/10/40110\">",
"     table 2A-B",
"    </a>",
"    ), and use of heliox in this setting probably should be limited to centers with substantial experience.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/1\">",
"      Barach, AL. The use of helium in the treatment of asthma and obstructive lesions in the larynx and trachea. Ann Intern Med 1935; 9:739.",
"     </a>",
"    </li>",
"    <li>",
"     Lumb AB. Nunn's Applied Respiratory Physiology, 5th ed, Butterworth Heinemann, Oxford 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/3\">",
"      Smith SW, Biros M. Relief of imminent respiratory failure from upper airway obstruction by use of helium-oxygen: a case series and brief review. Acad Emerg Med 1999; 6:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/4\">",
"      Polaner DM. The use of heliox and the laryngeal mask airway in a child with an anterior mediastinal mass. Anesth Analg 1996; 82:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/5\">",
"      Kemper KJ, Ritz RH, Benson MS, Bishop MS. Helium-oxygen mixture in the treatment of postextubation stridor in pediatric trauma patients. Crit Care Med 1991; 19:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/6\">",
"      Rodeberg DA, Easter AJ, Washam MA, et al. Use of a helium-oxygen mixture in the treatment of postextubation stridor in pediatric patients with burns. J Burn Care Rehabil 1995; 16:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/7\">",
"      Terregino CA, Nairn SJ, Chansky ME, Kass JE. The effect of heliox on croup: a pilot study. Acad Emerg Med 1998; 5:1130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/8\">",
"      Weber JE, Chudnofsky CR, Younger JG, et al. A randomized comparison of helium-oxygen mixture (Heliox) and racemic epinephrine for the treatment of moderate to severe croup. Pediatrics 2001; 107:E96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/9\">",
"      Hollman G, Shen G, Zeng L, et al. Helium-oxygen improves Clinical Asthma Scores in children with acute bronchiolitis. Crit Care Med 1998; 26:1731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/10\">",
"      Gross MF, Spear RM, Peterson BM. Helium-oxygen mixture does not improve gas exchange in mechanically ventilated children with bronchiolitis. Crit Care 2000; 4:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/11\">",
"      Kudukis TM, Manthous CA, Schmidt GA, et al. Inhaled helium-oxygen revisited: effect of inhaled helium-oxygen during the treatment of status asthmaticus in children. J Pediatr 1997; 130:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/12\">",
"      Carter ER, Webb CR, Moffitt DR. Evaluation of heliox in children hospitalized with acute severe asthma. A randomized crossover trial. Chest 1996; 109:1256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/13\">",
"      Elleau C, Galperine RI, Guenard H, Demarquez JL. Helium-oxygen mixture in respiratory distress syndrome: a double-blind study. J Pediatr 1993; 122:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/14\">",
"      Wolfson MR, Bhutani VK, Shaffer TH, Bowen FW Jr. Mechanics and energetics of breathing helium in infants with bronchopulmonary dysplasia. J Pediatr 1984; 104:752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/15\">",
"      Rodrigo GJ, Rodrigo C, Pollack CV, Rowe B. Use of helium-oxygen mixtures in the treatment of acute asthma: a systematic review. Chest 2003; 123:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/16\">",
"      Milner QJ, Abdy S, Allen JG. Management of severe tracheal obstruction with helium/oxygen and a laryngeal mask airway. Anaesthesia 1997; 52:1087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/17\">",
"      Boorstein JM, Boorstein SM, Humphries GN, Johnston CC. Using helium-oxygen mixtures in the emergency management of acute upper airway obstruction. Ann Emerg Med 1989; 18:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/18\">",
"      Hessan H, Houck J, Harvey H. Airway obstruction due to lymphoma of the larynx and trachea. Laryngoscope 1988; 98:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/19\">",
"      Khanlou H, Eiger G. Safety and efficacy of heliox as a treatment for upper airway obstruction due to radiation-induced laryngeal dysfunction. Heart Lung 2001; 30:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/20\">",
"      Rodrigo G, Rodrigo C, Pollack C, Travers A. Helium-oxygen mixture for nonintubated acute asthma patients. Cochrane Database Syst Rev 2001; :CD002884.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/21\">",
"      Ho AM, Lee A, Karmakar MK, et al. Heliox vs air-oxygen mixtures for the treatment of patients with acute asthma: a systematic overview. Chest 2003; 123:882.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/22\">",
"      Kass JE, Terregino CA. The effect of heliox in acute severe asthma: a randomized controlled trial. Chest 1999; 116:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/23\">",
"      Manthous CA, Hall JB, Caputo MA, et al. Heliox improves pulsus paradoxus and peak expiratory flow in nonintubated patients with severe asthma. Am J Respir Crit Care Med 1995; 151:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/24\">",
"      Gluck EH, Onorato DJ, Castriotta R. Helium-oxygen mixtures in intubated patients with status asthmaticus and respiratory acidosis. Chest 1990; 98:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/25\">",
"      Kass JE, Castriotta RJ. Heliox therapy in acute severe asthma. Chest 1995; 107:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/26\">",
"      Swidwa DM, Montenegro HD, Goldman MD, et al. Helium-oxygen breathing in severe chronic obstructive pulmonary disease. Chest 1985; 87:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/27\">",
"      Pecchiari M, Pelucchi A, D'Angelo E, et al. Effect of heliox breathing on dynamic hyperinflation in COPD patients. Chest 2004; 125:2075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/28\">",
"      Laude EA, Duffy NC, Baveystock C, et al. The effect of helium and oxygen on exercise performance in chronic obstructive pulmonary disease: a randomized crossover trial. Am J Respir Crit Care Med 2006; 173:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/29\">",
"      Marciniuk DD, Butcher SJ, Reid JK, et al. The effects of helium-hyperoxia on 6-min walking distance in COPD: a randomized, controlled trial. Chest 2007; 131:1659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/30\">",
"      Chiappa GR, Queiroga F Jr, Meda E, et al. Heliox improves oxygen delivery and utilization during dynamic exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 179:1004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/31\">",
"      Jaber S, Fodil R, Carlucci A, et al. Noninvasive ventilation with helium-oxygen in acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161:1191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/32\">",
"      Jolliet P, Tassaux D, Thouret JM, Chevrolet JC. Beneficial effects of helium:oxygen versus air:oxygen noninvasive pressure support in patients with decompensated chronic obstructive pulmonary disease. Crit Care Med 1999; 27:2422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/33\">",
"      Tassaux D, Jolliet P, Roeseler J, Chevrolet JC. Effects of helium-oxygen on intrinsic positive end-expiratory pressure in intubated and mechanically ventilated patients with severe chronic obstructive pulmonary disease. Crit Care Med 2000; 28:2721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/34\">",
"      Diehl JL, Mercat A, Gu&eacute;rot E, et al. Helium/oxygen mixture reduces the work of breathing at the end of the weaning process in patients with severe chronic obstructive pulmonary disease. Crit Care Med 2003; 31:1415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/35\">",
"      Gerbeaux P, Gainnier M, Boussuges A, et al. Use of heliox in patients with severe exacerbation of chronic obstructive pulmonary disease. Crit Care Med 2001; 29:2322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/36\">",
"      Jaber S, Carlucci A, Boussarsar M, et al. Helium-oxygen in the postextubation period decreases inspiratory effort. Am J Respir Crit Care Med 2001; 164:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/37\">",
"      Babb TG. Breathing He-O2 increases ventilation but does not decrease the work of breathing during exercise. Am J Respir Crit Care Med 2001; 163:1128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/38\">",
"      Hess DR, Acosta FL, Ritz RH, et al. The effect of heliox on nebulizer function using a beta-agonist bronchodilator. Chest 1999; 115:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/39\">",
"      Hess D, Chatmongkolchart S. Techniques to avoid intubation: noninvasive positive pressure ventilation and heliox therapy. Int Anesthesiol Clin 2000; 38:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/40\">",
"      Anderson M, Svartengren M, Bylin G, et al. Deposition in asthmatics of particles inhaled in air or in helium-oxygen. Am Rev Respir Dis 1993; 147:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/41\">",
"      Svartengren M, Anderson M, Philipson K, Camner P. Human lung deposition of particles suspended in air or in helium/oxygen mixture. Exp Lung Res 1989; 15:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/42\">",
"      Henderson SO, Acharya P, Kilaghbian T, et al. Use of heliox-driven nebulizer therapy in the treatment of acute asthma. Ann Emerg Med 1999; 33:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/43\">",
"      deBoisblanc BP, DeBleiux P, Resweber S, et al. Randomized trial of the use of heliox as a driving gas for updraft nebulization of bronchodilators in the emergent treatment of acute exacerbations of chronic obstructive pulmonary disease. Crit Care Med 2000; 28:3177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/44\">",
"      Kress JP, Noth I, Gehlbach BK, et al. The utility of albuterol nebulized with heliox during acute asthma exacerbations. Am J Respir Crit Care Med 2002; 165:1317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/45\">",
"      Tassaux D, Jolliet P, Thouret JM, et al. Calibration of seven ICU ventilators for mechanical ventilation with helium-oxygen mixtures. Am J Respir Crit Care Med 1999; 160:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/46\">",
"      Devabhaktuni VG, Torres A Jr, Wilson S, Yeh MP. Effect of nitric oxide, perfluorocarbon, and heliox on minute volume measurement and ventilator volumes delivered. Crit Care Med 1999; 27:1603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/47\">",
"      Oppenheim-Eden A, Cohen Y, Weissman C, Pizov R. The effect of helium on ventilator performance: study of five ventilators and a bedside Pitot tube spirometer. Chest 2001; 120:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/48\">",
"      Berkenbosch JW, Grueber RE, Dabbagh O, McKibben AW. Effect of helium-oxygen (heliox) gas mixtures on the function of four pediatric ventilators. Crit Care Med 2003; 31:2052.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/49\">",
"      Katz AL, Gentile MA, Craig DM, et al. Heliox does not affect gas exchange during high-frequency oscillatory ventilation if tidal volume is held constant. Crit Care Med 2003; 31:2006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/50\">",
"      Carter ER. Heliox for acute severe asthma. Chest 2000; 117:1212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/51\">",
"      Curtis JL, Mahlmeister M, Fink JB, et al. Helium-oxygen gas therapy. Use and availability for the emergency treatment of inoperable airway obstruction. Chest 1986; 90:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30568/abstract/52\">",
"      Berkenbosch JW, Grueber RE, Graff GR, Tobias JD. Patterns of helium-oxygen (heliox) usage in the critical care environment. J Intensive Care Med 2004; 19:335.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 541 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-210.101.131.231-3DC0084E0B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_54_30568=[""].join("\n");
var outline_f29_54_30568=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Reynolds number",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL APPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Limitations of clinical studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Use in children",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Postextubation stridor",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Croup",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Bronchiolitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Asthma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Respiratory distress syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Work of breathing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Use in adults",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Asthma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Asthma complicated by respiratory failure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Stable COPD",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Acute exacerbation of COPD",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Work of breathing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      TECHNICAL ISSUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Aerosol delivery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Instrument sensitivity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Cost and availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/541\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/541|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?11/33/11792\" title=\"figure 1\">",
"      Conditions of turbulent flow",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?10/41/10909\" title=\"figure 2\">",
"      Cross sectional area of airways",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?18/38/19041\" title=\"figure 3\">",
"      Patterns of airflow",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/541|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?12/31/12795\" title=\"table 1\">",
"      Physical properties O2 air helium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?10/41/10910\" title=\"table 2A\">",
"      Heliox ventilator calibration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?37/62/38892\" title=\"table 2B\">",
"      Delivered FIO2 using HeO2",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/26/31144?source=related_link\">",
"      Approach to the management of croup",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/19/27962?source=related_link\">",
"      Bronchiolitis in infants and children: Treatment; outcome; and prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/29/5591?source=related_link\">",
"      High-frequency ventilation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/51/1850?source=related_link\">",
"      Noninvasive positive pressure ventilation in acute respiratory failure in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/53/4952?source=related_link\">",
"      Overview of pulmonary function testing in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_54_30569="Metabolic bone disease in inflammatory bowel disease";
var content_f29_54_30569=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Metabolic bone disease in inflammatory bowel disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?29/54/30569/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?29/54/30569/contributors\">",
"     Harold N Rosen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?29/54/30569/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?29/54/30569/contributors\">",
"     Marc K Drezner, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?29/54/30569/contributors\">",
"     Paul Rutgeerts, MD, PhD, FRCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?29/54/30569/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?29/54/30569/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?29/54/30569/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 28, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteoporosis is common in patients with inflammatory bowel diseases (IBD) such as Crohn's disease (CD) or ulcerative colitis (UC). In cross-sectional studies of patients with IBD, the prevalence of osteoporosis ranges from 18 to 42 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. In patients newly diagnosed with IBD, the prevalence is much lower (0 to 5 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The etiology of low bone mass is multifactorial and includes corticosteroid therapy, disease-related inflammatory activity, malabsorption, and hypogonadism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic review will focus on the risk factors for and the evaluation and treatment of bone disease in patients with inflammatory bowel disease. The diagnosis and treatment of osteoporosis in pre- and postmenopausal women and men and the prevention and treatment of glucocorticoid-induced osteoporosis are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/35/42553?source=see_link\">",
"     \"Evaluation and treatment of premenopausal osteoporosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/55/11128?source=see_link\">",
"     \"Diagnosis and evaluation of osteoporosis in postmenopausal women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/52/39754?source=see_link\">",
"     \"Overview of the management of osteoporosis in postmenopausal women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/23/36213?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and evaluation of osteoporosis in men\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/58/31657?source=see_link\">",
"     \"Treatment of osteoporosis in men\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/36/17994?source=see_link\">",
"     \"Prevention and treatment of glucocorticoid-induced osteoporosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SKELETAL OUTCOMES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Bone mineral density",
"    </span>",
"    &nbsp;&mdash;&nbsp;In cross-sectional studies, osteoporosis (T-score &lt;-2.5) has been noted in approximately 18 to 42 percent of patients with established IBD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The prevalence of osteopenia (T-score between -1 and -2.5) ranges from 22 to 77 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/4\">",
"     4",
"    </a>",
"    ]. In some [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/5-8\">",
"     5-8",
"    </a>",
"    ] but not all [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/9-14\">",
"     9-14",
"    </a>",
"    ] studies, low bone mass is more common in patients with CD than UC.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Fracture",
"    </span>",
"    &nbsp;&mdash;&nbsp;In some [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/15-17\">",
"     15-17",
"    </a>",
"    ] but not all [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/18\">",
"     18",
"    </a>",
"    ] population-based studies, there was an increased risk of fracture in individuals with IBD. In the largest study (6027 patients with IBD), the overall fracture rate was higher than that for controls (RR 1.4, 95% CI 1.3-1.6) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/15\">",
"     15",
"    </a>",
"    ]. The increased risk occurred primarily in older (&gt;60 years) patients. There was no difference between UC and CD. In another study, risk of fracture increased with duration of corticosteroid use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The findings described above are based upon fracture data collected from medical records or patient questionnaire and therefore represent primarily symptomatic fractures. Asymptomatic vertebral fractures may be more common than symptomatic fractures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. As an example, in a study of 224 patients with CD, 20 percent of patients had vertebral compression fractures identified on vertebral radiographs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/19\">",
"     19",
"    </a>",
"    ]. Vertebral fractures occur on average at a younger age than in individuals without metabolic bone disease. Although low BMD is a risk for fracture, many individuals have normal BMD at the time of fracture diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/20,21\">",
"     20,21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with inflammatory bowel disease are at risk for osteoporosis and fracture for several reasons, including disease-related inflammatory activity, corticosteroid therapy, hypogonadism, and nutritional deficiencies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/4,22\">",
"     4,22",
"    </a>",
"    ]. Advanced age and low BMI further increase risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Disease-related inflammatory activity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some patients with inflammatory bowel disease have low bone mineral density in the absence of other identifiable risk factors. This can be illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Some patients with CD have a low bone mineral density at the time of diagnosis, before any treatment is given [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Osteoporosis is common in patients with inflammatory bowel disease who have received little corticosteroid and who are vitamin D replete [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The cause of low bone mineral density in these untreated patients is not understood. In some cases, bone resorption is increased without a compensatory increase in bone formation. One possibility is that the chronic inflammatory state leads to increased intestinal production of cytokines (eg, interleukins 1 and 6, tumor necrosis factor) that stimulate bone resorption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/1,4,22,25\">",
"     1,4,22,25",
"    </a>",
"    ]. In support of this hypothesis is the finding that maintenance treatment with the anti-tumor necrosis factor,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/6/28776?source=see_link\">",
"     infliximab",
"    </a>",
"    , was associated with improvement in bone mineral density in patients with CD, implicating a role for TNF alpha in bone loss. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/48/27401?source=see_link\">",
"     \"Immune and microbial mechanisms in the pathogenesis of inflammatory bowel disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/11/6329?source=see_link&amp;anchor=H11188279#H11188279\">",
"     \"Overview of the medical management of severe or refractory Crohn's disease in adults\", section on 'Anti-TNF therapies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Changes in the RANKL (Receptor Activator of NF-Kappa B",
"    <span class=\"nowrap\">",
"     Ligand)/OPG",
"    </span>",
"    (osteoprotegerin) system may also contribute to low bone mass in patients with IBD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. RANKL is expressed by cells of the osteoblast lineage. It interacts with a receptor on osteoclast precursors called RANK. The",
"    <span class=\"nowrap\">",
"     RANKL/RANK",
"    </span>",
"    interaction results in activation of cells in the osteoclast lineage to begin the process of osteoclastogenesis and bone resorption. However, RANKL can also bind to a soluble decoy receptor called osteoprotegerin (OPG). OPG blocks the interaction of RANKL and RANK, thereby preventing osteoclast activation and bone resorption. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/5/34906?source=see_link&amp;anchor=H593827#H593827\">",
"     \"Normal skeletal development and regulation of bone formation and resorption\", section on 'Osteoclasts'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In one study of patients with IBD, plasma OPG and RANKL were elevated and correlated with BMD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/27\">",
"     27",
"    </a>",
"    ]. Further studies are required to assess the role of the",
"    <span class=\"nowrap\">",
"     RANKL/RANK/OPG",
"    </span>",
"    system in bone loss in patients with IBD. If RANKL is shown to play an important role,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/53/21335?source=see_link\">",
"     denosumab",
"    </a>",
"    , a monoclonal antibody to RANKL, may prove to be an effective therapy for osteoporosis in IBD. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/33/22040?source=see_link&amp;anchor=H2#H2\">",
"     \"Denosumab for osteoporosis\", section on 'Mechanism of action'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Glucocorticoid therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many patients with inflammatory bowel disease receive glucocorticoids to reduce intestinal inflammation. Glucocorticoids cause bone loss by inhibiting bone formation, increasing bone resorption, decreasing intestinal absorption of calcium, and increasing renal excretion of calcium. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/54/42855?source=see_link\">",
"     \"Pathogenesis, clinical features, and evaluation of glucocorticoid-induced osteoporosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bone loss is more common in patients with inflammatory bowel disease who have been treated with glucocorticoids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/7\">",
"     7",
"    </a>",
"    ]. In one report, for example, the incidence of osteopenia was approximately twice as high (52 versus 28 percent) in patients who had been treated with corticosteroids compared with those who had not [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/10\">",
"     10",
"    </a>",
"    ]. In general, bone mineral density in patients with inflammatory bowel disease is inversely correlated with lifetime corticosteroids dose [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/3,5,9,10,12,28\">",
"     3,5,9,10,12,28",
"    </a>",
"    ]. However, it is difficult to distinguish the adverse skeletal effects of corticosteroids from those of disease-related inflammatory activity because the two factors are often linked [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Alterations in sex hormone status",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypogonadism is common in both men and women with inflammatory bowel disease, probably because of the inhibitory effects of the illness and corticosteroid therapy on pituitary-gonadal function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/29\">",
"     29",
"    </a>",
"    ]. In men, corticosteroid therapy lowers serum testosterone concentrations by about one-third, primarily by inhibiting gonadotropin secretion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/30\">",
"     30",
"    </a>",
"    ]. Gonadal steroid deficiency is a well-recognized cause of osteoporosis in both men and women. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/45/32473?source=see_link\">",
"     \"Epidemiology and etiology of osteoporosis in men\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/25/6553?source=see_link\">",
"     \"Epidemiology and etiology of premenopausal osteoporosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Vitamin D and calcium insufficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vitamin D insufficiency is common in patients with inflammatory bowel disease. In one study, 65 percent of patients with CD had low serum calcidiol (25-hydroxyvitamin D) concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/31\">",
"     31",
"    </a>",
"    ]. This problem is in part due to malabsorption, particularly in patients with CD who have a history of small bowel resection (",
"    <a class=\"graphic graphic_figure graphicRef70661 \" href=\"mobipreview.htm?35/5/35934\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/32\">",
"     32",
"    </a>",
"    ]. Avoidance of dairy products may also contribute to vitamin D insufficiency. One study, for example, found that dietary calcium intake below 1000",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    was more common in patients with CD than in normal subjects (53 versus 27 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, bone mineral density is reduced even in many patients who are vitamin D replete [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Thus, vitamin D deficiency is not the main cause of osteoporosis in most patients with inflammatory bowel disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Other nutritional deficiencies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Macronutrient (protein, overall calories) and micronutrient (vitamins and minerals) deficiencies are common in patients with IBD and may contribute to bone disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/6/43113?source=see_link\">",
"     \"Nutrient deficiencies in inflammatory bowel disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Assessment of clinical risk for fracture",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal of the clinical evaluation is to identify patients with IBD who are at high risk for bone loss and fracture. Many studies have demonstrated that low BMD is associated with an increased risk of fracture. However, there are several clinical risk factors for fracture that are independent of BMD, such as advancing age, prior history of fragility fracture, chronic corticosteroid use, low BMI, parental history of hip fracture, cigarette smoking, and excess alcohol. Thus, fracture risk assessment should include evaluation of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Clinical risk factors for osteoporosis",
"     </li>",
"     <li>",
"      Bone mineral density (BMD) measured by dual energy x-ray absorptiometry (DXA)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    We typically perform a history and physical examination to elicit clinical risk factors for fracture and lifestyle factors which contribute to bone loss, including smoking, excessive alcohol, physical inactivity, and poor nutrition (",
"    <a class=\"graphic graphic_table graphicRef76445 \" href=\"mobipreview.htm?2/21/2395\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    We obtain a bone mineral density study (DXA spine and hip) in patients with IBD who are at higher risk for osteoporosis and fracture (previous fragility fracture, postmenopausal, male &gt;50 years, hypogonadism, or chronic [&gt;three months] glucocorticoid therapy). This is largely in agreement with the American Gastroenterological Association and British Society of Gastroenterologists guidelines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/1,33,34\">",
"     1,33,34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Osteoporosis risk factor assessment is reviewed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/42/29354?source=see_link&amp;anchor=H7#H7\">",
"     \"Osteoporotic fracture risk assessment\", section on 'Dual-energy x-ray absorptiometry (DXA)'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/42/29354?source=see_link&amp;anchor=H16#H16\">",
"     \"Osteoporotic fracture risk assessment\", section on 'Skeletal site to measure'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/42/29354?source=see_link&amp;anchor=H17#H17\">",
"     \"Osteoporotic fracture risk assessment\", section on 'Clinical risk factor assessment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Interpretation of DXA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The WHO has established a classification of BMD according to DXA T-score that is the worldwide standard for diagnosis of osteoporosis in postmenopausal women and men &gt;50 years of age (",
"    <a class=\"graphic graphic_table graphicRef53999 \" href=\"mobipreview.htm?6/54/7019\">",
"     table 2",
"    </a>",
"    ). However, in premenopausal women, men &lt;50 years of age, and children, the relationship between BMD and fracture risk is not well established. In these groups, Z-scores, not T-scores, should be used to interpret DXA scans. In addition, a diagnosis of osteoporosis in younger men, premenopausal women, and children should not be based upon DXA results alone. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/37/42583?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of dual-energy x-ray absorptiometry\", section on 'Diagnosis of osteoporosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/25/6553?source=see_link&amp;anchor=H2#H2\">",
"     \"Epidemiology and etiology of premenopausal osteoporosis\", section on 'Definitions'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The DXA criteria used to make therapeutic decisions are discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     BMD monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;While there are a number of approaches to monitoring BMD, there is no consensus on the optimal approach. For patients with normal initial BMD results, the AGA recommends repeat testing in two to three years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/1\">",
"     1",
"    </a>",
"    ]. Repeat testing may be warranted earlier (one to two years) in patients with more severe disease requiring prolonged corticosteroid therapy or less frequently (three to five years) in patients with mild disease.",
"   </p>",
"   <p>",
"    Patients with low bone mass on initial evaluation require further assessment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Laboratory evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients who have low bone mass, laboratory evaluation may help identify other causes of osteoporosis, such as renal or liver disease, vitamin D deficiency, and hyperparathyroidism (",
"    <a class=\"graphic graphic_table graphicRef54926 \" href=\"mobipreview.htm?35/45/36573\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Patients with a history of a low trauma fracture or low bone mass (T-score below -2.5 for postmenopausal women and men &ge;50 years, or Z-score below -2.0 for premenopausal women and men &lt;50 years) should have the following basic tests:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Biochemistry profile (especially calcium, phosphorous, albumin, total protein, creatinine, liver enzymes including alkaline phosphatase, electrolytes)",
"     </li>",
"     <li>",
"      25-hydroxyvitamin D",
"     </li>",
"     <li>",
"      Complete blood count",
"     </li>",
"     <li>",
"      Testosterone (men only)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Measuring urinary calcium excretion (24-hour collection for calcium and creatinine) may identify patients with severe malabsorption (low urinary calcium level) and may be useful for monitoring response to calcium supplementation.",
"   </p>",
"   <p>",
"    Patients who have abnormalities on the initial laboratory testing or who have suspicious findings on history and physical examination may also require additional laboratory tests (",
"    <a class=\"graphic graphic_table graphicRef62821 \" href=\"mobipreview.htm?1/57/1948\">",
"     table 4",
"    </a>",
"    ). The evaluation of osteoporosis is reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/55/11128?source=see_link&amp;anchor=H14#H14\">",
"     \"Diagnosis and evaluation of osteoporosis in postmenopausal women\", section on 'Evaluation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/23/36213?source=see_link&amp;anchor=H6#H6\">",
"     \"Clinical manifestations, diagnosis, and evaluation of osteoporosis in men\", section on 'Evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are limited data on the prevention and treatment of low bone mass in patients with IBD. The approach outlined below is developed from guidelines for the prevention and treatment of osteoporosis in postmenopausal women, men, and in patients taking glucocorticoids. Most important is to use the lowest dose of glucocorticoid that controls the IBD. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/52/39754?source=see_link\">",
"     \"Overview of the management of osteoporosis in postmenopausal women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/58/31657?source=see_link\">",
"     \"Treatment of osteoporosis in men\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/36/17994?source=see_link\">",
"     \"Prevention and treatment of glucocorticoid-induced osteoporosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The treatment of low bone mass in patients with IBD includes lifestyle measures; correction of gonadal steroid and vitamin D deficiency, if these problems exist; minimizing glucocorticoid dose, duration, and type; and pharmacologic therapy, if necessary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Lifestyle measures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with IBD should adopt the same lifestyle measures that are recommended for all patients at risk for osteoporosis and fracture. These include regular weight bearing exercise, cessation of smoking, limiting alcohol intake, and preventing falls. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/52/39754?source=see_link&amp;anchor=H2#H2\">",
"     \"Overview of the management of osteoporosis in postmenopausal women\", section on 'Nonpharmacologic therapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/58/31657?source=see_link&amp;anchor=H2#H2\">",
"     \"Treatment of osteoporosis in men\", section on 'Lifestyle measures'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Physical activity and gravitational forces are important determinants of bone health, and physical activity can increase bone mineral density in patients with osteopenia. In a 12-month trial of low-impact exercise versus no exercise in 117 patients with Crohn's disease, nonsignificant gains in BMD occurred at the hip and spine in the group randomly assigned to the exercise program [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/35\">",
"     35",
"    </a>",
"    ]. Patients were asked to exercise at least twice a week, and at least 10 times per month. Increases in bone mineral density were significantly related to the number or exercise sessions completed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Calcium and vitamin D",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vitamin D insufficiency and calcium malabsorption are common in patients with inflammatory bowel disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/6/43113?source=see_link&amp;anchor=H9#H9\">",
"     \"Nutrient deficiencies in inflammatory bowel disease\", section on 'Vitamin D'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/6/43113?source=see_link&amp;anchor=H19#H19\">",
"     \"Nutrient deficiencies in inflammatory bowel disease\", section on 'Calcium'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are limited data on the skeletal effects of calcium and vitamin D supplementation in patients with IBD and low bone mass [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. As a general rule, patients with IBD and low bone mass should receive standard amounts of calcium (1200",
"    <span class=\"nowrap\">",
"     mg/day,",
"    </span>",
"    total diet plus supplement) and vitamin D (800 to 1000",
"    <span class=\"nowrap\">",
"     units/day).",
"    </span>",
"    In some meta-analyses, supplementation with calcium and vitamin D has been shown to reduce fracture risk in men and women. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/56/12170?source=see_link\">",
"     \"Calcium and vitamin D supplementation in osteoporosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When considering vitamin D and calcium supplementation in patients with IBD, several important factors merit special attention:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Vitamin D (800 to 1000",
"      <span class=\"nowrap\">",
"       units/day)",
"      </span>",
"      and calcium (1200",
"      <span class=\"nowrap\">",
"       mg/day)",
"      </span>",
"      should be sufficient to minimize bone loss in patients with UC but not in patients with extensive CD of the small bowel, since the latter may have poor absorption of calcium. In such patients, the adequacy of the calcium and vitamin D supplementation should be assessed by measurements of serum and urinary calcium, serum albumin, 25-hydroxyvitamin D, and parathyroid hormone.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/46/38628?source=see_link\">",
"       Calcium citrate",
"      </a>",
"      should generally be used instead of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/32/42504?source=see_link\">",
"       calcium carbonate",
"      </a>",
"      because it may be absorbed better. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/56/12170?source=see_link\">",
"       \"Calcium and vitamin D supplementation in osteoporosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The citrate and carbonate components of supplemental calcium compounds provide bicarbonate precursors that have two additional advantages in patients with inflammatory bowel disease: they can correct the metabolic acidosis that may result from persistent diarrhea and reduce the tendency to urolithiasis, which is increased in these patients. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/0/20490?source=see_link&amp;anchor=H12689099#H12689099\">",
"       \"Clinical manifestations, diagnosis and prognosis of Crohn's disease in adults\", section on 'Extraintestinal manifestations'",
"      </a>",
"      .) The reduction in stone formation is due to increased binding of oxalate in the intestinal lumen, increased urinary citrate excretion (citrate complexes with calcium to form a soluble product), and the rise in urine pH, which increases the solubility of uric acid. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/53/33626?source=see_link\">",
"       \"Risk factors for calcium stones in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Gonadal steroid replacement",
"    </span>",
"    &nbsp;&mdash;&nbsp;High doses of glucocorticoids inhibit the secretion of gonadotropins and thereby reduce the production of gonadal steroids. A woman of premenopausal age with IBD who has amenorrhea or severe oligomenorrhea should therefore be evaluated for hypogonadism by measurement of serum estradiol and gonadotropins. If hypogonadism is confirmed, she should be offered treatment with estradiol transdermally and a progestin orally (cyclically) or an oral contraceptive pill, if not contraindicated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/56/34697?source=see_link&amp;anchor=H16#H16\">",
"     \"Etiology, diagnosis, and treatment of secondary amenorrhea\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/22/28006?source=see_link&amp;anchor=H6#H6\">",
"     \"Treatment of hypopituitarism\", section on 'Women'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/5/18522?source=see_link&amp;anchor=H3033285#H3033285\">",
"     \"Overview of the use of estrogen-progestin contraceptives\", section on 'Contraindications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, results from a large, prospective, randomized trial of estrogen and progestin replacement therapy in otherwise healthy postmenopausal women documented an increased risk of adverse effects including breast cancer, myocardial infarction, and stroke in those receiving combination estrogen-progestin therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/38\">",
"     38",
"    </a>",
"    ]. Thus, bisphosphonates should be used instead of estrogen and progestin in postmenopausal women. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/23/32122?source=see_link\">",
"     \"Postmenopausal hormone therapy: Benefits and risks\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H20\">",
"     'Pharmacologic therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    High dose glucocorticoid therapy can also lower serum testosterone concentrations in men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/30\">",
"     30",
"    </a>",
"    ], so men with inflammatory bowel disease who take glucocorticoids should have periodic measurements of serum testosterone, and testosterone therapy should be offered if the concentration is low. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/33/12824?source=see_link\">",
"     \"Clinical features and diagnosis of male hypogonadism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/32/1545?source=see_link\">",
"     \"Testosterone treatment of male hypogonadism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Pharmacologic therapy",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H260141132\">",
"    <span class=\"h3\">",
"     Candidates for therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are few data that inform the decision as to which patients with IBD should receive pharmacologic therapy for bone disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/2\">",
"     2",
"    </a>",
"    ]. In the absence of data specifically in patients with IBD, recommendations for therapy are based upon data in men and postmenopausal women with osteoporosis and in patients receiving high dose glucocorticoids. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/52/39754?source=see_link\">",
"     \"Overview of the management of osteoporosis in postmenopausal women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/58/31657?source=see_link\">",
"     \"Treatment of osteoporosis in men\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/36/17994?source=see_link\">",
"     \"Prevention and treatment of glucocorticoid-induced osteoporosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with the highest risk for fracture, based on BMD and clinical risk factors, are the ones most likely to benefit from drug therapy.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Men &gt;50 years and postmenopausal women with IBD and established osteoporosis (history of fragility fracture or BMD T-score &le;-2.5) are candidates for pharmacologic therapy as are similar men and women without IBD.",
"     </li>",
"     <li>",
"      Men &gt;50 years and postmenopausal women without established osteoporosis should be assessed using the World health Organization Fracture Risk Assessment Tool (",
"      <a class=\"external\" href=\"file://www.shef.ac.uk/FRAX/\">",
"       FRAX",
"      </a>",
"      ). In the United States, a reasonable cut point to indicate high risk is a 10-year probability of hip or combined major osteoporotic fracture of &ge;3 and 20 percent, respectively. Fracture risk assessment, including the FRAX tool and its limitations, is reviewed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/42/29354?source=see_link&amp;anchor=H4#H4\">",
"       \"Osteoporotic fracture risk assessment\", section on 'Fracture risk assessment tool'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Men &gt;50 years and postmenopausal women who have a",
"      <a class=\"external\" href=\"file://www.shef.ac.uk/FRAX/\">",
"       FRAX",
"      </a>",
"      calculated absolute risk below these cut points, who are receiving &ge;7.5",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      or its equivalent for an anticipated duration of &ge;three months, are also candidates for therapy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The FRAX tool was not developed for use in premenopausal women or men &lt;40 years. Fracture risk in these patients with IBD is not clearly defined, so treatment must be extrapolated from data in premenopausal women and men taking high dose glucocorticoids. These recommendations are reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/36/17994?source=see_link&amp;anchor=H622811#H622811\">",
"     \"Prevention and treatment of glucocorticoid-induced osteoporosis\", section on 'Premenopausal women and younger men'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One area of uncertainty is the selection of hypogonadal men, who are already treated with testosterone therapy, for additional pharmacologic therapy. There are no clinical trial data that address this question and, in particular, the effect of testosterone on fracture risk has not been evaluated. For hypogonadal men who are at high risk for fracture (eg, chronic high-dose glucocorticoid therapy), we suggest the addition of pharmacologic therapy to testosterone therapy. The rationale for this recommendation is reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/58/31657?source=see_link&amp;anchor=H6#H6\">",
"     \"Treatment of osteoporosis in men\", section on 'Candidates for therapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/36/17994?source=see_link&amp;anchor=H15#H15\">",
"     \"Prevention and treatment of glucocorticoid-induced osteoporosis\", section on 'Hormone replacement'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H260141362\">",
"    <span class=\"h3\">",
"     Choice of therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In small randomized trials in men and pre- and postmenopausal women with IBD, bisphosphonates have been shown to prevent bone loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/39-41\">",
"     39-41",
"    </a>",
"    ]. These trials were not designed to assess fracture as a primary outcome. Nevertheless, we suggest oral bisphosphonates as the first-line pharmacologic option for prevention of bone loss and fractures in men and postmenopausal women with IBD.",
"   </p>",
"   <p>",
"    Although there are no trials comparing the relative efficacy of the individual bisphosphonates, we prefer",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/10/24743?source=see_link\">",
"     alendronate",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/41/17047?source=see_link\">",
"     risedronate",
"    </a>",
"    given orally once a week. IV",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/1/9241?source=see_link\">",
"     zoledronic acid",
"    </a>",
"    is a good option for those who cannot tolerate or absorb bisphosphonates orally. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/56/40842?source=see_link\">",
"     \"Bisphosphonates in the management of osteoporosis in postmenopausal women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For premenopausal women with fractures or accelerated bone loss who do not need estradiol replacement because they have normal menstrual function, we generally suggest bisphosphonates. However, it is important to consider the potential for harm to the fetus in women who become pregnant who are currently receiving or were recently treated with bisphosphonates. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/35/42553?source=see_link&amp;anchor=H11#H11\">",
"     \"Evaluation and treatment of premenopausal osteoporosis\", section on 'Bisphosphonates'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/36/17994?source=see_link&amp;anchor=H2707796#H2707796\">",
"     \"Prevention and treatment of glucocorticoid-induced osteoporosis\", section on 'Choice of therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Recombinant parathyroid hormone (teriparatide) or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/53/21335?source=see_link\">",
"     denosumab",
"    </a>",
"    could be considered for patients with IBD and osteoporosis who are intolerant of any bisphosphonate or who fail bisphosphonate therapy (fracture with loss of BMD in spite of compliance with therapy), or who have especially severe osteoporosis, although there are no data about use of these drugs in IBD. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/36/17994?source=see_link\">",
"     \"Prevention and treatment of glucocorticoid-induced osteoporosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H260141369\">",
"    <span class=\"h3\">",
"     Efficacy",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h4\">",
"     Bisphosphonates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bisphosphonates attenuate corticosteroid-induced bone loss, so they are frequently used for the prevention and treatment of osteoporosis in patients taking corticosteroids. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/36/17994?source=see_link&amp;anchor=H5#H5\">",
"     \"Prevention and treatment of glucocorticoid-induced osteoporosis\", section on 'Bisphosphonates'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Because corticosteroid treatment is a risk factor for IBD-associated bone loss, bisphosphonates are also frequently used for the prevention of bone loss in patients with IBD. In several small clinical trials in men, premenopausal and postmenopausal women with IBD, oral bisphosphonates were shown to improve BMD compared with placebo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/39-41\">",
"     39-41",
"    </a>",
"    ]. As an example, in a 12-month trial of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/41/17047?source=see_link\">",
"     risedronate",
"    </a>",
"    (35 mg weekly) versus placebo in 90 postmenopausal women with IBD in remission, BMD (lumbar spine, trochanter, and femoral neck) significantly increased in the risedronate group compared with placebo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/41\">",
"     41",
"    </a>",
"    ]. The incidence of vertebral fractures, a secondary endpoint, was significantly lower in the risedronate group (12.5 versus 34 percent).",
"   </p>",
"   <p>",
"    Intravenous (IV) bisphosphonates are an alternative option for patients unable to tolerate or absorb oral bisphosphonates. In a small trial, IV",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/8/12423?source=see_link\">",
"     ibandronate",
"    </a>",
"    (1 mg every three months) significantly improved BMD in patients with Crohn's disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/42\">",
"     42",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/56/40842?source=see_link\">",
"     \"Bisphosphonates in the management of osteoporosis in postmenopausal women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In another small one-year trial, IV",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/3/9270?source=see_link\">",
"     clodronate",
"    </a>",
"    (900 mg every three months) administered to men and premenopausal women with IBD within 15 days of initiating corticosteroid therapy prevented bone loss at the lumbar spine and femoral neck [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/43\">",
"     43",
"    </a>",
"    ]. IV clodronate is available in some countries, but not in the United States.",
"   </p>",
"   <p>",
"    IV",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/1/9241?source=see_link\">",
"     zoledronic acid",
"    </a>",
"    reduces bone loss and fracture in postmenopausal women with osteoporosis, reduces recurrent fracture in men and women with hip fracture, and reduces bone loss in corticosteroid-induced osteoporosis. It is likely effective in patients with IBD, but such data are not yet available. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/56/40842?source=see_link&amp;anchor=H29#H29\">",
"     \"Bisphosphonates in the management of osteoporosis in postmenopausal women\", section on 'Zoledronic acid'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/36/17994?source=see_link&amp;anchor=H8#H8\">",
"     \"Prevention and treatment of glucocorticoid-induced osteoporosis\", section on 'Zoledronic acid'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bisphosphonates should be used with caution in premenopausal women because of insufficient information on the potential for harm to the fetus in women who become pregnant while currently or recently receiving bisphosphonates. In these patients who require drug treatment, long-lasting drugs like",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/1/9241?source=see_link\">",
"     zoledronic acid",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/10/24743?source=see_link\">",
"     alendronate",
"    </a>",
"    should be avoided in favor of drugs that accumulate less (such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/41/17047?source=see_link\">",
"     risedronate",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/53/21335?source=see_link\">",
"     denosumab",
"    </a>",
"    ) or not at all (such as PTH) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/54/30569/abstract/44\">",
"     44",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/35/42553?source=see_link&amp;anchor=H11#H11\">",
"     \"Evaluation and treatment of premenopausal osteoporosis\", section on 'Bisphosphonates'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The dosing, side effects, and contraindications of bisphosphonates are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/56/40842?source=see_link&amp;anchor=H2#H2\">",
"     \"Bisphosphonates in the management of osteoporosis in postmenopausal women\", section on 'General principles'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/56/40842?source=see_link&amp;anchor=H37#H37\">",
"     \"Bisphosphonates in the management of osteoporosis in postmenopausal women\", section on 'Adverse effects'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h4\">",
"     Parathyroid hormone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parathyroid hormone (PTH) stimulates bone formation as well as resorption, and intermittent administration stimulates formation more than resorption. Although there are no clinical trials of parathyroid hormone for the treatment of osteoporosis in patients with IBD, several trials show that it is beneficial in patients with osteoporosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/26/15786?source=see_link\">",
"     \"Parathyroid hormone therapy for osteoporosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This benefit also appears to apply to patients with glucocorticoid-induced osteoporosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/36/17994?source=see_link&amp;anchor=H14#H14\">",
"     \"Prevention and treatment of glucocorticoid-induced osteoporosis\", section on 'Parathyroid hormone'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/35/42553?source=see_link&amp;anchor=H14#H14\">",
"     \"Evaluation and treatment of premenopausal osteoporosis\", section on 'Glucocorticoids'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the absence of any clinical trial data with teriparatide versus bisphosphonates in patients with IBD, we typically reserve the use of teriparatide for patients with severe osteoporosis and fracture who are not candidates for or are intolerant of bisphosphonates.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with inflammatory bowel disease are at risk for osteoporosis and fracture for several reasons, including disease-related inflammatory activity, glucocorticoid therapy, hypogonadism, and nutritional deficiencies. Advanced age and low BMI further increase risk. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The goal of the clinical evaluation is to identify patients with IBD who are at high risk for bone loss and fracture. We perform a history and physical examination to elicit clinical risk factors for fracture (",
"      <a class=\"graphic graphic_table graphicRef76445 \" href=\"mobipreview.htm?2/21/2395\">",
"       table 1",
"      </a>",
"      ). We obtain a bone mineral density study (DXA spine and hip) in patients with IBD who are at higher risk for osteoporosis and fracture (previous fragility fracture, postmenopausal, male &gt;50 years, hypogonadism, or chronic [&gt;three months] glucocorticoid therapy). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Assessment of clinical risk for fracture'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with a history of a fragility fracture or low bone mass by initial DXA require laboratory evaluation to identify possible secondary causes of osteoporosis (",
"      <a class=\"graphic graphic_table graphicRef54926 \" href=\"mobipreview.htm?35/45/36573\">",
"       table 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef62821 \" href=\"mobipreview.htm?1/57/1948\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Laboratory evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We counsel patients with IBD and low bone mass about lifestyle behaviors that will improve their bone health, including exercise, stopping smoking, means of preventing falls, and avoiding heavy alcohol use. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Lifestyle measures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with IBD and low bone mass, we suggest calcium and vitamin D supplementation (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Although the optimal total intake (diet plus supplement) has not been clearly established in this patient population, approximately 1200 mg of calcium and 800 to 1000 international units of vitamin D daily are the typical doses used in patients with low bone mass. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Calcium and vitamin D'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      Patients with malabsorption may require higher doses of calcium and vitamin D. Adequacy of the dose can be assessed by measuring serum and urinary calcium, albumin, PTH, and 25-hydroxyvitamin D. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Calcium and vitamin D'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/56/12170?source=see_link&amp;anchor=H19#H19\">",
"       \"Calcium and vitamin D supplementation in osteoporosis\", section on 'Underlying gastrointestinal disease'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      We generally use calcium citrate, which is better absorbed than calcium carbonate, in patients with IBD.",
"     </li>",
"     <li>",
"      Estrogen-progestin replacement therapy (if not contraindicated) is generally initiated in premenopausal women with IBD and menstrual irregularities while taking glucocorticoids. Testosterone replacement therapy (if not contraindicated) is generally initiated in men with IBD and symptomatic hypogonadism. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Gonadal steroid replacement'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/35/42553?source=see_link\">",
"       \"Evaluation and treatment of premenopausal osteoporosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/33/12824?source=see_link\">",
"       \"Clinical features and diagnosis of male hypogonadism\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/32/1545?source=see_link\">",
"       \"Testosterone treatment of male hypogonadism\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For postmenopausal women and for men &gt;50 years of age with IBD and T-scores below -2.5 or history of a fragility fracture, we recommend pharmacologic therapy (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      For high risk postmenopausal women and men &gt;50 years of age with IBD and T-scores between -1.0 and -2.5, we also suggest pharmacologic therapy (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Our definition of high risk, which also may be cost-effective in some settings, is a",
"      <a class=\"external\" href=\"file://www.shef.ac.uk/FRAX/\">",
"       FRAX",
"      </a>",
"      10-year probability of hip or combined major osteoporotic fracture of &ge;3 or 20 percent, respectively.",
"     </li>",
"     <li>",
"      For postmenopausal women and men &gt;50 years with IBD who have lower risk by",
"      <a class=\"external\" href=\"file://www.shef.ac.uk/FRAX/\">",
"       FRAX",
"      </a>",
"      , we suggest pharmacologic therapy if they are taking &ge;7.5",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      or its equivalent for an anticipated duration of &ge;three months (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      There are few data that inform the decision as to which premenopausal women and men &lt;50 years with IBD should receive pharmacologic therapy for bone disease. Recommendations for this population are extrapolated from limited data in premenopausal women and younger men taking glucocorticoids. These recommendations are reviewed in detail elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/36/17994?source=see_link&amp;anchor=H622811#H622811\">",
"       \"Prevention and treatment of glucocorticoid-induced osteoporosis\", section on 'Premenopausal women and younger men'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For pharmacologic therapy, we suggest bisphosphonates as first-line therapy (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Selective estrogen receptor modulators (postmenopausal women), parathyroid hormone (men and women), and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?20/53/21335?source=see_link\">",
"       denosumab",
"      </a>",
"      (men and postmenopausal women) have been shown to be effective for the treatment of osteoporosis, so they are options, but they have not been studied in patients with IBD. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Pharmacologic therapy'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/52/39754?source=see_link\">",
"       \"Overview of the management of osteoporosis in postmenopausal women\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/58/31657?source=see_link\">",
"       \"Treatment of osteoporosis in men\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/35/42553?source=see_link\">",
"       \"Evaluation and treatment of premenopausal osteoporosis\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Medical therapy in premenopausal women with IBD should take into account the insufficient information on the potential for harm to the fetus in women who become pregnant while taking bisphosphonates shortly after discontinuing them. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/36/17994?source=see_link&amp;anchor=H2707796#H2707796\">",
"       \"Prevention and treatment of glucocorticoid-induced osteoporosis\", section on 'Choice of therapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We prefer weekly oral",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/10/24743?source=see_link\">",
"       alendronate",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/41/17047?source=see_link\">",
"       risedronate",
"      </a>",
"      . IV bisphosphonate formulations are available for patients who cannot tolerate or absorb oral bisphosphonates or who have difficulty with dosing requirements.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/1\">",
"      Bernstein CN, Leslie WD, Leboff MS. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology 2003; 124:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/2\">",
"      van Hogezand RA, Hamdy NA. Skeletal morbidity in inflammatory bowel disease. Scand J Gastroenterol Suppl 2006; :59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/3\">",
"      Compston J. Osteoporosis in inflammatory bowel disease. Gut 2003; 52:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/4\">",
"      Ali T, Lam D, Bronze MS, Humphrey MB. Osteoporosis in inflammatory bowel disease. Am J Med 2009; 122:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/5\">",
"      Jahnsen J, Falch JA, Aadland E, Mowinckel P. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut 1997; 40:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/6\">",
"      Ghosh S, Cowen S, Hannan WJ, Ferguson A. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 1994; 107:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/7\">",
"      Gokhale R, Favus MJ, Karrison T, et al. Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology 1998; 114:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/8\">",
"      Targownik LE, Bernstein CN, Nugent Z, Leslie WD. Inflammatory bowel disease has a small effect on bone mineral density and risk for osteoporosis. Clin Gastroenterol Hepatol 2013; 11:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/9\">",
"      Pigot F, Roux C, Chaussade S, et al. Low bone mineral density in patients with inflammatory bowel disease. Dig Dis Sci 1992; 37:1396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/10\">",
"      Abitbol V, Roux C, Chaussade S, et al. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 1995; 108:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/11\">",
"      Bjarnason I, Macpherson A, Mackintosh C, et al. Reduced bone density in patients with inflammatory bowel disease. Gut 1997; 40:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/12\">",
"      Bernstein CN, Seeger LL, Sayre JW, et al. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res 1995; 10:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/13\">",
"      Jahnsen J, Falch JA, Mowinckel P, Aadland E. Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study. Scand J Gastroenterol 2004; 39:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/14\">",
"      Lee SH, Kim HJ, Yang SK, et al. Decreased trabecular bone mineral density in newly diagnosed inflammatory bowel disease patients in Korea. J Gastroenterol Hepatol 2000; 15:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/15\">",
"      Bernstein CN, Blanchard JF, Leslie W, et al. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med 2000; 133:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/16\">",
"      Vestergaard P, Krogh K, Rejnmark L, et al. Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut 2000; 46:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/17\">",
"      Targownik LE, Bernstein CN, Nugent Z, et al. Inflammatory bowel disease and the risk of fracture after controlling for FRAX. J Bone Miner Res 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/18\">",
"      Loftus EV Jr, Crowson CS, Sandborn WJ, et al. Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota. Gastroenterology 2002; 123:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/19\">",
"      Siffledeen JS, Siminoski K, Jen H, Fedorak RN. Vertebral fractures and role of low bone mineral density in Crohn's disease. Clin Gastroenterol Hepatol 2007; 5:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/20\">",
"      Klaus J, Armbrecht G, Steinkamp M, et al. High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease. Gut 2002; 51:654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/21\">",
"      Stockbr&uuml;gger RW, Schoon EJ, Bollani S, et al. Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease. Aliment Pharmacol Ther 2002; 16:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/22\">",
"      Agrawal M, Arora S, Li J, et al. Bone, inflammation, and inflammatory bowel disease. Curr Osteoporos Rep 2011; 9:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/23\">",
"      Shen B, Remzi FH, Oikonomou IK, et al. Risk factors for low bone mass in patients with ulcerative colitis following ileal pouch-anal anastomosis. Am J Gastroenterol 2009; 104:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/24\">",
"      Targownik LE, Leslie WD, Carr R, et al. Longitudinal change in bone mineral density in a population-based cohort of patients with inflammatory bowel disease. Calcif Tissue Int 2012; 91:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/25\">",
"      Schulte CM, Dignass AU, Goebell H, et al. Genetic factors determine extent of bone loss in inflammatory bowel disease. Gastroenterology 2000; 119:909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/26\">",
"      Bernstein CN, Sargent M, Leslie WD. Serum osteoprotegerin is increased in Crohn's disease: a population-based case control study. Inflamm Bowel Dis 2005; 11:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/27\">",
"      Moschen AR, Kaser A, Enrich B, et al. The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss. Gut 2005; 54:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/28\">",
"      Silvennoinen JA, Karttunen TJ, Niemel&auml; SE, et al. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut 1995; 37:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/29\">",
"      Quint AR, Kaiser FE. Gonadotropin determinations and thyrotropin-releasing hormone and luteinizing hormone-releasing hormone testing in critically ill postmenopausal women with hypothyroxinemia. J Clin Endocrinol Metab 1985; 60:464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/30\">",
"      Odell WD. Testosterone treatment of men treated with glucocorticoids. Arch Intern Med 1996; 156:1133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/31\">",
"      Driscoll RH Jr, Meredith SC, Sitrin M, Rosenberg IH. Vitamin D deficiency and bone disease in patients with Crohn's disease. Gastroenterology 1982; 83:1252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/32\">",
"      Leichtmann GA, Bengoa JM, Bolt MJ, Sitrin MD. Intestinal absorption of cholecalciferol and 25-hydroxycholecalciferol in patients with both Crohn's disease and intestinal resection. Am J Clin Nutr 1991; 54:548.",
"     </a>",
"    </li>",
"    <li>",
"     Lewis NR, Scott BB. Guidelines for osteoporosis in inflammatory bowel disease and coeliac disease. London (UK): British Society of Gastroenterology, 2007 www.guideline.gov/summary/summary.aspx?doc_id=14259 (Accessed on September 07, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/34\">",
"      Atreja A, Aggarwal A, Licata AA, Lashner BA. Low body mass index can identify majority of osteoporotic inflammatory bowel disease patients missed by current guidelines. ScientificWorldJournal 2012; 2012:807438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/35\">",
"      Robinson RJ, Krzywicki T, Almond L, et al. Effect of a low-impact exercise program on bone mineral density in Crohn's disease: a randomized controlled trial. Gastroenterology 1998; 115:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/36\">",
"      Bernstein CN, Seeger LL, Anton PA, et al. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study. Aliment Pharmacol Ther 1996; 10:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/37\">",
"      Vogelsang H, Ferenci P, Resch H, et al. Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation. Eur J Gastroenterol Hepatol 1995; 7:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/38\">",
"      Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/39\">",
"      Haderslev KV, Tjellesen L, Sorensen HA, Staun M. Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease. Gastroenterology 2000; 119:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/40\">",
"      Henderson S, Hoffman N, Prince R. A double-blind placebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel disease. Am J Gastroenterol 2006; 101:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/41\">",
"      Palomba S, Orio F Jr, Manguso F, et al. Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease. Osteoporos Int 2005; 16:1141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/42\">",
"      von Tirpitz C, Klaus J, Steinkamp M, et al. Therapy of osteoporosis in patients with Crohn's disease: a randomized study comparing sodium fluoride and ibandronate. Aliment Pharmacol Ther 2003; 17:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/43\">",
"      Abitbol V, Briot K, Roux C, et al. A double-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease. Clin Gastroenterol Hepatol 2007; 5:1184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/54/30569/abstract/44\">",
"      Hansen KE, Wilson HA, Zapalowski C, et al. Uncertainties in the prevention and treatment of glucocorticoid-induced osteoporosis. J Bone Miner Res 2011; 26:1989.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2028 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-183.1.191.153-863D5741FF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_54_30569=[""].join("\n");
var outline_f29_54_30569=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SKELETAL OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Bone mineral density",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Fracture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Disease-related inflammatory activity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Glucocorticoid therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Alterations in sex hormone status",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Vitamin D and calcium insufficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Other nutritional deficiencies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Assessment of clinical risk for fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Interpretation of DXA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      BMD monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Laboratory evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Lifestyle measures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Calcium and vitamin D",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Gonadal steroid replacement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Pharmacologic therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H260141132\">",
"      - Candidates for therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H260141362\">",
"      - Choice of therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H260141369\">",
"      - Efficacy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Bisphosphonates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Parathyroid hormone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/2028\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/2028|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?35/5/35934\" title=\"figure 1\">",
"      Vitamin D absorption Crohns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/2028|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?2/21/2395\" title=\"table 1\">",
"      Risk factors for osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?6/54/7019\" title=\"table 2\">",
"      Bone mineral density T-score",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?35/45/36573\" title=\"table 3\">",
"      Secondary causes osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?1/57/1948\" title=\"table 4\">",
"      Laboratory evaluation postmenopausal osteoporosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/56/40842?source=related_link\">",
"      Bisphosphonates in the management of osteoporosis in postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/56/12170?source=related_link\">",
"      Calcium and vitamin D supplementation in osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/33/12824?source=related_link\">",
"      Clinical features and diagnosis of male hypogonadism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/0/20490?source=related_link\">",
"      Clinical manifestations, diagnosis and prognosis of Crohn's disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/23/36213?source=related_link\">",
"      Clinical manifestations, diagnosis, and evaluation of osteoporosis in men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/33/22040?source=related_link\">",
"      Denosumab for osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/55/11128?source=related_link\">",
"      Diagnosis and evaluation of osteoporosis in postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/45/32473?source=related_link\">",
"      Epidemiology and etiology of osteoporosis in men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/25/6553?source=related_link\">",
"      Epidemiology and etiology of premenopausal osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/56/34697?source=related_link\">",
"      Etiology, diagnosis, and treatment of secondary amenorrhea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/35/42553?source=related_link\">",
"      Evaluation and treatment of premenopausal osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/48/27401?source=related_link\">",
"      Immune and microbial mechanisms in the pathogenesis of inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/5/34906?source=related_link\">",
"      Normal skeletal development and regulation of bone formation and resorption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/6/43113?source=related_link\">",
"      Nutrient deficiencies in inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/42/29354?source=related_link\">",
"      Osteoporotic fracture risk assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/37/42583?source=related_link\">",
"      Overview of dual-energy x-ray absorptiometry",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/52/39754?source=related_link\">",
"      Overview of the management of osteoporosis in postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/11/6329?source=related_link\">",
"      Overview of the medical management of severe or refractory Crohn's disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/5/18522?source=related_link\">",
"      Overview of the use of estrogen-progestin contraceptives",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/26/15786?source=related_link\">",
"      Parathyroid hormone therapy for osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/54/42855?source=related_link\">",
"      Pathogenesis, clinical features, and evaluation of glucocorticoid-induced osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/23/32122?source=related_link\">",
"      Postmenopausal hormone therapy: Benefits and risks",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/36/17994?source=related_link\">",
"      Prevention and treatment of glucocorticoid-induced osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/53/33626?source=related_link\">",
"      Risk factors for calcium stones in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/32/1545?source=related_link\">",
"      Testosterone treatment of male hypogonadism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/22/28006?source=related_link\">",
"      Treatment of hypopituitarism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/58/31657?source=related_link\">",
"      Treatment of osteoporosis in men",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_54_30570="Oral lichen planus histopathology - Lichenoid infiltrate";
var content_f29_54_30570=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86856%7EDERM%2F86857&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86856%7EDERM%2F86857&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Oral lichen planus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 236px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADsAfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6Uo4A6UH/ADmk71Ax3SjPUijpz+dHWgQfzpAOPrSgAdPWg8+xpAIQT3pMUp6/4UnANIAHSnDHpSdxn86UZpgAHHP6UCjke1J/Dx0oAU4zR24o/HmkP+fegAP400nv60o4/wDr0c+tACd+KU9eTzSADNL1OOaAA+3Sg9iKQZ9eaX68UBcOMZOeKOvSg/XNJ15H0FFgQDH+fWjuaXOeg70hByefypDEGRwxz+lGOKHZURmcgKoySegFJG+9Q21lB6A9cUxD/wDIpM0H3zSHJ/8A1UANZuPU0jE9u1OIz/hTT7HpSYADT175pgHXtT6YDv50dfrRR2/xpAJ070fhS5z7Ume/NABjNA44xxQetIeeuMUAKe3vSH2NLSDjFMBKKU9e9JSICiiigAooz2oJphYKKM0hOBnHFILC00nmlP6UnX6UxoQUvbHekz3zxQfc4oGByPT2pD15waMdPYUY59aBABkdaTr6c0p/zmkI4/lQMTtxQTR7j6Uh7/WkAH6GmseD2FKRg/WggU0IT8qTvz1pR0o79MUxi/hRQPXvRQCsWv8AOaUc9aVfWjvSKDr+FKc0ccYo59eRTEHGe/1oP86WkyPw9aQCcZ6n6+tHtR1OcfjS980ABNIOgFB60uOe9IA6njmjjGMdKB9OKTrwaADIHJ+vFJnIBB4PtzS/U/WkPbP86BCc9eKKO/FB7YHNFxgP1oPejv8ASmNJHEN0jqo9WOBTAeevWlIz9PWo1lR1LI6uB1KnNElxDFKI5LiFJCMhC4BI+maEn0HYf1PTpTZHCLubpkDj3OBWLrWqxwXdksVyiozHLLIpXPZT359+KrXWu2kc1vfz3kCWZgcGMSbnim652jg8ZGTVqm3qaqhN2stzcnVromBGKxBsTOvBb1RT2z3PYcd6nAXaAowAMAdMV5VdfE9IEePRNIaZPMLGWeRmBPtgVVsvi3eI5/trS9q7jta3UggehU9e1avDVLbHaspxTV+X8Vf7j1yeLz9qM37oEFkA+/jnBPp/OpcnPPJNeaJ8ZdBTyxdafrERP32WBWVffrn9K67w74s0XxFIYtJuzLMI/NMbIVYL0J564zzWcqNSKvJHLUwlekrzg0kbuR37U3I5yc5oJ+vpxWXpb6yL2/i1aKxNmjL9jubd28yZT1EiEYUj1BINZnPuaWeadn0NNU5GehpwBHWkIBxn9acBxSduPypfwphYX05pOn+FVru+t7JZZL6aC2gRN5lllVRjoeOuPeuO8RfFHwzo8O+O8S/f7u22kHB98/zqo05S2RtSw9Ws7U4tndZ45704RvuP7tgD7da8D8efFmfUtOgXwrdyWChd1wUw0rN2QNjge4rltD8PeO/F2lPqmmXk9ynmYX/TWRie+CxA4+vtWywzteTseksnnCn7SvNQv3PqQjGQRz79aaelfOnhPxr4m8PeNNN0/wARajPNYqWiuLK4BaWLjn3Yg4IxnIPFesx/EXRHjlaSLUYFjOCXt+p9Cc8fjUzw04vTU5q+XVqTSiuZPqjsu1KqsQdqE464FeX658S381F0hUgtjw006B3z9AcAfnXM61r2qa5eCfzp8R/cCOY1A9QoPH45q44Wb30Lp5XWkk56Huyhn+4rHHXik6DOQBnGScfhXhF1r2uXtwLia6kZlXCo8jcfgCKg1HVdU1dYJL+aSTykCr5hO0D2Hr79atYN9zT+yZ31kj38o4IG1t3pimHIOGzx+FeCxXGqQ2pigvp4g3VRK2D6d60dE8T6vod2nmXMt1Ay4aC4lLL9R3B96TwcraMzeWS1UZJs9pP04oPXmuP0z4g6NeSLFcrPZs2AHkAZCfqOR+IqzqPjbR7C+a2mkmfacPJEm8J9QKw9jUvaxyPC1lLl5Xc6c9DRnIrJ0vxHpGqz/Z7DUIpLgjIiYFHYewI5rUbID7FLMAcKTjJ9Pas3Fx0ZlKEou0lYU59aOmajgk82FJCrIWHKnqp7g+9SDqcUEbaBn0pDjPrRnkUDn15osADpSZ+maXGe2SegqNpI1hMxkjEKjJcsNoHuelADhQSPWorW7trwstpcwTkdRFIrEfgDxUpB5GOfShq24NNaMTuM0h6kUp56GgcnA/SgQ3vQe2acI35wp49qbg7C5HyLyWPQfjQAn1o74rE1PxXoem3It7q/BmPJWBTLtHqSvAq1p+t6dqIX7JOW3HaodChY+wNXyStexq6M0uZxdjSBzxRSheCRnHX1oqSC309KBnPTgnrSdAetBYAAscD1pAO9+M+9HT+tGcHpxQOhx0oAU4o7HFJ0PtQc9qAAH360i9/SlPToc0gFIA/nQaq6ldmztt6QtPcNxDApAMrdcZPAGMkk8ACufXx74fiaOK+vktbtvlMC5nwR1AdAVNXGEpLRXNI0pz+FXOrxgcik7dTivONQ+I+ZZvstuYrZRhGIBmbn7+G+XHtz+FT6N8QbNrxoNTadDtBaUr8gJPBAGcZHUDOD0rR4aolzWN3ga8VdxO+OOtHeuB8U/Ea3stsHh6GPUbp/+W0m5YY+f4scn8K5K++IGuuZBFc4bGwR2tvhVyeTuOScDvVxwtRrXQqjl1eqrpWXme1joelI5CAbiFHX5jivFLD4ma7ZGSC6Ed9vUrFJIBvjfsTgYYe1Yt2mq6ownmkmQ53EysWdvrnpVLBu75mdEcqmn+8kkvvufQEzsHgVMjzG6kZG0DJ/pWf4m1q18O6Jc6peqXVAEWNcbpnPRFz+f0zXjOgeKNX8MyicK13aMGDQysSuexGOhqrqGr6t4pvIJdVkV44h+6jVQgHqQvT8etUsI1L3ti4ZW1NOclyLr+hd1LxR4g8QtslumtoMFRFbjYj59f7x9zWY1ksIRpJbjgY3BsnP+FaUCQW9o8jlgkhCxlW3eYcE/geMAVh6pcNeXVpDZiaIeZvMQYZY4+63sepFddlFaLQ73VUFairIvabZWkjOhmlec4xKzkEfTtVptIaUbru5nntwMiALgt/vMOtS6fYBYFiuXSOaVhGHK/JF/vV0egQm81i0SNI7yIM3mqE+X5PvKSRwfrge9RKdlzEzxcqa1kc2FV7PCW8abQMxoeUHpx1P0p62ygIyeWcjupGDXq1zeaJpto0U0NnZyNGW8lEVjuOeMr1NecXLwyu4EUy26AGGVCP33sF7Y75NTTqOfQyo4pVbtxsY1zC+XZlh2jjIcHIPYisbw/f6h4V16O8sbJJpFZsJJnbyCDwD6GujubWNZtsS4mjQuykgcH+9/Snom4+Y0TNgbmc4bb7Vu2mrSO2FVcri1dMu2PxZv11K2/tvT/JtRuEiWwxnPRvmznHsRXa+KdZjj02G+s9Uls7aW2aRbiKASeYrYwFyQN4I98ZryfxHbiW2nYlCMZQAcrjrVG+1y7u/D2kaNBb7o7CN9zqSzOXPJx0AAwBWDw8W04oyll1Ko4zprl117W+Z6H4G8Z6t4j1L7NBcLHZIcLLcxq00g9WwQM/TivULdZFiVZ5PNlH3nChNx/3R0+lfMmjajdaPdkRK8MgXrt5K+g9K7sfEGT7bFfyO8cgXZ5EDqiSe7EgkH1rKrhnJ+6jDHZU3Pmo25bfiey8dD6VzHjbxO3hyO38tIAX+ZpJ9xUDOMADqfxrzR/iH4gW5LW93Ase84EivKuT29x6VR1jxnrmtW0ljq8VvcWDjBS0hVHznqCx4pQwklJOWxz0crnConUSa66nmHjfUdX1rWJ7q61KW7ikdlRyTgJkkDB6ACsjTNHu5wD83l9clc7vwrtJdLVr5ZLeza0sl52TSiR3Yn+IgAAewrobbT0MatJjcDnavAz610wo2d5H086tOnFKH3HGaJbaLb63Yr4ilu4NInfbKkR8rjpv3dwD1xX1rotlp+naRZ2mjxxR6bFGPIWP7pU87vcnrnvXilpNPFElp9isr6yD+YIb62WZFY91zyp+hrsYvHGrxx/vbLT52wdoQtGBjoPTAFZYmm6luX8z53Mo1sTK62Xnodzq+jaZrMPlatp1reLjGZYwWX6N1H4GvOvGXw68P6P4dub3TkuYJYnBPmXBk3gnGPm6Y7YpmpeO9YutiwRwWKEjjdkt6jNV9b1nUdelEV40C2kbbmtwvyDjr7n3NTSo1abTvZHJRo16Ul71l6nM2umxJDtO9xnPXlvrWjFGgRggOVGSoGDT49zTNvjAjxkEHBqVphGQFAMSD5suOPT611ybZ6LnK1myuIFL5jMSyEZAxzjvSPaJkbNxOOcHn/CpVcu2S0oyD8gAH4+tRTTlEjdCHXO07V+b3/D3o1vZEu5KsauwJbtnCnBqR44iQMZYccDO2s77SuxdiZQ8bwd2fxoa6mAZoVZ2UfMcAbgO2fWnysnfYszWYmGEwHHRhVc6bmNnlIkbocnGPoBUwuPNmVXcGNVAVWAyD9al+1AH50bLZAABIqbNFqc0rJmTLaTCRCssjBDnYTggezdjXVaX4+1GztXtbqNb1kwIZJHKyj/ZfAO4e4/HishwxjDbG+bnB6ge9U5LJtzMw3NztB4/A4olGM9JDlyVlasrnY2vxLaC5I1DRXRXAZjFMSfTcARzmr6/EG3kl3tFLBaRsWY7A8ko7DqAg568njpXmr6Ym8ybNrMOzH9KkGnRhslWZSP7xxWLw9PoJ4PCy1tY727+JcLW5NlYNFIchXuH3KPQ4HX6VhN4t1y6t7h59SVY2QoVjOwrkdQF5/KsVdPR0CrtUHoQO1SizWK3coGcE89OKcaUI9BLD4eHuxj+pu3firXL/AElYZH8mEqVlmjjMalcd3PQYHQc1zl1e3M9kttHfXbWcZ/dQTDanPcc5/A5q0loVKeYN8fGEYkD+dJcWcbD7rk5z8ygirUIx2RUHTpvRfgcnfw3cMavA8sdx0327MpbvjjpXqfgXxzJD4fSPxTcSz36nCNFHuZl9D7/WuUW0DEMTjHAy3BqG0ktdVsBdafcpdW5JVZIjwSDg4+lFSEajsy8TUpYiCpzXz6ncaj8RGwf7OtbeIA7T9qfL9eoUEZ/pXMXfiXxHqcrEapLEpBBjtcQIBn8ycd+tNhsQQMgux6nGMn61Yjsyh5jVR1IHXPrmojTpw2RyRp0afwx1MyS412bDN4gu/Nj5jbz2+U+vUZpb++1e+L/bdSursFQrRmcqpHqQOoq/cWitwy9Ocg/zpjWiKGLsyADO309600ZrGpFa2M2GytIV/dAiT5cyKcE85/EVZklmUl7d2t3+8TGxPI9j/SrUdsg2hWjDEYUsw5+g71IIGHO/cw4I7fUdqG+4nUVyvZarf2ab0lmBDB9xJU5+g4oqzsBHysMtwCDyKKl8vYm9N/FFHtrn5aCcMOOlB7A0DvXkngjgKAvOV3HtjtWV4j1yDQdLnupU8+ZYy0dsjBXkP48Ae5rzrX/Fmq3U8TW5IXBUW0WRHuOPlJ/jYevT2zW9LDzqarY1hSlPVbHq/nRlmVZFdlGWVWBI/KhXDk4BxjNeOaXfXEdliwuJI0djG86Hyw7553EgEEHsO1bFp4w1lPN3SQXKx5EjeUSEION2fQ8cHnNXLCyWxrPCtbM9LJGf6Vi+KoLy7SytbC4vLZ5JDmWFcxjjpIQQyg84I4z1rn7Hx6DBcNcWhunhUkC3IRpfZVPGeOx7Gt+w8V6PdpETdG1kkyFhul8tyR1x61n7KpTd7Gfs503exm3Fjqth4UvTfTNqd+3m+UnLMu8BQobuAuTnFc5Z+B7+5jhF9dpbblU7EjZyP+BDhcjtz17V6cssTbQJI8tnZ8wO7HcetSZOef1oVeUVoaQxdSmmo6XPEn8Nz2uoXNtd2s6PGqMuxGkKISRuG3qOOf5Ve1LwdeWcUs9tc21zGQqnn7qlcg4IHXoMc5r1m5ujbRlyjmMDOVPGc4xj9c9KrXGp2S2jzGZHt9pIcn923OMBjxnNa/WptrQ1+v1XY8FGmspxcyt8wwYdxVvcE1uWjC3iCRiMpGBtC9s9a7vXbPw/Pax5mFrLcN5sYGRI+EJ2ovQsQOmfWs6bwfdTWiz6beJKxAfyLqIBskZKPg8MPTtW8a8ZfFodk8cqq952OaeGJgp8uPLHcdy8ilVty5UbVVj8pP3h/Spf7F1gQxSS2N0RIdj+Xguue+B/nFKvh/WLq0eS2s5wInIYyHaWIGDwSCfr044rTmh3B1Y21ZneSssrYwZGI7gFvz7VnYhLSXTDiIspMfXI6DJwMcV2Fh4R1G7hjSaAbSmQHH3R6HJ4P+TV8eCIDeEXE29chURFxxjB3E+tJ4iEOpEsTCCtc8xsIJtaMTWsMkNtuaUBCQiH2/2vaux8OeGprzy4bCACNG3y3U44z2yepbvxXfCy0Twla24NssZnnVEZlDM7kgZ+bgAZH0raivbWYhIriB9uRsSRTtx1GB0x3rlqYiT1SOeWMlb3Ucc/gptwhOoQkS7tqmE7hx8xB7n+hqnc+GdSuNQ+yTxLIPKJ3RXJiMicDkhcHBA4POK724RbmJ4VkVHBDBgAxjbqpwf0zWR4tv47XT/s92HWG7HlpOsnlhZAQRuPUDjOeh6d6iNabdjGGIqPTcybLwHah1kurkyIwLPHH8wZ+zbzzx1rE1/SLjw6JZUWOSzmbzpJo4UBi24ySTyoYYB6jpXU3PivSrGyCC7DXaIoEMwZXLHs2FwDgE49uKowfEPR7jzg1lq626RtIzz2JCuo4I2nnOcAZ69quMqz1aujSEsQ3zOLaOMtrBL67Lx28hv402OYf9YqZyGcYwD7dsVV2ySkxStmeN9zFDjPHy59eK7601rSvEV88bwXOm3ZGIZHKoblXX7rAHn/AHT9RXO6xpKwXE9vBGE8tMBpV+4pyORx6EDFbxqO9pKx2UqzvyzVjlGtzdRwp5oOxvm3D5jjrirUSRQgrE6qrfdBwu40kNlLHdtL9q/0Z23r5kYyQpwQp64JyOxOPSpr4W+w27s5vF3OyeWR5eGxwxGOg54710PpY7HWTXKVvIhnlBkjKkcgsMioLmwi8wERLg9WwMGhNQMmV2+XMhDCL+HHuelSXNwsYEkynylxhiRgn296qzTCM5LS4x4EB+XMZP8AFjNTJCETkEHPUdKieZGdkMjAP04Hy496naZMJ8wPvnHTtik0ynVdtSNImYsxCkeoXt2FPaMJGSi7vTLcfWmedCryNGzMpHOTwfYDpUE15GsMbbF2NzlTkj64pqMmTzsvSKJxGm1vM4yFJwTSSykvsBCyopG4jO33xWZLeqUkMbxjBAjYZYt+A/lVrR3R7wNEVuQ+QyOuGc/3AOu72pum4q5m6nmSxxReV82SysGwDy2KmO9JvMfYHYbVTOMjvkd6zYr23jeVbIyRxhzjzxtJb+6AeehprXkMsqmKcDg5CDdz6ZH86OVg2pGxCI4Yg7FdzkbgMsM+3tTC5Kh0jSRNxDE8A46DHc1CDmXaz/dQlVHOR64/SppVeS1SEZJHVlT5R/te341NtSGxsl8soij2srJkhIsGSRe6Ee2aswaZMkIjls3e2yX3Doi5+XB+v4VWtFhS3mR7hllmcKHhcLyPmK5A5zgV1nhSa+ihd4Yp57dZdkqLIMKwHDMo6rg4PbioqPkWhlUm4xuc5bR2WmPi9eS2KybdzLkqT04wcdfTHpWhaabp17fRwzuRu3EiRizSP/t4wQuMEEAir+rTRXdhEse5rSKIyG6vWXaUCuXAXlzs2ZyBjBBFctewpNIxieHUEkdImaJwFaQLuVc8Hp6dutRGXPvozJNz62ZJcaELm5SXTb1YYJcu0bFWaHHGGOeTnPTOMVWu7DVLd2eIxuhz+7jk4U9uvJrQv9RSW2hmu7SSyu7Qqfs0e1Y8A5L8DJxx1qHUddN/5uLWzTUV/dq5ISEjgEq2PvEZz0wfetIub6XRopSW5mWt+ZZGSZWjnC4aFchw2fftUonR9xcKIs7JN36VYvbm1WaOBWi8pow1xFdTq5gGMEoQM7AeOpNVRYGG1M0EitO0mfJDbt69Rt74+vSrvFm6lomywCiS+UGA2oCAegHbmrsBEaKPlYN6Dj6ismyvJ5I51uI28lXx5I5Knuff04q7hY2UojF4+MHgLn9DUyjbRjbuiwpbylyEWXGAdxIqaZYZrTywHiJ6sDjmqvmLlUmd5CDvLlcBvTp/Kp48iEu0W93GDuyhJHbHaoa6kN3HwRJs+Ycnrk5yaWeMKgYj936A9B9BUVuWSJgiEkNxvfOR6/T2qV3kDbcnHfHUGl1JbbEP2UbfLwZm+bb93A9ajESxlfKgiCIPkWMBcfQdKdE5Eiwhh5mOGbq1NjkWNXAOWVsFWb+L0zTEPjdvmK/eHByehpZZCyk4YKADknAI74qrcXhjQlDubnORgDnGPrVKa5uDGw3uJAFztTLZPOCOg49Kag2Gm5qA7UyV+bnleAR2p7vG5LlcHHTOSv8AjWPcHUI1dmGdi43bckcZOfTHSpLZZI7JJLe5SV3GEjdcbsDJGfXrTcNNxXNAPHGuXUKACST29ck9BTv3in5EyjDO/eAPYVmSyebbOXhWaORMSRyn5GU9QR3q7G0LPFGqggfdKcIB2B9PpU2Y13JBMI3CBo1JOQAM5JorMv45GiClmyTtLYIyvfgUVpGmmrtg/Q+gDkseM1m+INZttC0yS8uleXaP3cEQ3SSt/dUfzPatNRuIAxkmvA/GXiePX9ekfe6Wgcw2im334RTzIO+8n9K87C0Pay12W55NKnzvXYk/tGe81W41nUtguXX7zSlmhDDCx7F4AAPfnn1NTRXIWwji1D7T9ptyyyRCMMtwFJIUfgcn0rMjRZJ1tp1kRI9okUKFZyCfnfB5/U5HtU1pC9xdxK5ZGDuxcKyqoAwAwHq2M8ZNeo0kteh6EtbW2LMUiMkj3kVuMhYcwfvJF3DgbewXPP4c1Fp8bC4ntY55bjEgEsTyfu367mxjqcDBHQ8Cr8sKs8UrJbJqBBjCiAiQJjnGPvA4/HvjrWXAqRtHdeeYYpUESpMpw43HBO3hQMryf1qU7xYnvqas1tBYvbXUc7zXEbGOLz4mLEM2OvAyoJ6fnUlxcw7Heby5jGud6YwVxkn1AHp15qrHcQyaddiV5p55mXEsTM6gAk7VGRjJBPpz17VVgSRjbTzGE3coIPmR4YscfJgH0HXsT3qFC/xDhNw0R0vyWzSTMsoDRq4dX6k/w7T0OPzzUdn4r1Hei2VxNFAI92yUh2HXI2kYyMdBzmsLUb5ZxHC8RKSMJVd1AWJlGCMZx0GP/r1OHglis3nixJsaaOFPkXOMZ3HHOMkVPskl76H8TfMdpovjkyKsN9C80q4R5Ik2PyM7ih46dge1Zd1qni037/2TqcGo2GctCLdFuAeR5bxPg7DxyM9c57Vz0XlxKbx7lZpXVY1J52AEgOVHJP4ZOabKBbi3+1sZzKh2xKTIwBJ289iOTjr0rNUYp3ihRpU1K9v6/rsdspSw0ZLjWLUaHrF4AXFpaecJD0CmJcgkDHJq4mhz3EEAsri406Hy9wFpELXAyRhgNwJPcNyMAg9a4Cd5NLSSLTTejuQJm39AVO4knOc1qw3mpWiB4dQ3CONnFvCo88554PGVznsf1zWUqMrXTInQeri+v9d/zOl1zxFquhyl7qxso7aaUKsoZ3CD5QpkZVAyQH5PT5O2apX/AI9ubC2LX+mPFOZf3SPC+x4S3yAbc5bb16Amsqx+IOrxvK81vFcxSBdkMq+VtC8NyvQn0Oa6LQL/AErX4tQu7m2k8uW4V5YriQssUqqACnIAGOcjGT2qXT9mrzj9xl7H2avUjp5GPY+Lb67KWkFvcXkKAM7CF3njYOTycAccfKe35Vm3niG+1HXVUapNBHChnZIR9k9FHmbgSSWzwmcH2rpH8PeFXkaGC5utOkLs7JaahcROJeBnZnBwOc44rN1zw7pdw8axXMl/td3jgaJyu8KOCwUgZIyzEYOfUVcZU77FwdG9+VmTq9zY28p1CWXT50G0SW8Z82SCL5jnc2V3HIDdTnpitXwampW083l/anlvyZXScRhSPvBvLA/dRnO0FuaraP4Z8P2n2d9Q1BmuoFdzH9mz5W4g9SvIAwASue/02bfWNFs5rl00x5omkVvtDS72kKgbN24DGM8AkgHPFObTXLFXLm7x5KabKl94t1Zbq6tLf+y9Ovwo2SajKJIN27BUmMZLYztU9APpXOXviTU57wCbWtJubhg8f2izswoiJZRtZpXKbOM5ZcA88mp7q38LyXd2z+EbxWmJdLlb/Epkznj5iUPXBHbirD6B4Nmsf3eo69CjZkMYnLljg54YHdgZ61UVCP2X9yNIwpwWsX9yf6tlfTNW0XR5l/4SHUNfe6uWwbi1vDPA4Ukgb1A4UkjHIB9q5G61u11LXJNR1zXbpod+1LeO0MyeXuIIfLYLbe4HPX0rstO0DwHDaCGTUdVvILlNiR3Lb+pzlQBwf/1Ulx8LvCl3AkOka20BXLhHcZYnpk8HjGB9a0jOlF3d0/Q6KNWhBtz5lfrZbfdoYdwPD9y8t3BdX+pRyQgCGOyMUcG9SIim0kxsijq3pWvompeIf+EhisNW1DR57iYBjYXLDCRsQDCknUSjggDI55qxP4B1nUTDHYXOi2kFkoVBblyZtyAMZGU/Mwweoxz6VMPhrNptobl9Rvb648xVaG3iUbmJAJ3DkAjA5xjrUyqU2uVy1F7ag48rl5aq/wDlYv6l4bk0ex1CRLWQ2IViJrcNLMhBAAVOuByS2T7Diube7knMqQXkYnkIZJztZZEPXawHJ3EZHXjHet7wBF4u0ycR3VlMsc+Sxu3JitwASFJByCe7AHqM13J0/Srmykke1sPJcea8mxRGDnJbPHcA/hWLrOnKz1OKVVUpOMve80eU38FvDbSwuDcGBcs8YKFj/EcY+9npWdDHbTb7bUvPsQ/B3LuZf7pEgO3Brorn/hGL2OZ7XxHHAwlZvOvAyKSrcbemeQfY9qhvPBetX6240jUtFvkWT544P3IweWMi856j3H410xml8Tt6nUqiivfVvXQ559Bj+Waynu4VdJDJDLIjMSD2UdeMd881QMlgtzHb/a5kulPk58lihY9Offiu8tvAfiFZpFvRoE6syStKyt5nmA4DA46qvANMi8J6rpcqtDpiPaCU5j+2K+SeN7A43Z9M8elUsUv5hRrUrtN3+ZzDaZZs6hr5lljZRJE0RjKtyOOx5qdtHtbO2aRyQFcFnuF+RsHjBHB65HPAGTXT2WgapaaZNFDohjtssscDpnyj3xgkkHJIrDbUjYvPPHEyLagqxeAIGz3UH2yOvrSVZy0iyeZPSLuV7Ca5it7W60qDMZIjkVo0aIEnBbkfNgnkj1Bqzdy6bbLBdRz2u7zCIWUNxIP+WjMBgAHv9KynunlkK28Da1dSSl40ijkUpk4AXHHBx14GPer0Eep6Tpw1WfSGhLx/vJng8zZtOCoUHAGcY4xnNU1qJtLQ7/wwL7U9KY+K3S7tkQBJbiMIsjAk71B5zjjjsBS6v4M0PxFNHf2syQFkKtLZBSHGMDvgYx0A5715a+taleN5+oXcmpbl3+XI7I8YVTuCc4B4z0/OtjRdeXRrASae8tpa3UizS3UqcNKADgAcspBAIrCWHqQfNF2fkYSozXvRdvyOvtfhxZ2iQrHqd5IqoY3Eirg56sB247etQS+C9QsooobOa2vbQsfPDrtds98Hg+4zRpXj+ea+ltL+wZWhkCtJEMh/lJwOw7fp611kmvWCC3c3NusEgbeXkxIh4C4QAk5JIOcYxWE514P3tTHnrxd3qec3Hh/WNLNxfW9vcJaQy/aGWVVK7QMMuOwHYev51W0TUUhtGjeJWguRvOEDr5itkb1PVWxt64z2NemXdzo+os9q+oQs0kZUAS/L1IyB0LA/0rDih0XRJXjuJrdbxWEcWF87bI+dpOAcDjnIxmqVZyjaS1No1+aLjOOpm+BvDoeW6u7mHTtQt5pJmtLxrcp5ccyYdUQ9VJwhBxnae1d7BZWsBZo7eBWbG4iMDooXIHbgY4qsJ/7L01Y5ZrrUryOLzGH35JSc/Mdowq5BAOMCvPdc+IusWcSQ2Gmb7qS42bp8KVzyVVBzhRxubk4zjmsVCdeWhzKFSvJtGr4lm8OjV10y/sLi3MEy+Zdg7FIKlgoIyXznG3jtWA3h+Ge9a0028s5IXiTy3kuESKWQsRl0HzbgvYDGR1FcrrCJfzTyzXA/fHe90X8zlQDnYeR1IP6VmS6ahjhkAiMyIM7VaNJkyNojGQdxH0B69816VOhyxVpanaoOCSUjX1LRLhJja6ml3LJbgQEtBsChW/1gYDBGO5yCabJbm2hlJSczSlY42tkIBiBxnOercHj36CrOna3rui3n9nPeC7spAB9jlXflWxtAByMkn1q7JqltJJOEtpLRVDwmWSQOsqr821QCNpwxGQCemaq84+aOlVOkkYljaZPlzEo3LMqkjZjgcir0EoZ4Y45DKzDd5h4JHoO1Tw2ulRwF7e+UbmHl2yEqir1Kuzc7iDkEA+hFRwW9hbyxbr9ZbpUdUlDZVZOcZPHyjgHjIzVOV9/yBTjtEdcNKlzFGVPmsBII2wWCkfe9MVZt7tXg/etIr5YdAVLdACc8ZqjPqWhuYQjQgIVIlfLSAAhQAnRBjgDnOQaZeRQmyne3uzDbKzbkmjK+YcncD/EMfKARU8ulmrDTUkrmmrxosLOr7wAcA/LzxS+VELhTGwQnL7MElhjnk9Kz45IorN/3ptBDtCidCSMj9ehFOtfNFqZGCTWyK5JikIRR3JDYzmptbUOW6umabxkqNo+fHBPPX09qQx712goQCGYFc8dxTLbznZEjjRHKMQDMrbVB+UgDsf6VLsc/aNssc5U5bZ82wcdvrUbMycraFK+tQXE0a5OOQR1wOPyqLSrxkaVQY/tSNtEcvRhjp6Bj78VbmQMkgQGVY2KIxOAcDJI7kfh2rPEkU7BIoRKXA3SbNgzjlj9O1aR96NmTzJ6l1biVtzPAZF3A7HbOzPPXpjg/iKh8ndKWECwJv+UyH5S31PGe4x6VXMUcMzRz8eVjdGilzkn+IdBkHNJe3CwhkBhjibBXzW24wcMMDIYUcv8AKVzX3L728sz/ALuZHQg7VGE3HPJ/+tTFt5oppGubby5d23Cc4x6+9VreaUyRXM0kLRjiMzfMCPQAD5T1NXVjS4kgjS+8zAD8kbmBPccZXj07VLbWjHfqiKCZW4VWDIpZGcZ/Lvn2oq75AkvVkNmsSbT+8xwMDn5geM9aKlzgtwV+p19v4pvNV8HeJzJb20Op2Suip5m2N42+427J6jPP0xXj15p/2GBZk22skzIgPm+Y4XqWA7dMDuce9ejW1hcaB4G1TSJrGOG1lvPsVnFKoMs9tnJHqwBJwfftXJNDLMbSP7MIUjc+Yu1Y5bYZOWXPqRnk4+mM1phGocyW1zBRScpQ20/Ig06G31OWFriM3EUUoxI0fknbjowyOc81sy+JVv7cyNDaxsmzdIn7tWTJCsFHUjAPp+NV9HvFukv7O5uhE/lI0RdUebIzgjsxzzj6detUJIE+wpILHAOVIiRcSBV3ZBzw2Bhh1BrVxU5PmX9bjb2saQuIIZftV2hSFSZsP95nwQCOpAwao77VhDZTpMuoSbZBKQGXHJOec4I6AdxyOlTwp9quUnt1JXYrxjeVKqwyMk43KP8A61V7q6SKGV7jTBHcxJHcNexviKIZ2qhH8e4kEDOQRUx3Ke2g+4kMzuCkjW5fciqmxhHxyxXt0AXv9atJNcT36SzSiFxEcCSFgCMLliR37AH0rPN9K1ws9sWPnQ7dochsY6kjgDPTP4U+VLi3EhdHEit5jNtwjDgHI5IyfUVTjd/IzbVrEq3DXNqlulpYLFtbe0zFWUMckEjjPHbOM1KXiuLoSXxQxyBIIlQkHjopyfTv3xmnxPNbW0E2YZFLEgbd2G6njjnJIz7VbdxJqhQI7RSDzNoCuXVcZ9dhHOAeTWbe7Q46ErRK4L8rLF+7l3PglQe7dTjrmqqt5dxbyGB3EsbEvsxtwPmbPrjp0zmryELO82IXhePepAYMM+oPAwKZdEPDIunSFjgbmhOGPYAE8H1rJOz8jdpaDVi8+4EqR3EpbaysXx5ZHOD/AFz+FIvm28qT20LG8T7s4YBiB03Z59cYqvYqtvbXbTqTC+VYc4UjuAB93gc8kmp2uQYFRJIo3kiBVpI90jcZzzwM5781TWtiLsuJq+t3F9FAtwy2+0eYsuJGz15znHGMZ61BqOpvp+ntHHl03kbnXYR82ST/AHjycfQVTeXyY/JeLY6jzi7Pkljxv9gDnrmmXFx5ssdw0nmp5qqiuMgqycNx0weefShU1dO2g9LaI0LfV57SRGWS8CQZj3l8Bfl3MeuRnPJzWU+rXh1OTbLJJvO3y95ZpMruDDsAM9evSmkmN7m1m5julDbmLACQHrgnkc1DbzXMC+XcB9pBjETJkBmAAbK8jPt7VpGnFatC57MsT3rtd/Z1uXeIjL3RO52B4PPYg+tVLGeRYYoVmhhmGVVDFnzB/eOeCwA4z1zSQNNLIIltg1z8zldpUnaOQc/eJOeOPWrNna24tPJjkjlZ8t5UkhUuSTx064/kKbslYJNvQYzzz3LQJDEGjiO6IuVcydNq4/hGCfQ1IhIeRtkrhdm+NmAXaykhVPrwBx2BFNaYW955TTXcQ8gMEUNMRGvB+TGTjI6H1qW0ihuo7dydjxK0/ls+QoHIRMZ2gj5jnp0oempLb6DVt5P7TRYpke7zsRUJxnbnAz1wQTntk0t1bTG0RbhLhpQHVPLJXdk9dg5BAycH0onuPstpLKVlMrAXHC7YyejYYYIznOKmtruO3SO8iRJniAbZIMszNx16Ac8YJIBxUu9rofNJ7GdFfXOnXKNpyzEY/c3KMys+CMsRxn0x61ueOpY4Y7LVdDlk0/XHj23n2GcjBwNpK9GPPIAzVK+tzealcCKWaBGZTbqi9JSOcDPtnnpTptjz273Uis0IJWF025IyMqecnNS0uZP+mXTq2kpS1/XyOi8N/E2C7sLW31ryJLkIyXknnLCZAeFaNO4PIIJB4rlfHHi2yuoYdP060tfK0+JHi3yEwW7LkIipn5jj7wOccEdCKzr3SLHU4IzNPLBfBj+6VMIJGOee/vj3qm/gq+t7i0knksnZ5E3kcrk85OemD19e1KNOlCV1odmHoYPm9pez7HKZm/eXZEU0koLuyruEZznoemevFNsNQ1bTp3ure6u7KzYYuJbePbuB6guvJz9f5V1uo6dd6Pf2l+NI0+WK3kMjRE70lJGGBjPVc8gda4m6uJpv3N1p18CMxpbFisManlSEAHKk5Geuea0i42Paq1fbxUVZp+aPoG0+Kvhqx8P2seny32t3UEYjMNnG8zDHALyMBjPqeeOldNPejxf4Vt5/Dmuf2ZFdiN/tccYkljBwwQAnAb1NfO3hrw5f6fa/uLeK2ScB5WdBI7hfmwc/QHA/GvStM8X3k+nRW76hBJEIcsvleSMsc5Y4wD/jXFLDaXgfMYnAxpP3JJu/r+ljq7zw3F4Z0rUryy17XJ9VnXcJLvUWPmv2ygGAB/sgelYXhPUtK8NwTjU7mZr5ovNk09Q86s5b/WBnyM4IyAcDJrLm8QyX0jXH34YnMMqkk4cdNpx0ORn61SOsN5ZlEn2UFBJ5g2yxhuV256gc8+vHpWkaErcsiIQXs3GWt9TR1LV4byO3ZLG5hlunMDpbTlIZVHKllUDaeeVyB9etQ3Op6xeXl1Bfaq6yRwmLyLeU7VhJGTgjB3YwSPmFU44Y4YbQsqM7rvufJ+YSD1HOc+/tS3rhY38iCJlEqoTLwoz/AAgDue+c4rWMYrRIFy/DYJNMK6RIlvHGjq63KujDhj13Hqcdf0xUGoWKOsJa8jF1DKGhkfJAJxt+XoDgdMVFZpdXNvOjtFveQs4GTtwPuD+Jl+uRUV1CJ28sywNOqRywlGZi6qoXJ7ZxkYxz61qlZ7j5rl+NLdNSQNJEJJCdwjIRpiF7HgE8jqOmPSrP2R1vftF1AXnVVXCSBgw98feIGDjpz9Kpx2QFlM0r4HzN5jPudlCgjbnpggU+x1Ca106HaVui5L/M3zk8AY4+UcDOO1TJfyk3ktype2iXaNIJry1tdxfBi+87nA6YwvOcdM1T0nUIUs4oreSVHjAgZUnw8qb8CUnsCOTmujuRcRwTqYIo1mVWBbLMxz/GATz71SNkL2X7awjtyQIpy0QWNjj5WAPzAnn8cdKandamqn7tmLqviO/eH/Rrq7leJF4aQKhz0XIxkDrxyDisqW8nBiknmkluY/klSdwWZhnOOzdQP85roosS7mjgea6f91IETiNjkE5OD06kY556VXvYnkWDa9vJfIpO6Aqd+W2xlWxtGSBn0HPrShKMdEjHmsZFiiW9vJNNH50qDYluzbPmABbt85HOTnB96t6XbWhW2juY5JbhAiPE+dzqQXTYDweOuPT6VIuitbtsVUM8gBOxyN7HPKdcHnHp7U6zWeK4S3n3/bAqyFbjcgXYMMCeD2/Etn2qpzTTswtdoi1G3m2vFbxSRGRE37B8ocKoQAk4zgkddpyRniqz6W15ujRPtDRDfKedu0HBCrnucEt0OBziuu1CxTVJftMKSiWG1JlKKCpB5bavUgcfQHpWPBptxN9nitEu28w5MyrvVgBt8vf04PHHpURq2W5SulqYMltKvmCVVu5riQF1iQDcQB8iqfRfftz0qRInRFtrfyZJIo2ASOPcF5GPmPHr1960ZNLupmZ1uPMkSXaY0UrtAwuc5GOAeTmmfY3N3DttmtGeT5ZvMATBXlQmfmHcjrx7Vrzp63BO2xUgOpXGozh4kknnhwzrEFJA78DGQvH41Pm2udIuJklFkVjZjFLJyQRgAk9SO4x3qWayjsvLlfFvKRjeTkBWboBj1B+u6ptQeK7SBZpoYVndCtwUI4DYC8jALYzzxzzjFQ5a6FyqOWphpqtvbeT9te4vHkjRLeC3IUqoPQgj15wMVoWFy/26e2RZ1uNgIikUKRHg5VweM/XGasf2bJPepdMtshDM5k4dsAjaDjH0z3x3q4+lwpFGZ55QHG4JbvvCt/Dkeh53elKU43KlKDjZKz7kNkWNt5lqskTvG0YaMKHCYIODjBAB6Z5Pams9qkKPCXhtpR5wihj+eVQMY/E85PbNT/Y7meSS8vSYxbTbVVCCzM3TYOhGMD5uOTUk9tJHeEtZSR+ZvXyzIGU5IKDAOeORmoclcyiruyKEkkyXIkQ/aZolbbEv7pm6ERkdMryTWWs8t3KytKVj2lwTh129dhHYgZGO2PetWO0BilJjSIxyMYUAaVuvzhhu+9kYpusWs93KLtHSKUfONqCPcgHO4AciqVSKZSptlAKweOeQzy27IesmAykE4z6cckZI7VHqF0bmI3CERRKVO4K7IrY+ZWz7Y5Fbslva3CxvbyDy0DBoWUEMABjk8gYH1IqCMfaIplSCUpORMGJ2jr1H0x070e06tFqGhBpogivUdEUOytliSWQjnv1zxj8ajvvJebz5xKt1FHuUiPBfk9/TsOnSrMliZYbkx7pkwA0hTdnHRQo54PPHFWdMN3LiIxn7bgTFmYLlA2Nyg/d9wP61Ll1TKS8jShjkvIrc7Ra703sX3HbjnGO2R+uKKZaCMys9mzSLEzCR1YMcc7uvfIHHrRXJKVnoxPm2Ok+IFyYvEcSIqPdm0UQlpfL2KXO4f7WTjj2rmjY5Wf8A0iCaXaxlkCE+YvdQGHCjPof1rV+J93af8JTb21zCh8i1ExEkfEgJI+93CnbwPXmslreVpY41ltHt1kDCISZ8wAAgFgeFznIHYCuilpCJy04SjBNdjBnjieWxnght7e4WMqGkODGEOGBHbqB+WKeJJXx5G6ZllCrcHAyzHBLE9R1XPQ1o3Wm2VxYH7Q+1/tAYzQtsBCjDbSSFI+7gcg/hULWdwsP2u12pHsCRpNsV5GJIJ/2Cce/WunnVir6i3LtHpttavN5bKXjzHCcSAEEDn6HkH6U6+uNSu9NuLGxewl8P3HF1byoCBI+MbCMOpBHDdM1qyt9mjvraLypZUbctvcOBtAO0uCeoAPQD86ghjdo7i2ZbcwMI55rgMJTFtyUjQDHDYPbg1jzLewPUz7fSLy5u1hcCUtEyqJJuVHAG5uAQMHr+VP8As89nIkww8lpKYpfJXazbRycMMkc44yD2osPJkF6xt7kTPNtYAM4XPIOM/dIPTtV4JALSWVraSTywMSByVAH3sepJ6+nanKpLZlKF3boZNvOVmSRU2IiOYGWNiAwGTljz1OcZ6VctIHsS0ixSQiSNVYIoABIGNxBwSfzp1uzv5qQ553SqEOduMcnt94jPfnFW3t5Y5psyCQf6yeNW/dqxwMqv93+vBpTn0Fa2oJKY4Gk8sGfywwjbpnIPIHIGAeTVQRmxuGaV1gspIUMHOQOMk56FT6npU1zFLbQSyGUJCuyLPlMTvYHGWAOF7d6syW6W8gtriFELQ7XXJYMMYwMcAD+uaz0SNVL3rr0Kl0iTbWjVmDOymXgPFx/D7D0qnJI6yvBuf52WPfNhtpxkMR1U45xWk0eYD5USqiDnyn2uWHGMDPHFUI3LyyW0r2sTmYKJN+44Azyf7w6c1cHpZhJJsh1CC4v3BhVPOWQmPcAFCr2cnqSPriq1vaFLm7Sdbm2t7qHDEDIDY6Kw4wMHj3xWuqTSJ5DyxStAcvvUEIAchxk5JApYooVfzLyaX92fPlES+YSpPJyeFJH+TVKraNiXo7mfHpjuVcC4Z7ZRveUjKrtx3GGOBkd+vHFXG0q1mMNvps1y6RgS7rcsEDEHjPXuDyP5VZ8+4mkMSwyGyD70hKgMM9HJ6scdW6cYqlCk832sCCFFaUO77yCxwc4ZT0GMn8aTnJ7sl26blQx39pbSzbZHyRHFGfkYNnG7PJAHOS3pSx6lOjtFdeZH5u6BliQMqg4wcj7uWHXI9aku4p3nEcTu9qSgVmfDKOBtY87ueSCO47VJbWzXKEJFv/euqx7SpbjcV35xj5erZH4Vo2nqyE77FWSe4vbgS8pGd8mBl8kD7pI+6BjjHLelU7XEQ85ZWSQv5YZU5UgHCnj5l6kn6VdLygtJZSEW6lS0xAA8vJyB3b5f4gfWqsTT6jYvdeUxuE8tIkLbQg5GcE7iNuPqTVLbyBSuy1awRTWIWGDyllh2g7gzKd2HwDzuBycGrdzEFtLSRIYY54tqMHYfdAG52255B5I9qW+uIpZbK3WCMTvG0k0JTa52tjfjuuCeDxnrmkvbeG5tM2zwwZO6Z9i7yWIK/OOAeO1Z31VykKlrKRb3eySeCBpJLmAuA2/5iZGAyWGAvT6VXC25jtws7lghdVlY/vHkBwGOOnPXPFTTWhhuLeV7kyvGmA0r8xhBks4HJBzjIB4NCQma4nu2kkvLW3UMLeQBPmPAbjnHQbsYAFJPS4bGW1ulsZJI7hIY0XjZJkqx5CdO47960dB1IQWTreXSZVwmwx4K55AHU0scfkxrHdPtuMLiXbtdzgYw2McD5c81Vtoo7e9kvbu3860+eKSXJwGV/lwMZOdxy3tVyamrMqMrbF+C+s4SssG4WrOVS5ckliT82T2Ge9V7rUJ3vfMihtbfc6BWkcZkLdOMfd71JCzWl20W6BFWTDRl1O9QMhgv8KkdOveqtnbgS3cTbikkWyBIhjdliVHI4AAPORnNSlHdmjnbYx55JLidxPNOZYFeWLAw0cpyD8vXpnv0+lWbdPKtyr2sk4kRMRysqbh/ERnhjwSP5gmnb5LOO4uY9N8q5SNVlGCxyO6qeMKCO545p0VrZgxQSTyxKyyW8scDeYvOWUhv7xzjI9B6Vu2ZuV2guxFLeJKLW4KsAy+TL5ZHOQSP7ykD67sVMZQVkt3sZXi8jPCqVU5JOR68/wD1qnmtmhtlllsreEkRrMseRMwyNobPG7n5iOnFFisE1tMlg0l1cq3my+U5B35BDhgOFGO3U9aybTVwc3yWJfKjurdyUjhiiXIkt5MsSOQAByDg529u9WgPMZ3tFNwfLXKFCPOTbgrjoWzjkcetSRvHFErWDkq6l0aMGVZzu3MTnp6Z65olhWOzuEkiuWG8yMsLlWWPgkjqCAW6Csr6itr5lC8gNlHpzyKIId4VFibcgcN1LdSSeMY7E5q5ZWdsthcAG3gmgiWOaOcbnZmYsJI8HIUdz3HahraB9Nswt4n2EO0IaMkggDJUk42jGCeDUN9aG5uractbIIWLRmF8xkEcNu/iUgf5FF09G7CtrcSyF0UInTMjfvEV+oIONw4wykdjjrmmxQlpCU/d2wYgTBAVQv8ALt4JwePTHNa1kwl2W7xmV9q7kCkxoBjcA3RiM5wOlW4ZZJLlxZRrPcxRbQXwd/zDEjjI54yO/B9alz1CTfTUp2r2yaeggRDcRytAVlJPl7t20GTrjtkjjv2NZSObnz47kLb3MbEtbmQEyHnDZI+vqK17e3WKZPsryCaRzKqmTJUcbmOeoyR7jNVrm3ELu94C6IWIDgLtjYg4H06+o/GhNJgkRp5waO3eOOHlo7iVm3Fwwztbtu9GXjB5ojit5La5vl3LaW7GKPy12uEXIbbj7wyRzVtZFa+32z2xknl3O0p8xZIkG1WTA+QnOPx9ajaQnUAEaOUiPzJI48DbHggHGPm4HKjjPQ9qXM+grtFS2R7GewjcG2iu5GVJJCFKNjAJJ9VBP41o6vaW91qNndXEc08ilhJJHJ5vnFR8qY67R12r1I5qI/YZYpLmFbm5aHaxlZcEKeFxuAAIJIBHpgkYp1hpdpfLaaempiO8WIy7kmKSTgNnfjJB6HqRntTcrvm2DTqXtEmjs57WXTwjPFO5GwbthI+bI9+QR1FXdZstQknSfUbiNrOZmWFLdMoCVJXbgFQRxhmAPXqaquEid5Ijb7mJYYAj3E/eJ54Pt745pf7RS0tpBKE+xAhswHapAwN/y+nAK8nFc7u3dA43aaRlXggv5ohc3cUcu5kaQq+10Xou0DqPX/GpWDPfW6+U3kXEZ+0NGOVK8BskfKcnGPTtUWp2El4J0ttaETYWVZDgMYW5AGeCDzyOcHvitCB3j06OJYWSAoVDbdofBwRk9ccYNaNpLQ0smUJbfMchvlRS2FdUyCvzZ4J9RgHjrmpI1kbVbcR2EFyuwKsSP5Q8kAqMuRkbRnkYq3KAwiuIPKIDYaFnKsfUgnPT2zWVHa21xKlnqskNyXUxtcHBWDLEo23jOD/LGKE+bcJWttqWJTJCqGBlW4CnyY4sbMHAbnrgdj2FRrYyw2t5IE3DO24uJWCLMx/5YptGS3OemMZzRAtvePN5FxeGebCrPIvlyTMMkHB5wMHjHbFal9ELiGV7xLWa52BnlmiwQV43dQUAHehuxD6JFCG3PkGIiWWPe37ub5SyjgBW4wAMnPrVOeDyfKiuJWmLSiKGcLliSTgAA8kcg9jWxFHJtjWV2kaFATIuHLA9uOvGOT6VSvp7a0EbapJDbwbty+e5QEhsbuBt4B46daSbb0NFLl1G2lu0kMyt8jIQ+DhpBzj1xj2HSqX2BzerICJbeRt0xdyPLXpyB2Pp7deav2Ucd1DHfXEDR3VrH5MbEtbptzlSQxHDds/oa0rKyMsrBnNyzHDTAIyqCc7crxjB6UnJxYOtvc54QeXaKlmyGUM7bG53tzyWwSB0IyOO1TjTXT/VLdBNwfGVC56/jjjjityPRpLazupZnhgmwVAQhhEv8Jdhg9OR39KZaeHnnuVW40q5u4oZVlS5ZjHlwDhthJyB2OT16UvaeYKtG2jMVI420+32XDzmaUJmZAd2eTkAj06Zq28LtHPOLdrpootscZ3CNmHOWP8AAePfOK6IaDeLsWG3WZgcB5JPKwnqxwdzD1xk1sR+H9kcS/bpSyDb5nljeV9M56fhWbqpGU8TBW1OR06WKeEC3jSIsCsjptKhlPTcOCMnt1zRXeWmk2NouI7aMsW3szqDknv6UVlKqm9EYPGWeiPLdRunn1qedLa2upWZblwQ21CV5EbHk8+gwOtV7owjR7L7SLSKHJ8iNQ7z4P8Affjdj6Y6fWp44bTSkjt43lmtL1GtmZhsZQfuoM5LDIwSuM1bg8x4odtt86AB5EINvET75GemMDvXpKVrM62rLToRQ/ZItNgSd5II5G8u4hYxkTMFwPnJwoAwcAD05p80EKRbZnURoyvMREFWXr1BPAyR6Cmaje2v9kCXyGlgimO6No/m5PGeOACB2P8AOnX6yX8KgxvHLM5IkMZMSnn779ME4+tLW9w5UtyG3s3vJ9uoq6SLGrxRRguYULHG5+wwPzqzZ3mjWXm20lm1zduzIreapjiIBDY7lsHBz07VNJC8lxt0+AT26wi389JvnlCrxlewJJ/MGqeiQxDM+EdBIyuUK5YLldu7vg4zx2qJPmi2wjGLlqMjiiu9OnLWt1cJEwPlr1WMEAFAvJAPXPrTdSit5kngmDqgTeDGzDClhnHP3x36kVajSPzraYNLBJbSeZmNCVn+TnGCCBjPtnNW7uJRbxpY7oELEq/AwhHPHv0I/Knz6oUm1dEVtJ5cQjDQW0QIRXIwD6EscA5JP149BUNxBFE6tNGMQNvk2DA39CcjqOgxTI4Ue0eRbfzbfCRyxtIQxwflbHr6jjI+lW7tJ/KlkBLA8OqgYKgfmOvSo66MqNopkFjPcWSXELXU0P32dhIWKZwQvIx9OuBUtyVihlkUSNLIm8E8MTgYGfyqO2jSKxjSQ5KqpJUEhF4+UZxnv+NW7swOjyrIjyE53FQGXPqCcbsUpNNlpcqu0ZtvCREC8sUc4JIfecknGVGO/wCFCIsk4ijRd06qm3bnKBsbiw6E89c9DReG2igSYpAPLAZvvFFLHAYjrjqc+1TzWsCzytDGVm8pP9IiJXcrE42noAOvH97FaX6md72ViF4o0uAMvIojVFVZSZN3OV2YPy45yTUcdxazxMZZpUEkiqdpZjD2HGRhR1wev41JcQh2DeZy2xXC8GZscEHjjqDnp1pdLgMERlug73HyguF3MqckAgDkDpk9ccUX0uyWrbjtMtPssv2eN5H6b53AAcj+HJ65x0HGMVLc+ZGzIbm5ubd4iBMAPL3E/MVUdAM4zz3PtU5tIvlaGTcqbEjggAYs7ElhGO21QSSeeaqGGSYx+VEyqQ/kxKSfNXduAzjgEdQR1PepvfUhO+vYofZZfPmYIUt7fLLOvzBz0OcdPmx05P0qjNDH5bPbtdIYIUYPG5DAueWHqSB0x3rbgszbWMMsESmV5xdRzIWHkbkwQR3wMjHT6U0Wzz232S0eWWC5mBmmBKhdhGVA7gkjucfhW0Z9ht3Rkeaslu2nS2pma3lEHygLJtC8EY6jPUdu9V9LhtY1tVieWaSWJozJcblCtvztZQMnaAefzraDxNeobeKXzSuwI8QBXL8qSwGAcE+p+lXGtrp7i1jlhs0it5jIphOSQeGHH8WMf5NHOkrCd+pXsIi0SNdRqVxhJIpWEkh3Ek542f7oJODzipLi3ilWZLhibSRk2wog2Aq2RzkEjg5B7ipbqZl0yR2jIRTuIC/OpBOAPTJ79hTprS7trGRbqGMv8rStkspLcsq5GAOeQMkcnPNYqTbuU7bGcY5Lu4gvbuzaOxtQ08/klS6qxzwcYVeBxnntUYuLWQxNd3MlvCYtiW8WWMiuTgseM/exg85qwbjy0uoCV+YAmES7Y2YbV5HQKMqcGn6ikplRI555Id6yJtG4nBwSAAOAB1zwPrWifRi9Dn764invLiSRJHiU7bQuu9yjYVgh7YI684x71q28kNykwiFykNspl2R5wcADOQcgtyR9BWrZ21oiwG3a5lg8rZGSN6OBkk56gjkcYHABqCe3eyLmEugOxWuY2bMYBwgXOM4B6YwOfam6ibsg6GfY2pVoFIAV43EDNwXwwJXHU9cZ4plvJB9rRpQ7oHJUSLt8pwSWO4fKw54FbyQS3k1nLZJJ9pEMufMKoihTlmbPrgHOc8VFBDHdabZeXCI4o4lmaIMTktkAtjr61PP3KvYxAk1qSNQhjVTh1y53lWOA57Bv04q7LpL2ckdjdwK8jxlRNBth3HIKEkDqBnDd+hpZLOILcyzRRyymTa8URLGVWOQAehxjp2/Grk8VvBeieyMsE9zutxsh4DlT1ByAeCD0FNyIl7xQMVpbovkxnJLpdvPKVlil2B0Y8kYJIHHU9qZYaXFf6VdW0BaG8hhUO8L7tr7gy4U9vfJzmtmKwe3VbaaOFESKOMu6rIZyV4BGSQVxyRQLe6sL27e1tUPnLGchjvkx1AOcKAOwxn2qPaBF2tYaluZU842/zOnmTyRYUYB5kTHK4ycjHXNNtmJvHu7URyJEuBlj8gH8TFuxzU7WklzFLPEyhHDXFvslx/DtKnA65AIPPXBqvdrLqcogSaMSKRJHJcRFSzsv3ZexB7jp36iluF2giu0sLWR7WAxW7Mxkh+VXgxkhl3cNnP0NSvGQri3tbaK1ZCDGsRLAEdsHjg5JIx6VJ5byabBI3mK8WW8p18/dIg27GOO4JAPoar6fE5sfOaWWMW8seVUbg6j7pUdSo5Xrz1pPVXGn95Z0XT5o7RbO4WG1SNcQxxlmIRejPI2MswOKWyin+2zgqHVsMqrKrYYDOznGOBkA54zVLVVvJXt5LNw8cbrb3cMewCWFjkkjhkdRyCpOfSrdwttLqCRXcS+ZbebIHVGVjldvHY43KeemTxSfd9SbspEwm5aSIR21wibwSQVRc4K4zgnOB16E+lTCC3hitzMhbzMiMuhYFydzbifUcDsMDANPe1SOWWYLGySAvEqgkcY4OB1IycHuetWp7+RJ7mwu4pxIgDYeba7rgMckDAKk8enrRe+xZmC3tliZEET29xuZ9wBMhz0XkLnpx7cc1PHptzBGhMzm3SICKV12llzu2N6eo9ASKhSzltZy1szra7/LulEYON4JBRu4OTkjv7GpnuLizbTMqrKxMC+SGJUv91jwdoCg9eRTu1oht3ehW1FJmgKLK6ZjYBinDBSGAdsjORnrik0rUYBo5uHUi1EgtyuFJSQEbiMfd5OcdKn0x4JbKNoytpBcK4ljbaREwYlpDweuOB360XlswgkmnltCH2x+a8vyuDjaM4IwTg5xRdJcrGmm7MnWeIbvPgg3yEjeuSGAJxgtypA68VLcC3ntnivIytk8TK7MN2SchumeOR6HrWDFAIbVYyxv5IWYE27CSTdg84yCPTI9avwXUeqFbSS+8mZRsY9Ajn+E8Dg+p9M5qXHqth8qWqM+3t30y2sLOOaaOytQAk11GJEkX5seWw5B5yMjHt2rXeJPNWJmLykAqGn2pcE/wsSMox7Yzk9cVDrcNzH81hfS2t2XFuGVNqMwGSdoJDMcg7h1qjtkaysvtbpDezygbnfcxcclgcHBOM44x61XxK423P3u5rzGOAfajp118m6NY0w/lyE9dq9OxPTH41mFDPqFubIQTYkId3QEAKrFT5fXG7271elYzSlbpXVVjOZeNrBhjnPOR3z6+1R2trZfafMtZ47VzGyRugyokHUk8tyccUouxCbV0yj4e/e3srO80V4Y/NdbqMsWJOcIT1XgjAxiuiljknDpGhgkGCHkUkcj247+4yDUUN1d2dvvs7rffswDW/mKquABu8otwGPBIJBqeSKR47stLujELGeJX2BZB6PwQfaonJt3MpSd7laztI7OyEks6ytEitNKUI3YPYLyee3b05qwsCSadK9pZu9vKzFldWDvuOcAHPybgDz0we4qlb2xiZNStdPS2mAZAssrFZV6j5gcEE56+oxnirUdrEL+LUlEjXhYJNFJ97ft5jYgfcwOuBnaMEZNEt9wk7q5nT2trPcQwa7AhKFpiMySIuOd3IwxHGAfzqPQ9OuovEE8dhHcW0s0zu5iG9fLOCHlGcR7jnC9cDtXUzxwLbGNhNbsEG53yqZ7Krfl09hW/otkbO2kaSNVnncvIyjBbsM+vFZus0mRLEOEbLqZ+meE9LsblLlojPcpkqXc+WrHqwTpn3OcVvk568/WlP5Ujd65nJy3OGTcndiZy2M8mgYxzSMBkHv0zQORUiHDGRmilHpRTGjyYW9tDc3MQd/LmkUl0JkfAXBYD+DHT0p1mt1bR26iV2s4mIWNYfNEYzkbuQGINXL62uC5lWUo0wK+cihWRlUEh/UY/pSK5to3eeWaRGw4QwhwemeB246V6d20e3zqSuU7ZZptSdUW6mkmmG62cruUMvXd2APYZ4qS0M1tbyRSrCXj6I5fZk9Qc/eIwDnt0qJtOlu9UZnvmsrYkNmEqXmAAy5xyG7cduoFaM0qXEtxHHaiMwyBY5rmVg8oHRyewwegFEnbYh+89RjWsz6YWMloZZXy1zsPlZ3fxDrjAx+FQxQsXZ5PIYowM06MQiE5IbaBk8Y7c1pXUEyRRIxXEzM8UauNhI/jxjjdim39vCxh3RqJoyWjBTzDGzdFA4J4HPWo5xalecJGGTM8mxTxIwzg/wAqzpJYLu1juyq3G9tqeWN3k7TgAjpmr6+dMkYRsOknmF/Mxg/3ckfMOMAUxk8yKTAjh3EPmM7fZgcdQck/4URt8y23FWIhMzzGZJdsMW6OVTGQFf2/vcZPoAPWrKyvujabY6JlVl2dZGOOnb5fWiWMfaBPPEESVdgQTB9pB6IvBx+vPU01Lq3hMTIhAkcKsUpY7UHXHYN9e/eh67Eq9rtDZmiJVZUeTywWKRoThRyTjuOlRQRyzZUIlzch1E0o+USE4+YqOAQD27etT20dyLiXkLhyzxthvNXaflx15yM4qNDmzu/KIaVbcmBHxlcEEsBnqBnGfTrR5Iqb1cuiEutgl2WQDQPGd8kbffzxyWAOD06ev1qOZop55wXCwQN5BCMV8gqMZKirFspuYBcG4dmMQYsowzuThSD0wODxkVDeILzUCzQ4MRCRynGdoBDDH1HU9apNIlXul1Kq3IC+ZcQvCu9YgQc7iRxkj8CfTNXLSRrKPV2eVrgzAW8MKyBC2B8xLE4HbB96eXitQyTlJLsHBDRZaMt9049Dg9PSktbGX7JeG2ZJF2lgrgN5JxjeSff15xQnEJ80k77FZZo5ooll3mOaLy3E7MCDyGUMBgZI68VYv7mOFYAEbzxHuUDd94Z5U9W28Z6Vnzb0sWgC3Ek8OJR5kxWPngkcdB1/CrUUN0+pGBpIkQRqwIUkheehPcDrmm0lqZp9CUSKpnKwRLCkSmCZXPmSEnDk91AJyBV7S7cWcMuo2JLtZqtpbRytuQOTkOen3eTj6ZqnHPuuSIo0VY8+fMkm0nB+bnB5J+v406/lSS1Eaq8cSkQwwwbZGSc5Yk9MtwCSeOn0qHzS0G4JEqs0qCWVfMn3s0ku8kOCCHHJ69vTHFUmMktzBbRWKsqDdHLkBI1Hdh3PI5+lTTWzm6aXe0jpwIlZQFkUZKkHk5znvg0tvbwWEE0aTJE4T92iRh3w2DxkgY55/T0pqyQ+bqivqdyBZyxaeJ7i5RvJxHlArM33WJHdTu3Y57cc0ty0Mez7XLN50jmTbC23BI52qcADgdeeM1auRHFA9o0Ty27D94p+88md2WGeCDjHOAAKgmSH7PdeXBFseAB43ALM5OAQD1OBQmtkLldrsi+zz2cFtFDZ4mltz5iblCodoC+Yep3Zznin28bWQjtLeYxooeF3nfEnGGKgd0OSQ3oBUrwCVWnura4jKlUYOVxJ8vJHXcOepOc+lPu0iKfZy7q/KxM0WCQR8qbsYHI5I7cU79CSO6hjinEbTtbRuohjjEmxTHt9cc7icmoDYldSt5GtZJZZS8O8XOQnycgdguARnHcVIloItJkkmaNriG4EUybWLFtuCeM7sAYBHoasKbaTTYpLWa6RY9odYjlhxwrjrjFDlbYd76Ecai4tZF3BcTL567zgopC7Rjk4U8+vepHi86V3ZJTLbxsPIiYbS3qSOy4JwOtQRxRx6zLqLTyLBc2bWXkR8pv6h+nDfhzVtoo7S1tTJOPMUbY5QCAH6KDjrknr+ZpbDaadrkOkx7RbXbt5kqxtlPIJUFhwQCc8bvvZ4PtU0amApBA1v/pEu8DBDGMLgkqOpztHpTLqeS2As45Y5EjjPnN95bZyeCT1JwThR6ZrPmvltniSC6wd2Cky53nA+YH0IGP6UWbCKctUXLW9kWO2vbp0nSdiD5MDLsC8ZJPTPaiOSIoYQYfs1xkxmFcIgZuGHY4446nHpTlmlUXBmlUmNWkEZlDN5eeSgzk4yQB7VFbLyjxZ+zXE/mwJtfzARjIwehzjHagppLcdOk0JRrVWgSCR5Y2EYWGRiPmIXOVGf/rVKhWw+2u8LSGfb5O5crbyK27HPPzc4PtUV1ZyXVtALlrnzjmVZsruwueGUcZB6EdzzT7u6ASRgkk/3JZfmLEPkDjucdcjine9kRe5LfXUllG6wi3gmuWVl2ORg/3mI4xz25GKLaO4gtoEt4rf7XOTKI+MSL3CgYAyMEAkc9anudt3BbQ3UcyqZwsrHGEQd8n3x05Jb2xVeNIY57c3UqxGNt0TsQSR1UluBk9Mdc4FQnpbqSthBJHcCRYrSJJoHRJJ2Y7yW5Ax0YdQcdcdasjzU+zxmUorbnijkQqz7SBu+mCOD7U26mSCF7hss7ADcoHCAktuz2GOvWm4QRxzwedMyruaOWXKygnGeRkH6Uty27IuLC063DPEFgKiIbSC7DAIJA5zjPrwBWOtms11IbqOSA2xKK0jZZ92C7L/AHkI4I4PHSn3MLWV1Df+WGhuWbdG2QCOmN44z6ZPbFT6sl3BcWahbe4dWeLeyCMIdu4J6g4wvv17ULTZ7kqWunUr22hpPqEhjQthQwkiclSoJAUt2IOTg9B1p19A1o6Q/wCkfbDkxMwI80E/PtI+UY+UZ6HNU4pitxdq9lGtwhD+SzgMQOdy7eMEnOSOT1NS3TSusxmuZ5IZIlMMayPGocHOPlxwRjPUHA4qtb6lNTbuQWxE1vPLtmhyr5aSJXk+VsKMDrkkdOPmrMv9UgtbCWW4b7GLcfdKhjbOQBtGRjnPXHet3VcyPBKZTdWgZYSYkDtGwywzggAHI5Pce1U7o202kC6X7S1vJE1vcwbMuOe4xzz2x096dzam+sjM+1wRCCGCeF9ibnktss0Tqc7eAAxI9M8mpv7QecTXP2mRxcKUR0j+QxsRgH/bB4/OrOi/DjVP7NtIrErp1oj5eG54eTvuGAcBuM9Dwaur8Nr/AE77VMupRNZCFpPssAYZk3ZO3J447/pTlOl/MX9ZoqSTdzOmtrnR44YNQYrN88yTSMsjRgcZwvTGcYGPeoL+9vZIZbKwe2ja5RWSS5QHdkYKq3fJIPTIzV5La4DqLeC3a5b90G84CQxnkjcc85xkEDnrUGoC6e6Mk7OvDKHkjDLvHbC9B246UotPVluSe5ZsgI5YY5mie2VQrK+4kELwI88kZ65zT5Y4zcKzyI08yv5ZlVXI+XnaO6g7cjrUWnXAn+zPJDD52zdGfLx5RPUbvb9etX7TSv7YUQtfx2tyRugaXLuWIOWHbripbs9TOpFLUpWlmm1oJ22yzkeYzMdoLd9o56jHHPvW19nE6TLMTtJMcyyomxwTjBHI2n8MGsu3sX0WQWl4beW6yE89R5f2iQfMSoOSTz2z39a0dC1CS91G403Kvd2w8/YqEIyH+E5/iGfXke9KV3quhhJqSui/btFe2b2xhZpIV/eQsh+4AQApPyk8DmodAkvfKlt74t9tSQwBUiYZjP3GTIIY4xuJPFXtPe4vrgR2kQWJVV/NJZhzkkE9jxgda6iytY7WPbGMNj7xYt9eTzWEqiS1OSpUcE4FSx0uO3+ztI8jvCpVV3YTnuR0YjsTWgPalyM+9B554rBtvc4229WIeuTik4GaXr04pDgnjtSEIe3FIeOTz/WlYZI5PFH+PWgY4dPT0oo6/WiqQjzaWYtOrG42JGucPGWIj48xmPXe/U9cYA7UyGHdfoZHaROZYYSi7FU44Y5yWxzz61Loqqlw0jmNjCrSIMEfdG7Dep4PIp07GCykknvIoLiQhombABGdzt9SOPau++tke5ZR91EaWfkSvLFYK0cChphFhsZYfKDnnAYls1VvGc3n+ho8mSYRkkoVPOdvTcOOc81YlK3V8ojBBb5emPvY5J/DIPU96nkvPNcpZNKhgYxO7qEAIPVR3z6n04FNPW5VpbdRdSSRUswtwSYVVQ7yBt/HLN/e5J/H6VZlu5Rcq0SiS43KQJE3AZ4+YZrLKsIfMUoAkmeQMtknJ/8Ar9KfZSpNNDGlm11PIx2WrSGN3dMHORzgYJGevHSs7aA6ajHXWxpan5+n2gt/MMaTEYWLG7Iw25sjg54GO1Y5RlvAroXgMbFsLksx5JbHRewFX73VYNYYyhJheI2QuV2qvHGOzDHbjrxRZi2Yyl4pjIQ+75lQO/VSf7vA96IvlXmZxjKnF861KcdlOiy3JZIoyR+53h1BxxyORwc4HHFRIqNcQtHHMwt7hvOKMQFwMnIPJHzDrxU2lGU2dzdRnaxzIZG+YHJAVNvGR1GfpVqCKG8025ku4iysybxE/wDx8DB4PPQEDmr+F6hKcmivst5LqIrLE0ipulj2Z3A9w3VT7dOahhgSIvKGzFFKdk8YD/MRwq4GWPIyB7g1bhjjuQQnlRwjljGMbMcgM2Bu54zVaWS/t9RN8xiWeOFYrUqo2xqzEs6kcbmx+Bo9GGu3cZerGl4lvdwtbOjq0hV/l2LhsnnIGR0FPluJGv7ZYdqwXPV1IKg7d24jqO3GOe1RpbSyRtLAqyeUkkmwchztP3vUkk98fjSJNdi2DHguIwqrFvdHOBzjnHbnpVWTSBuSehJJLF/Zj3F2Z7gEhSu4CSTH93uAT396siOSSWFLq3eBZVZd+xsAgFjvAADHGOnWq4kaJmu4x5FxbbQriNWCRnlpRFk55Bx71o6hcyGxslvtQkuGtmaQzRxeWbksOZWUcKRngD68VLVjKU53sjMnb713PPNOqoH+Yhi6kZAA555FbGhXSm11GJhFHLLvkim8va5QAggZHBwADishHltpZjgB0UBFY8v05BPJHIFW2nhglhhMcj3buWiM65KsVPKcnPBPX1NKSurFSp3VkUp4YY7aOW7mt4ZYpFKmQYB5GFQjGXJHc85rMub9jdi4tLaXffMyzxyxnEqgYGwDueDWndSxmSBbYwTyOoWSMDepUttz+B9+tSea1tAI8rbtbzq/mEF1MSD7xYnIIJ61pF23G1rdEMdzJI3m3r27bpj5JjXYYAAFw3ucH8sU9j56Lc/uQbYbyrZUpnglexOM8UxjYzag88HyxSphfIXghRgHOOOc9veobG3WS+TljG5LSspJEYCkg46sWxz+Y6GlpuC0hqaLRvI7IYnkQ7XMrzqw+bJJB/hUcdaqXcE0a2sskSKZBt+b+HBxkY6H6+vWrBtYdSa5aFkRLlhbu8LFwflJKZJyxXHb+97VT1SQ27rIqytJFs80qzK8i4+U4HGMYyvtSS1sONR7IYt3HHDFFLJJNabFViyqqqWJwRk5yeoHUYzUwuA01kq3cUiQuEJRjtZuSdwPPpjPc1DJdLf2tm3kIphZngkZFyD1Oc4547/nU+lr52lRm6aJUUHa0YwnHO/I+g/EcVTslqEr7jnkA1F5ohIsUi7md2wI88gIvABJJy3JOaktSLIwr5VxamRhL5a8MS3qCeSRzt/lULzR29vaR3E5G4BUEzfMR1Jx1z7enNSRziKDdKjo8h2hZAQwVj97PVSR074PapewlBvYsR3IUStOjxtE4VN+SNjHAA9SffpUFzeLCt2hdEQsIpDuwcZIKqDyxBPbpmpdMtbnUrFEsbV5kOFWaVcIp39CfarOuWul2kUkU039oX7cReSCkcYBDYdxyCSO2PQ0rq9g05rPX+vwM6Nbe81BmkhnmggmDXD2q7QmRg5OcEngevpVK4j33bSiIxpvYKnG6Jey7jyfqal1S6u9YaeaadUt7dQ81vChBjVW5UqpAB5PU5q1mC0urq2drdy67GjlQMYTjK5Y8Ele3Jz3ppNGiqKOiWpWtbeCG8iaeOMmRCUwpkLY4kTHUBepPfGaupOsSlrT/SVVS8IhYkyhRncfTkAAGs20kSN7wosKxrJ8uG5EeAQpc87iSD9Dj2q0moQzSw3UgeNXKyRSvJjczAqFKdl56nn2q3HUyk29RLESz2WZoXdWRp5JFxwHOdpH8IBIXHfmrVw8lhbRzJHEdOinG9niI3sW2gDPHynrVC6W7tbTDtHOkcSxbJG8vzzkEqxUZ4xx61bt3MNgXaYsDKGZZCpKljluOh2naBj0HWofd7A9S1mX7HcRwTLIgkG13UNljn5XOM9+w445NJHCN9xDGC8qMMmaTl2wSD+WMkClu4o1don/AHSOrsJTN86kDneD1PU5FRzEvsKecZEkQea42mLbj+Lqd3TvxUrYnzRNboL14kvFjVNn3QoIMgwyn6DBHvu5zUVybWPVdShaCT7Ohj3sG2pAihVBOe+TnIAyajhkDPazW0KSmTIDSkIQDuyMdvoPQU65uI7S5CwWsEkssPnIZpSiQBUKMzdioypAPPII701uDV3oW9TtWaNVw0V8kiTeWS3kMyEkHbnBJBJyOc4zVDUiTHNBJHdxgsZGdSWAO0f6zHQ7TxmrFtcQ3egTlHkcRW8bn5w8gRcFJlUZAbs4z270X0ltaXUd9b25S4vnRrgxHKOiLjeB05DAVKvexKum11KLo/nQt5c9yrAp5yqH+UHlc5HXOfao3d40u1uMzBgsSonynDfdKluA2OPxq19l+1TeZJBEkcR3GPHI544/DNFobiaeCfTY7gpJE4lV8khiSAF9D1PtjNO+h0qyKlrYm5toJPKkQ5y7SEo3oA+M4I9Rx3rrvDnh8pdrJcRxmBB5gby/mdyePn68Yz75FUdF0ybUWuIm+0wumI/te4Oo6bh/tNgnAxgHBrubWBLa1igjZ2SNdoaRtzH3J7msKtR7JnLicQ4r2afqTMc8nkk/nTQO2OKX0o9OTXMeccV418Jf2rAj6aDaXkUjXEbxKuxnPOHHfJ/+vXNjzbm2MS+VbatEoWaPyflnTPLRluQRweD16jB49ZPHtWZqOi2WoSGSZGWUjG9Gx+OOmcV0U69lys66eKaioT2R54yq16kVsn+tbJjkjMOCRwVB6jIzgcjOKlsNEl1GCaFZbqynA+RmTAjcHhl74PXB/Su8ttEtYWjcyXMwjO6NZpNyp9BitAxDCmNVVg2c46560SrLoavHNK0ThtO8O6pLaWceo+WsqtvkdOAp7lRzjJ5GD35zWz4Y8LxaLbMZLiee8kJMk5bBJOB+WAAK6Pjj06UH86h1ZPTucs8ROSsMiRYokijG2NBtUelKe9KQcDBxR04H41kYMCATSf5NKaQ9P14oEJ/nmk/zig889qACeB9KYxOSPU0oRiSCMAYwc9fwqVVA+tLSAYEx3op9FMR5jZlJDvhnSD+GQSbiAvcqPp+tVWiEl4YpZvllZ8lSD8ud2BnoTxUBmHmwCSRD5bBJGYbQg7g/07cVeSYOsi29vDd2gPmx3RXGEIwQPfA5xXpWZ78t731KixGSN0m2REvlgCQrgDPXOewB9fxpVnSApIYYSkjfu2mHLHoxBHbn8KS9jX7CswkeFXiJeIOoGAw5Ykjg/wB0c9zxUeGktkg8tpY3JO4tyMDnA5yPyNLzNYWl6F22nhtWf7ay3EMx3eVzGFOMEHGScYzmlliSwWZmnVUkzE7RksUiI5wwGR6Z4zWXNc+W8xSY26KgXE7hl44BGOeRjj2rStYLq8NtbWT209/KVkLT/LG3GPm7n5T065qeXqwklT1uZthFDBaxS6daxuXhDKHdiXwf4jwd3rj6VftNUuhfR3QiS0mQL+4AAAk5Xj0ByOOetJLI+oXN0ljJLHJYqV8iXG+QKfmO7r8uB04wfaqpvWktVjnLfOxkCSgZXIxtLAZK/Xnmqa6NERk6vvPfYsWLGyj+zqzrMitE0OAArhjkNu6jkEY+gNS2t3El3ay2UQzEWAFsPlfGRtIbhVznp096rz30klsRcgxu/Emx9wQgEDBxk+lNMoWJjGkRRUISJUwgGOOB6nk4o317kcj2kMhTeryoXitixeT5PlJHTPr7HNSom1Xd3VpC6lFGCDjnJB7dKZHI/wBngZJCUHAiSTKZHUA9cg5HPNOmSLCSyxMQRvAUYyB329SM8ZFJ3bOnRR16liG5kkjZZGMcG8yExp8p9mHOQB+tQSMFdo1kChs4c9xjHQc1Xd4hIFuTIgQ8S8jYfTI9OKW2bzYnDTLOSxV5kJGWB53A8j6U7aXJUVGVixNutoE2CGK2SMbsRbtwK8AAc4Ht71PZm3E8cszrPbiIZZHZSQx+6cjjHX3qlNdTEwrbTQI2QgyM5B5G0dM8VoWmoJ9lmsUhgjtpirMZGO/cD8rO/oe+PpgUnexk4W0sQ3LJ5jKChYhtu8ZxHnnOOvbvSXb3FxaJFYssTMqRyXCx4fYzBfk9O4J4PFQs7RmE3TjG/biPIWTJOVAzkfXvU9xYS2EM8xaVXcRpukyQytgqxH0zTjo0TUcUkhmnQXlvc5soo7lsSF4ZVUN5RBU46Y6BsCpy/lSyLcHagUhiF4Ofb0qpq8S3ASOFoi5laE5bjOOMkcj/APVS6Vbi1l3JvICjIncvuI65z7cZofvasIrlV+5eJkvktQXEU64C+W4K9DhcDuBzg+1R3Fs2l217c3Ejr56MsQDEymMLnAI4Q59M4HHeodPa8e3N99mWSZphFCAN5ZyeFCg85GfmPpVy8vP7RSSyu7i5lfdIn2YbSyOCNyOp5ClNxwMADJzyBQlZ26GM59FsVbOKax0my+0x5uJTI/ylVWJSpI+U8sx5wRgdDUccIto/LmSdp1lbMDEkBnGWK5z8uOOeOOBVqVxLPJKzJcSCLZH5gIYxAnBx/COP84qGzhDyzmOI/aXj3yNnbEmwffOeFUDqT1603K92yop/HILiGOCRZpLd9yocwKqu7kDgAHjPJoijm3RQ+XJJcTKCtpnGCOQo9SB17Cpbq/tdNZzBGNUlt41kU5xETkfKFJyWGcljgY+lIfEk1zqV3LDHb2mSgZYoSxWNlyWDgA89MgjmptJq6Q+aT1tobNn4JkWae71ueBI2iOEQbvLJOWOfXGRkc80sjaNo1q7aBaLf3hI3z3LGbHODkk++OOlc6dQEhu7CcSCK4kEcsM0jOCfvBhzkEe3XvVd7udFfyVxJ5reWY22b/fGcHI5JP86Xs5v4mZqlNv3n/kW9T1zU9VgETSixU7kEFsu0SbeQA3TBPODR4dsbK6aLzbqeNkJiEKuGAdju5GByc4HUcVUnu7mGzucriE4cLKN24kj5RjjgA9fWq5jkn1AzW7G1QJsMbKN6P1yrdCeQeOxrVKystEauGnKtGdH5iR6W5toQY5TLtSIBd43DbnHfHrzWfauxjia/kYFSclkAeMnk4PbHr0qaHUJfIupb9kmhC7iki+XsdeD67g3BwaxrK/u767NugS3vJ4srvjLDyyfulhnAJx8x4BHNKMHZmSjvcvTy2N/eRCwlAllKgRjC+YwGSuMcgZBI/lTr5AzraXihRMyklTtk3KMggDqAeT9BTrK5mtrRZLaOGNIklKmEh3eYDlc44Q5wCOTjvV7S7qDVmaO5iP2tYg8BiLHyo8HGMcnoSc8UNtarZBKWnoZlo9pDcagYp57a4LqkySMWV2ADNIB/C52ngfjUstxJeWtrBNFJFKiqjoY8MYz8wy39/B5YcA4FacelXnnN5qmUIPl2lehBbIJ6kE5Iz3rPaKwSy+2XRM08SMsYUnMS5+bLHsTwAKnmTdxq3Ri3CRiUSKI1VpF5kwx2jge+ck4z61de9XYymNoMyZVGcMxOOhxzjPIFZwmk2XC3ESCOIBpMHcB6DPVj0560hjE9q0issKoAu8DMigAZ256j3/rSa0sxuK3NFwjPC0zqsxkBCxnh8Akgg96ztRtl1bSngR5LO/t0+zmKRfkkBYEFOMbgQBx1Aqa6ldbhBKEhzyzn7zSZyceowfrmiA+ZHPFdAOpCsm8fu5ATkKMchhjORjmhaahZr3kUfh9Na2ms31mtj9nJgMLLtwr4fDqQfXk5JzjNbeGuNQ2MirAwdI9jbgV6qvP3SOO/pWXpck0WsSSTtd+aI2Zd2WVgRlGI6FuvPfNTuWihtHZltGikRo2eTGfkyXI9Dxkj/wCtRU1lcpx55uXVj4h9qmeMbV3yKwdGJUqv159P1rVgiE9ukUIEUxjWNYiu0MM4Hy9McfrmoBbvdHT5dNsyZnOzaFKx7xy7Z6bSD69uK7DSLBrWaaSSGJXcDLI27c3A3ZPOcBR26VzznZGVeqox8zQtozDDHDhfkQDKgAMe/AqUdeR1pgYMeM8dqf8AQ1zO7PLEPWlPHWkHXjpS9sGgQhox0xR9KD0zmgYHvSY/+tR0680HnHWgQmcnnoDgc0vFH/6qT19aLAJ39qXHPOfSj9KD+lACH68UmPSlKkg8lfcdaeBQIaE9acOKKKBhRRRQAUUUUAePNFK6q8UyqylGB3AiQgbWDJjjmi1lQzSPJsSCJ2VEQZUA8AsByBk81o6g1n58lxawvIZht+VCAp5Dt9ME4qmtvPvlkt7bzYCiESBwoyMowKjpgYJzXqaNHuqTb1IpLdEIWdVEC52LIC28+pHbmiwgbz1TdGrH590jfKjeuM8jtimOUFuN06eXGN7FCWUJjJ2jn86a0cE0Mq280TlDudlTcYy3Qk9sg5pM6UrLcfcl/N8qaJQWQgK0fJx/Fn9eae2pJZ6vZ3l0Jr1I2VpBGSHAA+ZgPbr747VNcQzi0jMwe4ih/dxLvyRnqoPpxmojDNJb+ZZaddXdwjqx8hWywz0PHA/nUobcbXmQ3l5E2k299Mj/AGmVAklrCpGA5yHPbpn5fcmqssxMRWLJu/L+ZTnlfUDpj3rRmheW5XCLFMXzsOQc9MfUdKbcxmCRWuc2zLvUM2MBRjsOo9arm2M4KMNnoRW00TxJCFV9xL5IJ2nGDz2+nvTYLeSWeFo/3UVuqhmV8oBnryOehqSNGSIxTuryKSWMK7EZSQE3Z5z1/A01YrjN7BYmK3u+NiyE7GJwQozyAwGPxpra1xS5W+ZdSLzmnmaRWKoQxVlUIpU/xAcAseKlczyW08GoSLEcAwyM+0qhYbgxHY/lTJLW6EVuhXyFddz28rg4Y87Se2MHmrKQpG5KsrbyQH5kyD1yP8ik31NNGuVIplFJa1lfOVO4yZAOPfuDjNWYr6a0tjHDHbifzAyIkYYNk/MGJ7kcZ688VSuIozFLbIHR0UzRyuf3Qf8Auqc8Dv7Uywml8+eW0nhefK7I04JYd8ng1pGKsY1Zc26Na2jt3vhMi24Zl3RtJwTwTtX1PXA/Gqct5PKZrzUnM0aHaYSquOowQRzt7kHnIp7PJ9ngm8guh82KSdTlYyDwP97GRUKKZFSGFiEGWVDgkH+8O/4GoatuEIqdm9yYgTx3FwkrRySRiSOSQ5C4PTYePYelWIL2S5s/mZ2eHbuUnqRxlfYVn3E5EaRXEgZpEP7wfKW/w+veo7pn8q3ZzdQyKqq0Yb95huue+QOKaV7XHOnbbU0Vuo45QpjwiON7M2wBj0Of4fTPqKtXLFojh3ikHp8wJPGzAOAeOprMWe3TTpLmRnCKVj+ZfMDKPu8eozznnmop7qOHzD8kWUG4luEPXjHXIPTJqHHXQqnFyWpo2ckUTXkczhzdhIIsgq65PGRjPB6H3qlpk7wWd5c3+7zruaRbmTBaSYBh0YnOe2O2KteFHebWDG8IEYR3WZXwMKpbBz2BAzXO+HpLi5tnSW3fMW+b7QVwuxm5IPrn8K1irp/Iy5FzNM19Dm02yhMWvtdrLCUjhSEGVyMZYH0HpngE1ae/1C8MtvDELDSxISILYZ3DqBKT98kdu1Z1osrrBG0bMZPlLsRvAznBH97+lVY7Hdq8T2ksyPt8sBH++2cc568dcc+lJpN36mipx1lv+hbuMsUjIji8t+DCwdUGO56nrgk9KqSQIjfZlbZ5hLec/KnHcD0P9Kmn2vI6gpEoOC2eQTzgZqvPctPp8ZiEckyOP3cj+XlBkYXI4PPfrThdlTSjtuX1C3LBLpsyAlPMc/KvH3lIyRx+dZmjW32Wxawu5jOIJC0b+ZtDgnIwfY8enNQXdlOkCCP7QZgS4y+FQDjOB3NUvMkhvLOBFFxcxxsDGjNt2jJGCeAT156Vfs7q6Zany3T2dvwOijnMCu7iXzCQWUvk5PGAB16cmliurYylFHms+SCwJ2HAGCe2cDp6VlRJOYZJpFSO2lUyFmIOOcAEenB5HWr0EzBVkCCNWwAgwyoD2/rn3qXGxmnzu5bjklTI2+WSjqY0GehBzu7EAcE9asbDM8RaUsQSJfmCBkOCFZR1XuazkkG5o9yqHb+7xGBjILe/WtHCPGUe18y2YfPuYKSh6hSOc+5pN2MXDUNReaBrePy2lPmERZcqgzk7jt5YjAAH9K05byWO3mgUoIpvmZlJVWI6Rlz/AA5ycYA71mwPbNeLLPNOiW7bUU/MgAHytuHO0DjA5J603UtPBSKVZYAkhIidWZw3y5wyYwOM5yfpUtJtJmco2V2R3NzGt1NbxvLtjBfYCCuOARx27AgetS3N/EsUlxEzK0Efm+VEmMoOMAY5/CogklvFCUAlM+4pJ1SIqcbQOuSc/wAhT440WeKaK72zszFopOm0ptKD0G7B+oodildIlkuPt0e+4kWOCUo6xxx48rA3fMOuTnJzUliXnbzZytuGYmJN2VZOW3EjouB196WwhLW8yCBhcSRmFjHyAeGKt7EZ59RU1ki3VvMY2RoBGI0bBCxkZHl4wBxjFZyaKiuXbYgZ4zc70UK8pEm8pvKnJ3YPc/rirzKTPCRLi3dzulKEFMYwB+OSM4PNNgto7K6soLxXt7ebbbbFTcCnAJJHuwwOvWt/wdpN1Lp93Bqbx3Fulw/kyvEMuNxyMjrjGM/rUykkrmdSrGCMS3kd3kN8FkiWPbazxZ3qSxJUjHB44+tbmj+D/wDiYC71RzPDsDeTIgDF+chuuF56Dqa6+G3ihWMKgJj4U4GRxj+VT8EZrmlWvscU8XJpqGg1QEjCIoVVAUKowAB0FBPI9PypelIMZ9qxv1OQRBy3GDn/ACaVvw54pQPyoPJ9aAuA4bHWkPWiigQfnRRRQAUUUUAFBHFFFADRSgfnS0UAFFFFABRRRQAUUUUAFFFFAHIz+H0s9PaSa5vUJJbzljDGFOCd2D/LqKqQeHr0WyyW0MJG52EkUnM6SAZbB78A4Nd9wTzQeepz71v7aSOtYqa1Z57qnhi6e5ihsI5okCcKgCrtH+16n0/KoE8O6nCBut/3CHYEjAyxJ/iPVgPyr0n2HOKRhwTR7aVrGkcdOKSsjz1tJu7FpDeIix7gQ0TEjjoMEdc85pDDqKRL/Zlw1rcvlI2jLs24AH5sjDZ7noPavQiqtt3KDj1qtPYrKUaOae2KZAMLbc59Rg0va33QRxf8yPPf7MY4XUHubya6GDOv+1kZAOAO4pF059Nuxa3KeZE0BiUPwcEfKQT0bjp7V3VxoWn3EYjlhZgowpLsSvuOevvTLrRYblnL3Fz8ybPmw2BnI6jnHQVcayRo8YpbnmsVm5hAlRmKrjzuVbCn0zUUdjezyLt09FhkLTSX7MV+YEFVVT7Ag8dT7V2l74YuUiMkMv2qQNjyzwSn1PU/kKqt4Y1O5tI/PaOCVCV2KQ3yg8YJ7ke9aqsjodem0pcxyi2oKJEsoS3JIM0vzN97LZA9T361DdCFnjyTHh2EYRTlvTP6VvX2h3UFyI3tJ58oACseQAc8HHU9vashYo5pLhGmRChKhJAV+YcgY6k8VcZX6nQqkXHmiyo0lw0PlmKJNwIIVQF3emPrVd7QSxwQiBFRhuUIxCRtjLe+OKvKI5Lj7TKzLIZGCFgQoBHf8cYzUiMrea6guifK0qr8w9VUZwee9Wpcuw201cS41LzVNqjxCZI2aSKNsNsyMMUzg4656jNVXnL25Cssrouzcq45A6/nS3FuZoylv5bSRECRsAFVbPzeg5x1NSlXMFvCkaISFDFRwx69exP6UOxUVyq6Kc0K5t5ZoCszBTvTLsSDwFB6AHJzUUcJlnuGMkolyGEhXcSBkZyfet02i3MizhlZ4JFZVkydsT8Ovv69+RWW8ZiaTy5vMCMWwcrkdue3ApqV9jOMtbMrNDMZNPJSWN5nZTgBoQAV3E9t2CeD6ZqxqMcaQNEbmT7VbXLREAA7IuoA49MY79abZxW9zBdWcvmNEQWkErbRHIF+VhjsMjmpEtZ5nOqzRrHFKzebFjLJIuA3OcYPXn8Ktuy9DJS963mO0JZY72HYTbmdgYjMpVQGbv8AiOfrRo97/at9rtqJnEFvMxE2wq6iME+WynPyfhxilhiW3Ecs6FbOCZZSithiT3Pt/hRpsTp4nMkFwq2luTqE078rOmCo2/3mLELzU2um0E5Rs01r/wAEpQ3BeB4rmQSSwESll+XeD83yt9KryCO7kVrVGkiDruiU5bYx+8fUZFa8NoJIo5N7QqS/mhdpdTyMKe3GKzxIZYmZEU3gILpbx5eZAdpUnsQT06c1UWr3K52tEUNRltbiWZJbpfLBAjgRTufJPTHYYxknvV6201QiQ+ULgZXaWBVmzjGSe/PWnwRnYEZCywqdsJjUAL1OT71bihjikjSNCse5EjeJAQuMMQQOmKJPZIFKV3fYzApuL1ppHdZRvV0/hADEfKB0PbmogZZUjjso0S/QGInqdoP3jz0K1v3GmfZfNe2gQTTHJlkOWdsbsn25zV2DTLq401lA2vLC26aNAmXIxGmeTgEMfxxS9qt0Zup7qbObgt5IbORLiSCW5t5XEIC7B5TYIRh1IBBOfU1NcWsy273C2joYSsixHLblI5IPbnPDdRWvBYB7sXEyxmTnfHcKSHGMH68446da1Y7KZWLKhe3vYHjuY4Q2+Nv4OCegwv0PB60nVJlNw0uc01vMJJYWgdnklYCNQAQo4IGOuOv6VoNY3Uc9oYD5kMtvucZwFfnK54weO/GTVgWt3bLI5EX2pOfIEghYJjknPU9emeTVkwMtvGyoBYxRJLuYBZEBJPKHqAcnPvms3JjlJvS+hmG1s5h5kKF/JUCKFwVMZdc4ZhwcZ9PypmkxXVvqBCN87oYisXKnORyOjDoB9c10dppc9xpcssFrFNAxYiOI4Z845HsM5z35qzpvhe7+ywgpFbttKt5uSy8nBAHG7HIPriodVK6uQ6kYr3nqciGid4rSaRHEEhWZ4mwUweEXj5jng9D6Vckhjmka2kzDdwcAuAHYY/2hyOnTnNdjYeC7C0uY3k3XccedqvyxfOfMZuMtWzJoemy+W1xaRzyRklZZfmcZOcZ9O1RKvHoZzxcL3WpwWl6dqM0sRVUDMdmw/KFU5B3cYJ4HfPB9K6OHwzJcpN9snlH2hCjMrbSmCSp29CSTn8BXTR20ERJihjQk7iQvf19qlGBWEqrb00Oepi5y20Muz0O0tp1mbdO6R+Wnm4IQYGSB6nHJrSjjSKJI4kCRoNqoowAPSnnpx1oHTNZtt7nNKTk7sQ0Dt/Kj6UvofWkIT6Z6UHjrRx0xQfSgBKKKKBBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUxn/u8mgB5NFR5yc5ooCxZ6Uewz7UAc80UygHXP50ds5zSn8qQ8N15FAB3pB1Pel9RSDpzz+NAgPI9PfFHuKCfzpOxNJAIeck0p/zmgdPegjpTABkDANQXFrDMymW2t5Tu3EvGDg469OT2qfnqeKXtQnYa0Mm70KwuGdzbJ5khBYgkD8qyNZ8HR3rf6Pd+RGx+eN0yhA6YAxz7mut+h+ppOvGatVJLqawr1KbvGRxFr4FXlrm9CsRtIjj+VhnOSD71TvfCtzaI0dpbG6DElHifaUPYMG46DtxXoY4x7UYqvby6mn1ure7Z5v8A2LqSia3a1kV1QFCvJPBOMjjr2z1rIl0640qZYrxDau5MnOD5ikZwO3U4x/jXruT6mo57aC4XbcRLKoBA3DOM9aarvqaRxrvqjyt7dk/dMqyhVJkZzjKt2b1PTA7VektIP7LSe1lYKkmZkjXcChGFbHcV3raRp7QxxGziZI8hdwyRkYPJ9qlTT7OOGOKO2iWNE8tVUYAX0GOnU1Xt0EsUnsjzGWBoXl2QB7ePC7t2TjHc9earTW/2aLyI0jubEKH4G1opc8A8AbRnr1zXfaj4Yhur0SR3MlvAY9jQxgYPHU569KpJ4OSSCdLy8LF2XY0IxwP7wOQSfyq4149WW69Nq7epx0pxNcXEixKWcuu7JUhT0J/E/pVOxQX1zAqALBcMuCdwZMN8oPQg5AyO9egP4Mh8gxwXZViNu+RNxHrkDrVjRPCFlpt+l7JIbqZeUMiAbX/vD6DoO3Jp/WIpPuVLEU+W8WYNp4Q1WS+Zbz7LDG7EvLF90pn7uw9T+ldDY+ENLsg/l/aHLqUO9xjBbccADAz/AEroupoPXmuaVaT0OSeIqT6mTcaBYXOfOEvOFIDAAr029OmOPWp49Jslj2NAsny7SW7jPT9B+VaGOev1pD0PHtU88u5k5SfU52/8N+b9pFrOscUsboI2U8Mx5IbsMdhVOy0aUa1NaS2l2kCwhxqIMXlSkjHlhAdwYdckc9a67Hc5zSYxn0p87tuW69S1rnOv4YheVlacvbMoBRxk7um4dhwPzJrTs9G06zWIQWUOYwVV3XcwB6jceenFXxx2+mKXPqPxpOcn1IdSUt2RwxRQLthjSNe20dKfgUYOcUdR6elIm9w4HH50gI7HrS/lijtSEJ2AB6Uv9aM5/wAaPegBe/8AhSHocdaBR2oAPxoHGe+KSg5+vegA6CkpT0FJTEwooopAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFIzAfX0prPx8v50zPfNAAzbue3pSc/40e386BnrTAXt796KB3x0ooQalujqTk0E5I+tB4YD14oKFPP40mevH5UGkxQAcnnFH9KCeaCMY96BCHr0oJ7A4owMfSgckUAHAGc0dTxQRwPrQSR+FIBe/HekVsjJBHsaD1NL0IxQAnY8ClPTBNI3Bo/xoC4Hj/PWk5ob7p9qP/wBdAAOtG3rk5zSA59OtKfu5oGAGfpmlxTc/KPen4+bFAhjKD1GaFXtyQOOaUdBSjoaBiDvTuh4oPUCjpnHrQAA89qb1I9KUnk0Dr9SKNgDoKO/NKPmOD0FIDgkUAHuTzSYH/wCul9KRuPzoAMD8KOOg7UDvSDq3tQIUetKOnIpAeM+5FHYe9OwByPrTATnBIJ7e9OzR0zgDrSGHWl/Wk7ClHU0CDHXOP8KOuMUmelOYYH4UAIPu8/nSD2OKQevrSg8H86BAaSlPWkoAKKKKACiiigAooooAO9FJ/EKRTyfrQA6iiigAooooAKY7dhin1ERnmgQ0e3Sg9+1BJoPJP0pjA+4oHbI696TOBx6UdRQA8fQ0UnfFFIL2P//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A lichenoid (band-like) infiltrate is present in the submucosa. Subepithelial clefting is also evident.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Dr. Bethanee Schlosser.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Oral lichen planus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Parakeratosis, apoptotic keratinocytes, subepithelial clefting, and a lichenoid lymphocytic infiltrate are present in this specimen of oral lichen planus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Dr. Bethanee Schlosser.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_54_30570=[""].join("\n");
var outline_f29_54_30570=null;
var title_f29_54_30571="Uveitis with systemic disease";
var content_f29_54_30571=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F55902&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F55902&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Systemic immune-mediated causes of uveitis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Ankylosing spondylitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Beh&ccedil;ets disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Blau syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Crohn's disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Drug or hypersensitivity reaction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interstitial nephritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Juvenile idiopathic arthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kawasaki's disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Multiple sclerosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neonatal onset multisystem inflammatory disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Psoriatic arthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reactive arthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Relapsing polychondritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sarcoidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sj&ouml;gren's syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Systemic lupus erythematosus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ulcerative colitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vasculitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vitiligo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vogt Koyanagi Harada syndrome",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_54_30571=[""].join("\n");
var outline_f29_54_30571=null;
var title_f29_54_30572="GHB product names";
var content_f29_54_30572=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F52665&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F52665&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Products containing GHB and related compounds",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       &nbsp;",
"      </td>",
"      <td class=\"subtitle1\">",
"       Gamma hydroxybutyrate (GHB)",
"      </td>",
"      <td class=\"subtitle1\">",
"       Gamma butyrolactone (GBL)",
"      </td>",
"      <td class=\"subtitle1\">",
"       1,4 Butanediol (BD)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Chemical synonyms",
"       </strong>",
"      </td>",
"      <td>",
"       Gamma hydroxybutyric acid, sodium oxybate",
"      </td>",
"      <td>",
"       2,3(H) furnanone dihydro, dihydro-2(3H) furanone dihydro",
"      </td>",
"      <td>",
"       Tetramethylene glycol, Sucol B, 1,4 butylene glycol",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Street names",
"       </strong>",
"      </td>",
"      <td>",
"       <p>",
"        G, Gina, Liquid Ecstasy, Liquid E, Liquid X, Georgia Home Boy, Grievous Bodily Harm, Fantasy (Australia, New Zealand), Gamma OH, Salty water, Soap, Swirl",
"       </p>",
"       <p>",
"        Names referring to sexual effects and/or use for sexual assault: Great Hormones at Bedtime, Easy Lay, Scoop",
"       </p>",
"      </td>",
"      <td>",
"       GBL, Lactone, Furanone",
"      </td>",
"      <td>",
"       BD, One4B, Fantasy (Australia, New Zealand)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Pharmaceutical preparations",
"       </strong>",
"      </td>",
"      <td>",
"       <p>",
"        Xyrem&reg; (US, sodium oxybate)",
"       </p>",
"       <p>",
"        Alcover&reg;, Somsanit&reg; (Europe)",
"       </p>",
"      </td>",
"      <td>",
"       None",
"      </td>",
"      <td>",
"       None",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        \"Dietary Supplements\"",
"       </strong>",
"       (Note: supplements have largely been removed from the market)",
"      </td>",
"      <td>",
"       Oxy-sleep, Gamma OH, Genetika, Alcover",
"      </td>",
"      <td>",
"       Blast, Blue Nitro, Blue Nitro Vitality, Eclipse 4.0, Firewater, Furan, Furanone, Furamax, G3, Gamma G, Gamma Ram, GenX, GH Gold, GH Revitalizer, Insom-X, Invigorate, Jolt, Nu-Life, ReActive, Regenerize, Remforce, Renewsolvent, RenewTrient, Rest-Eze, Revivarant, Thunder, V3, Verve, Verve 5.0, and others",
"      </td>",
"      <td>",
"       Amino Flex, Biocopia PM, BlueRaine&reg;, Cellu-plex, Dormir, Enliven, InnerG, Liquid Gold, N-Force, NRG3, Rejuv@Nite, Rest-Q, Serenity, Soma Solution, SomatoPro, Thunder Nectar, Ultradiol, Zen, and others",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Cleaners and solvents",
"       </strong>",
"      </td>",
"      <td>",
"       None",
"      </td>",
"      <td>",
"       Beta Tech, Bravo Ink Cleaner, Contact Cement Remover, Miracle Cleaning Cloth, Once Removed nail polish remover, Paton's (non acetone) nail polish remover pads, Tonercleen, Verve 5.0, and others",
"      </td>",
"      <td>",
"       BlueRaine&reg;, European Cosmetics, Miracle Cleaning Cloth, Organic Hurricane, Phantasy, Puritech, Rejoov, Thunder, Weight Belt Cleaner and others; also Flower Power \"plant hormones\"",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Other products",
"       </strong>",
"      </td>",
"      <td>",
"       GHB recipes available on the Internet for easy home synthesis of GHB using GBL and NaOH or KOH",
"      </td>",
"      <td>",
"       Industrial grade GBL, diverted from chemical supply companies",
"      </td>",
"      <td>",
"       Industrial grade BD, diverted from chemical supply companies",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_54_30572=[""].join("\n");
var outline_f29_54_30572=null;
var title_f29_54_30573="Lipid levels with aging";
var content_f29_54_30573=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F61522&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F61522&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Change in lipid levels with age",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 397px; height: 250px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Changes in plasma LDL- and HDL-cholesterol concentrations with age in men and women. LDL-cholesterol levels rise with age; this effect is initially more prominent in men but, by age 70, LDL-cholesterol levels are higher in women.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Heiss, G, Tamir, I, Davis, CE, et al, Circulation, 1980; 61:302.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_54_30573=[""].join("\n");
var outline_f29_54_30573=null;
var title_f29_54_30574="Preconceptional counseling questionnaire";
var content_f29_54_30574=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F55575&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F55575&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Preconceptional counseling questionnaire",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td colspan=\"4\">",
"        1. Are you considering getting pregnant within the next year?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        2. Are you currently attempting to conceive?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"4\">",
"        3. Do you use birth control on a regular basis?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        Type of birth control:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\" colspan=\"4\">",
"        a. Condoms and or diaphragm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\" colspan=\"4\">",
"        b. IUD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\" colspan=\"4\">",
"        c. Birth control pill",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\" colspan=\"4\">",
"        d. Depo-vera or norplant",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\" colspan=\"4\">",
"        e. Other",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Medical history",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"4\">",
"        4. List all chronic medical and psychiatric conditions for which you have been treated.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <p>",
"         &nbsp;",
"        </p>",
"        <p>",
"         &nbsp;",
"        </p>",
"        <p>",
"         &nbsp;",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"4\">",
"        5. Do you take any medications (prescription and over-the-counter) on a regular basis?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        List them:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <p>",
"         &nbsp;",
"        </p>",
"        <p>",
"         &nbsp;",
"        </p>",
"        <p>",
"         &nbsp;",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"4\">",
"        6. List all drug allergies.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <p>",
"         &nbsp;",
"        </p>",
"        <p>",
"         &nbsp;",
"        </p>",
"        <p>",
"         &nbsp;",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Gynecologic history",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"4\">",
"        7. Is there a history of any of the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        a. Irregular menstrual cycles",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        b. Abnormal pap smear",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        c. Uterine fibroids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        d. Ectopic pregnancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        e. Gynecologic surgery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"4\">",
"        8. Have you ever had any of the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        a. Chlamydia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        b. Genital wart",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        c. Syphilis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        d. Gonorrhea (GC)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        e. Herpes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Prior pregnancy and obstetrical history",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"4\">",
"        9. Is there a history of any of the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        a. Recurrent miscarriages?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        b. Stillbirth?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        c. Low birth weight?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        d. Diabetes or gestational diabetes?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        e. Phenylketonuria?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        f. Neonate with neural tube defects?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        g. Neonate with other congenital defects?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"4\">",
"        10. Please list all pregnancies below:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle5\">",
"        Pregnancy (date)",
"       </td>",
"       <td class=\"subtitle5\">",
"        Number of weeks pregnant",
"       </td>",
"       <td class=\"subtitle5\">",
"        Outcome",
"       </td>",
"       <td class=\"subtitle5\">",
"        Weight (for live births)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"4\">",
"        11. Have you received the following immunizations (or a history of the illness):",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        a. Rubella (German measles)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        b. Hepatitis B",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        c. Varicella (chicken pox)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Family history",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"4\">",
"        12. Is there a family history of any of the following?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        a. Tay Sachs disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        b. Beta or alpha thalessemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        c. Cystic fibrosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        d. Sickle cell disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        e. Epilepsy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        f. Mental retardation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Habits and exposures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        13. Do you drink alcohol? If so, how many drinks per day (week or month)?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        14. Do you smoke? If so, how many cigarettes per day?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        15. What is your daily caffeine intake?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"4\">",
"        16. Have you ever used any of the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        a. Cocaine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        b. Heroin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        c. Other illicit drugs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"4\">",
"        17. Have you ever received blood products? If so, please state dates and type of product.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <p>",
"         &nbsp;",
"        </p>",
"        <p>",
"         &nbsp;",
"        </p>",
"        <p>",
"         &nbsp;",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"4\">",
"        18. Are you on any special diet? Please describe.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <p>",
"         &nbsp;",
"        </p>",
"        <p>",
"         &nbsp;",
"        </p>",
"        <p>",
"         &nbsp;",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"4\">",
"        19. Do you use any herbal, dietary or vitamin supplements?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        List them:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <p>",
"         &nbsp;",
"        </p>",
"        <p>",
"         &nbsp;",
"        </p>",
"        <p>",
"         &nbsp;",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"4\">",
"        20. Do you exercise on a regular basis? Describe type of exercise and frequency.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <p>",
"         &nbsp;",
"        </p>",
"        <p>",
"         &nbsp;",
"        </p>",
"        <p>",
"         &nbsp;",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        21. Do you have any cats?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Employment and occupational history",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        22. Occupation.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        23. Are you currently employed?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"4\">",
"        24. Please list your last three places of work and your positions.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        1.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        2.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        3.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"4\">",
"        25. In your daily work are you exposed to any of the following on a regular basis?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        a. X-rays or radiation?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        b. Radioactive substances?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        c. Solvents?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        d. TB? Date and status of last PPD placement?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        e. Needle stick injury? Hepatitis B status?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"4\">",
"        f. Other (please list)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Joyce A Sackey, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_54_30574=[""].join("\n");
var outline_f29_54_30574=null;
var title_f29_54_30575="Peritonsillar abscess";
var content_f29_54_30575=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F69943&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F69943&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Peritonsillar abscess",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 397px; height: 259px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A large unilateral abscess is visible in the pharynx of a patient examined in the Emergency Department. Prominent swelling of the anterior pillar and soft palate is present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Lawrence B Stack, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_54_30575=[""].join("\n");
var outline_f29_54_30575=null;
